"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties"
"CHEMBL1569918";"";"None";"307.35";"0";"4.42";"SID85285581";"Cc1occc1C(=O)Nc1ccc(OCc2ccccc2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1097841";"";"None";"527.84";"2";"7.13";"12h";"CC1(C)C[C@@H](NC(=O)c2cn[nH]c2)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"10.36";"0.21";"-1.66";"6.84";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL519584";"";"None";"420.38";"1";"5.21";"16d";"CC(C)(C)NC(=O)N1CCN(C(c2ccc(Cl)cc2)c2ccccc2Cl)CC1";"IC50";"'='";"4820.0";"nM";"5.32";"";"";"UO_0000065";"12.65";"0.26";"0.11";"14.94";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL188";"WIN-552122";"None";"426.52";"0";"4.60";"3";"Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3";"IC50";"'='";"8.9";"nM";"8.05";"";"";"UO_0000065";"18.88";"0.34";"3.45";"18.42";"0";"CHEMBL895094";"Displacement of [3H]CP-55940 human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148711";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3307512";""
"CHEMBL3114182";"";"None";"418.51";"1";"5.16";"18";"O=C(NC1CCCCCC1)c1cc(-c2ccccc2)cn(Cc2ccc(F)cc2)c1=O";"IC50";"'='";"1.585";"nM";"8.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119419";"Inverse agonist activity at human CB2 receptor expressed in CHO membranes by [35S]GTPgammaS binding assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112511";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";""
"CHEMBL206492";"";"None";"395.46";"0";"4.35";"9l";"CCCCCOc1c(OC)ccc2cc(C(=O)Nc3ccccc3N)c(O)nc12";"IC50";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL1708243";"";"None";"294.35";"0";"4.16";"SID99303177";"CCOc1ccc(-c2n[nH]c(C)c2-c2ccccc2)c(O)c1";"IC50";"'='";"23800.0";"nM";"4.62";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1085566";"N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXY-2-METHYLPROPANAMIDE (ENANTIOMERIC MIX)";"None";"525.48";"2";"7.14";"12c, Enantiomer 1";"CC(C)(O)C(=O)NC1CC2(CCCCC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"10.46";"0.21";"-1.65";"7.69";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1727053";"";"None";"392.51";"1";"6.58";"SID99303188";"CC(C)(C)c1ccc(-c2c(-c3nc4ccccc4[nH]3)n[nH]c2-c2ccccc2)cc1";"IC50";"'='";"13900.0";"nM";"4.86";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1722769";"";"None";"478.57";"0";"3.01";"SID87544628";"COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(OCC(C)C)c(OC)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1704166";"";"None";"441.60";"0";"3.44";"SID87544622";"Cc1cccc(N2CCN(C(=O)c3cccc(S(=O)(=O)N4CCCCC4)c3)CC2)c1C";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1698745";"";"None";"405.50";"0";"3.22";"SID99303145";"Cc1ccc2nc3c(cc(C(=O)NC4CCCC4)c(=N)n3C3CCCC3)c(=O)n2c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1721827";"";"None";"370.52";"0";"3.18";"SID99303130";"Cc1nc(N2CCN(C(=O)C3CC3)CC2)c2c3c(sc2n1)CC(C)CC3";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1305795";"";"None";"511.56";"1";"4.75";"SID99303184";"COc1ccc(-c2cc(C(=O)Nc3ccc(S(=O)(=O)Nc4ncccn4)cc3)c3ccccc3n2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1484306";"";"None";"396.52";"0";"3.68";"SID87225742";"Cc1nc(N2CCN(C(=O)c3ccco3)CC2)c2c3c(sc2n1)CC(C)CC3";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL517488";"";"None";"649.20";"2";"9.61";"9ac";"CCc1c(-c2nnc(C3(c4ccc(Cl)cc4Cl)CC3)o2)nc(-c2ccc(Cl)cc2Cl)n1-c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL963902";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139276";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1430124";"";"None";"509.59";"2";"5.36";"SID99303183";"Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)c3cc(-c4ccccc4)nc4ccccc34)cc2)n1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1705660";"";"None";"351.41";"0";"1.99";"SID99303138";"CCNC(=O)c1cc2c(=O)n3ccccc3nc2n(C2CCCC2)c1=N";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1727434";"";"None";"492.61";"1";"5.47";"SID99303172";"O=C(Nc1ccc(S(=O)(=O)Nc2nccs2)cc1)c1cc(-c2cccs2)nc2ccccc12";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1310336";"";"None";"527.61";"2";"5.57";"SID87225762";"Cc1cc(C)c2nc(-c3ccccn3)cc(C(=O)Nc3ccc(S(=O)(=O)Nc4onc(C)c4C)cc3)c2c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL465";"DRONABINOL";"4.0";"314.47";"1";"5.74";"delta9-THC";"CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"25.51";"0.48";"2.28";"27.23";"0";"CHEMBL1932156";"Displacement of [3H]CP55940 from human recombinant CB2 receptor expressed in HEK293 cells after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1926606";"1";"Scientific Literature";"J Nat Prod";"2011";"CHEMBL3307715";""
"CHEMBL2163930";"";"None";"392.50";"0";"3.90";"37";"CCC1COc2cccc3c(=O)c(C(=O)NC4C5CC6CC(C5)CC4C6)cn1c23";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2096841";"";"None";"456.41";"1";"6.68";"(R,R)-18";"C[C@@H](NC(=O)C(C)(C)Oc1ccc(Cl)cc1)[C@H](Cc1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"12.64";"0.25";"-0.91";"15.05";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL2163942";"";"None";"366.46";"0";"3.80";"49";"O=C(NC1CCCCCC1)c1cn2c3c(cccc3c1=O)OCC2C1CC1";"IC50";"'='";"12.4";"nM";"7.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL259684";"";"None";"494.21";"1";"6.52";"23";"Cc1c(C(=O)NCc2ccc(Cl)c(Cl)c2)nn(-c2ccc(Cl)cc2Cl)c1-n1cccc1";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"12.52";"0.27";"-0.33";"11.93";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL259476";"";"None";"446.38";"1";"5.03";"25";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-n1c(C)ccc1C";"IC50";"'='";"1240.0";"nM";"5.91";"";"";"UO_0000065";"13.23";"0.27";"0.88";"10.72";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL2163929";"";"None";"454.57";"0";"4.88";"(R)-59";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cn2c3c(cccc3c1=O)OC[C@H]2Cc1ccccc1";"IC50";"'='";"17.5";"nM";"7.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163575";"";"None";"378.47";"0";"3.65";"(R)-33";"C[C@@H]1COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"153.0";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL1725618";"";"None";"345.20";"0";"4.23";"SID99303176";"Cc1[nH]nc(-c2ccc(O)cc2O)c1-c1ccc(Br)cc1";"IC50";"'='";"9200.0";"nM";"5.04";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3669102";"";"None";"448.45";"0";"4.17";"BDBM176653";"COc1nc(NCCc2ccc(OC(F)F)cc2)nc(-c2ccc(F)c(C(C)(C)O)c2)n1";"IC50";"'='";"30.0";"nM";"7.52";"";"322560";"UO_0000065";"16.78";"0.32";"3.35";"8.42";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1223180";"";"None";"609.99";"2";"7.35";"17q";"FC(F)(F)c1ccccc1-n1nc(-c2nnc(C3(C(F)(F)F)CCC3)s2)c(Cn2cncn2)c1-c1ccc(Cl)cc1";"IC50";"'='";"76.8";"nM";"7.12";"";"";"UO_0000065";"11.66";"0.24";"-0.24";"9.57";"0";"CHEMBL1227204";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221281";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL1222966";"";"None";"544.90";"2";"6.96";"17";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2Cn2cncn2)s1";"IC50";"'='";"1140.0";"nM";"5.94";"";"";"UO_0000065";"10.91";"0.23";"-1.02";"8.00";"0";"CHEMBL1227204";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221281";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL231240";"";"None";"473.43";"1";"5.70";"(S,S)-29";"C[C@H](NS(=O)(=O)Cc1ccc(Cl)cc1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1757.0";"nM";"5.75";"";"";"UO_0000065";"12.16";"0.25";"0.06";"8.23";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL512422";"";"None";"502.42";"2";"8.77";"35";"CC(C)(C)c1nc(-c2ccc(F)cc2)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2n1";"IC50";"'='";"9833.0";"nM";"5.01";"";"";"UO_0000065";"9.97";"0.20";"-3.76";"12.95";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL558535";"";"None";"487.87";"1";"6.93";"13b";"CCCCNc1cc(N[C@@H](C)[C@@H](Cc2ccc(Cl)cc2)c2cccc(Br)c2)ncn1";"IC50";"'='";"2960.0";"nM";"5.53";"";"";"UO_0000065";"11.33";"0.25";"-1.40";"11.09";"0";"CHEMBL1060015";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154032";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL466294";"";"None";"451.40";"1";"7.03";"41";"CN(C)c1nc(C(C)(C)C)nc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"12.73";"0.25";"-1.29";"13.71";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"Rimonabant";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL981472";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143356";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL4067246";"";"None";"508.04";"2";"6.00";"8";"Cc1cc(-c2cc(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)c(=O)n(Cc3ccc(F)cc3)n2)ccc1Cl";"IC50";"'='";"51.2";"nM";"7.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3998735";"Inverse agonist activity at human CB2 receptor expressed in HEK293 EBNA cell membranes after 30 mins by [35S]-GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997787";"1";"Scientific Literature";"Eur J Med Chem";"2017";"CHEMBL3307715";""
"CHEMBL3956145";"";"None";"376.44";"0";"4.14";"BDBM242509";"O=S(=O)(NCC1CC1)c1ccc(NC2CCCCC2)cc1C(F)(F)F";"IC50";"'='";"547.0";"nM";"6.26";"";"422872";"UO_0000065";"16.63";"0.34";"2.12";"10.76";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4064299";"";"None";"366.80";"1";"5.38";"26";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccc3c(c2)OCO3)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4067016";"";"None";"391.69";"1";"6.96";"31";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cc(Cl)cc(Cl)c2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4091847";"";"None";"372.86";"1";"6.80";"42";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccc3ccccc3c2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL1084610";"";"None";"263.38";"0";"2.90";"2";"C/C=C/C=C/C=C\CC/C=C/C(=O)NCC(C)(C)O";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"27.45";"0.52";"4.33";"14.65";"0";"CHEMBL3089351";"Displacement of [3H]-CP55940 from human CB2 receptor expressed in CHO cells preincubated for 1 hr followed by radioligand addition measured after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3085628";"1";"Scientific Literature";"J Nat Prod";"2013";"CHEMBL3308072";""
"CHEMBL256262";"";"None";"518.25";"2";"6.69";"9a";"Cc1c(-c2nnnn2C2CCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1";"IC50";"'='";"4240.0";"nM";"5.37";"";"";"UO_0000065";"10.37";"0.24";"-1.32";"8.75";"0";"CHEMBL950211";"Displacement of [3H]WIN-55212-2 from human cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143900";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";""
"CHEMBL410912";"";"None";"384.43";"0";"4.31";"37";"Cc1c(C(=O)NC2CCCCC2)nn(-c2ccc(F)cc2F)c1-n1cccc1";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"18.42";"0.35";"2.77";"13.66";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL230189";"";"None";"457.79";"1";"6.66";"(S,S)-34";"C[C@H](NC(=O)c1c(Cl)cccc1Cl)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"945.0";"nM";"6.03";"";"";"UO_0000065";"13.16";"0.27";"-0.64";"11.39";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL231342";"";"None";"450.99";"1";"5.52";"(S,S)-31";"C[C@H](NS(=O)(=O)/C=C/c1ccccc1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1077.0";"nM";"5.97";"";"";"UO_0000065";"13.23";"0.26";"0.45";"8.53";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL496901";"";"None";"461.78";"1";"5.81";"32";"Cc1c(C2=NC(C)(C)C(=O)N2C)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"3249.2";"nM";"5.49";"";"";"UO_0000065";"11.88";"0.25";"-0.32";"10.87";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL1420151";"";"None";"374.40";"0";"2.35";"SID87225746";"CCOC(=O)c1cc2c(=O)n3ccccc3nc2n(Cc2ccccc2)c1=N";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1734939";"";"None";"413.91";"0";"4.12";"SID99303181";"Cc1[nH]nc(-c2ccc(OCCN3CCOCC3)cc2O)c1-c1ccc(Cl)cc1";"IC50";"'='";"29100.0";"nM";"4.54";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4566417";"";"None";"434.50";"1";"6.35";"13";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(NCc3ccccn3)cc2)cc1";"IC50";"'='";"5090.0";"nM";"5.29";"";"";"UO_0000065";"12.18";"0.22";"-1.06";"8.22";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4530405";"";"None";"465.52";"1";"7.11";"10";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(N(C)Cc3ccc(F)cc3)cc2)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"17.19";"0.31";"0.89";"18.74";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL402938";"";"None";"397.42";"0";"4.43";"6e";"Cn1c(C(C)(C)C)c/c(=N\C(=O)c2cc(C(F)(F)F)ccc2F)n1CC1CC1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"19.22";"0.37";"3.21";"19.44";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL230715";"";"None";"560.95";"2";"6.94";"(S,S)-20";"C[C@H](NS(=O)(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1755.0";"nM";"5.76";"";"";"UO_0000065";"10.26";"0.21";"-1.18";"8.23";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL230506";"";"None";"493.84";"1";"6.21";"(S,S)-16";"C[C@H](NS(=O)(=O)c1c(Cl)cccc1Cl)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"283.5";"nM";"6.55";"";"";"UO_0000065";"13.26";"0.29";"0.34";"9.36";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL230825";"";"None";"501.05";"2";"6.57";"(S,S)-23";"C[C@H](NS(=O)(=O)c1ccc(-c2ccccc2)cc1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"406.0";"nM";"6.39";"";"";"UO_0000065";"12.76";"0.25";"-0.18";"9.14";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL244606";"";"None";"382.50";"1";"7.18";"14";"CCCCCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"16.16";"0.29";"-1.00";"23.50";"0";"CHEMBL895094";"Displacement of [3H]CP-55940 human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148711";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3307512";""
"CHEMBL1368569";"";"None";"459.57";"1";"5.18";"SID99303174";"CCN(CC)S(=O)(=O)c1ccc(NC(=O)c2cc(-c3ccccc3)nc3ccccc23)cc1";"IC50";"'>'";"10800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL2316110";"";"None";"451.55";"0";"3.56";"19";"CS(=O)(=O)Cc1ccc(C(=O)Nc2cccnc2C(=O)NCC2CCC2)c2ccccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL246900";"";"None";"407.30";"1";"5.72";"6b";"CC(C)(O)C#Cc1nc(-c2ccccc2Cl)c(-c2ccc(Cl)cc2)cc1C#N";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"14.10";"0.28";"0.02";"10.09";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL2071071";"";"None";"381.91";"0";"4.78";"21";"O=C(NCCc1ccc(N2CCCCC2)cc1)c1cc2cc(Cl)ccc2[nH]1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL2071067";"";"None";"423.94";"0";"4.99";"17";"CC(=O)c1c(C(=O)NCCc2ccc(N3CCCCC3)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL1083025";"N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)";"None";"505.83";"2";"6.48";"13g, Enantiomer 1";"CC1(C)CC(NC(=O)CCO)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"2460.0";"nM";"5.61";"";"";"UO_0000065";"11.09";"0.23";"-0.87";"7.85";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1082650";"6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-((R)-1-HYDROXYETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)";"None";"518.87";"2";"6.53";"17c, Enantiomer 1";"C[C@@H](O)NC(=O)C1CC(C)(C)N(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"2330.0";"nM";"5.63";"";"";"UO_0000065";"10.86";"0.23";"-0.90";"8.60";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL2071070";"";"None";"375.52";"0";"4.69";"20";"CCc1c(C(=O)NCCc2ccc(N3CCCCC3)cc2)[nH]c2ccccc12";"IC50";"'='";"8970.0";"nM";"5.05";"";"";"UO_0000065";"13.44";"0.25";"0.36";"10.49";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL248201";"";"None";"412.43";"0";"4.20";"4-20";"CCOC(=O)c1s/c(=N\C(=O)c2cccc(C(F)(F)F)c2)n(CC2CC2)c1C";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"16.87";"0.34";"2.76";"11.47";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL471980";"";"None";"421.59";"1";"5.55";"A";"CCOc1ccc(Cc2nc3cc(C(=O)N(CC)CC)ccc3n2CCC(C)C)cc1";"IC50";"'='";"39.81";"nM";"7.40";"";"";"UO_0000065";"17.55";"0.33";"1.85";"15.63";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL520571";"";"None";"630.83";"2";"9.42";"10ad";"CCc1c(-c2nnc(C3(c4ccc(Cl)cc4)CC3)s2)nc(-c2ccc(Cl)cc2Cl)n1-c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL963902";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139276";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1765276";"";"None";"350.46";"0";"3.68";"4-13a";"Cc1ccc(C(=O)N2CC[C@@](O)(c3ccccc3)[C@@H]3CCCC[C@@H]32)cn1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765288";"";"None";"426.48";"0";"2.93";"5-9";"O=C(C1CN(CC(F)(F)F)CCO1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL4082785";"";"None";"518.75";"2";"6.55";"24";"CCOc1ccc(Cc2nc3cc(C(=O)N(CC)CC)ccc3n2CCCCCCN2CCCCC2)cc1";"IC50";"'='";"1258.93";"nM";"5.90";"";"";"UO_0000065";"11.37";"0.21";"-0.65";"11.66";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL1733320";"";"None";"405.50";"0";"3.31";"SID99303144";"N=c1c(C(=O)NC2CCCCC2)cc2c(=O)n3ccccc3nc2n1C1CCCC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1765247";"";"None";"419.50";"0";"4.51";"Table 1, R5C2, 3";"O=C(c1cc(-c2ccccc2F)[nH]n1)N1CC[C@](O)(c2ccccc2)[C@H]2CCCC[C@H]21";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL462069";"";"None";"488.48";"1";"7.29";"31";"CCCCC#Cc1ccc(-c2c(C)c(C(=O)NCCCC)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"637.7";"nM";"6.20";"";"";"UO_0000065";"12.68";"0.26";"-1.09";"13.20";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL461429";"";"None";"541.55";"2";"7.13";"29";"CCCCC#Cc1ccc(-c2c(C)c(C(=O)NN3CC4CCCC4C3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"158.0";"nM";"6.80";"";"";"UO_0000065";"12.56";"0.26";"-0.33";"13.56";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL428579";"";"None";"514.75";"2";"7.78";"5f";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1NC(=O)c1ccc(F)c(F)c1";"IC50";"'='";"315.0";"nM";"6.50";"";"";"UO_0000065";"12.63";"0.26";"-1.28";"9.88";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL272203";"";"None";"417.34";"1";"5.34";"30";"Cc1c(C(=O)NC2CCCCC2)nn(-c2ccc(Cl)c(Cl)c2)c1-n1cccc1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"20.74";"0.42";"3.32";"16.70";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL408968";"";"None";"385.42";"0";"3.38";"34";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(F)cc2F)c1-n1cccc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"14.33";"0.27";"2.14";"10.03";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL2023580";"";"None";"443.57";"0";"4.49";"18";"O=C(O)c1cnc(NC(=O)c2cc3c(n(CC4CCCCC4)c2=O)CCCCCC3)s1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL2023583";"";"None";"471.62";"0";"4.81";"21";"O=C(O)CCc1csc(NC(=O)c2cc3c(n(CC4CCCCC4)c2=O)CCCCCC3)n1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL259042";"";"None";"522.26";"2";"7.13";"32";"Cc1c(C(=O)NCc2ccc(Cl)c(Cl)c2)nn(-c2ccc(Cl)c(Cl)c2)c1-n1c(C)ccc1C";"IC50";"'='";"1740.0";"nM";"5.76";"";"";"UO_0000065";"11.03";"0.24";"-1.37";"11.11";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL202064";"";"None";"584.89";"2";"7.03";"25";"CC(=O)Nc1c(C(C)=O)c(=O)n(CC2CCCO2)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"10.01";"0.20";"-1.18";"6.48";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL204391";"";"None";"472.76";"1";"6.19";"34";"CC(=O)Nc1cc(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"13.58";"0.28";"0.23";"10.03";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3696827";"";"None";"291.44";"0";"3.84";"BDBM163045";"CCCNc1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1";"IC50";"'='";"68.0";"nM";"7.17";"";"306184";"UO_0000065";"24.59";"0.47";"3.33";"15.28";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3897023";"";"None";"406.38";"0";"4.42";"BDBM242460";"O=S(=O)(NCC1CC1)c1ccc(Nc2ccc(F)cc2F)cc1C(F)(F)F";"IC50";"'='";"1933.0";"nM";"5.71";"";"422807";"UO_0000065";"14.06";"0.29";"1.29";"9.82";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL370388";"";"None";"500.81";"2";"6.50";"17";"CC(=O)c1c(N(C)C)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"11.69";"0.24";"-0.65";"10.60";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3964264";"";"None";"432.51";"0";"4.01";"BDBM242465";"O=S(=O)(NCC1CCOCC1)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"64.5";"nM";"7.19";"";"422815";"UO_0000065";"16.62";"0.34";"3.18";"10.66";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3953781";"";"None";"430.54";"0";"4.88";"BDBM242472";"CC1(C)C2CCC(CNc3ccc(S(=O)(=O)NCC4CC4)c(C(F)(F)F)c3)C1C2";"IC50";"'='";"398.0";"nM";"6.40";"";"422824";"UO_0000065";"14.87";"0.30";"1.52";"11.00";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3929652";"";"None";"432.55";"1";"5.41";"BDBM242506";"CC(C)(C)C1CCC(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)CC1";"IC50";"'='";"1893.0";"nM";"5.72";"";"422864";"UO_0000065";"13.23";"0.27";"0.31";"9.83";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3971303";"";"None";"428.43";"0";"3.91";"BDBM242471";"O=S(=O)(NCC1CC1)c1ccc(Nc2ccc3c(c2)OCCO3)cc1C(F)(F)F";"IC50";"'='";"137.7";"nM";"6.86";"";"422823";"UO_0000065";"16.01";"0.32";"2.95";"8.95";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3942034";"";"None";"446.45";"0";"4.03";"BDBM242437";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)c(OC(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"59970.0";"nM";"4.22";"";"422776";"UO_0000065";"9.46";"0.19";"0.19";"4.92";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3922890";"";"None";"469.31";"1";"5.21";"BDBM242435";"O=S(=O)(NCC1CCCO1)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"84.0";"nM";"7.08";"";"422774";"UO_0000065";"15.08";"0.33";"1.87";"10.49";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3940142";"";"None";"420.50";"0";"3.79";"BDBM242456";"CCCN(CC1CC1)c1ccc(S(=O)(=O)NCC2CCCO2)c(C(F)(F)F)c1";"IC50";"'='";"181.0";"nM";"6.74";"";"422802";"UO_0000065";"16.03";"0.33";"2.95";"11.50";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3669099";"";"None";"445.86";"0";"4.94";"BDBM176650";"COc1nc(NCCc2ccc(OC(F)F)cc2)nc(-c2cc3c(Cl)cccc3[nH]2)n1";"IC50";"'='";"24.0";"nM";"7.62";"";"322557";"UO_0000065";"17.09";"0.34";"2.68";"8.97";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3975498";"";"None";"416.51";"0";"4.77";"BDBM242493";"CC(C)(NS(=O)(=O)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F)C1CC1";"IC50";"'='";"153.0";"nM";"6.82";"";"422847";"UO_0000065";"16.36";"0.33";"2.05";"11.71";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3903346";"";"None";"390.47";"0";"4.02";"BDBM242514";"CCCN(CC1CC1)c1ccc(S(=O)(=O)NCC2CC2)c(C(F)(F)F)c1";"IC50";"'='";"404.0";"nM";"6.39";"";"422874";"UO_0000065";"16.37";"0.34";"2.37";"12.94";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3938871";"";"None";"433.88";"0";"4.96";"BDBM242495";"CC(C)(NS(=O)(=O)c1ccc(Nc2cccnc2Cl)cc1C(F)(F)F)C1CC1";"IC50";"'='";"452.0";"nM";"6.34";"";"422849";"UO_0000065";"14.62";"0.31";"1.38";"8.93";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3923239";"";"None";"414.45";"0";"4.38";"BDBM242466";"O=S(=O)(NCc1ccco1)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"245.0";"nM";"6.61";"";"422818";"UO_0000065";"15.95";"0.32";"2.23";"9.27";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3965462";"";"None";"428.46";"0";"3.18";"BDBM242443";"COc1cc(Nc2cc(F)c(S(=O)(=O)NCC3CCCO3)cc2F)cc(OC)c1";"IC50";"'='";"255.0";"nM";"6.59";"";"422788";"UO_0000065";"15.39";"0.31";"3.41";"7.68";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1223259";"";"None";"554.91";"2";"6.41";"17s";"CC(C)(C)c1nnc(-c2nn(-c3ccccc3Cl)c(-c3ccc(Br)cc3)c2Cn2cncn2)s1";"IC50";"'='";"549.0";"nM";"6.26";"";"";"UO_0000065";"11.28";"0.25";"-0.15";"8.42";"0";"CHEMBL1227204";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221281";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"1";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1760.0";"nM";"5.75";"";"";"UO_0000065";"12.41";"0.26";"-0.19";"11.47";"1";"CHEMBL1227204";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221281";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL2316394";"";"None";"387.48";"0";"4.80";"8d";"O=C(NCC1CCCCC1)c1ccncc1NC(=O)c1cccc2ccccc12";"IC50";"'>'";"8900.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL381969";"";"None";"447.54";"0";"4.97";"9m";"CCCCCOc1c(OC)ccc2cc(C(=O)NCCc3c[nH]c4ccccc34)c(O)nc12";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL1086493";"";"None";"481.42";"1";"7.39";"rac-12a";"CC(=O)NC1CC2(CCCCC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"11.24";"0.22";"-1.98";"10.56";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1086012";"";"None";"412.32";"1";"6.71";"rac-5e";"CC(C)C1CC(=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2O1";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"13.29";"0.27";"-1.23";"13.99";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL2153757";"";"None";"560.46";"1";"2.98";"28";"NC(=O)[C@H](CO)N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL1083619";"(2R)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)";"None";"511.45";"2";"6.75";"12g, Enantiomer 1";"C[C@@H](O)C(=O)NC1CC2(CCCCC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"10.64";"0.21";"-1.31";"7.62";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1083000";"";"None";"448.78";"1";"7.14";"rac-7b";"CC1(C)CC(C)(O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"2920.0";"nM";"5.54";"";"";"UO_0000065";"12.33";"0.26";"-1.61";"13.07";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1765092";"";"None";"419.55";"0";"4.50";"page no 2364, R4C1, Enantiomer 3b";"O=C(c1csc(-c2ccncc2)n1)N1CCC(O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'>'";"17000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1083016";"N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXY-2,2-DIMETHYLPROPANAMIDE (ENANTIOMERIC MIX)";"None";"533.88";"2";"7.11";"13f, Enantiomer 2";"CC1(C)CC(NC(=O)C(C)(C)CO)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"7600.0";"nM";"5.12";"";"";"UO_0000065";"9.59";"0.20";"-1.99";"7.16";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL381314";"";"None";"408.50";"0";"4.08";"9d";"CCCCCOc1c(OC)ccc2cc(C(=O)NCCc3ccccc3)c(=O)[nH]c12";"IC50";"'='";"0.631";"nM";"9.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL487912";"";"None";"586.56";"2";"5.06";"58";"Cc1n[nH]cc1-c1cc(C(F)(F)F)cc(S(=O)(=O)N2CCN(C(=O)[C@@H]3C[C@H]3c3ccc(C(F)(F)F)cc3)CC2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL488324";"";"None";"589.52";"1";"3.44";"61";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3n[nH]c(=O)[nH]3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL1765156";"";"None";"374.48";"0";"4.46";"Table 1, R4C2, 2";"O=C(c1cccc2[nH]ccc12)N1CC[C@](O)(c2ccccc2)[C@H]2CCCC[C@@H]21";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL230181";"";"None";"404.96";"0";"4.65";"7";"CCCCS(=O)(=O)N[C@@H](C)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1441.0";"nM";"5.84";"";"";"UO_0000065";"14.42";"0.30";"1.19";"8.35";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL397690";"";"None";"362.88";"0";"3.48";"5";"C[C@H](NS(C)(=O)=O)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL1288088";"";"None";"331.41";"0";"3.08";"VII";"COc1ccc(/C=C/C(=O)CCC(=O)N2CCCCC2)cc1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1288089";"";"None";"307.35";"0";"1.17";"VIII";"COc1ccc(/C=C/C(=O)CCC(=O)NCCO)cc1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1288179";"";"None";"341.41";"0";"2.02";"XV";"O=C(/C=C/c1ccc2ccccc2c1)CCC(=O)N(CCO)CCO";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL244402";"";"None";"354.45";"1";"6.40";"12";"CCCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12";"IC50";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"19.95";"0.36";"0.67";"26.88";"0";"CHEMBL895094";"Displacement of [3H]CP-55940 human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148711";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3307512";""
"CHEMBL3942034";"";"None";"446.45";"0";"4.03";"BDBM242437";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)c(OC(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"1056.0";"nM";"5.98";"";"422778";"UO_0000065";"13.39";"0.27";"1.95";"6.96";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3912856";"";"None";"362.45";"0";"3.14";"BDBM242438";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)cc2)cc(OC)c1";"IC50";"'='";"235.0";"nM";"6.63";"";"422779";"UO_0000065";"18.29";"0.36";"3.49";"8.65";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1084557";"";"None";"438.35";"1";"7.39";"5i";"O=C1CC2(CCCCC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"8300.0";"nM";"5.08";"";"";"UO_0000065";"11.59";"0.23";"-2.31";"12.96";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1223034";"";"None";"589.35";"2";"7.06";"17g";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Br)cc3)c2Cn2cncn2)s1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"10.80";"0.25";"-0.69";"8.57";"0";"CHEMBL1227204";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221281";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL1765092";"";"None";"419.55";"0";"4.50";"page no 2364, R1C1, Enantiomer 3b";"O=C(c1csc(-c2ccncc2)n1)N1CCC(O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"388.0";"nM";"6.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765092";"";"None";"419.55";"0";"4.50";"page no 2364, R1C1, Enantiomer 3b";"O=C(c1csc(-c2ccncc2)n1)N1CCC(O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"0.55";"nM";"9.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765092";"";"None";"419.55";"0";"4.50";"page no 2364, R1C1, Enantiomer 3b";"O=C(c1csc(-c2ccncc2)n1)N1CCC(O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"7.9";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL2386558";"MK-3168";"1.0";"412.95";"0";"4.48";"6";"CN(C)C(=O)[C@H]1C[C@@H]1c1ccc(-c2ncn(C)c2Sc2ccc(Cl)cn2)cc1";"IC50";"'='";"150000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2388890";"Inhibition of CB2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385021";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";""
"CHEMBL481774";"";"None";"626.41";"2";"8.78";"10aa";"CCc1c(-c2nnc(C3(c4ccc(OC)cc4)CC3)s2)nc(-c2ccc(Cl)cc2Cl)n1-c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL963902";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139276";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL4476184";"";"None";"452.39";"1";"5.36";"5";"CCCCCCCN1C(=O)C2C3c4ccccc4C(Br)(c4ccccc43)C2C1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL504005";"";"None";"275.31";"0";"2.17";"1";"O=C1NC(=O)C2C3c4ccccc4C(c4ccccc43)C12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL1592197";"";"None";"486.64";"0";"2.90";"SID87544645";"CCOc1ccccc1N1CCN(C(=O)c2cc(S(=O)(=O)N(C)C)ccc2N2CCCC2)CC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL2163951";"";"None";"440.54";"0";"4.68";"22";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cn2c3c(cccc3c1=O)OCC2c1ccccc1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL4461463";"";"None";"373.50";"0";"4.63";"8";"CCCCCCN1C(=O)C2C3c4ccccc4C(C)(c4ccccc43)C2C1=O";"IC50";"'='";"3930.0";"nM";"5.41";"";"";"UO_0000065";"14.47";"0.26";"0.78";"14.46";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL559612";"CP-55940";"None";"376.58";"1";"5.66";"CP-55940";"CCCCCCC(C)(C)c1ccc([C@@H]2C[C@H](O)CC[C@H]2CCCO)c(O)c1";"IC50";"'='";"0.82";"nM";"9.09";"";"";"UO_0000065";"24.13";"0.46";"3.43";"14.97";"1";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL2153766";"";"None";"615.54";"1";"3.51";"38";"C[C@H](NC(=O)[C@H](C)N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL1698983";"";"None";"300.37";"0";"4.10";"SID99303157";"Cc1ccc(-n2cc3c(-c4ccccc4)nnc(C)c3n2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1382214";"";"None";"514.63";"2";"6.03";"SID99303171";"Cc1ccc(-c2cc(C(=O)Nc3ccc(S(=O)(=O)Nc4nccs4)cc3)c3ccccc3n2)c(C)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1715363";"";"None";"435.98";"0";"3.17";"SID87544633";"Cc1cccc(N2CCN(C(=O)c3cc(S(=O)(=O)N(C)C)ccc3Cl)CC2)c1C";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1735479";"";"None";"478.64";"0";"4.08";"SID87544625";"CC(C)Oc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1cc2c(s1)CCCCC2";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL399219";"";"None";"378.56";"0";"4.41";"3c";"CC(C)=CCn1c(C)c(C(C)(C)C)s/c1=N\S(=O)(=O)c1ccccc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"17.88";"0.37";"2.36";"13.16";"0";"CHEMBL897874";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149669";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL1465869";"";"None";"488.57";"0";"3.88";"SID99303175";"Cc1ccc2nc(-c3ccccn3)cc(C(=O)Nc3ccc(S(=O)(=O)N4CCOCC4)cc3)c2c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3912856";"";"None";"362.45";"0";"3.14";"BDBM242438";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)cc2)cc(OC)c1";"IC50";"'='";"853.0";"nM";"6.07";"";"422782";"UO_0000065";"16.74";"0.33";"2.93";"7.92";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL2153668";"";"None";"620.56";"2";"5.23";"22";"NC(=O)[C@H](Cc1ccccc1)N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL499076";"";"None";"503.86";"2";"6.98";"13";"CCCCN1C(c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C)=NC(=O)C1(C)C";"IC50";"'='";"4763.3";"nM";"5.32";"";"";"UO_0000065";"10.56";"0.22";"-1.66";"10.54";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL381791";"";"None";"476.06";"1";"6.81";"SR144528";"Cc1ccc(Cn2nc(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)cc2-c2ccc(Cl)c(C)c2)cc1";"IC50";"'='";"96.2";"nM";"7.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3998735";"Inverse agonist activity at human CB2 receptor expressed in HEK293 EBNA cell membranes after 30 mins by [35S]-GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997787";"1";"Scientific Literature";"Eur J Med Chem";"2017";"CHEMBL3307715";""
"CHEMBL498746";"";"None";"491.88";"1";"6.86";"24, BPR-890";"CCc1c(C2=NC(=S)C(C)(C)N2C)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"4746.0";"nM";"5.32";"";"";"UO_0000065";"10.82";"0.23";"-1.54";"15.93";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL3933513";"";"None";"429.85";"0";"4.66";"BDBM242467";"N#Cc1ccc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)c(Cl)c1";"IC50";"'='";"50.2";"nM";"7.30";"";"422819";"UO_0000065";"16.98";"0.36";"2.64";"8.90";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1717635";"";"None";"438.57";"0";"3.29";"SID87544634";"CCCc1cc(C(=O)Nc2cc(S(=O)(=O)N3CCOCC3)ccc2OC)sc1C";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL271782";"";"None";"479.84";"1";"6.61";"44";"Cc1c(C(=O)NC2CCCCC2)nn(-c2c(Cl)cc(Cl)cc2Cl)c1-n1c(C)ccc1C";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"13.13";"0.28";"-0.31";"12.15";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL270749";"";"None";"459.76";"1";"5.86";"21";"Cc1nn(-c2ccc(Cl)cc2)c(-n2cccc2)c1C(=O)NCc1ccc(Cl)c(Cl)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1094521";"";"None";"505.83";"2";"6.48";"13j, Enantiomer 2";"C[C@H](O)C(=O)NC1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"5310.0";"nM";"5.28";"";"";"UO_0000065";"10.43";"0.22";"-1.21";"7.38";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1082650";"6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-((R)-1-HYDROXYETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)";"None";"518.87";"2";"6.53";"17c, Enantiomer 1";"C[C@@H](O)NC(=O)C1CC(C)(C)N(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"1280.0";"nM";"5.89";"";"";"UO_0000065";"11.36";"0.24";"-0.64";"9.00";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL226591";"";"None";"489.59";"1";"5.30";"5";"Cc1ccc(OC(C)(C)C(=O)N[C@@H](C)[C@@H](Cc2ccc(OCCF)cc2)c2cccc(C#N)c2)nc1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"15.03";"0.28";"2.06";"8.73";"0";"CHEMBL1767554";"Displacement of [3H]CP55940 from CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1764973";"1";"Scientific Literature";"J Med Chem";"2011";"None";""
"CHEMBL1085261";"N-(7-(2-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX)";"None";"457.36";"1";"5.43";"13b, Enantiomer 2";"CC1(C)CC(NC(=O)CO)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2O1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1085261";"N-(7-(2-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX)";"None";"457.36";"1";"5.43";"13b, Enantiomer 2";"CC1(C)CC(NC(=O)CO)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2O1";"IC50";"'='";"10130.0";"nM";"4.99";"";"";"UO_0000065";"10.92";"0.22";"-0.44";"6.99";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL513550";"";"None";"612.32";"2";"7.60";"12r";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Br)cc3)c2C(=O)Nc2ccccn2)o1";"IC50";"'='";"374.0";"nM";"6.43";"";"";"UO_0000065";"10.50";"0.23";"-1.17";"6.51";"0";"CHEMBL957520";"Displacement of [3H]WIN-55212-2 from human recombinant cannabinoid CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL498897";"";"None";"705.83";"2";"9.64";"12s";"O=C(Nc1ccccc1)c1c(-c2nnc(C3(c4ccc(Cl)cc4)CC3)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL957520";"Displacement of [3H]WIN-55212-2 from human recombinant cannabinoid CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL1288210";"";"None";"353.42";"0";"3.27";"XX";"CCOC(=O)CNC(=O)CCCC(=O)/C=C/c1ccc2ccccc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1094521";"";"None";"505.83";"2";"6.48";"13i, Enantiomer 1";"C[C@H](O)C(=O)NC1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"2260.0";"nM";"5.65";"";"";"UO_0000065";"11.16";"0.23";"-0.83";"7.90";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL497318";"CANNABIGEROL";"1.0";"316.49";"1";"6.07";"1, CBG";"CCCCCc1cc(O)c(C/C=C(\C)CCC=C(C)C)c(O)c1";"IC50";"'='";"3460.0";"nM";"5.46";"";"";"UO_0000065";"17.25";"0.32";"-0.61";"13.50";"0";"CHEMBL1825335";"Displacement of [3H]-CP-55,940 from human recombinant CB2 receptor expressed in HEK293 cells membrane incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821606";"1";"Scientific Literature";"J Nat Prod";"2011";"CHEMBL3307715";""
"CHEMBL461216";"";"None";"528.30";"2";"6.50";"7";"Cc1c(C(=O)NN2CCCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)s1";"IC50";"'='";"704.9";"nM";"6.15";"";"";"UO_0000065";"11.64";"0.28";"-0.35";"12.26";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3889879";"";"None";"410.47";"0";"3.04";"BDBM242441";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CCCO3)c(F)c2)cc(OC)c1";"IC50";"'='";"953.0";"nM";"6.02";"";"422786";"UO_0000065";"14.67";"0.29";"2.98";"7.01";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL250699";"";"None";"357.79";"0";"4.87";"A-803467";"COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL928140";"Displacement of [3H]Win 55212-2 from cannabinoid CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142222";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"None";""
"CHEMBL3911376";"";"None";"455.29";"1";"5.38";"BDBM242496";"O=S(=O)(NOCC1CC1)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"2262.0";"nM";"5.65";"";"422851";"UO_0000065";"12.40";"0.28";"0.27";"8.37";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3696841";"";"None";"291.78";"0";"3.32";"BDBM163060";"CCCNc1cnn(-c2cc(C)ccc2C)c(=O)c1Cl";"IC50";"'='";"10000.0";"nM";"5.00";"";"306200";"UO_0000065";"17.14";"0.34";"1.68";"10.66";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3891231";"";"None";"430.45";"0";"4.15";"BDBM242431";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"68.0";"nM";"7.17";"";"422767";"UO_0000065";"16.65";"0.34";"3.02";"9.35";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3914042";"";"None";"390.47";"0";"4.53";"BDBM242504";"O=S(=O)(NCC1CC1)c1ccc(NC2CCCCCC2)cc1C(F)(F)F";"IC50";"'='";"37.0";"nM";"7.43";"";"422862";"UO_0000065";"19.03";"0.39";"2.90";"12.77";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3920675";"";"None";"453.49";"0";"4.05";"BDBM242488";"CC(=O)N1CCc2ccc(Nc3ccc(S(=O)(=O)NCC4CC4)c(C(F)(F)F)c3)cc21";"IC50";"'='";"1216.0";"nM";"5.92";"";"422842";"UO_0000065";"13.04";"0.26";"1.87";"7.53";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL480405";"";"None";"665.27";"2";"10.08";"10ac";"CCc1c(-c2nnc(C3(c4ccc(Cl)cc4Cl)CC3)s2)nc(-c2ccc(Cl)cc2Cl)n1-c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL963902";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139276";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL3696834";"";"None";"277.75";"0";"2.57";"BDBM163053";"Cc1cc(C)cc(-n2ncc(N(C)C)c(Cl)c2=O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"306193";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL488109";"";"None";"590.50";"1";"3.70";"60";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3n[nH]c(=O)o3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL496695";"";"None";"447.75";"1";"5.46";"27";"Cc1c(C2=NC(C)(C)C(=O)N2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"3500.6";"nM";"5.46";"";"";"UO_0000065";"12.19";"0.26";"0.00";"9.20";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL3905036";"";"None";"439.29";"1";"5.44";"BDBM242430";"O=S(=O)(NCC1CC1)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"30.0";"nM";"7.52";"";"422764";"UO_0000065";"17.13";"0.38";"2.08";"12.93";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4169849";"";"None";"398.46";"1";"5.56";"12a";"COC(=O)CCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12";"IC50";"'='";"1690.0";"nM";"5.77";"";"";"UO_0000065";"14.49";"0.26";"0.21";"10.97";"0";"CHEMBL4157966";"Displacement of [3H]CP55940 from membrane bound human CB2 receptor after 1 hr by beta scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152361";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL597489";"";"None";"637.37";"2";"6.21";"44d";"O=C(c1nn(-c2ccccc2Cl)c(-c2ccc(Br)cc2)c1Cn1cncn1)N1CCN(c2cccc(Cl)c2)CC1";"IC50";"'='";"296.0";"nM";"6.53";"";"";"UO_0000065";"10.24";"0.22";"0.32";"9.06";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL474602";"";"None";"524.21";"2";"6.68";"9f";"O=C(Cn1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2Cl)n1)NCc1ccccc1F";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL4176556";"";"None";"384.43";"1";"5.47";"9a";"O=C(O)CCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4157966";"Displacement of [3H]CP55940 from membrane bound human CB2 receptor after 1 hr by beta scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152361";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL487855";"";"None";"426.00";"1";"5.40";"17a";"Cc1ccccc1C(c1ccc(Cl)cc1)N1CCN(C(=O)NC2CCCCC2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL3590642";"";"None";"384.52";"0";"4.61";"57";"CCCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(OC)ccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL2348277";"";"None";"312.41";"0";"3.83";"39f";"CCCCn1c(C)c(C)cc(NC(=O)c2ccccc2C)c1=O";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2352785";"Agonist activity at human recombinant CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced accumulation of cAMP";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346633";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL381791";"";"None";"476.06";"1";"6.81";"SR-144,528";"Cc1ccc(Cn2nc(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)cc2-c2ccc(Cl)c(C)c2)cc1";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4255276";"Inverse agonist activity at N-terminal HA-tagged human CB2 receptor expressed in HEK293 cells transfected with YFP-Epac-RLuc assessed as increase in forskolin-stimulated cAMP level by BRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251662";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL4283967";"";"None";"479.57";"1";"5.03";"19";"COC(=O)CCCCOc1cccc2c(C(=O)c3ccc(OC)cc3)cn(CC3CCOCC3)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4255276";"Inverse agonist activity at N-terminal HA-tagged human CB2 receptor expressed in HEK293 cells transfected with YFP-Epac-RLuc assessed as increase in forskolin-stimulated cAMP level by BRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251662";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL3696846";"";"None";"368.95";"0";"3.67";"BDBM163065";"CN(C)CCN(C)c1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1Cl";"IC50";"'='";"20.0";"nM";"7.70";"";"306205";"UO_0000065";"20.87";"0.42";"4.03";"18.61";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"SR-141716A";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"18.80";"0.40";"2.78";"17.39";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL3891231";"";"None";"430.45";"0";"4.15";"BDBM242431";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"56.0";"nM";"7.25";"";"422766";"UO_0000065";"16.85";"0.34";"3.10";"9.46";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL2153670";"";"None";"572.52";"1";"4.64";"23a";"CC(C)[C@H](N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1C[C@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL462070";"";"None";"501.48";"2";"6.50";"12";"CCCC#Cc1ccc(-c2c(C)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"2214.0";"nM";"5.66";"";"";"UO_0000065";"11.28";"0.23";"-0.85";"11.27";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3907056";"";"None";"430.54";"1";"5.02";"BDBM242525";"CC12CC(Nc3ccc(S(=O)(=O)NCC4CC4)c(C(F)(F)F)c3)CC(C1)C2(C)C";"IC50";"'='";"37.2";"nM";"7.43";"";"422885";"UO_0000065";"17.26";"0.35";"2.41";"12.77";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL2153767";"";"None";"631.54";"1";"2.48";"39";"C[C@H](N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(=O)N[C@@H](CO)C(N)=O";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL481773";"";"None";"596.38";"2";"8.77";"10z";"CCc1c(-c2nnc(C3(c4ccccc4)CC3)s2)nc(-c2ccc(Cl)cc2Cl)n1-c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL963902";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139276";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL2387076";"";"None";"338.45";"0";"3.46";"18c";"CCCCn1c2c(cc(C(=O)NCc3ccccc3)c1=O)CCCC2";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2389080";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385064";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL3669053";"";"None";"473.53";"0";"2.79";"BDBM176601";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(OC)c(S(=O)(=O)NC3CC3)c2)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"322527";"UO_0000065";"16.73";"0.33";"5.13";"6.87";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2387186";"";"None";"380.53";"0";"4.28";"22f";"CCCCn1c2c(cc(C(=O)NCCc3ccccc3)c1=O)CCCCCC2";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2389080";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385064";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL217862";"";"None";"421.97";"1";"6.03";"35c";"C[C@H](NC(=O)C(C)(C)Oc1ccccc1)[C@@H](Cc1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"15.04";"0.29";"0.32";"16.56";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL2113251";"";"None";"474.40";"1";"6.82";"10c";"C[C@H](NC(=O)C(C)(C)Oc1ccc(Cl)cc1)[C@@H](Cc1ccc(Cl)cc1)c1ccccc1F";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"13.46";"0.27";"-0.43";"16.66";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL3696845";"";"None";"277.75";"0";"2.77";"BDBM163064";"CCCNc1cnn(Cc2ccccc2)c(=O)c1Cl";"IC50";"'>'";"10000.0";"nM";"";"";"306204";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3774565";"";"None";"487.65";"1";"5.23";"21";"CCCCCn1cc(C(=O)NC23CC4CC(C)(CC(C)(C4)C2)C3)c(=O)n2nc(-c3ccccc3)nc12";"IC50";"'='";"18.4";"nM";"7.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL3775966";"";"None";"407.52";"0";"3.81";"19";"CCCCCn1cc(C(=O)NC2CCCCC2)c(=O)n2nc(-c3ccccc3)nc12";"IC50";"'='";"111.0";"nM";"6.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL247832";"";"None";"356.41";"0";"4.45";"4-13";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2cccc(C(F)(F)F)c2)n1C";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"18.68";"0.38";"2.21";"19.38";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL3891231";"";"None";"430.45";"0";"4.15";"BDBM242431";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"76.0";"nM";"7.12";"";"422768";"UO_0000065";"16.54";"0.34";"2.97";"9.29";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3969620";"";"None";"483.34";"1";"5.46";"BDBM242459";"O=S(=O)(NCC1CCOCC1)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"206.0";"nM";"6.69";"";"422805";"UO_0000065";"13.83";"0.30";"1.23";"9.92";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL2023047";"";"None";"464.61";"0";"4.51";"9";"O=C(N[C@@H](Cc1ccccc1)C(=O)O)c1cc2c(n(CC3CCCCC3)c1=O)CCCCCC2";"IC50";"'='";"126.0";"nM";"6.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL2387181";"";"None";"276.38";"0";"2.41";"22a";"CCCCn1c2c(cc(C(N)=O)c1=O)CCCCCC2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2389080";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385064";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL1086271";"";"None";"488.39";"1";"5.64";"5k";"O=C1CC2(CCS(=O)(=O)CC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"11.03";"0.23";"-0.25";"7.35";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL452912";"TETRAHYDROBUNGEANOOL";"None";"295.47";"0";"4.13";"8";"CCCCCCCCC/C=C/C=C/C(=O)NCC(C)(C)O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"29.44";"0.57";"4.57";"17.63";"0";"CHEMBL3089351";"Displacement of [3H]-CP55940 from human CB2 receptor expressed in CHO cells preincubated for 1 hr followed by radioligand addition measured after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3085628";"1";"Scientific Literature";"J Nat Prod";"2013";"CHEMBL3308072";""
"CHEMBL493917";"";"None";"525.51";"2";"6.35";"37";"Cc1c(C(=O)NN2CC3CCCC3C2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CC2CC2)s1";"IC50";"'='";"5719.5";"nM";"5.24";"";"";"UO_0000065";"9.98";"0.20";"-1.11";"10.45";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1090402";"";"None";"481.38";"1";"7.66";"7a";"CC(=O)Nc1c(C(=O)C(C)(C)C)oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL2023049";"";"None";"436.55";"1";"5.04";"11";"O=C(O)c1cccc(NC(=O)c2cc3c(n(CC4CCCCC4)c2=O)CCCCCC3)c1";"IC50";"'='";"268.0";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL505802";"";"None";"291.43";"0";"3.68";"6";"CC/C=C/C/C=C\CC/C=C/C=C/C(=O)NCC(C)(C)O";"IC50";"'='";"9100.0";"nM";"5.04";"";"";"UO_0000065";"17.30";"0.33";"1.36";"10.22";"0";"CHEMBL3089351";"Displacement of [3H]-CP55940 from human CB2 receptor expressed in CHO cells preincubated for 1 hr followed by radioligand addition measured after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3085628";"1";"Scientific Literature";"J Nat Prod";"2013";"CHEMBL3308072";""
"CHEMBL230610";"";"None";"493.84";"1";"6.21";"(S,S)-17";"C[C@H](NS(=O)(=O)c1cc(Cl)cc(Cl)c1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"997.8";"nM";"6.00";"";"";"UO_0000065";"12.15";"0.26";"-0.21";"8.58";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL381791";"";"None";"476.06";"1";"6.81";"SR-144528";"Cc1ccc(Cn2nc(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)cc2-c2ccc(Cl)c(C)c2)cc1";"IC50";"'='";"19.95";"nM";"7.70";"";"";"UO_0000065";"16.17";"0.31";"0.89";"16.41";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL390053";"";"None";"528.29";"2";"6.87";"(S,S)-19";"C[C@H](NS(=O)(=O)c1cc(Cl)c(Cl)cc1Cl)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"622.0";"nM";"6.21";"";"";"UO_0000065";"11.75";"0.26";"-0.66";"8.87";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL271783";"";"None";"396.92";"0";"4.93";"18";"Cc1c(C(=O)NCC2CCCCC2)nn(-c2ccc(Cl)cc2)c1-n1cccc1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"15.87";"0.31";"1.37";"12.15";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3696839";"";"None";"243.74";"0";"2.47";"BDBM163058";"CCCNc1cnn(C(C)(C)C)c(=O)c1Cl";"IC50";"'>'";"10000.0";"nM";"";"";"306198";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL231241";"";"None";"453.01";"1";"5.09";"30";"C[C@H](NS(=O)(=O)CCc1ccccc1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"904.0";"nM";"6.04";"";"";"UO_0000065";"13.34";"0.27";"0.95";"8.64";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL465697";"";"None";"494.00";"1";"6.36";"18c";"O=C(NCC1CCCCC1)N1CCN(C(c2ccc(Cl)cc2)c2ccccc2C(F)(F)F)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL488218";"";"None";"460.45";"1";"6.13";"16b";"O=C(NC1CCCCCC1)N1CCN(C(c2ccc(Cl)cc2)c2ccccc2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL399912";"";"None";"354.40";"0";"4.34";"4-18";"Cc1s/c(=N\C(=O)c2cccc(C(F)(F)F)c2)n(CC2CC2)c1C";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"21.45";"0.43";"3.26";"22.12";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL248015";"";"None";"414.49";"0";"4.95";"4-17";"CCOCCn1c(C)c(C(C)(C)C)s/c1=N\C(=O)c1cccc(C(F)(F)F)c1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"20.84";"0.42";"3.69";"19.82";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL390675";"";"None";"367.49";"1";"6.83";"16";"CCCCCNc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"18.83";"0.34";"0.09";"23.78";"0";"CHEMBL895094";"Displacement of [3H]CP-55940 human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148711";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3307512";""
"CHEMBL2316377";"";"None";"470.53";"0";"3.67";"13b";"COc1ccc(NC(=O)c2ccc(Cn3ccnn3)c3ccccc23)c(C(=O)NCC2CCC2)n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL3930296";"";"None";"385.41";"0";"3.40";"BDBM242519";"O=S(=O)(NCC1CC1)c1ccc(NCc2ccncc2)cc1C(F)(F)F";"IC50";"'='";"3167.0";"nM";"5.50";"";"422879";"UO_0000065";"14.27";"0.29";"2.10";"7.74";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3590644";"";"None";"396.58";"1";"5.51";"59";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(C(C)(C)C)ccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL594935";"";"None";"374.46";"1";"5.82";"25";"COc1ccc(C(=O)c2c(-c3ccc(OC)cc3)sc3ccccc23)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"17.09";"0.32";"0.58";"18.01";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3907898";"";"None";"310.42";"1";"5.09";"17l";"CCCc1sc2ccccc2c1C(=O)c1ccc(OC)cc1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"19.07";"0.37";"0.83";"22.51";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL2316393";"";"None";"387.48";"0";"4.80";"8c";"O=C(NCC1CCCCC1)c1cnccc1NC(=O)c1cccc2ccccc12";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"13.02";"0.24";"0.25";"7.10";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL1095499";"";"None";"517.84";"2";"6.62";"rac-8b";"CC1(C)CC(NC(=O)C2(O)CC2)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"10.67";"0.22";"-1.10";"7.73";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1169572";"";"None";"539.38";"2";"6.67";"8c, diastereomer";"Cc1cc(Cl)ccc1-c1nc2c(cc1-c1ccc(Cl)cc1)C(NC(=O)C(O)C(F)(F)F)CC(C)(C)O2";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"10.14";"0.21";"-1.20";"7.65";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1097455";"";"None";"573.83";"2";"7.41";"8e";"CC1(C)CC(NC(=O)C(C)(O)C(F)(F)F)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"10.20";"0.22";"-1.56";"8.19";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1288209";"";"None";"307.39";"0";"3.87";"XIX";"O=C(/C=C/c1ccc2ccccc2c1)CCCC(=O)NC1CC1";"IC50";"'='";"8020.0";"nM";"5.10";"";"";"UO_0000065";"16.58";"0.30";"1.23";"11.04";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1553629";"";"None";"409.96";"1";"5.35";"1, Org 27569";"CCc1c(C(=O)NCCc2ccc(N3CCCCC3)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL2071066";"";"None";"344.82";"0";"4.50";"16";"CCc1c(C(=O)NCCc2ccc(F)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL1095789";"";"None";"555.89";"2";"7.69";"12d";"CCc1cc(C(=O)N[C@@H]2CC(C)(C)Oc3nc(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)cc32)n[nH]1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"11.34";"0.23";"-1.39";"7.89";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1288265";"";"None";"323.39";"0";"3.18";"XXIV";"O=C(CCC(=O)N1CCOCC1)c1ccc(-c2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1097795";"";"None";"577.90";"2";"8.28";"12n";"CC1(C)C[C@@H](NC(=O)c2cccc3[nH]ncc23)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"9.90";"0.20";"-2.56";"7.16";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1765283";"";"None";"326.40";"0";"2.97";"4-12";"O=C(c1cnco1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"156.0";"nM";"6.81";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765153";"";"None";"335.45";"0";"3.98";"Table 1, R1C2, 2";"O=C(c1ccccc1)N1CC[C@](O)(c2ccccc2)[C@H]2CCCC[C@@H]21";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765259";"";"None";"386.50";"0";"4.53";"3-2";"O=C(c1ccc2ncccc2c1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"0.53";"nM";"9.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765270";"";"None";"376.50";"0";"4.25";"4-7";"O=C(c1ccc(C2CC2)nc1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL2071055";"";"None";"410.95";"1";"5.77";"5";"CCc1c(C(=O)OCCc2ccc(N3CCCCC3)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'='";"8260.0";"nM";"5.08";"";"";"UO_0000065";"12.37";"0.24";"-0.69";"11.21";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL2071057";"";"None";"370.88";"0";"4.85";"7";"CCc1c(C(=O)OCCc2ccc(N(C)C)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'='";"5570.0";"nM";"5.25";"";"";"UO_0000065";"14.17";"0.28";"0.40";"11.59";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL2316382";"";"None";"495.60";"0";"3.53";"18b";"COc1ccc(NC(=O)c2ccc(C[S+](C)[O-])c3ccccc23)c(C(=O)NCC2CCOCC2)n1";"IC50";"'>'";"690.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL4086928";"";"None";"437.58";"0";"3.68";"27";"COc1cccc2c(C(=O)NC34CC5CC(CC(C5)C3)C4)cn(CCN3CCOCC3)c12";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4040541";"Antagonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of CP55940-induced Ca2+ flux preincubated for 10 mins followed by agonist addition by Fluor-4 AM dye based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038324";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3410718";"";"None";"420.30";"0";"4.41";"38";"O=C(NC1CCCCC1)c1cc2cc(Br)cc(OCC3CC3)c2oc1=O";"IC50";"'='";"746.0";"nM";"6.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL528325";"";"None";"399.97";"0";"4.86";"17d";"Cc1ccccc1C(c1ccc(Cl)cc1)N1CCN(C(=O)NC(C)(C)C)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL2153662";"";"None";"530.44";"1";"3.62";"16a, Enantiomer 1";"NC(=O)CN/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL1429129";"";"None";"408.50";"0";"4.61";"SID87225766";"CC1=CC(C)(C)N2C(=O)C3(SCC(=O)N3c3ccc(F)cc3)c3cc(C)cc1c32";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL492860";"";"None";"517.48";"2";"5.73";"44";"CCOCC#Cc1ccc(-c2c(C)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"985.6";"nM";"6.01";"";"";"UO_0000065";"11.61";"0.24";"0.28";"10.11";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL401555";"";"None";"366.38";"0";"4.55";"5";"CC(C)(C)c1c/c(=N\C(=O)c2cccc(C(F)(F)F)c2)n(CC2CC2)o1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"20.03";"0.39";"2.79";"15.45";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL1084039";"";"None";"432.73";"1";"7.12";"5a";"CC1(C)CC(=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"13.60";"0.29";"-1.23";"15.02";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL459506";"";"None";"503.50";"2";"7.16";"21";"CCC/C=C/c1ccc(-c2c(C)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"3838.3";"nM";"5.42";"";"";"UO_0000065";"10.76";"0.22";"-1.74";"10.80";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1084602";"";"None";"398.29";"1";"6.47";"5b";"CC1(C)CC(=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2O1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"14.16";"0.29";"-0.83";"14.39";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL488535";"";"None";"589.52";"1";"3.99";"62";"Nc1nnc(-c2cc(C(F)(F)F)cc(S(=O)(=O)N3CCN(C(=O)[C@@H]4C[C@H]4c4ccc(C(F)(F)F)cc4)CC3)c2)o1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL488730";"";"None";"587.55";"1";"4.45";"66";"Cc1nnc(-c2cc(C(F)(F)F)cc(S(=O)(=O)N3CCN(C(=O)[C@@H]4C[C@H]4c4ccc(C(F)(F)F)cc4)CC3)c2)[nH]1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL1411212";"";"None";"405.50";"0";"3.22";"SID87225745";"Cc1cccn2c(=O)c3cc(C(=O)NC4CCCC4)c(=N)n(C4CCCC4)c3nc12";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1705711";"";"None";"484.67";"0";"3.67";"SID87544632";"CCN(CC)S(=O)(=O)c1ccc(N2CCCCC2)c(C(=O)N2CCN(c3ccccc3)CC2)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL2153666";"";"None";"558.49";"1";"4.40";"20";"CC(C)(N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL1765260";"";"None";"387.48";"0";"3.92";"3-3";"O=C(c1ccc2cnccc2n1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765263";"";"None";"375.47";"0";"3.86";"3-6";"O=C(c1cccc2[nH]ncc12)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765279";"";"None";"342.46";"0";"3.44";"4-8";"O=C(c1cscn1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1544821";"";"None";"474.55";"1";"7.24";"SID85285579";"O=C(CSc1nc2ccccc2s1)N1c2ccccc2Sc2ccc(C(F)(F)F)cc21";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4565127";"";"None";"363.27";"1";"6.37";"23";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2ccc(Cl)cc2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL3410717";"";"None";"450.37";"1";"5.58";"37";"CCCCCCOc1cc(Br)cc2cc(C(=O)NC3CCCCC3)c(=O)oc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL4544453";"";"None";"363.27";"1";"6.37";"22";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2cccc(Cl)c2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL4438047";"";"None";"342.85";"1";"6.02";"32";"Cc1cccc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)s2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL524277";"";"None";"461.78";"1";"5.72";"28";"CCc1c(C2=NC(C)(C)C(=O)N2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"10260.0";"nM";"4.99";"";"";"UO_0000065";"10.80";"0.23";"-0.73";"8.42";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL1094847";"";"None";"519.86";"2";"6.87";"8a";"CC1(C)CC(NC(=O)C(C)(C)O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"10.78";"0.23";"-1.27";"7.84";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1094839";"";"None";"553.87";"2";"8.11";"12a";"CC1(C)C[C@@H](NC(=O)c2ccccc2O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"9.90";"0.20";"-2.63";"7.67";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1096182";"";"None";"541.87";"2";"7.44";"12C";"Cc1cc(C(=O)N[C@@H]2CC(C)(C)Oc3nc(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)cc32)n[nH]1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"10.75";"0.22";"-1.62";"7.29";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1169572";"";"None";"539.38";"2";"6.67";"8c, diastereomer";"Cc1cc(Cl)ccc1-c1nc2c(cc1-c1ccc(Cl)cc1)C(NC(=O)C(O)C(F)(F)F)CC(C)(C)O2";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"10.85";"0.22";"-0.82";"8.19";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL220360";"TARANABANT";"3.0";"515.96";"2";"6.31";"TARANABANT";"C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"12.67";"0.25";"0.23";"8.72";"0";"CHEMBL1105742";"Inhibition of cannabinoid CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"None";""
"CHEMBL1719526";"";"None";"407.47";"0";"3.31";"SID99303153";"CCOc1ccc(CC(=O)N2CCC(n3nc(-c4ccccc4)oc3=O)CC2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1765248";"";"None";"342.48";"0";"2.62";"Table 1, R6C2, 3";"CN1CCC(C(=O)N2CC[C@](O)(c3ccccc3)[C@H]3CCCC[C@H]32)C1";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765251";"";"None";"336.44";"0";"3.37";"2-3";"O=C(c1ccccc1)N1CC[C@](O)(c2cccnc2)[C@H]2CCCC[C@@H]21";"IC50";"'='";"938.0";"nM";"6.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765276";"";"None";"350.46";"0";"3.68";"4-13a";"Cc1ccc(C(=O)N2CC[C@@](O)(c3ccccc3)[C@@H]3CCCC[C@@H]32)cn1";"IC50";"'='";"7.3";"nM";"8.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765277";"";"None";"358.48";"0";"2.00";"5-2a";"CN1CCOC[C@H]1C(=O)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1402210";"";"None";"533.01";"2";"6.21";"SID99303185";"Cc1noc(NS(=O)(=O)c2ccc(NC(=O)c3cc(-c4ccccc4Cl)nc4ccccc34)cc2)c1C";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1765258";"";"None";"386.50";"0";"4.53";"3-1";"O=C(c1cnc2ccccc2c1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"3.38";"nM";"8.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765157";"";"None";"419.50";"0";"4.51";"Table 1, R5C2, 2";"O=C(c1cc(-c2ccccc2F)[nH]n1)N1CC[C@](O)(c2ccccc2)[C@H]2CCCC[C@@H]21";"IC50";"'='";"1286.0";"nM";"5.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1542604";"";"None";"314.77";"0";"4.42";"SID99303179";"COc1ccc(-c2[nH]nc(C)c2-c2ccc(Cl)cc2)c(O)c1";"IC50";"'='";"4830.0";"nM";"5.32";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1703896";"";"None";"436.58";"0";"3.91";"SID99303132";"Cc1nc(N2CCN(C(=O)COc3ccccc3C)CC2)c2c3c(sc2n1)CCCC3";"IC50";"'>'";"13100.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1765249";"";"None";"413.54";"0";"3.38";"2-1";"CS(=O)(=O)c1ccc([C@@]2(O)CCN(C(=O)c3ccccc3)[C@H]3CCCC[C@@H]32)cc1";"IC50";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765250";"";"None";"365.47";"0";"3.99";"2-2";"COc1ccc([C@@]2(O)CCN(C(=O)c3ccccc3)[C@H]3CCCC[C@@H]32)cc1";"IC50";"'='";"358.0";"nM";"6.45";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765286";"";"None";"342.44";"0";"1.80";"5-7";"O=C1CC(C(=O)N2CC[C@@](O)(c3ccccc3)[C@@H]3CCCC[C@@H]32)CN1";"IC50";"'='";"3471.0";"nM";"5.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765287";"";"None";"342.44";"0";"1.94";"5-8";"O=C1CCC(C(=O)N2CC[C@@](O)(c3ccccc3)[C@@H]3CCCC[C@@H]32)N1";"IC50";"'='";"193.0";"nM";"6.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1586567";"";"None";"403.44";"0";"2.77";"SID99303140";"N=c1c(C(=O)NCc2ccco2)cc2c(=O)n3ccccc3nc2n1C1CCCC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL582820";"";"None";"493.05";"1";"6.22";"3k";"C[C@H](NC(=O)C(C)(C)Nc1cc(C(C)(C)C)on1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"254.0";"nM";"6.59";"";"";"UO_0000065";"13.38";"0.26";"0.38";"7.25";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1581985";"";"None";"406.51";"0";"4.18";"SID87225770";"CC1=CC(C)(C)N2C(=O)C3(SCC(=O)N3c3ccc(O)cc3)c3cc(C)cc1c32";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL246515";"";"None";"469.73";"1";"8.18";"3b";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Oc1ccc(F)cc1";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"11.40";"0.24";"-2.82";"11.67";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL246930";"";"None";"487.72";"1";"8.32";"3g";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Oc1cc(F)cc(F)c1";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"13.32";"0.28";"-1.83";"14.15";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL247139";"";"None";"468.75";"1";"8.13";"3k";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Nc1ccc(F)cc1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"11.85";"0.24";"-2.58";"11.40";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL248311";"";"None";"445.73";"1";"6.42";"4b";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1OC1CCOC1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"13.77";"0.29";"-0.28";"11.13";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL3928444";"";"None";"378.46";"0";"4.39";"BDBM242508";"CCCCCCNc1ccc(S(=O)(=O)NCC2CC2)c(C(F)(F)F)c1";"IC50";"'='";"29390.0";"nM";"4.53";"";"422867";"UO_0000065";"11.97";"0.25";"0.14";"7.79";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1288181";"";"None";"335.45";"0";"4.60";"XVII";"O=C(/C=C/c1ccc2ccccc2c1)CCCC(=O)N1CCCCC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1715078";"";"None";"436.52";"0";"1.31";"SID99303142";"N=c1c(C(=O)NCCN2CCOCC2)cc2c(=O)n3ccccc3nc2n1C1CCCC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"SR141716A, Rimonabant";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"9800.0";"nM";"5.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL1707517";"";"None";"314.39";"0";"4.41";"SID99303166";"Cc1ccc(-c2nnc(C)c3nn(-c4ccc(C)cc4)cc23)cc1";"IC50";"'>'";"18000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1765257";"";"None";"336.44";"0";"3.37";"2-9";"O=C(c1ccccc1)N1CC[C@](O)(c2ccccn2)[C@H]2CCCC[C@@H]21";"IC50";"'='";"1357.0";"nM";"5.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1704084";"";"None";"417.51";"0";"4.18";"SID99303149";"O=C(N1CCC(n2nc(-c3ccccc3)oc2=O)CC1)C1(c2ccccc2)CCCC1";"IC50";"'='";"14000.0";"nM";"4.85";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1703285";"";"None";"421.57";"0";"3.91";"SID99303127";"Cc1nc(N2CCN(C(=O)NCc3ccccc3)CC2)c2c3c(sc2n1)CCCC3";"IC50";"'>'";"15200.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1736438";"";"None";"320.78";"0";"4.44";"SID99303156";"Cc1nnc(-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1765254";"";"None";"360.46";"0";"3.85";"2-6";"N#Cc1cccc([C@@]2(O)CCN(C(=O)c3ccccc3)[C@H]3CCCC[C@@H]32)c1";"IC50";"'='";"1045.0";"nM";"5.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL2153674";"";"None";"574.49";"1";"3.37";"26";"C[C@@H](O)[C@H](N/C(=N/S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL395704";"";"None";"328.48";"0";"4.31";"4-1";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2ccccc2)n1CC1CC1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"20.05";"0.39";"2.28";"19.16";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL395216";"";"None";"371.55";"0";"4.37";"4-5";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2cccc(N(C)C)c2)n1CC1CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"20.91";"0.41";"3.40";"20.66";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL2071065";"";"None";"361.27";"1";"5.01";"15";"CCc1c(C(=O)NCCc2ccc(Cl)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL2071072";"";"None";"343.77";"0";"3.70";"22";"O=C(NCCc1ccc([N+](=O)[O-])cc1)c1cc2cc(Cl)ccc2[nH]1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL1765284";"";"None";"407.44";"0";"3.74";"4-14";"O=C(c1cn(CC(F)(F)F)cn1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL2071060";"";"None";"371.82";"0";"4.26";"10";"CCc1c(C(=O)NCCc2ccc([N+](=O)[O-])cc2)[nH]c2ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL2071064";"";"None";"340.85";"0";"4.66";"14";"CCc1c(C(=O)NCCc2ccc(C)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL260095";"";"None";"452.77";"1";"5.06";"41";"Cc1c(C(=O)NN2CCCCC2)nn(-c2c(Cl)cc(Cl)cc2Cl)c1-n1cccc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL397857";"";"None";"342.51";"0";"4.62";"4-6";"Cc1cccc(C(=O)/N=c2\sc(C(C)(C)C)c(C)n2CC2CC2)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"22.36";"0.44";"3.04";"22.29";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL248385";"";"None";"414.47";"1";"5.46";"4-25";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2cc(C(F)(F)F)ccc2F)n1CC1CC1";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"20.43";"0.41";"3.01";"24.65";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL248203";"";"None";"430.92";"1";"5.98";"4-23";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2ccc(Cl)c(C(F)(F)F)c2)n1CC1CC1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"15.40";"0.32";"0.66";"19.32";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL248013";"";"None";"370.44";"0";"4.94";"4-14";"CCn1c(C)c(C(C)(C)C)s/c1=N\C(=O)c1cccc(C(F)(F)F)c1";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"19.25";"0.39";"2.19";"20.75";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL1765262";"";"None";"375.47";"0";"3.86";"3-5";"O=C(c1cccc2[nH]cnc12)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765255";"";"None";"413.54";"0";"3.38";"2-7";"CS(=O)(=O)c1cccc([C@@]2(O)CCN(C(=O)c3ccccc3)[C@H]3CCCC[C@@H]32)c1";"IC50";"'='";"338.0";"nM";"6.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL571302";"";"None";"700.90";"2";"9.69";"16u";"Cc1nnc(-c2c(-c3nnc(C4(c5ccc(Cl)cc5)CC4)s3)nn(-c3ccc(Cl)cc3Cl)c2-c2ccc(Br)cc2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1038202";"Displacement of [3H]WIN-552122 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156125";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL1823117";"SESQUICANNABIGEROL";"None";"384.60";"1";"7.79";"4, sesqui-CBG";"CCCCCc1cc(O)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(O)c1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"15.99";"0.30";"-1.64";"15.20";"0";"CHEMBL1825335";"Displacement of [3H]-CP-55,940 from human recombinant CB2 receptor expressed in HEK293 cells membrane incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821606";"1";"Scientific Literature";"J Nat Prod";"2011";"CHEMBL3307715";""
"CHEMBL1950329";"";"None";"524.71";"2";"5.89";"17; AZ11713908";"CCOc1ccc(Cc2nc3cc(N(C)S(=O)(=O)c4cccs4)ccc3n2CC2CCCCC2)nc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"17.15";"0.34";"3.11";"11.64";"0";"CHEMBL4354886";"Inhibition of 3H-CP55,940 tracer binding to human CB2 receptor expressed in Sf9 insect cell membranes after 1 hr by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354779";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3308860";""
"CHEMBL480025";"";"None";"385.89";"1";"6.40";"8a";"Cc1c(C(=O)c2ccccc2)cc(-c2ccccc2)n1Cc1ccc(Cl)cc1";"IC50";"'='";"498.0";"nM";"6.30";"";"";"UO_0000065";"16.33";"0.31";"-0.10";"28.65";"0";"CHEMBL981472";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143356";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL1468612";"";"None";"489.94";"0";"4.59";"SID87225748";"CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1420800";"";"None";"459.53";"1";"5.10";"SID87225767";"COc1ccc(NS(=O)(=O)c2ccc3[nH]c(COc4cccc5ccccc45)nc3c2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1545109";"";"None";"473.53";"1";"5.32";"SID87225757";"CCCCC1(Cc2ccc(OC)c([N+](=O)[O-])c2)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL271824";"";"None";"445.39";"1";"5.96";"33";"Cc1c(C(=O)NC2CCCCC2)nn(-c2ccc(Cl)c(Cl)c2)c1-n1c(C)ccc1C";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"19.69";"0.40";"2.81";"16.91";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1094521";"";"None";"505.83";"2";"6.48";"3";"C[C@H](O)C(=O)NC1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"10.51";"0.22";"-1.16";"7.44";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL492861";"";"None";"531.51";"2";"6.12";"45";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CCOC(C)C)s1";"IC50";"'='";"1761.1";"nM";"5.75";"";"";"UO_0000065";"10.83";"0.22";"-0.37";"9.69";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1288119";"";"None";"321.42";"0";"4.21";"X";"O=C(/C=C/c1ccc2ccccc2c1)CCC(=O)N1CCCCC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1288208";"";"None";"311.38";"0";"2.70";"XVIII";"O=C(/C=C/c1ccc2ccccc2c1)CCCC(=O)NCCO";"IC50";"'='";"4080.0";"nM";"5.39";"";"";"UO_0000065";"17.31";"0.32";"2.69";"8.12";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL4088509";"";"None";"467.97";"1";"5.37";"9";"Cc1cc(-c2cc(C(=O)N[C@H]3CC[C@@H](C)CC3)c(=O)n(Cc3ccc(F)cc3)n2)ccc1Cl";"IC50";"'='";"20.7";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3998735";"Inverse agonist activity at human CB2 receptor expressed in HEK293 EBNA cell membranes after 30 mins by [35S]-GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997787";"1";"Scientific Literature";"Eur J Med Chem";"2017";"CHEMBL3307715";""
"CHEMBL3596741";"";"None";"301.39";"0";"4.11";"6b";"O=C(/C=C/C=C/c1ccc2c(c1)-c1ccccc1C2)NC1CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL1091832";"";"None";"483.35";"1";"6.24";"7e";"CC(C)C(=O)c1oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c1NC(=O)CO";"IC50";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"10.95";"0.22";"-0.95";"5.73";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL271610";"";"None";"394.87";"0";"3.32";"19";"N#Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2)c1-n1cccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL230062";"";"None";"493.84";"1";"6.21";"(S,S)-13";"C[C@H](NS(=O)(=O)c1cccc(Cl)c1Cl)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"201.7";"nM";"6.70";"";"";"UO_0000065";"13.56";"0.29";"0.49";"9.57";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL495110";"";"None";"516.50";"2";"5.26";"47";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CCN(C)C)s1";"IC50";"'='";"1269.4";"nM";"5.90";"";"";"UO_0000065";"11.42";"0.24";"0.64";"11.04";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL460987";"";"None";"529.54";"2";"7.14";"19";"CCCC#Cc1ccc(-c2c(CC)c(C(=O)NN3CCCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"309.9";"nM";"6.51";"";"";"UO_0000065";"12.29";"0.25";"-0.63";"12.98";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1089018";"";"None";"493.78";"1";"7.94";"6f";"Nc1c(C(=O)c2ccccc2)oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"12.87";"0.26";"-1.58";"9.20";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1089353";"";"None";"441.31";"1";"6.00";"6i";"CC(C)(O)C(=O)c1oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c1N";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"12.87";"0.26";"-0.32";"6.35";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1090404";"";"None";"510.42";"2";"6.86";"7c";"CNCC(=O)Nc1c(C(=O)C(C)(C)C)oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"10.74";"0.21";"-1.38";"6.51";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1085259";"";"None";"448.78";"1";"7.62";"rac-7c";"COC1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"3790.0";"nM";"5.42";"";"";"UO_0000065";"12.08";"0.26";"-2.20";"17.29";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL3914042";"";"None";"390.47";"0";"4.53";"BDBM242504";"O=S(=O)(NCC1CC1)c1ccc(NC2CCCCCC2)cc1C(F)(F)F";"IC50";"'='";"78.0";"nM";"7.11";"";"422861";"UO_0000065";"18.20";"0.37";"2.58";"12.21";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3948197";"";"None";"448.46";"0";"3.78";"BDBM242444";"COCCCNS(=O)(=O)c1ccc(Nc2cc(OC)cc(OC)c2)cc1C(F)(F)F";"IC50";"'='";"3978.0";"nM";"5.40";"";"422789";"UO_0000065";"12.04";"0.25";"1.62";"6.29";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL247308";"";"None";"548.80";"2";"7.65";"15c";"CN(C)NC(=O)c1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Oc1ccc(F)c(F)c1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"10.47";"0.22";"-1.91";"10.55";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL4539271";"";"None";"323.78";"1";"5.05";"9";"O=C(Nc1ccc(Cl)cc1)Nc1cncc(-c2ccccc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL4577814";"";"None";"323.78";"1";"5.05";"10";"O=C(Nc1ccc(Cl)cc1)Nc1ccnc(-c2ccccc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL488614";"";"None";"479.97";"1";"6.11";"18a";"O=C(NC1CCCCC1)N1CCN(C(c2ccc(Cl)cc2)c2ccccc2C(F)(F)F)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL567874";"";"None";"549.42";"2";"7.00";"3c";"C[C@H](NC(=O)C(C)(C)Nc1ncc(C(F)(F)F)cc1Cl)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"419.0";"nM";"6.38";"";"";"UO_0000065";"11.61";"0.24";"-0.62";"8.20";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL567679";"";"None";"514.98";"2";"6.35";"3d";"C[C@H](NC(=O)C(C)(C)Nc1cc(C(F)(F)F)ccn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"353.0";"nM";"6.45";"";"";"UO_0000065";"12.53";"0.24";"0.10";"8.29";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL248202";"";"None";"411.45";"0";"3.73";"4-21";"Cc1c(C(=O)N(C)C)s/c(=N\C(=O)c2cccc(C(F)(F)F)c2)n1CC1CC1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"14.58";"0.29";"2.27";"10.97";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL398666";"";"None";"396.48";"1";"5.33";"4-9";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2cccc(C(F)(F)F)c2)n1CC1CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"19.89";"0.40";"2.56";"22.95";"1";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL248387";"";"None";"439.55";"1";"5.39";"4-28";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2cc(C(F)(F)F)ccc2N(C)C)n1CC1CC1";"IC50";"'='";"9.4";"nM";"8.03";"";"";"UO_0000065";"18.26";"0.37";"2.64";"21.35";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL247830";"";"None";"396.48";"1";"5.33";"4-10";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2ccccc2C(F)(F)F)n1CC1CC1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"23.46";"0.47";"3.97";"27.07";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL202659";"";"None";"515.83";"2";"6.25";"30";"CC(=O)Nc1c(N(C)C)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"10.86";"0.23";"-0.65";"8.33";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL393620";"";"None";"414.60";"1";"5.01";"3g";"Cc1c(C(C)(C)C)s/c(=N\S(=O)(=O)c2ccc3ccccc3c2)n1CC1CC1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"15.22";"0.31";"1.30";"12.27";"0";"CHEMBL897874";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149669";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL1090403";"";"None";"510.42";"2";"7.79";"7b";"CN(C)C(=O)Nc1c(C(=O)C(C)(C)C)oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"1970.0";"nM";"5.71";"";"";"UO_0000065";"11.18";"0.22";"-2.08";"7.56";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1092168";"";"None";"483.35";"1";"6.38";"7f";"CC(=O)Nc1c(C(=O)C(C)(C)O)oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"10.90";"0.22";"-1.11";"5.70";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL271988";"";"None";"383.88";"0";"3.76";"17";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2)c1-n1cccc1";"IC50";"'='";"2770.0";"nM";"5.56";"";"";"UO_0000065";"14.48";"0.28";"1.80";"10.09";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1760938";"";"None";"405.38";"0";"2.60";"17a";"O=C(N[C@H](c1ccccn1)C(F)(F)F)c1nc(N2CCOCC2)n2ccccc12";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL398778";"";"None";"348.49";"0";"3.08";"3e";"C#CCn1c(C)c(C(C)(C)C)s/c1=N\S(=O)(=O)c1ccccc1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"19.16";"0.40";"3.60";"12.98";"0";"CHEMBL897874";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149669";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL393263";"";"None";"505.74";"2";"7.55";"15a";"NC(=O)c1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Oc1ccc(F)c(F)c1";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"10.50";"0.22";"-2.24";"8.14";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL400931";"";"None";"382.45";"1";"5.15";"4-19";"Cc1c(C(C)C)s/c(=N\C(=O)c2cccc(C(F)(F)F)c2)n1CC1CC1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"19.71";"0.40";"2.39";"21.94";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL230923";"";"None";"493.84";"1";"6.21";"(S,S)-14";"C[C@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"300.8";"nM";"6.52";"";"";"UO_0000065";"13.21";"0.29";"0.31";"9.32";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL230182";"";"None";"404.96";"0";"4.64";"8";"C[C@H](NS(=O)(=O)C(C)(C)C)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL3774721";"";"None";"435.57";"0";"4.51";"27";"CCCCCn1cc(C(=O)NC2CCCCCC2)c(=O)n2nc(-c3ccc(C)cc3)nc12";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL410727";"";"None";"522.26";"2";"7.13";"26";"Cc1c(C(=O)NCc2ccc(Cl)c(Cl)c2)nn(-c2ccc(Cl)cc2Cl)c1-n1c(C)ccc1C";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"10.15";"0.22";"-1.83";"10.22";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL4104806";"";"None";"453.65";"0";"4.39";"28";"CSc1cccc2c(C(=O)NC34CC5CC(CC(C5)C3)C4)cn(CCN3CCOCC3)c12";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4040541";"Antagonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of CP55940-induced Ca2+ flux preincubated for 10 mins followed by agonist addition by Fluor-4 AM dye based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038324";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL487090";"";"None";"572.53";"1";"4.55";"51";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-n3cccn3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL603053";"";"None";"671.81";"2";"6.86";"45c";"O=C(c1nn(-c2ccccc2Cl)c(-c2ccc(Br)cc2)c1Cn1cncn1)N1CCN(c2cccc(Cl)c2Cl)CC1";"IC50";"'='";"582.0";"nM";"6.24";"";"";"UO_0000065";"9.28";"0.21";"-0.62";"8.65";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL598549";"";"None";"675.21";"2";"7.25";"52c";"Cc1cc(Br)ccc1CNC(=O)c1nn(-c2ccc(Cl)cc2Cl)c(-c2ccc(Br)cc2)c1Cn1cncn1";"IC50";"'='";"6480.0";"nM";"5.19";"";"";"UO_0000065";"7.68";"0.19";"-2.06";"6.68";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL487172";"";"None";"486.79";"1";"6.91";"26";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2CC#N)o1";"IC50";"'='";"539.0";"nM";"6.27";"";"";"UO_0000065";"12.88";"0.27";"-0.64";"7.78";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL603875";"";"None";"608.33";"2";"6.67";"55d";"O=C(NC1(c2ccc(Cl)cc2)CC1)c1nn(-c2ccccc2Cl)c(-c2ccc(Br)cc2)c1Cn1cncn1";"IC50";"'='";"2570.0";"nM";"5.59";"";"";"UO_0000065";"9.19";"0.20";"-1.08";"7.20";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL4521036";"";"None";"295.39";"0";"3.26";"34";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cc2cccnc2[nH]1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL4578936";"";"None";"365.52";"0";"4.93";"19";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c2ncccc21";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL521068";"";"None";"494.89";"1";"6.64";"14c";"O=C(NCC1CCCCC1)N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL381689";"SR-144528";"None";"476.06";"1";"6.81";"SR-144528";"Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1";"IC50";"'='";"3.162";"nM";"8.50";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL3696853";"";"None";"345.49";"0";"2.93";"BDBM163072";"CN(C)CCn1cc2c(=O)n(C3CC(C)(C)CC(C)(C)C3)ncc2n1";"IC50";"'='";"2042.0";"nM";"5.69";"";"306212";"UO_0000065";"16.47";"0.31";"2.76";"10.17";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL389774";"";"None";"473.43";"1";"5.70";"(S,S)-28";"C[C@H](NS(=O)(=O)Cc1cccc(Cl)c1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"12.04";"0.25";"0.00";"8.15";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL2153665";"";"None";"544.46";"1";"4.01";"19";"C[C@H](N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL2153667";"";"None";"587.49";"1";"2.86";"21";"NC(=O)C[C@H](N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL261031";"";"None";"413.87";"0";"4.95";"6c";"Cn1c(C(C)(C)C)c/c(=N\C(=O)c2cccc(C(F)(F)F)c2Cl)n1CC1CC1";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"20.37";"0.41";"3.48";"21.46";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL408430";"";"None";"503.34";"1";"4.87";"AM-1241";"CN1CCCCC1Cn1cc(C(=O)c2cc([N+](=O)[O-])ccc2I)c2ccccc21";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"16.82";"0.40";"3.60";"12.38";"0";"CHEMBL921013";"Binding affinity to CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"SR-141716";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1760.0";"nM";"5.75";"";"";"UO_0000065";"12.41";"0.26";"-0.19";"11.47";"1";"CHEMBL957520";"Displacement of [3H]WIN-55212-2 from human recombinant cannabinoid CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL1288118";"";"None";"325.36";"0";"3.40";"IX";"COc1ccc(/C=C/C(=O)CCC(=O)Nc2ccc(O)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL397119";"";"None";"459.76";"1";"6.66";"4c";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1OCC1CCOC1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"13.85";"0.29";"-0.29";"11.55";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL391555";"";"None";"469.73";"1";"8.18";"3a";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Oc1cccc(F)c1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"12.00";"0.25";"-2.54";"12.28";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"1";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"603.3";"nM";"6.22";"";"";"UO_0000065";"13.41";"0.28";"0.28";"12.40";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL467917";"";"None";"472.98";"1";"5.32";"47";"CN(C)c1ccc(-c2cc3c(nc2-c2ccccc2Cl)nc(C(C)(C)C)n2c(=O)[nH]nc32)cc1";"IC50";"'='";"770.0";"nM";"6.11";"";"";"UO_0000065";"12.93";"0.25";"0.79";"7.72";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL467701";"";"None";"459.94";"1";"5.26";"44";"COc1ccc(-c2cc3c(nc2-c2ccccc2Cl)nc(C(C)(C)C)n2c(=O)[nH]nc32)cc1";"IC50";"'='";"891.0";"nM";"6.05";"";"";"UO_0000065";"13.15";"0.25";"0.79";"7.10";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL466062";"";"None";"409.32";"1";"6.37";"29";"CC(C)c1nc(N)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2n1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL2153673";"";"None";"584.53";"1";"4.79";"25";"NC(=O)[C@@H](N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C1CCC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL2153760";"";"None";"511.99";"1";"2.67";"31";"NC(=O)CN/C(=N\S(=O)(=O)c1ccc(O)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"10.35";"0.21";"2.63";"3.86";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL2153765";"";"None";"601.52";"1";"3.12";"37";"C[C@H](N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(=O)NCC(N)=O";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL1288238";"";"None";"323.39";"0";"2.82";"XXII";"O=C(/C=C/c1ccc(-c2ccccc2)cc1)CCC(=O)NCCO";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL568094";"";"None";"446.98";"1";"5.33";"3f";"C[C@H](NC(=O)C(C)(C)Nc1ccccn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1830.0";"nM";"5.74";"";"";"UO_0000065";"12.84";"0.24";"0.41";"7.37";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL188";"WIN-552122";"None";"426.52";"0";"4.60";"WIN-55212-2";"Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL888167";"Agonist activity at human CB2 in CHO cells assessed as inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140004";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL218649";"";"None";"456.41";"1";"6.68";"(S,S)-17";"C[C@H](NC(=O)C(C)(C)Oc1ccc(Cl)cc1)[C@@H](Cc1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"770.0";"nM";"6.11";"";"";"UO_0000065";"13.39";"0.27";"-0.57";"15.95";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL3669118";"";"None";"479.87";"0";"3.32";"BDBM176670";"COc1nc(NCCc2ccc(OC(F)F)cc2)nc(-c2ccc(Cl)c(OCC(N)=O)c2)n1";"IC50";"'='";"11.0";"nM";"7.96";"";"322583";"UO_0000065";"16.58";"0.33";"4.64";"6.55";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL247511";"";"None";"425.71";"1";"6.43";"5c";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1-n1ccnc1";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"15.29";"0.32";"0.08";"11.94";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL393262";"";"None";"403.27";"1";"6.05";"7b";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccccc2Cl)nc1-c1cncnc1";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"13.31";"0.26";"-0.68";"8.59";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL246686";"";"None";"493.44";"1";"6.29";"5h";"CC(C)(C)C(=O)N1CCN(c2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2C#N)CC1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"12.08";"0.24";"-0.33";"9.89";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL527108";"";"None";"487.82";"1";"6.36";"14";"C=CCN1C(c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C)=NC(=O)C1(C)C";"IC50";"'='";"2881.5";"nM";"5.54";"";"";"UO_0000065";"11.36";"0.24";"-0.82";"10.97";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL524727";"";"None";"487.82";"1";"6.34";"15";"Cc1c(C2=NC(=O)C(C)(C)N2C2CC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1950.4";"nM";"5.71";"";"";"UO_0000065";"11.70";"0.24";"-0.63";"11.31";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL500688";"";"None";"447.75";"1";"5.50";"17";"CN1C(c2cc(-c3ccc(Cl)cc3)n(-c3ccc(Cl)cc3Cl)n2)=NC(=O)C1(C)C";"IC50";"'='";"7946.1";"nM";"5.10";"";"";"UO_0000065";"11.39";"0.24";"-0.40";"10.10";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL230826";"";"None";"475.01";"1";"6.06";"24";"C[C@H](NS(=O)(=O)c1cccc2ccccc12)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1117.0";"nM";"5.95";"";"";"UO_0000065";"12.53";"0.25";"-0.11";"8.51";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL231636";"";"None";"515.96";"2";"6.31";"2";"C[C@H](NC(=O)C(C)(C)Oc1cncc(C(F)(F)F)c1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"284.7";"nM";"6.55";"";"";"UO_0000065";"12.69";"0.25";"0.24";"8.73";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL231034";"";"None";"473.43";"1";"5.70";"(S,S)-27";"C[C@H](NS(=O)(=O)Cc1ccccc1Cl)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1918.0";"nM";"5.72";"";"";"UO_0000065";"12.08";"0.25";"0.02";"8.17";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL230716";"";"None";"460.93";"1";"5.18";"(S,S)-21";"C[C@H](NS(=O)(=O)c1cc(F)cc(F)c1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1079.0";"nM";"5.97";"";"";"UO_0000065";"12.95";"0.26";"0.79";"8.53";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL4559573";"";"None";"365.52";"0";"4.93";"35";"CCCCCn1c(C(=O)NC23CC4CC(CC(C4)C2)C3)cc2ncccc21";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL1092169";"";"None";"499.35";"1";"5.35";"2";"CC(C)(O)C(=O)c1oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c1NC(=O)CO";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"10.55";"0.21";"-0.08";"4.68";"1";"CHEMBL1105742";"Inhibition of cannabinoid CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"None";""
"CHEMBL243334";"";"None";"340.42";"1";"6.01";"11";"CCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"20.70";"0.37";"1.04";"26.79";"0";"CHEMBL895094";"Displacement of [3H]CP-55940 human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148711";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3307512";""
"CHEMBL4457227";"";"None";"323.78";"1";"5.05";"8";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccccc2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL512618";"";"None";"471.95";"1";"5.45";"46";"CC(=O)c1ccc(-c2cc3c(nc2-c2ccccc2Cl)nc(C(C)(C)C)n2c(=O)[nH]nc32)cc1";"IC50";"'='";"5800.0";"nM";"5.24";"";"";"UO_0000065";"11.10";"0.21";"-0.21";"5.63";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL261381";"";"None";"418.33";"0";"4.41";"28";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)c(Cl)c2)c1-n1cccc1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"18.17";"0.37";"3.19";"13.80";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL367819";"";"None";"501.75";"2";"8.10";"10d";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1OCc1ccc(F)c(F)c1";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"12.52";"0.26";"-1.82";"13.69";"0";"CHEMBL827164";"Inhibitory concentration tested against human Cannabinoid receptor 2 (hCB2)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"1, rimonabant, SR-141716A";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1939.8";"nM";"5.71";"";"";"UO_0000065";"12.32";"0.26";"-0.23";"11.39";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL497913";"";"None";"473.79";"1";"5.86";"29";"CCc1c(C2=NC3(CCC3)C(=O)N2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"3177.2";"nM";"5.50";"";"";"UO_0000065";"11.60";"0.24";"-0.36";"9.27";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL248135";"";"None";"334.49";"1";"5.03";"1";"CCOC(=O)N1CC(C)(C)CS/C1=N\c1ccccc1C(C)C";"IC50";"'='";"322.0";"nM";"6.49";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL888167";"Agonist activity at human CB2 in CHO cells assessed as inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140004";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL380483";"";"None";"544.82";"2";"5.84";"26";"CC(=O)Nc1c(C(C)=O)c(=O)n(CCO)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"10.69";"0.22";"-0.02";"5.75";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL381677";"";"None";"514.84";"2";"7.31";"29";"CC(=O)Nc1c(C(C)C)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"10.23";"0.21";"-2.04";"8.23";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL1084820";"(2S)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)";"None";"511.45";"2";"6.75";"12e, Enantiomer 1";"C[C@H](O)C(=O)NC1CC2(CCCCC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"11.23";"0.22";"-1.01";"8.04";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL406924";"";"None";"417.34";"1";"5.34";"24";"Cc1c(C(=O)NC2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-n1cccc1";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"16.99";"0.35";"1.75";"13.68";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3964674";"";"None";"358.52";"1";"5.25";"BDBM235945";"CCCCCc1cc(OC)c(C2=C[C@H]3CC[C@]2(CO)C3(C)C)c(OC)c1";"IC50";"'='";"1150.0";"nM";"5.94";"";"411180";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3120198";"";"None";"426.90";"0";"4.25";"5a";"COc1ccc(-n2c(-c3ccc(Cl)cc3)nn(C(=O)NC3CCCCC3)c2=O)cc1";"IC50";"'='";"1510.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL397509";"";"None";"459.40";"1";"5.56";"12";"C[C@H](NS(=O)(=O)c1ccc(Cl)cc1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"454.2";"nM";"6.34";"";"";"UO_0000065";"13.81";"0.29";"0.78";"9.07";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL493303";"";"None";"553.56";"2";"7.13";"39";"Cc1c(C(=O)NN2CC3CCCC3C2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CC2CCCC2)s1";"IC50";"'='";"901.7";"nM";"6.04";"";"";"UO_0000065";"10.92";"0.22";"-1.09";"12.05";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL494728";"";"None";"541.55";"2";"7.28";"40";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CC2CCCCC2)s1";"IC50";"'='";"1576.4";"nM";"5.80";"";"";"UO_0000065";"10.71";"0.22";"-1.48";"11.57";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL518817";"";"None";"531.55";"2";"7.33";"24";"CCCCCc1ccc(-c2c(C)c(C(=O)NN3CC4CCCC4C3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"3664.3";"nM";"5.44";"";"";"UO_0000065";"10.23";"0.21";"-1.89";"10.84";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"2, SR-141716A, rimonabant";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"4570.0";"nM";"5.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL966990";"Binding affinity to human CB2 receptor by [35S]GTPgammaS binding assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140076";"1";"Scientific Literature";"J Med Chem";"2008";"None";""
"CHEMBL3109763";"";"None";"497.00";"1";"6.75";"3";"Cc1c(C(=O)N[C@@H]2CCCC[C@H]2O)cc(-c2cc(C(F)(F)F)ccc2Cl)n1CC1CCCCC1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3111770";"Displacement of [3H]CP55940 from human CB2 receptor expressed in CHOK1 cells after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108674";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3307512";""
"CHEMBL3120200";"";"None";"410.91";"0";"4.55";"5c";"Cc1ccc(-n2c(-c3ccc(Cl)cc3)nn(C(=O)NC3CCCCC3)c2=O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL445936";"";"None";"350.51";"0";"3.63";"3b";"C=CCn1c(C)c(C(C)(C)C)s/c1=N\S(=O)(=O)c1ccccc1";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"20.33";"0.42";"3.49";"13.85";"0";"CHEMBL897874";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149669";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL1713756";"";"None";"392.46";"1";"5.47";"SID99303159";"COc1ccc(-n2cc3c(-c4ccc(-c5ccccc5)cc4)nnc(C)c3n2)cc1";"IC50";"'='";"2090.0";"nM";"5.68";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3921018";"";"None";"419.51";"0";"4.38";"BDBM242521";"CC(C)(NS(=O)(=O)c1ccc(NN2CCCCCC2)cc1C(F)(F)F)C1CC1";"IC50";"'='";"264.0";"nM";"6.58";"";"422881";"UO_0000065";"15.68";"0.32";"2.20";"10.71";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL440407";"";"None";"429.46";"0";"4.45";"6j";"CC(C)OCCn1/c(=N/C(=O)c2cccc(C(F)(F)F)c2F)cc(C(C)(C)C)n1C";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"19.99";"0.39";"4.14";"17.69";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL4542056";"";"None";"408.55";"0";"3.07";"38";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cc2ncccc2n1CCN1CCOCC1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL4587636";"";"None";"295.39";"0";"3.26";"16";"O=C(NC12CC3CC(CC(C3)C1)C2)c1c[nH]c2cccnc12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL246723";"";"None";"487.72";"1";"8.32";"3f";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Oc1ccc(F)c(F)c1";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"11.05";"0.23";"-2.93";"11.73";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL246721";"";"None";"486.19";"1";"8.69";"3c";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Oc1cccc(Cl)c1";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"11.08";"0.24";"-3.30";"11.73";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL469765";"";"None";"567.86";"2";"7.49";"12k";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C(=O)Nc2ccccn2)o1";"IC50";"'='";"636.0";"nM";"6.20";"";"";"UO_0000065";"10.91";"0.22";"-1.29";"6.28";"0";"CHEMBL957520";"Displacement of [3H]WIN-55212-2 from human recombinant cannabinoid CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL2071056";"";"None";"372.81";"0";"4.69";"6";"CCc1c(C(=O)OCCc2ccc([N+](=O)[O-])cc2)[nH]c2ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL2071059";"";"None";"424.98";"0";"4.11";"9";"CCc1c(C(=O)NCCc2ccc(N3CCN(C)CC3)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'='";"6970.0";"nM";"5.16";"";"";"UO_0000065";"12.13";"0.23";"1.05";"10.04";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL3785379";"";"None";"463.47";"0";"2.95";"(+/-)-4a";"O=C1[C@H](c2ccc(F)cc2)[C@@H](c2ccc3c(c2)OCO3)N1C1CCN(C(=O)n2cncn2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3791992";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785023";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL244189";"";"None";"411.50";"0";"4.94";"7";"O=C(c1cccc2ccccc12)c1ccc(OCCN2CCOCC2)c2ccccc12";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"12.05";"0.22";"0.02";"12.79";"0";"CHEMBL895094";"Displacement of [3H]CP-55940 human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148711";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3307512";""
"CHEMBL4860470";"";"None";"357.89";"0";"4.69";"9";"O=C(NCCc1ccc(N2CCCCC2)cc1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL4848650";"";"None";"317.82";"0";"3.77";"12";"CN(C)c1ccc(CCNC(=O)Nc2ccc(Cl)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL492486";"";"None";"503.46";"2";"5.34";"43";"COCC#Cc1ccc(-c2c(C)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"2737.4";"nM";"5.56";"";"";"UO_0000065";"11.05";"0.23";"0.22";"9.37";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1089032";"";"None";"497.38";"1";"6.63";"7d";"CC(C)(C)C(=O)c1oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c1NC(=O)CO";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"10.99";"0.22";"-1.16";"5.92";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1097456";"N-[6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-YL]-4,4,4-TRIFLUORO-3-HYDROXYBUTANAMIDE (DIASTEREOMERIC MIX)";"None";"573.83";"2";"7.41";"8f, diastereomer";"CC1(C)CC(NC(=O)CC(O)C(F)(F)F)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"11.51";"0.24";"-0.81";"9.24";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1095159";"";"None";"541.81";"2";"6.72";"8h";"CC1(C)CC(NC(=O)C(F)(F)CO)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"10.86";"0.23";"-0.83";"8.24";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1094840";"";"None";"552.89";"2";"7.99";"12b";"CC1(C)C[C@@H](NC(=O)c2ccccc2N)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"11.68";"0.24";"-1.53";"8.36";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1098847";"";"None";"475.80";"1";"7.11";"14";"CC(=O)N[C@H]1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"9400.0";"nM";"5.03";"";"";"UO_0000065";"10.57";"0.22";"-2.08";"9.81";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1095211";"";"None";"641.82";"2";"8.34";"15";"CC1(C)C[C@@H](NC(=O)CC(O)(C(F)(F)F)C(F)(F)F)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"11.30";"0.24";"-1.09";"10.15";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL3915743";"";"None";"340.43";"1";"5.54";"8h";"O=C(c1cccc2ccccc12)n1c(C2CCCC2)nc2ccccc21";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"16.27";"0.29";"0.00";"15.87";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3889952";"";"None";"330.45";"1";"6.24";"16l";"CCCc1sc2ccccc2c1C(=O)c1cccc2ccccc12";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"16.24";"0.31";"-0.87";"31.44";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3892181";"";"None";"328.42";"1";"5.08";"8d";"CC(C)Cc1nc2ccccc2n1C(=O)c1cccc2ccccc12";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"19.19";"0.34";"1.22";"18.06";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3919567";"";"None";"430.49";"0";"4.25";"BDBM242503";"CC(=O)N(CC1CC1)S(=O)(=O)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"431.0";"nM";"6.37";"";"422859";"UO_0000065";"14.79";"0.30";"2.12";"9.58";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3905264";"";"None";"432.42";"0";"2.94";"BDBM242440";"COc1cc(OC)nc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)n1";"IC50";"'='";"511.0";"nM";"6.29";"";"422785";"UO_0000065";"14.55";"0.30";"3.35";"6.14";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1095476";"";"None";"555.89";"2";"7.75";"12f";"Cc1[nH]nc(C(=O)N[C@@H]2CC(C)(C)Oc3nc(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)cc32)c1C";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"10.53";"0.22";"-1.90";"7.33";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL479833";"";"None";"276.34";"0";"3.80";"5b";"Cc1[nH]c(-c2ccccc2)c(N)c1C(=O)c1ccccc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL981472";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143356";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL4100917";"";"None";"470.62";"1";"7.10";"C";"CCN(CC)C(=O)c1ccc2c(c1)nc(Nc1ccc(Oc3ccccc3)cc1)n2CCC(C)C";"IC50";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"13.39";"0.25";"-0.80";"10.61";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL3905573";"";"None";"294.35";"0";"3.69";"9b";"CCCc1nc2ccccc2n1C(=O)c1ccc(OC)cc1";"IC50";"'='";"7600.0";"nM";"5.12";"";"";"UO_0000065";"17.39";"0.32";"1.43";"11.60";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3898407";"";"None";"288.37";"1";"5.29";"19";"O=C(c1cccc2ccccc12)c1csc2ccccc12";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"20.66";"0.39";"0.67";"34.91";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL1086494";"";"None";"497.42";"1";"6.36";"rac-12b";"O=C(CO)NC1CC2(CCCCC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"10.81";"0.22";"-0.98";"7.53";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL3590640";"";"None";"356.47";"0";"3.83";"55";"CCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(OC)ccc21";"IC50";"'='";"4190.0";"nM";"5.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL474424";"";"None";"506.22";"2";"6.54";"9c";"O=C(Cn1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2Cl)n1)NCc1ccccc1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL521084";"";"None";"542.20";"2";"6.82";"9l";"O=C(Cn1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2Cl)n1)NCc1cc(F)ccc1F";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL3669114";"";"None";"477.95";"0";"3.44";"BDBM176666";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(Cl)c(S(=O)(=O)NC3CC3)c2)n1";"IC50";"'='";"4.0";"nM";"8.40";"";"322577";"UO_0000065";"17.57";"0.36";"4.96";"7.92";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2153669";"";"None";"572.52";"1";"4.64";"23, JD-5037";"CC(C)[C@H](N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL2153675";"";"None";"574.49";"1";"3.37";"27";"C[C@H](O)[C@@H](N/C(=N/S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL2153759";"";"None";"526.02";"1";"2.97";"30";"COc1ccc(S(=O)(=O)/N=C(\NCC(N)=O)N2CC(c3ccccc3)C(c3ccc(Cl)cc3)=N2)cc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL2153761";"";"None";"540.05";"1";"3.36";"33";"COc1ccc(S(=O)(=O)/N=C(\N[C@@H](C)C(N)=O)N2CC(c3ccccc3)C(c3ccc(Cl)cc3)=N2)cc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL3590290";"";"None";"354.49";"0";"4.52";"64";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2ccc(C)cc21";"IC50";"'='";"9.03";"nM";"8.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3590297";"";"None";"426.99";"1";"5.50";"71";"CCCCCN1C(=O)/C(=C/NC23CC4CC(CC(C4)C2)C3)C(=O)c2cc(Cl)ccc21";"IC50";"'='";"957.0";"nM";"6.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3669088";"";"None";"366.36";"0";"2.88";"BDBM176639";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc3nonc3c2)n1";"IC50";"'='";"42.0";"nM";"7.38";"";"322546";"UO_0000065";"20.14";"0.37";"4.50";"7.46";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2163938";"";"None";"434.58";"1";"5.21";"45";"CCCC1COc2cccc3c(=O)c(C(=O)NC45CC6CC(C)(CC(C)(C6)C4)C5)cn1c23";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL3669061";"";"None";"558.01";"1";"3.77";"BDBM176609";"COc1nc(NCCc2ccc(OC(F)F)cc2)nc(-c2ccc(Cl)c(OCCCNS(C)(=O)=O)c2)n1";"IC50";"'='";"41.0";"nM";"7.39";"";"322582";"UO_0000065";"13.24";"0.27";"3.62";"5.93";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL442275";"";"None";"548.80";"2";"7.65";"15d";"CNN(C)C(=O)c1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Oc1ccc(F)c(F)c1";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"11.27";"0.23";"-1.46";"11.36";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL247307";"";"None";"547.82";"2";"8.58";"15b";"CC(C)NC(=O)c1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Oc1ccc(F)c(F)c1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"10.58";"0.22";"-2.78";"11.32";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL3932516";"";"None";"308.38";"0";"3.93";"9d";"COc1ccc(C(=O)n2c(CC(C)C)nc3ccccc32)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL462053";"";"None";"505.52";"2";"7.08";"23";"CCCCCc1ccc(-c2c(C)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"6346.0";"nM";"5.20";"";"";"UO_0000065";"10.28";"0.22";"-1.88";"10.36";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL493302";"";"None";"527.52";"2";"6.89";"38";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CC2CCCC2)s1";"IC50";"'='";"1809.1";"nM";"5.74";"";"";"UO_0000065";"10.89";"0.22";"-1.15";"11.45";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL522165";"";"None";"515.51";"2";"6.74";"34";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CC(C)(C)C)s1";"IC50";"'='";"1900.1";"nM";"5.72";"";"";"UO_0000065";"11.10";"0.23";"-1.02";"11.41";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL523872";"";"None";"565.53";"2";"6.78";"48";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CCOc2ccccc2)s1";"IC50";"'='";"7032.2";"nM";"5.15";"";"";"UO_0000065";"9.11";"0.19";"-1.63";"8.68";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL4161451";"";"None";"398.46";"1";"5.86";"9b";"O=C(O)CCCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12";"IC50";"'='";"12620.0";"nM";"4.90";"";"";"UO_0000065";"12.29";"0.22";"-0.96";"7.70";"0";"CHEMBL4157966";"Displacement of [3H]CP55940 from membrane bound human CB2 receptor after 1 hr by beta scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152361";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL529213";"";"None";"573.52";"1";"4.15";"65";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3nnc[nH]3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL4085482";"";"None";"490.69";"1";"5.77";"23";"CCOc1ccc(Cc2nc3cc(C(=O)N(CC)CC)ccc3n2CCCCN2CCCCC2)cc1";"IC50";"'='";"5011.87";"nM";"5.30";"";"";"UO_0000065";"10.80";"0.20";"-0.47";"10.47";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4078901";"";"None";"340.79";"1";"5.79";"34";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccc(F)cc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL598769";"";"None";"640.77";"2";"6.60";"52d";"Cc1cc(Br)ccc1CNC(=O)c1nn(-c2ccccc2Cl)c(-c2ccc(Br)cc2)c1Cn1cncn1";"IC50";"'='";"1790.0";"nM";"5.75";"";"";"UO_0000065";"8.97";"0.21";"-0.85";"7.40";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL4070648";"";"None";"322.80";"1";"5.65";"22";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL1084555";"";"None";"464.32";"1";"7.57";"rac-5g";"O=C1CC(c2cccc(F)c2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1760933";"";"None";"439.39";"0";"4.23";"7a";"O=C(Nc1cccc(C(F)(F)F)n1)c1nc(CN2CCC(F)(F)CC2)c2ccccn12";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL4062376";"";"None";"362.82";"1";"6.40";"41";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccc3occc3c2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4094495";"";"None";"357.24";"1";"6.30";"30";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccc(Cl)cc2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL1082330";"6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(HYDROXYMETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)";"None";"504.85";"2";"6.14";"17a, Enantiomer 1";"CN1c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc2C(C(=O)NCO)CC1(C)C";"IC50";"'='";"3390.0";"nM";"5.47";"";"";"UO_0000065";"10.83";"0.23";"-0.67";"8.36";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1760932";"";"None";"424.28";"1";"5.10";"6c";"O=C(c1cccc(Cl)c1Cl)c1nc(CN2CCC(F)(F)CC2)c2ccccn12";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL4174271";"";"None";"357.85";"0";"3.39";"48";"CCN1CCN(c2nc(C)nc3oc(-c4ccccc4Cl)nc23)CC1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4147300";"Neutral antagonist activity at human CB2 assessed as restoration of forskolin-induced cAMP formation preincubated for 15 mins followed by forskolin addition for 30 mins measured after 1 hr by HTRF assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145495";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL3696843";"";"None";"403.70";"0";"2.94";"BDBM163062";"O=c1c(Cl)c(NCCN2CCOCC2)cnn1-c1cc(Cl)cc(Cl)c1";"IC50";"'>'";"10000.0";"nM";"";"";"306202";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3596745";"";"None";"301.39";"0";"2.89";"10a";"O=C(CCCCCOc1ccc2ccccc2c1)NCCO";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL1083014";"N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX)";"None";"491.80";"1";"6.09";"13c, Enantiomer 1";"CC1(C)CC(NC(=O)CO)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"4780.0";"nM";"5.32";"";"";"UO_0000065";"10.82";"0.23";"-0.77";"7.45";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1085566";"N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXY-2-METHYLPROPANAMIDE (ENANTIOMERIC MIX)";"None";"525.48";"2";"7.14";"12c, Enantiomer 1";"CC(C)(O)C(=O)NC1CC2(CCCCC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"9.36";"0.19";"-2.22";"6.89";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL3086844";"";"None";"273.42";"0";"4.34";"7, gamma-sanshool";"C/C=C/C=C/C=C/CC/C=C/C=C/C(=O)NCC(C)C";"IC50";"'='";"664.0";"nM";"6.18";"";"";"UO_0000065";"22.59";"0.42";"1.84";"21.23";"0";"CHEMBL3089351";"Displacement of [3H]-CP55940 from human CB2 receptor expressed in CHO cells preincubated for 1 hr followed by radioligand addition measured after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3085628";"1";"Scientific Literature";"J Nat Prod";"2013";"CHEMBL3308072";""
"CHEMBL3341861";"";"None";"392.89";"1";"5.65";"4, PSNCBAM-1";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cccc(N3CCCC3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3366075";"Antagonist activity at human CB2 receptor stably expressed in CHO-RD-HGA16 cells assessed as inhibition of CP55,940-induced calcium mobilization after 15 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351332";"1";"Scientific Literature";"J Med Chem";"2014";"None";""
"CHEMBL3696824";"";"None";"325.88";"0";"4.50";"BDBM163042";"CCCNc1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1Cl";"IC50";"'='";"5.4";"nM";"8.27";"";"306181";"UO_0000065";"25.37";"0.51";"3.77";"17.62";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669116";"";"None";"431.86";"0";"2.86";"BDBM176668";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(Cl)c(OCC(N)=O)c2)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"322580";"UO_0000065";"20.84";"0.41";"6.14";"8.02";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669115";"";"None";"379.39";"0";"3.22";"BDBM176667";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(OC)c(C#N)c2)n1";"IC50";"'='";"19.0";"nM";"7.72";"";"322579";"UO_0000065";"20.35";"0.38";"4.50";"8.31";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3086845";"";"None";"289.42";"0";"3.45";"5";"C/C=C/C=C/C=C/CC/C=C/C=C/C(=O)NCC(C)(C)O";"IC50";"'='";"224.0";"nM";"6.65";"";"";"UO_0000065";"22.98";"0.43";"3.20";"13.48";"0";"CHEMBL3089351";"Displacement of [3H]-CP55940 from human CB2 receptor expressed in CHO cells preincubated for 1 hr followed by radioligand addition measured after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3085628";"1";"Scientific Literature";"J Nat Prod";"2013";"CHEMBL3308072";""
"CHEMBL3086847";"";"None";"279.38";"0";"1.87";"1";"C/C=C/C=C/C=C\CC/C=C/C(=O)NCC(C)(O)CO";"IC50";"'='";"168.0";"nM";"6.78";"";"";"UO_0000065";"24.25";"0.46";"4.90";"9.74";"0";"CHEMBL3089351";"Displacement of [3H]-CP55940 from human CB2 receptor expressed in CHO cells preincubated for 1 hr followed by radioligand addition measured after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3085628";"1";"Scientific Literature";"J Nat Prod";"2013";"CHEMBL3308072";""
"CHEMBL1086013";"";"None";"426.34";"1";"7.10";"rac-5f";"CC(C)(C)C1CC(=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2O1";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"12.83";"0.26";"-1.63";"13.95";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1586706";"";"None";"512.59";"2";"5.87";"SID99303162";"Cc1ccc(-c2cc(C(=O)Nc3ccc(S(=O)(=O)Nc4cc(C)on4)cc3)c3ccccc3n2)c(C)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL2096743";"";"None";"409.49";"0";"3.27";"20";"CCCCOc1c(OC)ccc2cc(C(=O)NCCc3ccc(N)cc3)c(=O)[nH]c12";"IC50";"'='";"1.585";"nM";"8.80";"";"";"UO_0000065";"21.49";"0.40";"5.53";"8.27";"0";"CHEMBL1825304";"Binding affinity to CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821585";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"None";""
"CHEMBL3596753";"";"None";"321.44";"0";"3.33";"17c";"CCS(=O)(=O)NCCCCCOc1cccc2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL2010905";"";"None";"364.51";"0";"3.58";"4i";"CCCNC(=O)c1c(NC(=O)C2C(C)(C)C2(C)C)sc2c1CCOC2";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2013482";"Agonist activity at human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP production after 20 mins by ELISA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307715";""
"CHEMBL3696833";"";"None";"291.78";"0";"3.32";"BDBM163052";"CCCNc1cnn(-c2cc(C)cc(C)c2)c(=O)c1Cl";"IC50";"'='";"10000.0";"nM";"5.00";"";"306192";"UO_0000065";"17.14";"0.34";"1.68";"10.66";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3780792";"";"None";"520.50";"2";"7.57";"14";"CC1(C)[C@@H]2CC[C@]1(C)[C@H](NC(=O)c1nn(-c3ccc(Cl)cc3Cl)c3c1Cc1cc(C4CC4)ccc1-3)C2";"IC50";"'='";"26.9";"nM";"7.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3782508";"Antagonist/inverse agonist activity at human CB2 receptors expressed in human Chem4 cell membrane incubated for 30 mins by [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Chem4";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779789";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";""
"CHEMBL3596752";"";"None";"300.40";"0";"3.71";"18a";"CCNC(=O)NCCCCCOc1ccc2ccccc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL1765160";"";"None";"369.89";"0";"4.63";"Table 1, R2C2, 3";"O=C(c1ccc(Cl)cc1)N1CC[C@](O)(c2ccccc2)[C@H]2CCCC[C@H]21";"IC50";"'='";"0.14";"nM";"9.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL3596751";"";"None";"321.44";"0";"3.33";"17a";"CCS(=O)(=O)NCCCCCOc1ccc2ccccc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL2316384";"";"None";"465.58";"0";"3.52";"18d";"C[S@@+]([O-])Cc1ccc(C(=O)Nc2cccnc2C(=O)NCC2CCOCC2)c2ccccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL2316109";"";"None";"435.55";"0";"3.90";"18a";"C[S+]([O-])Cc1ccc(C(=O)Nc2cccnc2C(=O)NCC2CCC2)c2ccccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL487582";"";"None";"529.82";"2";"5.88";"32g";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2Cn2cnnn2)o1";"IC50";"'='";"736.0";"nM";"6.13";"";"";"UO_0000065";"11.58";"0.24";"0.25";"6.11";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL402555";"";"None";"473.80";"1";"6.58";"6s";"Cc1c(-c2nnnn2C2CCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL950211";"Displacement of [3H]WIN-55212-2 from human cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143900";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";""
"CHEMBL3696826";"";"None";"277.41";"0";"3.09";"BDBM163044";"CN(C)c1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1";"IC50";"'='";"380.0";"nM";"6.42";"";"306183";"UO_0000065";"23.14";"0.44";"3.33";"16.84";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3696822";"";"None";"297.83";"0";"3.72";"BDBM163040";"CNc1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1Cl";"IC50";"'='";"355.0";"nM";"6.45";"";"306179";"UO_0000065";"21.66";"0.44";"2.73";"13.75";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3696831";"";"None";"354.93";"0";"3.65";"BDBM163049";"CN(C)CCNc1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1Cl";"IC50";"'='";"204.0";"nM";"6.69";"";"306188";"UO_0000065";"18.85";"0.38";"3.04";"13.34";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL269919";"";"None";"412.48";"0";"4.93";"40";"Cc1c(C(=O)NC2CCCCC2)nn(-c2ccc(F)cc2F)c1-n1c(C)ccc1C";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"14.89";"0.28";"1.21";"11.85";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1760934";"";"None";"453.45";"0";"2.23";"7b";"O=C(Nc1cccc(C(F)(F)F)n1)c1nc(CN2CCS(=O)(=O)CC2)c2ccccn12";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1602521";"";"None";"473.55";"0";"2.49";"SID87544643";"CCOc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(N2CCCC2=O)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1097456";"N-[6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-YL]-4,4,4-TRIFLUORO-3-HYDROXYBUTANAMIDE (DIASTEREOMERIC MIX)";"None";"573.83";"2";"7.41";"8g, diastereomer";"CC1(C)CC(NC(=O)CC(O)C(F)(F)F)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"11.60";"0.25";"-0.75";"9.32";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL3669080";"";"None";"393.42";"0";"3.83";"BDBM176631";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3c(OC)cccc3[nH]2)n1";"IC50";"'='";"33.0";"nM";"7.48";"";"322538";"UO_0000065";"19.02";"0.35";"3.65";"8.81";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3341876";"";"None";"380.84";"1";"5.00";"25";"CC(=O)Nc1cccc(-c2cccc(NC(=O)Nc3ccc(Cl)cc3)c2)n1";"IC50";"'='";"5120.0";"nM";"5.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3366075";"Antagonist activity at human CB2 receptor stably expressed in CHO-RD-HGA16 cells assessed as inhibition of CP55,940-induced calcium mobilization after 15 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351332";"1";"Scientific Literature";"J Med Chem";"2014";"None";""
"CHEMBL3669107";"";"None";"398.83";"0";"4.74";"BDBM176658";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3cc(Cl)ccc3o2)n1";"IC50";"'='";"23.0";"nM";"7.64";"";"322566";"UO_0000065";"19.15";"0.37";"2.90";"10.45";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1094521";"";"None";"505.83";"2";"6.48";"3";"C[C@H](O)C(=O)NC1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"2260.0";"nM";"5.65";"";"";"UO_0000065";"11.16";"0.23";"-0.83";"7.90";"1";"CHEMBL1105742";"Inhibition of cannabinoid CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"None";""
"CHEMBL1083016";"N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXY-2,2-DIMETHYLPROPANAMIDE (ENANTIOMERIC MIX)";"None";"533.88";"2";"7.11";"13e, Enantiomer 1";"CC1(C)CC(NC(=O)C(C)(C)CO)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"11.70";"0.24";"-0.87";"8.74";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1083646";"(2R)-N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)";"None";"505.83";"2";"6.48";"13k, Enantiomer 1";"C[C@@H](O)C(=O)NC1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"4750.0";"nM";"5.32";"";"";"UO_0000065";"10.52";"0.22";"-1.16";"7.45";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1724849";"";"None";"477.03";"0";"3.15";"SID87544642";"CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(C(=O)N2CCN(c3cccc(Cl)c3)CC2)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3909238";"";"None";"387.55";"0";"4.96";"6b";"CCOC(=O)c1c(NC(=O)C23CC4CC(CC(C4)C2)C3)sc2c1CCCC2";"IC50";"'='";"474.9";"nM";"6.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3866934";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as reduction in NKH-477-induced intracellular cAMP levels after 30 mins in presence of NKH-477 by luminescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3865825";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307512";""
"CHEMBL3982062";"";"None";"348.49";"0";"4.79";"19a";"Cc1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(C)n1-c1ccccc1";"IC50";"'='";"108.6";"nM";"6.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3866934";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as reduction in NKH-477-induced intracellular cAMP levels after 30 mins in presence of NKH-477 by luminescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3865825";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307512";""
"CHEMBL3962080";"";"None";"362.52";"1";"5.05";"19b";"CCc1c(C(=O)NC23CC4CC(CC(C4)C2)C3)cc(C)n1-c1ccccc1";"IC50";"'='";"398.3";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3866934";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as reduction in NKH-477-induced intracellular cAMP levels after 30 mins in presence of NKH-477 by luminescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3865825";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307512";""
"CHEMBL1542168";"";"None";"423.90";"0";"4.05";"SID87225751";"O=C(N1CCC(n2nc(-c3ccccc3)oc2=O)CC1)C1(c2ccc(Cl)cc2)CC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3669094";"";"None";"393.40";"0";"4.03";"BDBM176645";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(F)c3cccnc23)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"322552";"UO_0000065";"22.88";"0.42";"4.97";"12.36";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2010907";"";"None";"402.56";"0";"4.12";"4k";"CCCNC(=O)c1c(NC(=O)C23CC4CC(CC(C4)C2)C3)sc2c1CCOC2";"IC50";"'='";"42.66";"nM";"7.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2013478";"Agonist activity at human recombinant CB2 receptor expressed in HEK293 cells co-expressing chimeric Gaq/o protein by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307715";""
"CHEMBL1765272";"";"None";"358.48";"0";"2.00";"5-2";"CN1CCOCC1C(=O)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL3669093";"";"None";"375.41";"0";"3.89";"BDBM176644";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cccc3cccnc23)n1";"IC50";"'='";"17.0";"nM";"7.77";"";"322551";"UO_0000065";"20.70";"0.38";"3.88";"10.67";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669083";"";"None";"409.49";"0";"4.54";"BDBM176634";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3ccc(SC)cc3[nH]2)n1";"IC50";"'='";"37.0";"nM";"7.43";"";"322541";"UO_0000065";"18.15";"0.35";"2.89";"9.81";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2163962";"";"None";"378.47";"0";"3.65";"33";"CC1COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL466651";"";"None";"393.46";"0";"3.89";"A2";"CC1CCC(NC(=O)c2cc3cccnc3n(Cc3ccc(F)cc3)c2=O)CC1";"IC50";"'='";"1.37";"nM";"8.86";"";"";"UO_0000065";"22.53";"0.42";"4.97";"13.85";"0";"CHEMBL3383059";"Displacement of [3H]CP-55,940 from human recombinant CB2R expressed in HEK-293 cells after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352718";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307715";""
"CHEMBL2096743";"";"None";"409.49";"0";"3.27";"6, JTE-907";"CCCCOc1c(OC)ccc2cc(C(=O)NCCc3ccc(N)cc3)c(=O)[nH]c12";"IC50";"'='";"545.0";"nM";"6.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3590641";"";"None";"370.49";"0";"4.22";"56";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(OC)ccc21";"IC50";"'='";"1650.0";"nM";"5.78";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3590645";"";"None";"424.46";"1";"5.11";"60";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(OC(F)(F)F)ccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL487161";"";"None";"491.81";"1";"6.90";"17";"CC(O)c1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1890.0";"nM";"5.72";"";"";"UO_0000065";"11.64";"0.24";"-1.18";"7.44";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL3596757";"";"None";"294.35";"0";"2.28";"18d";"CCNC(=O)NCCCCCOc1ccc2c(c1)OCO2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL4861932";"";"None";"255.71";"0";"1.60";"31";"CC(=O)NCCNC(=O)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL467914";"";"None";"497.91";"1";"6.27";"45";"CC(C)(C)c1nc2nc(-c3ccccc3Cl)c(-c3ccc(C(F)(F)F)cc3)cc2c2n[nH]c(=O)n12";"IC50";"'='";"9200.0";"nM";"5.04";"";"";"UO_0000065";"10.11";"0.20";"-1.23";"6.63";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1441155";"";"None";"417.47";"0";"3.08";"SID87225744";"Cc1ccc2nc3c(cc(C(=O)NCc4ccco4)c(=N)n3C3CCCC3)c(=O)n2c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1452959";"";"None";"345.40";"0";"3.80";"SID87225753";"CCN1C(=O)C(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3898880";"";"None";"306.37";"0";"4.00";"9j";"COc1ccc(C(=O)n2c(C3CCC3)nc3ccccc32)cc1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"17.77";"0.32";"1.44";"12.34";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3984372";"";"None";"378.43";"1";"5.55";"8i";"COc1ccc(-c2nc3ccccc3n2C(=O)c2cccc3ccccc23)cc1";"IC50";"'='";"7700.0";"nM";"5.11";"";"";"UO_0000065";"13.51";"0.24";"-0.44";"11.59";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3590292";"";"None";"374.91";"0";"4.87";"66";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2ccc(Cl)cc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL488615";"";"None";"494.00";"1";"6.50";"18b";"O=C(NC1CCCCCC1)N1CCN(C(c2ccc(Cl)cc2)c2ccccc2C(F)(F)F)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL497914";"";"None";"487.82";"1";"6.25";"30";"CCc1c(C2=NC3(CCCC3)C(=O)N2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1372.2";"nM";"5.86";"";"";"UO_0000065";"12.02";"0.25";"-0.39";"9.89";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL520729";"";"None";"527.84";"2";"7.09";"32c";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2Cn2ccnc2)o1";"IC50";"'='";"376.0";"nM";"6.42";"";"";"UO_0000065";"12.17";"0.25";"-0.67";"8.62";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL485754";"";"None";"534.83";"2";"6.70";"14";"COC(=O)NCc1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1670.0";"nM";"5.78";"";"";"UO_0000065";"10.80";"0.23";"-0.92";"6.08";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL521042";"";"None";"487.82";"1";"7.72";"41";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C2CC2)o1";"IC50";"'='";"3320.0";"nM";"5.48";"";"";"UO_0000065";"11.23";"0.23";"-2.24";"9.66";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL3909817";"";"None";"386.53";"1";"5.43";"BDBM235946";"CCCCCc1cc(OC)c(C2=C[C@@H]3CC[C@@]2(C(=O)OC)C3(C)C)c(OC)c1";"IC50";"'='";"1530.0";"nM";"5.82";"";"411181";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3590293";"";"None";"384.52";"0";"4.53";"67";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(OC)cc(C)c21";"IC50";"'='";"93.3";"nM";"7.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3669073";"";"None";"400.43";"0";"3.71";"BDBM176623";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(F)c(C(C)(C)O)c2)n1";"IC50";"'='";"8.0";"nM";"8.10";"";"322529";"UO_0000065";"20.22";"0.38";"4.39";"10.10";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2153662";"";"None";"530.44";"1";"3.62";"16a, Enantiomer 1";"NC(=O)CN/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"9.99";"0.21";"1.68";"4.52";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL3899579";"";"None";"353.22";"1";"5.02";"BDBM242432";"O=C(NCC1CC1)c1ccc(Nc2ccc(Cl)cc2Cl)cc1F";"IC50";"'='";"2150.0";"nM";"5.67";"";"422770";"UO_0000065";"16.05";"0.34";"0.65";"13.78";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3669098";"";"None";"375.41";"0";"3.89";"BDBM176649";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cccc3cnccc23)n1";"IC50";"'='";"20.0";"nM";"7.70";"";"322556";"UO_0000065";"20.51";"0.38";"3.81";"10.57";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669095";"";"None";"389.43";"0";"4.20";"BDBM176646";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(C)c3ncccc23)n1";"IC50";"'='";"38.0";"nM";"7.42";"";"322553";"UO_0000065";"19.05";"0.35";"3.22";"10.19";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4588694";"";"None";"401.55";"1";"5.98";"44";"CCCCCCC(C)(C)c1cc(OCCCO)c2c(c1)OC(C)(C)c1cnoc1-2";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4426148";"Agonist activity at human CB2 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP accumulation after 60 mins by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425113";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL523100";"";"None";"386.52";"0";"3.25";"4";"O=C(C1CCCCC1)N1CCN(S(=O)(=O)c2cccc3ccccc23)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL470846";"";"None";"566.88";"2";"8.10";"12j";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C(=O)Nc2ccccc2)o1";"IC50";"'='";"738.0";"nM";"6.13";"";"";"UO_0000065";"10.82";"0.22";"-1.97";"7.14";"0";"CHEMBL957520";"Displacement of [3H]WIN-55212-2 from human recombinant cannabinoid CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL488786";"";"None";"526.82";"2";"6.24";"42b";"CC1(c2nnc(-c3nn(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)c3Cn3cncn3)o2)CC1";"IC50";"'='";"954.0";"nM";"6.02";"";"";"UO_0000065";"11.43";"0.23";"-0.22";"6.88";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL468425";"";"None";"602.91";"2";"7.58";"42e";"Cc1ccc(C2(c3nnc(-c4nn(-c5ccc(Cl)cc5Cl)c(-c5ccc(Cl)cc5)c4Cn4cncn4)o3)CC2)cc1";"IC50";"'='";"1240.0";"nM";"5.91";"";"";"UO_0000065";"9.80";"0.20";"-1.67";"6.75";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL4082936";"";"None";"462.64";"0";"4.99";"D";"CCOc1ccc(Cc2nc3cc(C(=O)N(CC)CC)ccc3n2CCN2CCCCC2)cc1";"IC50";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"14.48";"0.27";"1.71";"13.24";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL2071074";"";"None";"327.81";"0";"3.84";"24";"CNc1ccc(CCNC(=O)c2cc3cc(Cl)ccc3[nH]2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL2071075";"";"None";"341.84";"0";"3.86";"25";"CN(C)c1ccc(CCNC(=O)c2cc3cc(Cl)ccc3[nH]2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL476253";"";"None";"548.43";"1";"4.82";"33";"O=C(Cc1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL4532188";"";"None";"295.39";"0";"3.26";"32";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cc2ncccc2[nH]1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL3596740";"";"None";"305.38";"0";"2.94";"5b";"O=C(/C=C/C=C/c1ccc2c(c1)-c1ccccc1C2)NCCO";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL3596742";"";"None";"347.41";"0";"3.51";"7b";"CCOC(=O)CNC(=O)/C=C/C=C/c1ccc2c(c1)-c1ccccc1C2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL2096840";"";"None";"490.86";"1";"7.34";"(R,R)-3";"C[C@@H](NC(=O)C(C)(C)Oc1ccc(Cl)cc1)[C@H](Cc1ccc(Cl)cc1)c1ccc(Cl)cc1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"12.68";"0.27";"-1.12";"16.23";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL3341886";"";"None";"448.52";"1";"5.02";"35";"COc1cc(NC(=O)Nc2cccc(-c3cccc(N4CCCC4)n3)c2)cc(OC)c1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3366075";"Antagonist activity at human CB2 receptor stably expressed in CHO-RD-HGA16 cells assessed as inhibition of CP55,940-induced calcium mobilization after 15 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351332";"1";"Scientific Literature";"J Med Chem";"2014";"None";""
"CHEMBL3353427";"";"None";"357.45";"0";"2.48";"5";"CC1CCC(NC(=O)c2cc3cccnc3n(CCCCO)c2=O)CC1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"18.68";"0.35";"4.20";"7.93";"0";"CHEMBL3383059";"Displacement of [3H]CP-55,940 from human recombinant CB2R expressed in HEK-293 cells after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352718";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307715";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"1";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1980.0";"nM";"5.70";"";"";"UO_0000065";"12.30";"0.26";"-0.24";"11.37";"0";"CHEMBL1816991";"Displacement of [3H]CP55940 from human cannabinoid CB2 receptor expressed in CHO cells at pH 7.4 after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1811766";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";""
"CHEMBL4282822";"";"None";"330.47";"0";"4.71";"23";"CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C=C[C@@](C)(O)C[C@@H]21";"IC50";"'='";"11420.0";"nM";"4.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4253360";"Agonist activity at recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 2 hrs by [35S]GTP-gammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL3922890";"";"None";"469.31";"1";"5.21";"BDBM242435";"O=S(=O)(NCC1CCCO1)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"50.0";"nM";"7.30";"";"422773";"UO_0000065";"15.56";"0.34";"2.09";"10.83";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4452850";"";"None";"346.81";"1";"5.85";"18";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2ccc(F)cc2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL1471590";"";"None";"441.50";"1";"2.27";"SID87225738";"CCCN(CCC)Cc1c(C(=O)NN=C/C(C)=C\c2ccco2)nnn1-c1nonc1N";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1712952";"";"None";"442.44";"0";"2.57";"SID87544626";"COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(OC(F)F)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL397329";"";"None";"465.43";"1";"6.51";"5g";"CC(C)(C)N1CCN(c2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2C#N)CC1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"12.00";"0.24";"-0.92";"12.94";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL3109764";"";"None";"482.93";"1";"5.78";"4";"O=C(N[C@@H]1CCCC[C@H]1O)c1cnc(OC2CCCC2)c(-c2cc(C(F)(F)F)ccc2Cl)c1";"IC50";"'='";"2390.0";"nM";"5.62";"";"";"UO_0000065";"11.64";"0.23";"-0.16";"7.87";"0";"CHEMBL3111770";"Displacement of [3H]CP55940 from human CB2 receptor expressed in CHOK1 cells after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108674";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3307512";""
"CHEMBL3410727";"";"None";"361.44";"0";"3.90";"48";"CCCCOc1c(OC)ccc2cc(C(=O)NC(CC)CC)c(=O)oc12";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL482152";"";"None";"489.77";"1";"6.03";"13g";"O=C(Cn1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)n1)NCc1ccc(F)cc1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL1760936";"";"None";"295.39";"0";"3.13";"10a";"O=C(NC(C1CC1)C1CC1)c1nc(C2CC2)n2ccccc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1760941";"";"None";"365.43";"0";"3.13";"22b";"C[C@@H](NC(=O)c1nc(N2CCC(F)(F)CC2)c2cnccn12)C(C)(C)C";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL4085844";"";"None";"336.82";"1";"5.96";"27";"Cc1cccc(-c2cccc(NC(=O)Nc3ccc(Cl)cc3)c2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4096928";"";"None";"358.78";"1";"5.93";"35";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccc(F)cc2F)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4092811";"";"None";"435.01";"1";"8.25";"37";"CC(C)(C)c1cc(-c2cccc(NC(=O)Nc3ccc(Cl)cc3)c2)cc(C(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4071010";"";"None";"373.84";"1";"6.20";"43";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccc3ccccc3n2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL5087401";"";"None";"495.63";"1";"6.41";"14-trans";"Cc1c(C(=O)NCCc2ccc(/N=N/c3ccccc3)cc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"2, SR141716A";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"9100.0";"nM";"5.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL4747195";"";"None";"302.41";"0";"3.93";"4";"CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(CO)=C[C@@H]21";"IC50";"'='";"29.8";"nM";"7.53";"";"";"UO_0000065";"24.89";"0.47";"3.60";"15.15";"0";"CHEMBL4668801";"Displacement of [3H]-CP-55,940 from recombinant human CB2R expressed in HEK293 cell membranes after 90 mins";"B";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"Kidney";"HEK293";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665697";"1";"Scientific Literature";"J Nat Prod";"2020";"None";"TIME = 1.5 hr"
"CHEMBL1089351";"";"None";"473.79";"1";"7.93";"6g";"CC(C)(C)C(=O)c1oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc2c1N";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"13.42";"0.28";"-1.57";"9.20";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL5075782";"";"None";"481.60";"1";"6.37";"10-cis";"Cc1c(C(=O)NCc2cccc(/N=N\c3ccccc3)c2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL3906589";"";"None";"456.44";"0";"4.54";"BDBM242453";"COc1cc(Nc2ccc(S(=O)(=O)NCc3ccco3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"344.0";"nM";"6.46";"";"422799";"UO_0000065";"14.16";"0.28";"1.92";"7.20";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4084087";"";"None";"453.95";"1";"5.12";"5";"Cc1cc(-c2cc(C(=O)NC3CCCCC3)c(=O)n(Cc3ccc(F)cc3)n2)ccc1Cl";"IC50";"'='";"25.3";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3998735";"Inverse agonist activity at human CB2 receptor expressed in HEK293 EBNA cell membranes after 30 mins by [35S]-GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997787";"1";"Scientific Literature";"Eur J Med Chem";"2017";"CHEMBL3307715";""
"CHEMBL487708";"";"None";"572.53";"1";"4.75";"56";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3ccn[nH]3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL3780166";"";"None";"408.54";"0";"4.60";"7a";"CCCCCn1c(=O)c(C(=O)NC23CC4CC(CC(C4)C2)C3)c(O)c2ccccc21";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.29";"0.40";"4.10";"12.20";"0";"CHEMBL3782259";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells after 90 mins by Competition binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779817";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3353442";"";"None";"477.40";"0";"2.80";"18";"CC1CCC(NC(=O)c2cc3cc(Br)cnc3n(CCN3CCOCC3)c2=O)CC1";"IC50";"'='";"59.6";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3383064";"Antagonist activity at human recombinant CB2R expressed in WIN-55212-stimulated U2OS cells assessed as increase in forskolin-mediated cAMP level after 30 mins by time-resolved fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352718";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307757";""
"CHEMBL511558";"";"None";"478.77";"1";"7.69";"33";"Oc1nc(-c2ccc(Cl)cc2)nc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL4104660";"";"None";"391.69";"1";"6.96";"33";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2c(Cl)cccc2Cl)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL482153";"";"None";"524.21";"2";"6.68";"9h";"O=C(Cn1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2Cl)n1)NCc1cccc(F)c1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL246901";"";"None";"434.37";"1";"6.46";"6c";"CCC(N)(C#Cc1nc(-c2ccccc2Cl)c(-c2ccc(Cl)cc2)cc1C#N)CC";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"13.72";"0.27";"-0.50";"9.50";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL4176969";"";"None";"398.50";"1";"6.16";"8d";"O=C(c1cccc2ccccc12)c1ccc(OCCCCCCO)c2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4157966";"Displacement of [3H]CP55940 from membrane bound human CB2 receptor after 1 hr by beta scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152361";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3899134";"";"None";"461.29";"1";"6.56";"BDBM242484";"O=S(=O)(Nc1ccccc1)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"6246.0";"nM";"5.20";"";"422838";"UO_0000065";"11.28";"0.25";"-1.36";"8.94";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3981255";"";"None";"314.39";"0";"4.83";"8b";"CCCc1nc2ccccc2n1C(=O)c1cccc2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3907542";"";"None";"403.47";"0";"2.90";"BDBM242499";"O=S(=O)(NCC1CC1)c1ccc(NC2CN3CCC2CC3)cc1C(F)(F)F";"IC50";"'='";"696.0";"nM";"6.16";"";"422854";"UO_0000065";"15.26";"0.31";"3.26";"10.02";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3963183";"";"None";"338.38";"0";"3.40";"BDBM242463";"O=S(=O)(NCC1CC1)c1ccc(Nc2ccc(F)cc2F)cc1";"IC50";"'='";"6000.0";"nM";"5.22";"";"422813";"UO_0000065";"15.43";"0.31";"1.82";"8.97";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3942936";"";"None";"391.46";"0";"3.60";"BDBM242520";"O=S(=O)(NCC1CC1)c1ccc(NN2CCCCCC2)cc1C(F)(F)F";"IC50";"'='";"83.4";"nM";"7.08";"";"422880";"UO_0000065";"18.08";"0.37";"3.48";"11.52";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL2071068";"";"None";"425.96";"0";"4.84";"18";"CC(O)c1c(C(=O)NCCc2ccc(N3CCCCC3)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL4857633";"";"None";"343.86";"0";"4.30";"10";"O=C(NCCc1ccc(N2CCCC2)cc1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL3904520";"";"None";"308.38";"0";"4.08";"9c";"CCCCc1nc2ccccc2n1C(=O)c1ccc(OC)cc1";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"16.86";"0.31";"1.12";"11.79";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL4293423";"";"None";"429.58";"1";"7.78";"14a";"CCCCCCCCCCCCC/C(=N\O)c1cc(-c2ccc(O)c(F)c2)ccc1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4275255";"Displacement of [3H]CP55940 from recombinant human CB2 expressed crude membranes after 90 mins by liquid scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270621";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL1431953";"";"None";"444.13";"1";"5.32";"SID87225776";"Cc1nnc(-c2cccc(Br)c2)c2cn(-c3ccc(Br)cc3)nc12";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1498988";"";"None";"481.00";"0";"4.28";"SID87225765";"COc1ccc(S(=O)(=O)Nc2ccc(C)cc2)cc1N(C)S(=O)(=O)c1ccc(Cl)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL246722";"";"None";"481.77";"1";"8.05";"3e";"COc1ccc(Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc2C#N)cc1";"IC50";"'='";"3800.0";"nM";"5.42";"";"";"UO_0000065";"11.25";"0.23";"-2.63";"9.83";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL3596758";"";"None";"266.30";"0";"1.63";"19d";"NC(=O)NCCCCCOc1ccc2c(c1)OCO2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL3596737";"";"None";"267.33";"0";"2.52";"5a";"O=C(/C=C/C=C/c1ccc2ccccc2c1)NCCO";"IC50";"'='";"4810.0";"nM";"5.32";"";"";"UO_0000065";"19.89";"0.36";"2.80";"10.78";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL2387075";"";"None";"324.42";"0";"3.07";"18b";"CCCCn1c2c(cc(C(=O)NCc3ccccc3)c1=O)CCC2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2389080";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385064";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL1082321";"6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(1-HYDROXY-2-METHYLPROPAN-2-YL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)";"None";"533.88";"2";"6.91";"14c, Enantiomer 1";"CC(C)(CO)NC(=O)C1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"5150.0";"nM";"5.29";"";"";"UO_0000065";"9.91";"0.21";"-1.62";"7.40";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL2316386";"";"None";"539.65";"1";"3.28";"20";"C[S+]([O-])Cc1ccc(C(=O)Nc2ccc(OCCOCCO)nc2C(=O)NCC2CCC2)c2ccccc12";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"11.68";"0.23";"3.02";"4.74";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL247103";"";"None";"402.28";"1";"6.66";"7a";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccccc2Cl)nc1-c1cccnc1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"13.50";"0.26";"-1.23";"10.96";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL392457";"";"None";"430.77";"1";"7.32";"5a";"CC(C)CNc1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2)cc1C#N";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"13.34";"0.28";"-1.58";"11.79";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL391556";"";"None";"486.19";"1";"8.69";"3d";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Oc1ccc(Cl)cc1";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"11.06";"0.24";"-3.31";"11.71";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL498747";"";"None";"526.65";"2";"6.26";"25";"CN1C(c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2Br)=NC(=O)C1(C)C";"IC50";"'='";"1570.6";"nM";"5.80";"";"";"UO_0000065";"11.02";"0.26";"-0.46";"11.50";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL381689";"SR-144528";"None";"476.06";"1";"6.81";"SR144528";"Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119419";"Inverse agonist activity at human CB2 receptor expressed in CHO membranes by [35S]GTPgammaS binding assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112511";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";""
"CHEMBL1402920";"";"None";"382.49";"0";"3.43";"SID87225747";"Cc1nc(N2CCN(C(=O)c3ccco3)CC2)c2c3c(sc2n1)CCCC3";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL394883";"";"None";"331.37";"0";"3.69";"SID87225754";"Cc1cccc2c1NC(=O)C2(c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1420151";"";"None";"374.40";"0";"2.35";"SID87225746";"CCOC(=O)c1cc2c(=O)n3ccccc3nc2n(Cc2ccccc2)c1=N";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL571831";"";"None";"513.04";"2";"6.59";"3l";"C[C@H](NC(=O)C(C)(C)Nc1cc(-c2ccccc2)on1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"234.0";"nM";"6.63";"";"";"UO_0000065";"12.92";"0.24";"0.04";"7.29";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL584332";"";"None";"449.99";"0";"4.96";"3m";"Cc1cc(NC(C)(C)C(=O)N[C@@H](C)[C@@H](Cc2ccc(Cl)cc2)c2cccc(C#N)c2)n[nH]1";"IC50";"'='";"6113.0";"nM";"5.21";"";"";"UO_0000065";"11.59";"0.22";"0.25";"5.57";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1095150";"";"None";"541.87";"2";"7.44";"12i";"Cc1n[nH]cc1C(=O)N[C@@H]1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"10.80";"0.22";"-1.59";"7.33";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL2316391";"";"None";"387.48";"0";"4.80";"8a";"O=C(NCC1CCCCC1)c1ncccc1NC(=O)c1cccc2ccccc12";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"17.96";"0.33";"2.16";"9.79";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL569614";"";"None";"455.05";"0";"4.36";"3r";"C[C@H](NC(=O)C(C)(C)NCCCN(C)C)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"25890.0";"nM";"4.59";"";"";"UO_0000065";"10.08";"0.20";"0.23";"6.73";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL463846";"";"None";"464.84";"1";"5.32";"29d";"CC(C)(C)NC(=O)N1CCN(C(c2ccc(Br)cc2)c2ccccc2Cl)CC1";"IC50";"'='";"4950.0";"nM";"5.30";"";"";"UO_0000065";"11.41";"0.26";"-0.01";"14.91";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL3410715";"";"None";"422.32";"0";"4.80";"35";"CCCCOc1cc(Br)cc2cc(C(=O)NC3CCCCC3)c(=O)oc12";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL4078811";"";"None";"353.81";"1";"5.05";"17";"COc1cc(-c2cccc(NC(=O)Nc3ccc(Cl)cc3)c2)ccn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL2113258";"";"None";"422.96";"1";"5.42";"35h";"C[C@H](NC(=O)C(C)(C)Oc1ccncc1)[C@H](Cc1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"14.00";"0.27";"0.50";"11.56";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL1765092";"";"None";"419.55";"0";"4.50";"page no 2364, R3C1, Enantiomer 3b";"O=C(c1csc(-c2ccncc2)n1)N1CCC(O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"597.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL2023574";"";"None";"436.55";"1";"5.04";"12";"O=C(O)c1ccc(NC(=O)c2cc3c(n(CC4CCCCC4)c2=O)CCCCCC3)cc1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL466711";"";"None";"464.36";"1";"5.90";"16";"CC(C)(C)c1nc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c2n[nH]c(=O)n12";"IC50";"'='";"3800.0";"nM";"5.42";"";"";"UO_0000065";"11.67";"0.23";"-0.48";"7.14";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL567297";"";"None";"449.99";"0";"4.67";"3n";"C[C@H](NC(=O)C(C)(C)Nc1ccnn1C)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"13290.0";"nM";"4.88";"";"";"UO_0000065";"10.84";"0.21";"0.21";"5.89";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL559612";"CP-55940";"None";"376.58";"1";"5.66";"CP-55940";"CCCCCCC(C)(C)c1ccc([C@@H]2C[C@H](O)CC[C@H]2CCCO)c(O)c1";"IC50";"'='";"0.82";"nM";"9.09";"";"";"UO_0000065";"24.13";"0.46";"3.43";"14.97";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL264154";"";"None";"411.44";"0";"4.82";"6g";"Cn1c(C(C)(C)C)c/c(=N\C(=O)c2cccc(C(F)(F)F)c2F)n1CC1CCC1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"21.31";"0.41";"3.95";"22.32";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL402734";"";"None";"393.45";"0";"4.60";"6f";"Cc1ccc(C(F)(F)F)cc1C(=O)/N=c1\cc(C(C)(C)C)n(C)n1CC1CC1";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"17.93";"0.34";"2.46";"17.96";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL257020";"";"None";"379.43";"0";"4.29";"6a";"Cn1c(C(C)(C)C)c/c(=N\C(=O)c2cccc(C(F)(F)F)c2)n1CC1CC1";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"19.22";"0.37";"3.00";"18.56";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL490043";"";"None";"412.56";"0";"3.77";"5";"O=C(C1CCCCC1)N1CCN(S(=O)(=O)c2cccc(-c3ccccc3)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL489438";"";"None";"546.53";"2";"5.24";"38";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(C3CC3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL2023582";"";"None";"457.60";"0";"4.42";"20";"O=C(O)Cc1cnc(NC(=O)c2cc3c(n(CC4CCCCC4)c2=O)CCCCCC3)s1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL488031";"";"None";"440.03";"1";"5.79";"17b";"Cc1ccccc1C(c1ccc(Cl)cc1)N1CCN(C(=O)NC2CCCCCC2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL1715811";"";"None";"464.54";"0";"3.63";"SID87544637";"COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1sc2cccc(F)c2c1C";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL461855";"";"None";"463.95";"0";"3.72";"(+)-12a";"N#Cc1ccc(S(=O)(=O)/N=C(\N)N2C[C@@H](c3ccccc3)C(c3ccc(Cl)cc3)=N2)cc1";"IC50";"'>'";"33000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL966990";"Binding affinity to human CB2 receptor by [35S]GTPgammaS binding assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140076";"1";"Scientific Literature";"J Med Chem";"2008";"None";""
"CHEMBL521277";"";"None";"524.21";"2";"6.68";"9g";"O=C(Cn1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2Cl)n1)NCc1ccc(F)cc1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL524634";"";"None";"477.85";"1";"6.61";"23";"Cc1c(C2=NC(=S)C(C)(C)N2C)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"901.4";"nM";"6.04";"";"";"UO_0000065";"12.65";"0.28";"-0.56";"18.09";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL498268";"";"None";"461.78";"1";"5.81";"5";"Cc1c(C2=NC(=O)C(C)(C)N2C)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"486.9";"nM";"6.31";"";"";"UO_0000065";"13.67";"0.29";"0.50";"12.50";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL381689";"SR-144528";"None";"476.06";"1";"6.81";"SR144528";"Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1";"IC50";"'='";"3.162";"nM";"8.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119419";"Inverse agonist activity at human CB2 receptor expressed in CHO membranes by [35S]GTPgammaS binding assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112511";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";""
"CHEMBL4104311";"";"None";"433.60";"1";"5.70";"20d";"CCOc1ccc(Cc2nc3cc(C(=O)N4CCCCC4)ccc3n2CCC(C)C)cc1";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"14.76";"0.27";"0.70";"13.51";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL2019082";"";"None";"456.63";"0";"4.85";"6";"O=C(N[C@H](C(=O)O)C1CCCCC1)c1cc2c(n(CC3CCCCC3)c1=O)CCCCCC2";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2020077";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release after 45 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2016545";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL3938871";"";"None";"433.88";"0";"4.96";"BDBM242495";"CC(C)(NS(=O)(=O)c1ccc(Nc2cccnc2Cl)cc1C(F)(F)F)C1CC1";"IC50";"'='";"855.0";"nM";"6.07";"";"422850";"UO_0000065";"13.99";"0.30";"1.11";"8.54";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4166345";"";"None";"384.48";"1";"5.77";"8c";"O=C(c1cccc2ccccc12)c1ccc(OCCCCCO)c2ccccc12";"IC50";"'='";"1080.0";"nM";"5.97";"";"";"UO_0000065";"15.52";"0.28";"0.20";"12.82";"0";"CHEMBL4157966";"Displacement of [3H]CP55940 from membrane bound human CB2 receptor after 1 hr by beta scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152361";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4159535";"";"None";"412.49";"1";"5.95";"12b";"COC(=O)CCCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12";"IC50";"'='";"47710.0";"nM";"4.32";"";"";"UO_0000065";"10.48";"0.19";"-1.63";"8.22";"0";"CHEMBL4157966";"Displacement of [3H]CP55940 from membrane bound human CB2 receptor after 1 hr by beta scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152361";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4282822";"";"None";"330.47";"0";"4.71";"23";"CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C=C[C@@](C)(O)C[C@@H]21";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"23.36";"0.44";"3.01";"15.54";"0";"CHEMBL4253358";"Displacement of [3H]CP-55,940 from recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 90 mins by topcount method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL272616";"";"None";"413.47";"0";"4.00";"38";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(F)cc2F)c1-n1c(C)ccc1C";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"12.82";"0.24";"1.30";"9.62";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3590643";"";"None";"354.49";"0";"4.52";"58";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(C)ccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL2387078";"";"None";"366.51";"0";"4.24";"18e";"CCCCn1c2c(cc(C(=O)NCc3ccccc3)c1=O)CCCCCC2";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2389080";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385064";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL2387074";"";"None";"326.44";"0";"3.45";"18a";"CCCCn1c(CC)c(C)cc(C(=O)NCc2ccccc2)c1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2389080";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385064";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL1718220";"";"None";"415.29";"1";"5.71";"SID99303158";"Cc1nnc(-c2cccc3ccccc23)c2cn(-c3cccc(Br)c3)nc12";"IC50";"'='";"3870.0";"nM";"5.41";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1765265";"";"None";"354.43";"0";"3.51";"4-2";"O=C(c1ccncc1F)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1760937";"";"None";"271.36";"0";"2.99";"10b";"CC(C)(C)CNC(=O)c1nc(C2CC2)n2ccccc12";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1733298";"";"None";"491.06";"0";"3.46";"SID87544631";"Cc1ccc(Cl)cc1N1CCN(C(=O)c2cc(S(=O)(=O)N(C)C)ccc2N2CCCC2)CC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL247996";"";"None";"407.38";"1";"5.07";"4-4";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2cccc(Br)c2)n1CC1CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"21.90";"0.51";"3.85";"25.96";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL3596743";"";"None";"271.32";"0";"2.31";"6c";"O=C(/C=C/C=C/c1ccc2c(c1)OCCO2)NC1CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL4064182";"";"None";"380.88";"1";"6.44";"25";"CC(C)Oc1cccc(-c2cccc(NC(=O)Nc3ccc(Cl)cc3)c2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL467924";"";"None";"448.36";"1";"6.61";"17";"CC(C)(C)c1nc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c2nncn12";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"12.20";"0.24";"-1.14";"9.77";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL389114";"";"None";"493.84";"1";"6.21";"(S,S)-15";"C[C@H](NS(=O)(=O)c1cc(Cl)ccc1Cl)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"498.2";"nM";"6.30";"";"";"UO_0000065";"12.76";"0.28";"0.09";"9.01";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL397243";"";"None";"424.95";"0";"4.90";"9";"C[C@H](NS(=O)(=O)c1ccccc1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1488.0";"nM";"5.83";"";"";"UO_0000065";"13.71";"0.27";"0.93";"8.33";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL230067";"";"None";"376.91";"0";"3.82";"6";"C[C@@H]([C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1)N(C)S(C)(=O)=O";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL3696830";"";"None";"396.96";"0";"3.42";"BDBM163048";"CC1(C)CC(n2ncc(NCCN3CCOCC3)c(Cl)c2=O)CC(C)(C)C1";"IC50";"'='";"83.0";"nM";"7.08";"";"306187";"UO_0000065";"17.84";"0.36";"3.66";"11.92";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1729479";"";"None";"419.48";"0";"3.41";"SID99303152";"COc1ccc(C2(C(=O)N3CCC(n4nc(-c5ccccc5)oc4=O)CC3)CC2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1760931";"";"None";"407.37";"0";"3.56";"6b";"O=C(c1cccc(F)c1C(F)(F)F)c1nc(CN2CCOCC2)c2ccccn12";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1760930";"";"None";"390.27";"0";"3.70";"6a";"O=C(c1cccc(Cl)c1Cl)c1nc(CN2CCOCC2)c2ccccn12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL3410726";"";"None";"361.44";"0";"3.75";"47";"CCCCOc1c(OC)ccc2cc(C(=O)NC(C)C(C)C)c(=O)oc12";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3696851";"";"None";"387.53";"0";"2.70";"BDBM163070";"CC1(C)CC(n2ncc3nn(CCN4CCOCC4)cc3c2=O)CC(C)(C)C1";"IC50";"'='";"1514.0";"nM";"5.82";"";"306210";"UO_0000065";"15.02";"0.28";"3.12";"8.93";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2316389";"";"None";"464.52";"0";"2.80";"10b";"O=C(NCC1CCC1)c1nc(OCCOCCO)ccc1NC(=O)c1ccnc2ccccc12";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"12.75";"0.24";"3.12";"4.83";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL2163958";"";"None";"402.49";"0";"4.35";"29";"Cc1cc2c3c(c1)c(=O)c(C(=O)NC1CCCCC1)cn3C(c1ccccc1)CO2";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163940";"";"None";"420.55";"0";"4.74";"47";"CCCC1COc2ccc(C)c3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163935";"";"None";"354.45";"0";"3.80";"42";"CCCC1COc2cccc3c(=O)c(C(=O)NC4CCCCC4)cn1c23";"IC50";"'='";"1.53";"nM";"8.81";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL399911";"";"None";"384.47";"1";"5.33";"4-15";"CCCn1c(C)c(C(C)(C)C)s/c1=N\C(=O)c1cccc(C(F)(F)F)c1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"19.08";"0.39";"2.01";"21.35";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL247651";"";"None";"412.48";"1";"5.21";"4-8";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2cccc(OC(F)(F)F)c2)n1CC1CC1";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"19.99";"0.40";"3.03";"18.91";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL1410009";"";"None";"454.62";"1";"5.24";"SID87225759";"CC(C)(C)NS(=O)(=O)c1ccc(NC(=O)C(Sc2ccccc2)c2ccccc2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1310336";"";"None";"527.61";"2";"5.57";"ML-193";"Cc1cc(C)c2nc(-c3ccccn3)cc(C(=O)Nc3ccc(S(=O)(=O)Nc4onc(C)c4C)cc3)c2c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1582765";"";"None";"308.31";"0";"2.49";"SID87225775";"COC(=O)C1=C(N)c2c(F)cccc2C1(C#N)c1ccccc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1098876";"";"None";"542.85";"2";"6.83";"12k";"Cc1nc(C(=O)N[C@@H]2CC(C)(C)Oc3nc(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)cc32)n[nH]1";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"9.73";"0.20";"-1.55";"5.69";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL513812";"";"None";"517.41";"2";"7.00";"42";"CC(C)(C)c1nc(NCC(F)(F)CO)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2n1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL3099055";"";"None";"435.89";"0";"4.52";"11";"[2H]C([2H])([18F])Oc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(Cl)c(C(C)(C)O)c2)n1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"20.36";"0.40";"4.33";"11.05";"0";"CHEMBL4030391";"Inhibition of CB2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028847";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3696821";"";"None";"303.23";"0";"4.33";"BDBM163039";"CC1(C)CC(n2ncc(Cl)c(Cl)c2=O)CC(C)(C)C1";"IC50";"'='";"389.0";"nM";"6.41";"";"306178";"UO_0000065";"21.14";"0.46";"2.08";"18.37";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL257224";"";"None";"382.45";"1";"5.02";"4";"CC(C)(C)c1c/c(=N\C(=O)c2cccc(C(F)(F)F)c2)n(CC2CC2)s1";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"20.98";"0.42";"3.00";"23.35";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL228349";"";"None";"499.69";"1";"6.78";"13";"CCCCCc1cc(O)cc(OCCCCCCCCCCC(=O)NCCc2ccc(O)c(O)c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL906562";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143734";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"CHEMBL3307715";""
"CHEMBL1578189";"";"None";"417.47";"0";"3.08";"SID87225743";"Cc1cccn2c(=O)c3cc(C(=O)NCc4ccco4)c(=N)n(C4CCCC4)c3nc12";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3120206";"";"None";"432.91";"1";"5.11";"5i";"Cc1ccc(Cn2c(-c3ccc(C)cc3)nn(C(=O)Nc3ccc(Cl)cc3)c2=O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL3774454";"";"None";"429.59";"0";"3.50";"32";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)n2nc(SC)nc12";"IC50";"'='";"139.0";"nM";"6.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL3696848";"";"None";"316.45";"0";"3.78";"BDBM163067";"CCCn1ncc2c(=O)n(C3CC(C)(C)CC(C)(C)C3)ncc21";"IC50";"'='";"17.0";"nM";"7.77";"";"306207";"UO_0000065";"24.55";"0.46";"3.99";"14.74";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL398666";"";"None";"396.48";"1";"5.33";"1";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2cccc(C(F)(F)F)c2)n1CC1CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"19.89";"0.40";"2.56";"22.95";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL498748";"";"None";"487.82";"1";"6.37";"26";"CN1C(c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C2CC2)=NC(=O)C1(C)C";"IC50";"'='";"822.0";"nM";"6.08";"";"";"UO_0000065";"12.47";"0.26";"-0.28";"12.05";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL559612";"CP-55940";"None";"376.58";"1";"5.66";"CP55,940";"CCCCCCC(C)(C)c1ccc([C@@H]2C[C@H](O)CC[C@H]2CCCO)c(O)c1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"23.60";"0.45";"3.23";"14.64";"0";"CHEMBL895094";"Displacement of [3H]CP-55940 human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148711";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3307512";""
"CHEMBL2316385";"";"None";"436.54";"0";"3.29";"18f";"C[S+]([O-])Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC2CCC2)c2ccccc12";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"14.94";"0.29";"3.23";"6.09";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL2316379";"";"None";"470.53";"0";"3.28";"13d";"O=C(NCC1CCOCC1)c1ncccc1NC(=O)c1ccc(Cn2ccnn2)c2ccccc12";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"12.58";"0.23";"2.64";"5.33";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL2316378";"";"None";"500.56";"1";"3.29";"13c";"COc1ccc(NC(=O)c2ccc(Cn3ccnn3)c3ccccc23)c(C(=O)NCC2CCOCC2)n1";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"12.64";"0.23";"3.04";"5.26";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL597317";"";"None";"586.31";"2";"7.03";"53b";"Cc1cc(Cl)cc(Cl)c1CNC(=O)c1nn(-c2ccccc2Cl)c(-c2ccc(Cl)cc2)c1Cn1cncn1";"IC50";"'='";"3330.0";"nM";"5.48";"";"";"UO_0000065";"9.34";"0.20";"-1.55";"7.06";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL236374";"";"None";"414.60";"1";"5.01";"3f";"Cc1c(C(C)(C)C)s/c(=N\S(=O)(=O)c2cccc3ccccc23)n1CC1CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"18.80";"0.38";"2.79";"15.16";"0";"CHEMBL897874";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149669";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL429804";"";"None";"364.54";"0";"3.86";"3d";"Cc1c(C(C)(C)C)s/c(=N\S(=O)(=O)c2ccccc2)n1CC1CC1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"19.72";"0.41";"3.33";"13.97";"0";"CHEMBL897874";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149669";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL463845";"";"None";"504.90";"2";"6.10";"29c";"O=C(NCC1CCCCC1)N1CCN(C(c2ccc(Br)cc2)c2ccccc2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL3596739";"";"None";"309.37";"0";"3.09";"7a";"CCOC(=O)CNC(=O)/C=C/C=C/c1ccc2ccccc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL460986";"";"None";"515.51";"2";"6.75";"18";"CCCC#Cc1ccc(-c2c(CC)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"919.6";"nM";"6.04";"";"";"UO_0000065";"11.71";"0.24";"-0.71";"12.03";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL459730";"";"None";"463.95";"0";"3.72";"(-)-12a";"N#Cc1ccc(S(=O)(=O)/N=C(\N)N2C[C@H](c3ccccc3)C(c3ccc(Cl)cc3)=N2)cc1";"IC50";"'>'";"33000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL966990";"Binding affinity to human CB2 receptor by [35S]GTPgammaS binding assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140076";"1";"Scientific Literature";"J Med Chem";"2008";"None";""
"CHEMBL3410716";"";"None";"436.35";"1";"5.19";"36";"CCCCCOc1cc(Br)cc2cc(C(=O)NC3CCCCC3)c(=O)oc12";"IC50";"'='";"2190.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3613118";"ONTERNABEZ";"-1.0";"414.63";"1";"6.63";"BDBM50117099";"CCCCCCC(C)(C)c1cc(OC)c([C@@H]2C=C(CO)[C@@H]3C[C@H]2C3(C)C)c(OC)c1";"IC50";"'='";"117.0";"nM";"6.93";"";"411184";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL488037";"";"None";"446.42";"1";"5.74";"16a";"O=C(NC1CCCCC1)N1CCN(C(c2ccc(Cl)cc2)c2ccccc2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL2316409";"";"None";"439.52";"0";"4.26";"9d";"O=C(NCC1CCC1)c1ncccc1NC(=O)c1ccc(Cn2ccnc2)c2ccccc12";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"14.75";"0.27";"2.22";"7.29";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL1709725";"";"None";"496.68";"0";"3.73";"SID87544639";"Cc1ccccc1N1CCN(C(=O)c2cc(S(=O)(=O)N3CCCCC3)ccc2N2CCCC2)CC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3120199";"";"None";"434.88";"0";"4.75";"5b";"COc1ccc(-n2c(-c3ccc(Cl)cc3)nn(C(=O)Nc3ccc(C)cc3)c2=O)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL3958050";"";"None";"442.64";"1";"6.94";"BDBM235936";"CCCCCCC(C)(C)c1cc(OC)c(C2=C[C@@H]3CC[C@@]2(C(=O)OC)C3(C)C)c(OC)c1";"IC50";"'='";"385.0";"nM";"6.42";"";"411174";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL1288694";"";"None";"268.31";"0";"3.68";"IV";"O=C(O)CCCC(=O)/C=C/c1ccc2ccccc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL255197";"";"None";"546.30";"2";"7.47";"9b";"Cc1c(-c2nnnn2C2CCCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL950211";"Displacement of [3H]WIN-55212-2 from human cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143900";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";""
"CHEMBL235747";"";"None";"324.47";"0";"2.98";"3a";"Cc1c(C(C)(C)C)s/c(=N\S(=O)(=O)c2ccccc2)n1C";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"19.94";"0.42";"3.49";"12.58";"0";"CHEMBL897874";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149669";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL1532240";"";"None";"481.60";"0";"4.05";"SID87225722";"COc1ccccc1/C=C/C(=O)NC(=S)Nc1ccc(S(=O)(=O)N(C)c2ccccc2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3669082";"";"None";"388.41";"0";"3.69";"BDBM176633";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3cc(C#N)ccc3[nH]2)n1";"IC50";"'='";"27.0";"nM";"7.57";"";"322540";"UO_0000065";"19.49";"0.36";"3.88";"7.61";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL230717";"";"None";"501.05";"2";"6.57";"(S,S)-22";"C[C@H](NS(=O)(=O)c1cccc(-c2ccccc2)c1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"394.4";"nM";"6.40";"";"";"UO_0000065";"12.78";"0.25";"-0.17";"9.15";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL230611";"";"None";"507.87";"2";"6.55";"(S,S)-18";"C[C@@H]([C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1)N(C)S(=O)(=O)c1cc(Cl)cc(Cl)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL1713121";"";"None";"452.92";"0";"2.46";"SID87544621";"CN(C)S(=O)(=O)c1ccc(Cl)c(C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1398595";"";"None";"498.05";"0";"4.09";"SID87225726";"CC(Sc1nc2cc(Cl)ccc2s1)C(=O)Nc1cccc(S(=O)(=O)N2CCOCC2)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL178372";"";"None";"438.48";"0";"3.76";"JTE-907";"CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4c(c3)OCO4)c(=O)[nH]c12";"IC50";"'='";"644.0";"nM";"6.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL2163955";"";"None";"516.64";"2";"6.42";"26";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cn2c3c(cccc3c1=O)OC(c1ccccc1)C2c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163950";"";"None";"402.49";"0";"4.44";"21";"O=C(NC1CCCCCC1)c1cn2c3c(cccc3c1=O)OCC2c1ccccc1";"IC50";"'='";"5.23";"nM";"8.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163963";"";"None";"340.42";"0";"3.41";"34";"CCC1COc2cccc3c(=O)c(C(=O)NC4CCCCC4)cn1c23";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163946";"";"None";"410.49";"0";"4.18";"53";"CCC1COc2c(F)ccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL3114534";"";"None";"402.50";"0";"3.51";"Figure 2, R1C1, 3";"O=C(NC12CC3CC(CC(C3)C1)C2)c1nc(C(O)c2cccnc2)c2ccccn12";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3117775";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation after 1 hr";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112571";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307512";""
"CHEMBL2163579";"";"None";"392.50";"0";"4.04";"(R)-36";"CC[C@@H]1COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"18.1";"nM";"7.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163937";"";"None";"406.53";"0";"4.43";"44";"CCCC1COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"15.3";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL509780";"";"None";"663.28";"2";"8.50";"12t";"O=C(Nc1ccccc1)c1c(-c2nnc(C3(C(F)(F)F)CC3)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1";"IC50";"'='";"488.0";"nM";"6.31";"";"";"UO_0000065";"9.52";"0.21";"-2.19";"7.35";"0";"CHEMBL957520";"Displacement of [3H]WIN-55212-2 from human recombinant cannabinoid CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL3934009";"";"None";"442.64";"1";"6.94";"BDBM235937";"CCCCCCC(C)(C)c1cc(OC)c(C2=C[C@H]3CC[C@]2(C(=O)OC)C3(C)C)c(OC)c1";"IC50";"'='";"239.0";"nM";"6.62";"";"411175";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"Rimonabant";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"92.5";"nM";"7.03";"";"";"UO_0000065";"15.17";"0.32";"1.09";"14.02";"0";"CHEMBL1038208";"Binding affinity to human CB2 receptor expressed in CHO cells by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156125";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1091692";"";"None";"425.32";"1";"6.89";"6e";"CC(C)C(=O)c1oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c1N";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"13.84";"0.28";"-1.00";"8.52";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL3410728";"";"None";"361.44";"0";"3.90";"49";"CCCCOc1c(OC)ccc2cc(C(=O)NC(C)CCC)c(=O)oc12";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL558598";"RIMONABANT HYDROCHLORIDE";"None";"500.26";"1";"5.94";"SR141716A";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1.Cl";"IC50";"'='";"9800.0";"nM";"5.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3696823";"";"None";"311.86";"0";"3.74";"BDBM163041";"CN(C)c1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1Cl";"IC50";"'='";"17.0";"nM";"7.77";"";"306180";"UO_0000065";"24.91";"0.51";"4.03";"20.38";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL522522";"";"None";"529.54";"2";"7.28";"30";"CCCCC#Cc1ccc(-c2c(C)c(C(=O)NN3CCCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"564.0";"nM";"6.25";"";"";"UO_0000065";"11.80";"0.24";"-1.03";"12.46";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL428610";"";"None";"369.86";"0";"3.45";"15";"O=C(NN1CCCCC1)c1cc(-n2cccc2)n(-c2ccc(Cl)cc2)n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1092169";"";"None";"499.35";"1";"5.35";"7g";"CC(C)(O)C(=O)c1oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c1NC(=O)CO";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"10.55";"0.21";"-0.08";"4.68";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL412252";"";"None";"383.88";"0";"3.76";"20";"Cc1nn(-c2ccc(Cl)cc2)c(-n2cccc2)c1C(=O)NN1CCCCC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"1";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1760.0";"nM";"5.75";"";"";"UO_0000065";"12.41";"0.26";"-0.19";"11.47";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL500690";"";"None";"506.23";"2";"5.91";"19";"Cc1c(C2=NC(=O)C(C)(C)N2C)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1";"IC50";"'='";"1095.5";"nM";"5.96";"";"";"UO_0000065";"11.77";"0.27";"0.05";"11.81";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL4449536";"";"None";"408.55";"0";"3.07";"40";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cc2cccnc2n1CCN1CCOCC1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL204433";"";"None";"422.53";"0";"4.47";"9e";"CCCCCOc1c(OC)ccc2cc(C(=O)NCCCc3ccccc3)c(=O)[nH]c12";"IC50";"'='";"0.7943";"nM";"9.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL529436";"";"None";"480.87";"1";"6.40";"14a";"O=C(NC1CCCCC1)N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL488613";"";"None";"440.03";"1";"5.65";"17c";"Cc1ccccc1C(c1ccc(Cl)cc1)N1CCN(C(=O)NCC2CCCCC2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL487854";"";"None";"460.45";"1";"5.99";"16c";"O=C(NCC1CCCCC1)N1CCN(C(c2ccc(Cl)cc2)c2ccccc2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL487676";"";"None";"494.89";"1";"6.79";"14b";"O=C(NC1CCCCCC1)N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL472299";"";"None";"454.83";"1";"5.86";"15d";"CC(C)(C)NC(=O)N1CCN(C(c2ccc(Cl)cc2)c2cccc(Cl)c2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL597742";"";"None";"630.76";"2";"7.14";"53d";"Cc1cc(Cl)cc(Cl)c1CNC(=O)c1nn(-c2ccccc2Cl)c(-c2ccc(Br)cc2)c1Cn1cncn1";"IC50";"'='";"2420.0";"nM";"5.62";"";"";"UO_0000065";"8.90";"0.20";"-1.52";"7.23";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL582806";"";"None";"514.98";"2";"6.35";"3a";"C[C@H](NC(=O)C(C)(C)Nc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"322.0";"nM";"6.49";"";"";"UO_0000065";"12.61";"0.25";"0.14";"8.34";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL569292";"";"None";"515.87";"2";"6.64";"3b";"C[C@H](NC(=O)C(C)(C)Nc1ncc(Cl)cc1Cl)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"699.0";"nM";"6.16";"";"";"UO_0000065";"11.93";"0.25";"-0.48";"7.91";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL4073323";"";"None";"407.56";"0";"3.67";"16";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cn(CCN2CCOCC2)c2ccccc12";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4040541";"Antagonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of CP55940-induced Ca2+ flux preincubated for 10 mins followed by agonist addition by Fluor-4 AM dye based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038324";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4077975";"";"None";"367.79";"1";"5.56";"29";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cccc([N+](=O)[O-])c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL1089337";"";"None";"411.29";"1";"6.64";"6c";"CCC(=O)c1oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c1N";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"14.59";"0.29";"-0.64";"8.68";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1089338";"";"None";"459.76";"1";"7.54";"6d";"CC(C)C(=O)c1oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc2c1N";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"13.47";"0.28";"-1.35";"8.96";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL3590291";"";"None";"370.49";"0";"4.22";"65";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2ccc(OC)cc21";"IC50";"'='";"194.0";"nM";"6.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL202169";"";"None";"590.89";"2";"7.90";"23";"CC(=O)Nc1c(C(C)=O)c(=O)n(Cc2ccccc2)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"8.96";"0.18";"-2.61";"6.53";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL203152";"";"None";"500.77";"2";"6.79";"21";"CC(=O)Nc1c(C(C)=O)c(O)nc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"11.69";"0.24";"-0.94";"6.35";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL1332976";"";"None";"434.52";"1";"5.67";"SID87225727";"COc1cc2c(cc1NC(=O)C(C)Sc1ccc(NC(C)=O)cc1)oc1ccccc12";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4578199";"";"None";"407.94";"1";"5.50";"13";"CCCCCCCN1C(=O)C2C3c4ccccc4C(c4cc(Cl)ccc43)C2C1=O";"IC50";"'='";"6850.0";"nM";"5.16";"";"";"UO_0000065";"12.66";"0.24";"-0.34";"13.82";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL490026";"";"None";"550.52";"1";"3.90";"47";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(CCO)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL4078924";"";"None";"465.60";"1";"5.71";"26";"Cc1cccc(Cn2nc(C(=O)N3CCC(Cc4ccccc4)CC3)cc2-c2ccc(O)cc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4037469";"Displacement of [3H]CP55,940 from human CB2 receptor expressed in CHOK1 cell membranes after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033784";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4437290";"";"None";"300.44";"1";"5.35";"delta9-THCB";"CCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"23.64";"0.44";"1.75";"24.11";"0";"CHEMBL4344063";"Displacement of [3H]WIN 55212-2 from human CB2 receptor incubated for 120 mins by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342449";"1";"Scientific Literature";"J Nat Prod";"2020";"None";""
"CHEMBL1095553";"";"None";"577.90";"2";"8.28";"12l";"CC1(C)C[C@@H](NC(=O)c2n[nH]c3ccccc23)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"8.40";"0.17";"-3.43";"6.07";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1765273";"";"None";"343.47";"0";"1.23";"5-3";"O=C(C1CNCCN1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1705807";"";"None";"386.52";"0";"2.71";"SID99303187";"Cc1nc(N2CCN(C(=O)C3CCCO3)CC2)c2c3c(sc2n1)CCCC3";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL572080";"";"None";"513.04";"2";"6.59";"10l";"C[C@H](NC(C)(C)C(=O)Nc1cc(-c2ccccc2)on1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"2312.0";"nM";"5.64";"";"";"UO_0000065";"10.99";"0.21";"-0.95";"6.20";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL188";"WIN-552122";"None";"426.52";"0";"4.60";"6, R-(+)-WIN-55212-2";"Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3";"IC50";"'='";"15.7";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL1443900";"";"None";"320.27";"0";"4.17";"SID99303173";"Oc1ccc(-c2[nH]nc(C(F)(F)F)c2-c2ccccc2)c(O)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL2163576";"";"None";"378.47";"0";"3.65";"(S)-33";"C[C@H]1COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL3957783";"";"None";"379.40";"0";"2.05";"BDBM242518";"O=S(=O)(NCC1CC1)c1ccc(NN2CCOCC2)cc1C(F)(F)F";"IC50";"'='";"663.0";"nM";"6.18";"";"422878";"UO_0000065";"16.28";"0.34";"4.13";"8.74";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3960069";"";"None";"453.31";"1";"5.79";"BDBM242479";"CN(CC1CC1)S(=O)(=O)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"4195.0";"nM";"5.38";"";"422831";"UO_0000065";"11.86";"0.26";"-0.41";"10.88";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3917235";"";"None";"497.41";"1";"7.25";"BDBM242483";"CC(C)(C)CC(C)(C)NS(=O)(=O)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"4934.0";"nM";"5.31";"";"422837";"UO_0000065";"10.67";"0.23";"-1.94";"9.12";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3407533";"";"None";"425.28";"0";"2.71";"40";"CCCCOc1cc(Br)cc2cc(C(=O)NN3CCOCC3)c(=O)oc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL4289543";"";"None";"372.51";"0";"4.84";"14";"CCCCCC1=CC(=O)C2=C(OC(C)(C)[C@@H]3CC[C@](C)(OCC)C=C23)C1=O";"IC50";"'='";"4070.0";"nM";"5.39";"";"";"UO_0000065";"14.47";"0.27";"0.55";"10.25";"0";"CHEMBL4253358";"Displacement of [3H]CP-55,940 from recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 90 mins by topcount method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL570893";"";"None";"642.29";"2";"8.08";"16l";"Cc1nnc(-c2c(-c3nnc(C4(C(F)(F)F)CC4)o3)nn(-c3ccc(Cl)cc3Cl)c2-c2ccc(Br)cc2)s1";"IC50";"'='";"38.5";"nM";"7.42";"";"";"UO_0000065";"11.54";"0.27";"-0.67";"8.99";"0";"CHEMBL1038208";"Binding affinity to human CB2 receptor expressed in CHO cells by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156125";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1719423";"";"None";"391.47";"0";"3.78";"SID99303147";"Cc1ccc(C(C)C(=O)N2CCC(n3nc(-c4ccccc4)oc3=O)CC2)cc1";"IC50";"'='";"22900.0";"nM";"4.64";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3099056";"";"None";"416.88";"0";"4.22";"2";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(Cl)c(C(C)(C)O)c2)n1";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"22.16";"0.43";"5.02";"11.52";"0";"CHEMBL3101346";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3098084";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";""
"CHEMBL3669071";"";"None";"384.39";"0";"3.68";"BDBM176619";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cccc(C(C)=O)c2F)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"322525";"UO_0000065";"20.81";"0.39";"4.32";"10.39";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3958344";"";"None";"472.53";"1";"5.28";"BDBM242469";"CCCN(CC1CC1)S(=O)(=O)c1ccc(Nc2ccc(OC)cc2OC)cc1C(F)(F)F";"IC50";"'='";"1748.0";"nM";"5.76";"";"422821";"UO_0000065";"12.18";"0.25";"0.48";"8.48";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3945138";"";"None";"334.36";"0";"2.95";"BDBM242482";"NS(=O)(=O)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"2133.0";"nM";"5.67";"";"422836";"UO_0000065";"16.96";"0.35";"2.72";"7.86";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL517116";"";"None";"529.54";"2";"7.00";"20";"CCc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CCC(C)C)s1";"IC50";"'='";"1206.0";"nM";"5.92";"";"";"UO_0000065";"11.18";"0.23";"-1.08";"11.80";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3781131";"";"None";"520.50";"2";"7.57";"10";"CC1(C)C2CC[C@@](C)(C2)C1NC(=O)c1nn(-c2ccc(Cl)cc2Cl)c2c1Cc1cc(C3CC3)ccc1-2";"IC50";"'='";"80.4";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3782508";"Antagonist/inverse agonist activity at human CB2 receptors expressed in human Chem4 cell membrane incubated for 30 mins by [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Chem4";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779789";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";""
"CHEMBL4763058";"";"None";"302.41";"0";"3.93";"3";"CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C[C@@H](O)C(C)=C[C@@H]21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4668801";"Displacement of [3H]-CP-55,940 from recombinant human CB2R expressed in HEK293 cell membranes after 90 mins";"B";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"Kidney";"HEK293";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665697";"1";"Scientific Literature";"J Nat Prod";"2020";"None";"TIME = 1.5 hr"
"CHEMBL3120205";"";"None";"404.51";"0";"4.27";"5h";"Cc1ccc(Cn2c(-c3ccc(C)cc3)nn(C(=O)NC3CCCCC3)c2=O)cc1";"IC50";"'='";"5030.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL3120203";"";"None";"406.49";"0";"3.91";"5f";"COc1ccc(-c2nn(C(=O)NC3CCCCC3)c(=O)n2-c2ccc(C)cc2)cc1";"IC50";"'='";"4090.0";"nM";"5.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL3120202";"";"None";"432.91";"1";"5.11";"5e";"Cc1ccc(Cn2c(-c3ccc(Cl)cc3)nn(C(=O)Nc3ccc(C)cc3)c2=O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL2316399";"";"None";"396.47";"0";"3.10";"8i";"O=C(Nc1cccnc1C(=O)NCC1CCOCC1)c1ccc2ncsc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL3932295";"";"None";"314.39";"1";"5.00";"8e";"CC(C)c1nc2ccccc2n1C(=O)c1cccc2ccccc12";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"18.06";"0.32";"0.68";"16.27";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL1453578";"";"None";"410.88";"0";"2.62";"SID56320449";"COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(Cl)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1469952";"";"None";"450.51";"0";"2.10";"SID87225737";"CCCN(CCC)Cc1c(C(=O)NN=Cc2c[nH]c3ccccc23)nnn1-c1nonc1N";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1718746";"";"None";"401.53";"0";"2.52";"SID87544618";"Cc1cccc(N2CCN(C(=O)c3cccc(S(=O)(=O)N(C)C)c3)CC2)c1C";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL478228";"";"None";"295.39";"0";"3.26";"11";"O=C(NC12CC3CC(CC(C3)C1)C2)c1n[nH]c2ccccc12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL3696847";"";"None";"382.98";"0";"4.43";"BDBM163066";"CCN(CC)CCNc1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1Cl";"IC50";"'='";"1288.0";"nM";"5.89";"";"306206";"UO_0000065";"15.38";"0.31";"1.46";"11.74";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL462686";"";"None";"529.54";"2";"7.13";"16";"Cc1c(C(=O)NN2CCCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CCC(C)C)s1";"IC50";"'='";"687.7";"nM";"6.16";"";"";"UO_0000065";"11.64";"0.24";"-0.97";"12.29";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL381791";"";"None";"476.06";"1";"6.81";"SR144528";"Cc1ccc(Cn2nc(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)cc2-c2ccc(Cl)c(C)c2)cc1";"IC50";"'='";"7160.0";"nM";"5.14";"";"";"UO_0000065";"10.81";"0.21";"-1.66";"10.97";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL201989";"";"None";"453.50";"0";"4.40";"9f";"CCCCCOc1c(OC)ccc2cc(C(=O)NCCc3ccc([N+](=O)[O-])cc3)c(O)nc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL1288150";"";"None";"339.39";"0";"2.88";"XIV";"CCOC(=O)CNC(=O)CCC(=O)/C=C/c1ccc2ccccc2c1";"IC50";"'='";"9820.0";"nM";"5.01";"";"";"UO_0000065";"14.76";"0.27";"2.13";"6.91";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1288237";"";"None";"325.41";"0";"3.09";"XXI";"C[C@@H](CO)NC(=O)CCCC(=O)/C=C/c1ccc2ccccc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1084471";"";"None";"384.26";"1";"6.08";"rac-5d";"CC1CC(=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2O1";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"13.53";"0.27";"-0.88";"13.27";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL4084091";"";"None";"426.90";"1";"6.88";"40";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccc(C(=O)c3ccccc3)cc2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3912007";"";"None";"392.44";"0";"3.23";"BDBM242510";"O=S(=O)(NCC1CC1)c1ccc(NCC2CCOCC2)cc1C(F)(F)F";"IC50";"'='";"1715.0";"nM";"5.77";"";"422870";"UO_0000065";"14.69";"0.30";"2.54";"8.55";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3922555";"";"None";"377.43";"0";"3.21";"BDBM242511";"O=S(=O)(NCC1CC1)c1ccc(NN2CCCCC2)cc1C(F)(F)F";"IC50";"'='";"146.0";"nM";"6.84";"";"422871";"UO_0000065";"18.11";"0.37";"3.63";"11.13";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1531383";"";"None";"344.41";"0";"4.77";"7i'";"COc1ccc(Cn2c(-c3ccc(OC)cc3)nc3ccccc32)cc1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"16.17";"0.29";"0.80";"15.35";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3938131";"";"None";"354.45";"1";"5.93";"8g";"O=C(c1cccc2ccccc12)n1c(C2CCCCC2)nc2ccccc21";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"16.28";"0.29";"-0.16";"16.54";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3911245";"";"None";"286.33";"0";"4.19";"8a";"Cc1nc2ccccc2n1C(=O)c1cccc2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL203811";"";"None";"472.76";"1";"6.01";"15";"CC(=O)c1c(N)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"12.60";"0.26";"-0.05";"7.64";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL201552";"";"None";"544.82";"2";"6.02";"27";"COCC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"10.09";"0.21";"-0.53";"6.09";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"rimonabant, SR-141716";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1760.0";"nM";"5.75";"";"";"UO_0000065";"12.41";"0.26";"-0.19";"11.47";"1";"CHEMBL963902";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139276";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL520121";"";"None";"644.85";"2";"9.81";"10ae";"CCc1c(-c2nnc(C3(c4ccc(Cl)cc4)CCC3)s2)nc(-c2ccc(Cl)cc2Cl)n1-c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL963902";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139276";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1366039";"";"None";"403.48";"0";"3.71";"SID87225750";"Cc1ccc(C2(C(=O)N3CCC(n4nc(-c5ccccc5)oc4=O)CC3)CC2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1720072";"";"None";"414.47";"0";"2.57";"SID99303135";"N=c1c(C(=O)NCc2cccnc2)cc2c(=O)n3ccccc3nc2n1C1CCCC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1507657";"";"None";"408.53";"0";"4.00";"SID87225740";"O=C(c1ccco1)N1CCN(c2nc(C3CC3)nc3sc4c(c23)CCCC4)CC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1567371";"";"None";"527.61";"2";"5.57";"SID87225761";"Cc1cc(C)c2nc(-c3cccnc3)cc(C(=O)Nc3ccc(S(=O)(=O)Nc4onc(C)c4C)cc3)c2c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1722450";"";"None";"334.81";"0";"4.75";"SID99303165";"Cc1ccc(-n2cc3c(-c4ccc(Cl)cc4)nnc(C)c3n2)cc1";"IC50";"'='";"29800.0";"nM";"4.53";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1611658";"";"None";"454.62";"1";"5.24";"SID87225760";"CCC(C)NS(=O)(=O)c1ccc(NC(=O)C(Sc2ccccc2)c2ccccc2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4442623";"";"None";"358.85";"1";"5.72";"29";"COc1ccccc1-c1ccc(NC(=O)Nc2ccc(Cl)cc2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL1585996";"";"None";"487.58";"0";"2.41";"SID87225728";"CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL520551";"";"None";"528.83";"2";"6.49";"32d";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2Cn2cncn2)o1";"IC50";"'='";"804.0";"nM";"6.09";"";"";"UO_0000065";"11.52";"0.24";"-0.40";"6.97";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL4443540";"";"None";"286.76";"0";"4.02";"15";"O=C(Nc1ccc(Cl)cc1)N[C@H]1C[C@@H]1c1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL3696840";"";"None";"332.62";"0";"4.01";"BDBM163059";"CCCNc1cnn(-c2cc(Cl)cc(Cl)c2)c(=O)c1Cl";"IC50";"'>'";"10000.0";"nM";"";"";"306199";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2387184";"";"None";"373.54";"0";"3.13";"22d";"CCCCn1c2c(cc(C(=O)NC3CCN(C)CC3)c1=O)CCCCCC2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2389080";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385064";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL1700716";"";"None";"365.44";"0";"2.38";"SID99303169";"CC(C)NC(=O)c1cc2c(=O)n3ccccc3nc2n(C2CCCC2)c1=N";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1721058";"";"None";"427.51";"0";"3.22";"SID99303143";"N=c1c(C(=O)NCCc2ccccc2)cc2c(=O)n3ccccc3nc2n1C1CCCC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4513477";"";"None";"358.85";"1";"5.72";"30";"COc1cccc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)s2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL460573";"";"None";"487.46";"1";"6.11";"25";"CCC#Cc1ccc(-c2c(C)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"4328.3";"nM";"5.36";"";"";"UO_0000065";"11.00";"0.23";"-0.75";"10.69";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL497392";"";"None";"414.63";"1";"6.63";"HU308";"CCCCCCC(C)(C)c1cc(OC)c([C@H]2C=C(CO)[C@@H]3C[C@H]2C3(C)C)c(OC)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4426148";"Agonist activity at human CB2 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP accumulation after 60 mins by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425113";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL464058";"";"None";"594.34";"2";"8.61";"9ab";"CCc1c(-c2nnc(C3(c4ccc(C)cc4)CC3)o2)nc(-c2ccc(Cl)cc2Cl)n1-c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL963902";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139276";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL3341862";"";"None";"406.92";"1";"6.04";"10";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cccc(N3CCCCC3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3366075";"Antagonist activity at human CB2 receptor stably expressed in CHO-RD-HGA16 cells assessed as inhibition of CP55,940-induced calcium mobilization after 15 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351332";"1";"Scientific Literature";"J Med Chem";"2014";"None";""
"CHEMBL1572633";"";"None";"290.32";"0";"2.35";"SID87225774";"COC(=O)C1=C(N)c2ccccc2C1(C#N)c1ccccc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1507172";"";"None";"513.58";"2";"5.26";"SID87225763";"Cc1cc(C)c2nc(-c3ccccn3)cc(C(=O)Nc3ccc(S(=O)(=O)Nc4cc(C)on4)cc3)c2c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3341892";"";"None";"427.34";"1";"6.30";"41";"O=C(Nc1cccc(-c2cccc(N3CCCC3)n2)c1)Nc1ccc(Cl)c(Cl)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3366075";"Antagonist activity at human CB2 receptor stably expressed in CHO-RD-HGA16 cells assessed as inhibition of CP55,940-induced calcium mobilization after 15 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351332";"1";"Scientific Literature";"J Med Chem";"2014";"None";""
"CHEMBL3353451";"";"None";"504.63";"1";"3.71";"23";"COc1ccc(-c2cnc3c(c2)cc(C(=O)NC2CCC(C)CC2)c(=O)n3CCN2CCOCC2)cc1";"IC50";"";"";"";"";"";"ND(Insoluble)";"";"";"";"";"";"0";"CHEMBL3383064";"Antagonist activity at human recombinant CB2R expressed in WIN-55212-stimulated U2OS cells assessed as increase in forskolin-mediated cAMP level after 30 mins by time-resolved fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352718";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307757";""
"CHEMBL4100542";"";"None";"398.89";"1";"7.32";"39";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccc(-c3ccccc3)cc2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3669101";"";"None";"430.46";"0";"4.03";"BDBM176652";"COc1nc(NCCc2ccc(OC(F)F)cc2)nc(-c2cccc(C(C)(C)O)c2)n1";"IC50";"'='";"18.0";"nM";"7.75";"";"322559";"UO_0000065";"17.99";"0.34";"3.71";"8.66";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL461428";"";"None";"515.51";"2";"6.89";"28";"CCCCC#Cc1ccc(-c2c(C)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"310.5";"nM";"6.51";"";"";"UO_0000065";"12.62";"0.26";"-0.38";"12.97";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL4540286";"";"None";"519.53";"2";"6.64";"19";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(-n3cc(COc4cccc(F)c4)nn3)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4285088";"";"None";"500.66";"2";"6.57";"18";"CCCCCc1cc2c(c(OS(=O)(=O)c3ccc(C)cc3)c1)[C@H]1[C@@H](CC=C(C)[C@@H]1OO)C(C)(C)O2";"IC50";"'='";"851.0";"nM";"6.07";"";"";"UO_0000065";"12.12";"0.24";"-0.50";"7.40";"0";"CHEMBL4253358";"Displacement of [3H]CP-55,940 from recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 90 mins by topcount method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL3341872";"";"None";"406.92";"1";"6.40";"21";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cccc(NC3CCCC3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3366075";"Antagonist activity at human CB2 receptor stably expressed in CHO-RD-HGA16 cells assessed as inhibition of CP55,940-induced calcium mobilization after 15 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351332";"1";"Scientific Literature";"J Med Chem";"2014";"None";""
"CHEMBL3696849";"";"None";"316.45";"0";"3.78";"BDBM163068";"CCCn1cc2c(=O)n(C3CC(C)(C)CC(C)(C)C3)ncc2n1";"IC50";"'='";"240.0";"nM";"6.62";"";"306208";"UO_0000065";"20.92";"0.39";"2.84";"12.56";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3912856";"";"None";"362.45";"0";"3.14";"BDBM242438";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)cc2)cc(OC)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"422780";"UO_0000065";"21.96";"0.43";"4.82";"10.38";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1698243";"";"None";"324.38";"0";"4.17";"SID99303180";"CCOc1ccc(-c2n[nH]c(C)c2-c2ccc(OC)cc2)c(O)c1";"IC50";"'='";"3790.0";"nM";"5.42";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL518046";"";"None";"469.83";"1";"6.00";"8";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)s1";"IC50";"'='";"1291.0";"nM";"5.89";"";"";"UO_0000065";"12.53";"0.28";"-0.11";"11.74";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1085260";"";"None";"433.77";"1";"6.94";"rac-7d";"CC1(C)CC(N)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"7760.0";"nM";"5.11";"";"";"UO_0000065";"11.78";"0.25";"-1.83";"10.62";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL3891003";"";"None";"338.47";"1";"5.87";"17m";"CCCCCc1sc2ccccc2c1C(=O)c1ccc(OC)cc1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"17.49";"0.34";"0.05";"22.51";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3926929";"";"None";"358.40";"0";"4.41";"9i";"COc1ccc(C(=O)n2c(-c3ccc(OC)cc3)nc3ccccc32)cc1";"IC50";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"14.59";"0.26";"0.82";"9.80";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL2163953";"";"None";"402.49";"0";"4.43";"24";"CC1Oc2cccc3c(=O)c(C(=O)NC4CCCCC4)cn(c23)C1c1ccccc1";"IC50";"'='";"2749.0";"nM";"5.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL4292923";"";"None";"484.66";"1";"6.08";"19";"CCCCCc1cc2c(c(OS(=O)(=O)c3ccc(C)cc3)c1)[C@@H]1[C@H](O)C(C)=CC[C@H]1C(C)(C)O2";"IC50";"'='";"1110.0";"nM";"5.96";"";"";"UO_0000065";"12.29";"0.24";"-0.13";"8.18";"0";"CHEMBL4253358";"Displacement of [3H]CP-55,940 from recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 90 mins by topcount method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL1726224";"";"None";"320.78";"0";"4.44";"SID99303155";"Cc1nnc(-c2ccc(Cl)cc2)c2cn(-c3ccccc3)nc12";"IC50";"'='";"19500.0";"nM";"4.71";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1703615";"";"None";"395.46";"0";"2.01";"SID99303139";"COCCCNC(=O)c1cc2c(=O)n3ccccc3nc2n(C2CCCC2)c1=N";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3410720";"";"None";"382.25";"0";"3.87";"41";"CCCCOc1cc(Br)cc2cc(C(=O)NC(C)C)c(=O)oc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL1760942";"";"None";"406.37";"0";"1.99";"22c";"O=C(N[C@H](c1ccccn1)C(F)(F)F)c1nc(N2CCOCC2)c2cnccn12";"IC50";"'='";"139.0";"nM";"6.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL394055";"";"None";"585.46";"2";"6.38";"5i";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccccc2Cl)nc1N1CCN(S(=O)(=O)c2cc(F)cc(F)c2)CC1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"10.00";"0.20";"-0.53";"7.57";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL3596203";"";"None";"300.40";"0";"3.71";"18c";"CCNC(=O)NCCCCCOc1cccc2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL3596756";"";"None";"316.47";"0";"4.42";"18b";"CCNC(=O)NCCCCCSc1ccc2ccccc2c1";"IC50";"'='";"2110.0";"nM";"5.68";"";"";"UO_0000065";"17.93";"0.35";"1.26";"13.80";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL1760943";"";"None";"406.37";"0";"1.99";"22d";"O=C(NC(c1cccnc1)C(F)(F)F)c1nc(N2CCOCC2)c2cnccn12";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL4070526";"";"None";"337.47";"0";"4.65";"38";"CCOc1ccc(Cc2nc3cc(N)ccc3n2CCC(C)C)cc1";"IC50";"'='";"19952.62";"nM";"4.70";"";"";"UO_0000065";"13.93";"0.26";"0.05";"8.86";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL3957634";"";"None";"473.90";"0";"4.68";"BDBM242478";"N#Cc1ccc(Nc2ccc(S(=O)(=O)NCC3CCOCC3)c(C(F)(F)F)c2)c(Cl)c1";"IC50";"'='";"359.0";"nM";"6.45";"";"422830";"UO_0000065";"13.60";"0.28";"1.76";"7.07";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL528997";"";"None";"573.52";"1";"4.15";"64";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3cn[nH]n3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL524158";"";"None";"567.59";"2";"7.52";"41";"Cc1c(C(=O)NN2CC3CCCC3C2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CC2CCCCC2)s1";"IC50";"'='";"1725.9";"nM";"5.76";"";"";"UO_0000065";"10.15";"0.21";"-1.76";"11.49";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL493916";"";"None";"499.47";"1";"6.11";"36";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CC2CC2)s1";"IC50";"'='";"4234.4";"nM";"5.37";"";"";"UO_0000065";"10.76";"0.22";"-0.74";"10.71";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3916878";"";"None";"460.47";"0";"3.92";"BDBM242445";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CCCO3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"725.0";"nM";"6.14";"";"422790";"UO_0000065";"13.33";"0.27";"2.22";"7.15";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4537149";"";"None";"463.53";"1";"6.96";"15";"COc1ccc(CNc2ccc(C(=O)c3c(-c4ccc(OC)cc4)oc4ccccc34)cc2)cc1";"IC50";"'='";"3860.0";"nM";"5.41";"";"";"UO_0000065";"11.68";"0.21";"-1.55";"8.92";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL3918752";"";"None";"372.51";"1";"5.34";"BDBM235948";"CCCCCc1cc(OC)c(C2=C[C@@H]3CC[C@@]2(C(=O)O)C3(C)C)c(OC)c1";"IC50";"'='";"2090.0";"nM";"5.68";"";"411183";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL570893";"";"None";"642.29";"2";"8.08";"16l";"Cc1nnc(-c2c(-c3nnc(C4(C(F)(F)F)CC4)o3)nn(-c3ccc(Cl)cc3Cl)c2-c2ccc(Br)cc2)s1";"IC50";"'='";"245.0";"nM";"6.61";"";"";"UO_0000065";"10.29";"0.24";"-1.47";"8.01";"0";"CHEMBL1038202";"Displacement of [3H]WIN-552122 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156125";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL585526";"";"None";"606.40";"2";"8.25";"16t";"Cc1nnc(-c2c(-c3nnc(C(C)(C)C)s3)nn(-c3ccc(Cl)cc3Cl)c2-c2ccc(Br)cc2)s1";"IC50";"'='";"427.0";"nM";"6.37";"";"";"UO_0000065";"10.50";"0.25";"-1.88";"9.18";"0";"CHEMBL1038202";"Displacement of [3H]WIN-552122 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156125";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL3120207";"";"None";"410.91";"0";"4.55";"5j";"Cc1ccc(-c2nn(C(=O)NC3CCCCC3)c(=O)n2-c2ccc(Cl)cc2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL4452732";"";"None";"408.55";"0";"3.07";"22";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cn(CCN2CCOCC2)c2cccnc12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL4544885";"";"None";"408.55";"0";"3.07";"28";"O=C(NC12CC3CC(CC(C3)C1)C2)c1nc2ccccc2n1CCN1CCOCC1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL571204";"";"None";"514.98";"2";"6.35";"10a";"C[C@H](NC(C)(C)C(=O)Nc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1721.0";"nM";"5.76";"";"";"UO_0000065";"11.19";"0.22";"-0.59";"7.41";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL3901140";"";"None";"328.42";"1";"5.18";"8f";"CC(C)(C)c1nc2ccccc2n1C(=O)c1cccc2ccccc12";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"19.86";"0.36";"1.34";"18.70";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL4569234";"";"None";"501.71";"2";"6.99";"10";"CCCCCCCOCC12c3ccccc3C(c3ccccc31)C1C(=O)N(CCCCCCC)C(=O)C12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL604089";"";"None";"539.87";"2";"5.66";"21d";"O=C(NC1CCCCC1)c1nn(-c2ccccc2Cl)c(-c2ccc(Br)cc2)c1Cn1cncn1";"IC50";"'='";"4060.0";"nM";"5.39";"";"";"UO_0000065";"9.99";"0.22";"-0.27";"6.95";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL2316402";"";"None";"360.42";"0";"3.41";"8l";"O=C(NCC1CCC1)c1ncccc1NC(=O)c1cccc2cccnc12";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"17.88";"0.33";"3.03";"7.67";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL487586";"";"None";"529.82";"2";"5.88";"32f";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2Cn2ncnn2)o1";"IC50";"'='";"680.0";"nM";"6.17";"";"";"UO_0000065";"11.64";"0.24";"0.29";"6.15";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL488787";"";"None";"588.89";"2";"7.27";"42d";"Clc1ccc(-c2c(Cn3cncn3)c(-c3nnc(C4(c5ccccc5)CC4)o3)nn2-c2ccc(Cl)cc2Cl)cc1";"IC50";"'='";"1130.0";"nM";"5.95";"";"";"UO_0000065";"10.10";"0.20";"-1.32";"6.80";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL530339";"";"None";"580.79";"2";"6.78";"42c";"FC(F)(F)C1(c2nnc(-c3nn(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)c3Cn3cncn3)o2)CC1";"IC50";"'='";"1750.0";"nM";"5.76";"";"";"UO_0000065";"9.91";"0.21";"-1.02";"6.58";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL3669108";"";"None";"480.95";"0";"3.41";"BDBM176659";"COCCS(=O)(=O)c1cc(-c2nc(NCCc3ccc(F)cc3)nc(OC)n2)ccc1Cl";"IC50";"'='";"42.0";"nM";"7.38";"";"322567";"UO_0000065";"15.34";"0.31";"3.97";"7.14";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3898882";"";"None";"308.38";"0";"4.03";"9f";"COc1ccc(C(=O)n2c(C(C)(C)C)nc3ccccc32)cc1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"18.22";"0.33";"1.59";"12.74";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL466686";"";"None";"479.46";"1";"7.81";"37";"CCN(CC)c1nc(C(C)(C)C)nc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"11.61";"0.23";"-2.24";"13.29";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL516900";"";"None";"520.50";"1";"4.68";"36";"O=C(Cc1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(C3CC3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL478696";"";"None";"538.47";"1";"3.59";"35";"COC(=O)c1cc(C(F)(F)F)cc(S(=O)(=O)N2CCN(C(=O)Cc3ccc(C(F)(F)F)cc3)CC2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL522930";"";"None";"364.51";"0";"2.72";"2";"Cc1cc(C)cc(S(=O)(=O)N2CCN(C(=O)C3CCCCC3)CC2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL480640";"";"None";"418.97";"1";"6.08";"3b";"Cc1c(C(=O)NC2CC3CCC2C3)cc(-c2ccccc2)n1Cc1ccc(Cl)cc1";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"15.22";"0.29";"0.30";"18.74";"0";"CHEMBL981472";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143356";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL597337";"";"None";"573.88";"2";"5.88";"54d";"O=C(NC1CC1c1ccccc1)c1nn(-c2ccccc2Cl)c(-c2ccc(Br)cc2)c1Cn1cncn1";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"9.57";"0.20";"-0.39";"7.08";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL523550";"";"None";"541.55";"2";"6.99";"35";"Cc1c(C(=O)NN2CC3CCCC3C2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CC(C)(C)C)s1";"IC50";"'='";"1158.1";"nM";"5.94";"";"";"UO_0000065";"10.96";"0.23";"-1.05";"11.83";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL246688";"";"None";"479.37";"1";"5.18";"5j";"CC(C)N1CCN(c2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2C#N)C(=O)C1=O";"IC50";"'='";"715.0";"nM";"6.15";"";"";"UO_0000065";"12.82";"0.25";"0.97";"7.95";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL246899";"";"None";"405.33";"1";"6.99";"6a";"CC(C)(C)C#Cc1nc(-c2ccccc2Cl)c(-c2ccc(Cl)cc2)cc1C#N";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"14.01";"0.28";"-1.31";"15.48";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL4163588";"";"None";"343.82";"0";"3.00";"47";"Cc1nc(N2CCN(C)CC2)c2nc(-c3ccccc3Cl)oc2n1";"IC50";"'='";"930.0";"nM";"6.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4147299";"Neutral antagonist activity at human CB2 assessed as inhibition of WIN552122-induced suppression of cAMP formation preincubated for 15 mins followed by forskolin addition for 30 mins measured after 1 hr by HTRF assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145495";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL230073";"";"None";"457.79";"1";"6.66";"33";"C[C@H](NC(=O)c1cc(Cl)cc(Cl)c1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"180.7";"nM";"6.74";"";"";"UO_0000065";"14.73";"0.31";"0.08";"12.75";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL1724290";"";"None";"519.61";"1";"4.83";"SID87544678";"COc1ccc(-c2csc(NC(=O)CSc3nnc4c(C)cc5cc6c(cc5n34)OCCO6)n2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL202013";"";"None";"486.79";"1";"6.49";"32";"CC(=O)Nc1c(C)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"11.96";"0.25";"-0.67";"9.10";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL1448070";"";"None";"415.52";"1";"5.24";"SID87225752";"Cc1cccc(-c2cc(C(=O)Nc3sc(C)c(C)c3C(N)=O)c3ccccc3n2)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL389353";"";"None";"475.01";"1";"6.06";"25";"C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1092.0";"nM";"5.96";"";"";"UO_0000065";"12.55";"0.25";"-0.10";"8.52";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL230927";"";"None";"438.98";"1";"5.05";"26";"C[C@H](NS(=O)(=O)Cc1ccccc1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL201102";"";"None";"502.79";"2";"6.19";"31";"COc1c(NC(C)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"11.85";"0.25";"-0.23";"8.14";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL204232";"NAPHTHYRIDINONE";"None";"514.80";"2";"6.39";"14";"CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"10.46";"0.22";"-1.00";"6.65";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3590294";"";"None";"388.94";"1";"5.17";"68";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(Cl)cc(C)c21";"IC50";"'='";"1480.0";"nM";"5.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL2071076";"";"None";"333.22";"0";"4.45";"26";"O=C(NCCc1ccc(Cl)cc1)c1cc2cc(Cl)ccc2[nH]1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL3669063";"";"None";"382.44";"0";"4.13";"BDBM176611";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cccc(OC(C)C)c2)n1";"IC50";"'='";"39.0";"nM";"7.41";"";"322517";"UO_0000065";"19.37";"0.36";"3.28";"10.71";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL411041";"";"None";"528.65";"2";"7.17";"42";"Cc1c(C(=O)NCc2ccc(Cl)c(Cl)c2)nn(-c2c(Cl)cc(Cl)cc2Cl)c1-n1cccc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL261382";"";"None";"445.39";"1";"5.96";"27";"Cc1c(C(=O)NC2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-n1c(C)ccc1C";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"15.62";"0.32";"1.00";"13.42";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL2071073";"";"None";"313.79";"0";"3.38";"23";"Nc1ccc(CCNC(=O)c2cc3cc(Cl)ccc3[nH]2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL4096828";"";"None";"337.81";"1";"5.35";"16";"Cc1ccnc(-c2cccc(NC(=O)Nc3ccc(Cl)cc3)c2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4081259";"";"None";"323.78";"1";"5.05";"20";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccncc2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3896335";"";"None";"467.47";"0";"4.34";"BDBM242446";"COc1cc(Nc2ccc(S(=O)(=O)NCc3ccncc3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"332.0";"nM";"6.48";"";"422792";"UO_0000065";"13.86";"0.28";"2.14";"7.23";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3968673";"";"None";"474.50";"0";"4.17";"BDBM242476";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CCOCC3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"439.0";"nM";"6.36";"";"422828";"UO_0000065";"13.40";"0.27";"2.19";"7.40";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1726562";"";"None";"409.49";"0";"3.48";"SID99303182";"COc1ccc(-c2c(-c3ccc(OCCN4CCOCC4)cc3O)n[nH]c2C)cc1";"IC50";"'='";"26800.0";"nM";"4.57";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1734382";"";"None";"489.58";"0";"4.82";"SID87544677";"Cc1cc2cc3c(cc2n2c(SCC(=O)Nc4nc(-c5ccccc5)cs4)nnc12)OCCO3";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1701998";"";"None";"450.56";"0";"3.61";"SID99303133";"Cc1nc(N2CCN(C(=O)c3ccc4c(c3)OCCO4)CC2)c2c3c(sc2n1)CCCC3";"IC50";"'='";"24200.0";"nM";"4.62";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3933394";"";"None";"463.40";"1";"5.03";"BDBM242524";"N#Cc1ccc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)cc1C(F)(F)F";"IC50";"'='";"431.0";"nM";"6.37";"";"422884";"UO_0000065";"13.74";"0.28";"1.34";"7.76";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1728454";"";"None";"381.41";"0";"3.05";"SID99303148";"O=C(Cc1ccccc1F)N1CCC(n2nc(-c3ccccc3)oc2=O)CC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3891231";"";"None";"430.45";"0";"4.15";"BDBM242431";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"37.0";"nM";"7.43";"";"422765";"UO_0000065";"17.27";"0.35";"3.28";"9.69";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL259255";"";"None";"446.38";"1";"5.03";"31";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)c(Cl)c2)c1-n1c(C)ccc1C";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"16.65";"0.34";"2.40";"13.49";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL1398414";"";"None";"420.44";"0";"1.70";"SID87544620";"COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc2c(c1)OCO2";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1732131";"";"None";"459.60";"1";"5.38";"SID87544676";"Cc1ccc2cc(C)c3nnc(SCC(=O)N(C)c4nc(-c5ccccc5)cs4)n3c2c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1730381";"";"None";"413.48";"0";"3.17";"SID99303141";"N=c1c(C(=O)NCc2ccccc2)cc2c(=O)n3ccccc3nc2n1C1CCCC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4442586";"";"None";"595.59";"2";"9.10";"12";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(N(Cc3cc(F)cc(F)c3)Cc3cc(F)cc(F)c3)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL248014";"";"None";"400.47";"0";"4.56";"4-16";"COCCn1c(C)c(C(C)(C)C)s/c1=N\C(=O)c1cccc(C(F)(F)F)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"19.98";"0.40";"3.44";"18.35";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL1083646";"(2R)-N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)";"None";"505.83";"2";"6.48";"13l, Enantiomer 2";"C[C@@H](O)C(=O)NC1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"3450.0";"nM";"5.46";"";"";"UO_0000065";"10.80";"0.23";"-1.02";"7.64";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1083025";"N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)";"None";"505.83";"2";"6.48";"13h, Enantiomer 2";"CC1(C)CC(NC(=O)CCO)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"10.41";"0.22";"-1.21";"7.37";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL3696836";"";"None";"399.72";"0";"4.75";"BDBM163055";"CCCNc1cnn(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c(=O)c1Cl";"IC50";"'>'";"10000.0";"nM";"";"";"306195";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL584309";"";"None";"436.94";"0";"4.92";"3i";"C[C@H](NC(=O)C(C)(C)Nc1ccon1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"3213.0";"nM";"5.49";"";"";"UO_0000065";"12.57";"0.24";"0.57";"6.04";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL603054";"";"None";"630.98";"2";"6.17";"46d";"Cc1cccc(N2CCN(C(=O)c3nn(-c4ccccc4Cl)c(-c4ccc(Br)cc4)c3Cn3cncn3)CC2)c1C";"IC50";"'='";"547.0";"nM";"6.26";"";"";"UO_0000065";"9.92";"0.21";"0.09";"8.69";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL1093997";"";"None";"445.73";"1";"7.30";"6b";"CCC(=O)c1oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc2c1N";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"14.46";"0.30";"-0.86";"9.32";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL4104374";"";"None";"367.45";"0";"4.98";"37";"CCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCC(C)C)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"16.33";"0.30";"1.02";"8.55";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL1091466";"";"None";"431.71";"1";"6.91";"6a";"CC(=O)c1oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc2c1N";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.90";"0.29";"-0.91";"8.68";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL270663";"";"None";"487.82";"1";"6.83";"9c";"CCc1c(-c2nnnn2C2CCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"12.45";"0.26";"-0.75";"9.89";"0";"CHEMBL950211";"Displacement of [3H]WIN-55212-2 from human cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143900";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";""
"CHEMBL1765264";"";"None";"326.40";"0";"2.97";"4-1";"O=C(c1ccon1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL410014";"";"None";"397.42";"0";"4.43";"6b, CBS-0550";"Cn1c(C(C)(C)C)c/c(=N\C(=O)c2cccc(C(F)(F)F)c2F)n1CC1CC1";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"21.48";"0.42";"4.11";"21.73";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL3976311";"";"None";"266.30";"0";"3.04";"9a";"COc1ccc(C(=O)n2c(C)nc3ccccc32)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL263913";"";"None";"425.47";"1";"5.21";"6h";"Cn1c(C(C)(C)C)c/c(=N\C(=O)c2cccc(C(F)(F)F)c2F)n1CC1CCCC1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"21.06";"0.41";"3.75";"22.80";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL481543";"";"None";"492.19";"1";"6.86";"9m";"O=C(Cn1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2Cl)n1)Nc1ccccc1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL2397751";"SAD448";"1.0";"532.58";"1";"1.31";"1";"CCOC(=O)c1c(C)cc2nc(COC(=O)NCCO)n(-c3ccccc3S(=O)(=O)NC)c(=O)c2c1C";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"15.88";"0.31";"7.15";"5.10";"0";"CHEMBL2399678";"Agonist activity at CB2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396634";"1";"Scientific Literature";"J Med Chem";"2013";"None";""
"CHEMBL4798508";"";"None";"417.48";"0";"4.86";"21b";"O=C(c1ccc(Cc2ccccc2)cc1)C1CCN(C(=O)c2cc(O)ccc2F)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4733366";"Displacement of [3H]CP55940 from human CB2 receptor incubated for 90 mins by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732057";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.5 hr"
"CHEMBL3696832";"";"None";"370.34";"0";"4.61";"BDBM163050";"CCCNc1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1Br";"IC50";"'='";"4.8";"nM";"8.32";"";"306189";"UO_0000065";"22.46";"0.52";"3.71";"17.73";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4454140";"";"None";"365.52";"0";"4.93";"27";"CCCCCn1c(C(=O)NC23CC4CC(CC(C4)C2)C3)nc2ccccc21";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL487163";"";"None";"489.83";"1";"7.97";"4hc";"CC(C)c1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"2820.0";"nM";"5.55";"";"";"UO_0000065";"11.33";"0.24";"-2.42";"9.78";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL181633";"";"None";"504.37";"1";"4.13";"56, AM-630";"COc1ccc(C(=O)c2c(C)n(CCN3CCOCC3)c3cc(I)ccc23)cc1";"IC50";"'='";"7200.0";"nM";"5.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1117763";"Antagonist activity at cannabinoid CB2 receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155461";"1";"Scientific Literature";"J Med Chem";"2010";"None";""
"CHEMBL3669090";"";"None";"375.41";"0";"3.89";"BDBM176641";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccnc3ccccc23)n1";"IC50";"'='";"11.0";"nM";"7.96";"";"322548";"UO_0000065";"21.20";"0.39";"4.07";"10.93";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1222968";"";"None";"596.85";"2";"7.25";"17b";"FC(F)(F)C1(c2nnc(-c3nn(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)c3Cn3cncn3)s2)CC1";"IC50";"'='";"3631.0";"nM";"5.44";"";"";"UO_0000065";"9.11";"0.20";"-1.81";"7.32";"0";"CHEMBL1227204";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221281";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL3915237";"";"None";"404.45";"0";"3.93";"BDBM242502";"O=S(=O)(NOCC1CC1)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"437.0";"nM";"6.36";"";"422858";"UO_0000065";"15.72";"0.32";"2.43";"9.43";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3921366";"";"None";"462.88";"0";"4.58";"BDBM242497";"COC(=O)c1ccc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)c(Cl)c1";"IC50";"'='";"1107.0";"nM";"5.96";"";"422852";"UO_0000065";"12.87";"0.27";"1.38";"7.05";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3932103";"";"None";"426.92";"0";"3.56";"BDBM242451";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CCCO3)c(Cl)c2)cc(OC)c1";"IC50";"'='";"1441.0";"nM";"5.84";"";"422797";"UO_0000065";"13.68";"0.28";"2.28";"6.80";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3669105";"";"None";"460.48";"0";"4.04";"BDBM176656";"COc1nc(NCCc2ccc(OC(F)F)cc2)nc(-c2cccc(OC)c2C(C)(C)O)n1";"IC50";"'='";"4.0";"nM";"8.40";"";"322564";"UO_0000065";"18.24";"0.35";"4.36";"8.52";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1095158";"";"None";"541.87";"2";"7.44";"12e";"Cc1c[nH]nc1C(=O)N[C@@H]1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"10.44";"0.21";"-1.78";"7.08";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL3922691";"";"None";"376.48";"0";"3.44";"BDBM242481";"COc1ccc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C)c2)c(OC)c1";"IC50";"'='";"586.0";"nM";"6.23";"";"422834";"UO_0000065";"16.55";"0.33";"2.79";"8.13";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3960069";"";"None";"453.31";"1";"5.79";"BDBM242479";"CN(CC1CC1)S(=O)(=O)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"327.0";"nM";"6.49";"";"422832";"UO_0000065";"14.31";"0.32";"0.70";"13.13";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL487377";"";"None";"553.88";"2";"8.43";"27a";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2COc2ccccc2)o1";"IC50";"'='";"5910.0";"nM";"5.23";"";"";"UO_0000065";"9.44";"0.19";"-3.20";"7.93";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL4071738";"";"None";"417.55";"0";"4.72";"18";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cc(-c2ccccc2)nn(C2CCCC2)c1=O";"IC50";"'='";"54.6";"nM";"7.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3998735";"Inverse agonist activity at human CB2 receptor expressed in HEK293 EBNA cell membranes after 30 mins by [35S]-GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997787";"1";"Scientific Literature";"Eur J Med Chem";"2017";"CHEMBL3307715";""
"CHEMBL3669100";"";"None";"429.40";"0";"4.42";"BDBM176651";"COc1nc(NCCc2ccc(OC(F)F)cc2)nc(-c2cc3cc(F)ccc3[nH]2)n1";"IC50";"'='";"45.0";"nM";"7.35";"";"322558";"UO_0000065";"17.11";"0.32";"2.93";"8.65";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4464357";"";"None";"433.51";"1";"6.95";"6";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(NCc3ccccc3)cc2)cc1";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"14.26";"0.26";"-0.77";"12.01";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4454301";"";"None";"413.52";"1";"6.94";"17";"CCCCCNc1ccc(C(=O)c2c(-c3ccc(OC)cc3)oc3ccccc23)cc1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"15.92";"0.29";"-0.35";"12.79";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL3895713";"";"None";"405.49";"0";"3.99";"BDBM242522";"CC(C)(NS(=O)(=O)c1ccc(NN2CCCCC2)cc1C(F)(F)F)C1CC1";"IC50";"'='";"187.0";"nM";"6.73";"";"422882";"UO_0000065";"16.59";"0.34";"2.74";"10.95";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3942971";"";"None";"428.61";"1";"6.86";"BDBM235939";"CCCCCCC(C)(C)c1cc(OC)c(C2=C[C@H]3CC[C@]2(C(=O)O)C3(C)C)c(OC)c1";"IC50";"'='";"2290.0";"nM";"5.64";"";"411177";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4284088";"";"None";"401.52";"1";"7.00";"13a";"CCCCCCCCCCC/C(=N\O)c1cc(-c2ccc(O)c(F)c2)ccc1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4275255";"Displacement of [3H]CP55940 from recombinant human CB2 expressed crude membranes after 90 mins by liquid scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270621";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL3963516";"";"None";"320.46";"0";"2.98";"BDBM242464";"O=S(=O)(NCC1CC1)c1ccc(NC2CC3CCC2C3)cc1";"IC50";"'='";"1940.0";"nM";"5.71";"";"422814";"UO_0000065";"17.82";"0.35";"2.73";"9.81";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL410728";"";"None";"418.33";"0";"4.41";"22";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-n1cccc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"16.01";"0.33";"2.29";"12.16";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL4637658";"";"None";"392.89";"0";"4.98";"36";"O=C(Nc1cccc(Cl)c1)C1CCN(C(=O)c2ccc3ccccc3c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4615448";"Inhibition of CB2 receptor (unknown origin) expressed in Flpin-CHO cells incubated for 10 mins by Eu-cAMP tracer based cAMP accumulation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613273";"1";"Scientific Literature";"J Med Chem";"2020";"None";""
"CHEMBL4086412";"";"None";"449.64";"1";"6.38";"20c";"CCCCCCNC(=O)c1ccc2c(c1)nc(Cc1ccc(OCC)cc1)n2CCC(C)C";"IC50";"'='";"1995.26";"nM";"5.70";"";"";"UO_0000065";"12.68";"0.24";"-0.68";"10.15";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4063907";"";"None";"499.70";"1";"6.77";"20e";"CCOc1ccc(Cc2nc3cc(C(=O)NC45CC6CC(CC(C6)C4)C5)ccc3n2CCC(C)C)cc1";"IC50";"'='";"5011.87";"nM";"5.30";"";"";"UO_0000065";"10.61";"0.20";"-1.47";"9.44";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4861073";"";"None";"300.79";"0";"4.27";"20";"O=C(NC[C@H]1C[C@@H]1c1ccccc1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL1096845";"";"None";"641.82";"2";"8.34";"16";"CC1(C)C[C@H](NC(=O)CC(O)(C(F)(F)F)C(F)(F)F)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"7.43";"0.16";"-3.57";"6.68";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL3916509";"";"None";"413.47";"0";"4.20";"BDBM242491";"CN(C)c1ccc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)cc1";"IC50";"'='";"2655.0";"nM";"5.58";"";"422845";"UO_0000065";"13.49";"0.27";"1.38";"9.08";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3986120";"";"None";"430.45";"0";"4.15";"BDBM242468";"COc1ccc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)c(OC)c1";"IC50";"'='";"108.9";"nM";"6.96";"";"422820";"UO_0000065";"16.18";"0.33";"2.81";"9.08";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1085732";"";"None";"434.75";"1";"6.97";"rac-7a";"CC1(C)CC(O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"4950.0";"nM";"5.30";"";"";"UO_0000065";"12.20";"0.26";"-1.66";"12.53";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL410496";"";"None";"368.87";"0";"4.38";"16";"O=C(NC1CCCCC1)c1cc(-n2cccc2)n(-c2ccc(Cl)cc2)n1";"IC50";"'='";"2220.0";"nM";"5.65";"";"";"UO_0000065";"15.33";"0.30";"1.27";"10.90";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3596736";"";"None";"315.39";"0";"1.90";"17d";"CCS(=O)(=O)NCCCCCOc1ccc2c(c1)OCO2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL4468436";"";"None";"286.76";"0";"4.02";"16";"O=C(Nc1ccc(Cl)cc1)N[C@H]1C[C@H]1c1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL2163577";"";"None";"354.45";"0";"3.80";"(R)-35";"CC[C@@H]1COc2cccc3c(=O)c(C(=O)NC4CCCCCC4)cn1c23";"IC50";"'='";"17.2";"nM";"7.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163961";"";"None";"340.42";"0";"3.41";"32";"CC1COc2cccc3c(=O)c(C(=O)NC4CCCCCC4)cn1c23";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL480539";"";"None";"536.25";"2";"6.55";"9i";"COc1ccc(CNC(=O)Cn2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3Cl)n2)cc1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL2163956";"";"None";"402.49";"0";"4.35";"27";"Cc1ccc(C2COc3cccc4c(=O)c(C(=O)NC5CCCCC5)cn2c34)cc1";"IC50";"'='";"2457.0";"nM";"5.61";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL374791";"";"None";"422.96";"1";"5.42";"35f";"C[C@H](NC(=O)C(C)(C)Oc1ccccn1)[C@@H](Cc1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"16.68";"0.32";"1.64";"13.77";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL481886";"";"None";"484.21";"1";"6.24";"9b";"O=C(Cn1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2Cl)n1)N1CCCCC1";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"16.99";"0.37";"1.99";"16.13";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL3669111";"";"None";"505.55";"1";"3.55";"BDBM176662";"COc1nc(NCCc2ccc(OC(F)F)cc2)nc(-c2ccc(C)c(S(=O)(=O)NC3CC3)c2)n1";"IC50";"'='";"44.0";"nM";"7.36";"";"322570";"UO_0000065";"14.55";"0.29";"3.81";"6.38";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669057";"";"None";"382.44";"0";"3.57";"BDBM176605";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cccc(C(C)(C)O)c2)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"322571";"UO_0000065";"21.04";"0.39";"4.48";"10.04";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669113";"";"None";"491.52";"0";"3.24";"BDBM176665";"COc1nc(NCCc2ccc(OC(F)F)cc2)nc(-c2cccc(S(=O)(=O)NC3CC3)c2)n1";"IC50";"'='";"23.0";"nM";"7.64";"";"322575";"UO_0000065";"15.54";"0.31";"4.40";"6.62";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3120201";"";"None";"424.93";"0";"4.61";"5d";"Cc1ccc(Cn2c(-c3ccc(Cl)cc3)nn(C(=O)NC3CCCCC3)c2=O)cc1";"IC50";"'='";"1930.0";"nM";"5.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL3596744";"";"None";"317.34";"0";"1.71";"7c";"CCOC(=O)CNC(=O)/C=C/C=C/c1ccc2c(c1)OCCO2";"IC50";"'='";"9690.0";"nM";"5.01";"";"";"UO_0000065";"15.80";"0.30";"3.30";"6.79";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL3780521";"";"None";"450.62";"1";"5.72";"7b";"CCCCCn1c(=O)c(C(=O)NC23CC4CC(CC(C4)C2)C3)c(O)c2cc(C(C)C)ccc21";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"18.71";"0.35";"2.71";"11.82";"0";"CHEMBL3782259";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells after 90 mins by Competition binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779817";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3120209";"";"None";"434.88";"0";"4.75";"5l";"COc1ccc(-c2nn(C(=O)Nc3ccc(C)cc3)c(=O)n2-c2ccc(Cl)cc2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL1836188";"";"None";"430.55";"0";"4.96";"48b";"CCOC(=O)/C(=C/c1cn(CCN2CCCCC2)c2ccccc12)C(=O)c1ccccc1";"IC50";"'='";"5480.0";"nM";"5.26";"";"";"UO_0000065";"12.22";"0.22";"0.30";"10.21";"0";"CHEMBL1837632";"Displacement of [3H]-WIN 55,212-2 from human CB2 receptor expressed in human HEK293 cells after 90 mins by radioligand assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833961";"1";"Scientific Literature";"Eur J Med Chem";"2011";"CHEMBL3307715";""
"CHEMBL3669106";"";"None";"482.89";"0";"4.98";"BDBM176657";"COc1nc(NCCc2ccc(OC(F)(F)F)cc2)nc(-c2ccc(Cl)c(C(C)(C)O)c2)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"322565";"UO_0000065";"16.40";"0.33";"2.94";"8.86";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669059";"";"None";"374.80";"0";"3.70";"BDBM176607";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(Cl)c(O)c2)n1";"IC50";"'='";"21.0";"nM";"7.68";"";"322576";"UO_0000065";"20.49";"0.40";"3.98";"9.58";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4590595";"";"None";"295.39";"0";"3.26";"26";"O=C(NC12CC3CC(CC(C3)C1)C2)c1nc2ccccc2[nH]1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL4585014";"";"None";"359.47";"0";"4.46";"2";"CCCCCCN1C(=O)C2C3c4ccccc4C(c4ccccc43)C2C1=O";"IC50";"'='";"8140.0";"nM";"5.09";"";"";"UO_0000065";"14.16";"0.26";"0.63";"13.62";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL4475934";"";"None";"329.83";"0";"4.13";"17";"O=C(Nc1ccc(Cl)cc1)N[C@@H]1CCCN(c2ccccc2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL411303";"";"None";"360.42";"0";"2.67";"13";"N#Cc1c(C(=O)NN2CCCCC2)nn(-c2ccccc2)c1-n1cccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3669077";"";"None";"397.84";"0";"4.48";"BDBM176628";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3cc(Cl)ccc3[nH]2)n1";"IC50";"'='";"14.0";"nM";"7.85";"";"322534";"UO_0000065";"19.74";"0.38";"3.37";"10.37";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1097840";"";"None";"567.90";"2";"7.62";"12g";"CC1(C)C[C@@H](NC(=O)c2n[nH]c3c2CCC3)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"11.05";"0.23";"-1.34";"7.85";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL572271";"";"None";"450.97";"1";"5.23";"3j";"Cc1cc(NC(C)(C)C(=O)N[C@@H](C)[C@@H](Cc2ccc(Cl)cc2)c2cccc(C#N)c2)no1";"IC50";"'='";"5158.0";"nM";"5.29";"";"";"UO_0000065";"11.72";"0.23";"0.06";"5.81";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1765275";"";"None";"358.48";"0";"1.78";"5-5";"O=C([C@@H]1C[C@@H](O)CCN1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"2175.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL2019081";"";"None";"442.60";"0";"4.60";"5";"O=C(NC1(C(=O)O)CCCCC1)c1cc2c(n(CC3CCCCC3)c1=O)CCCCCC2";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2020077";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release after 45 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2016545";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL1714272";"";"None";"461.57";"1";"5.05";"SID87225724";"COc1ccc(-c2csc(NC(=O)CSc3nnc4c(C)cc5ccccc5n34)n2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL2316381";"";"None";"646.65";"1";"3.94";"14";"O=C(NCC1CCOCC1)c1nc(OS(=O)(=O)CCC(F)(F)F)ccc1NC(=O)c1ccc(Cn2ccnn2)c2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL519302";"";"None";"537.93";"2";"7.48";"4";"Cc1c(C(=O)NC2C3CC4CC(C3)CC2C4)c(Br)c(-c2ccccc2)n1Cc1ccc(Cl)cc1";"IC50";"'='";"123.0";"nM";"6.91";"";"";"UO_0000065";"12.85";"0.28";"-0.57";"20.31";"0";"CHEMBL981472";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143356";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL519946";"";"None";"610.41";"2";"9.08";"10ab";"CCc1c(-c2nnc(C3(c4ccc(C)cc4)CC3)s2)nc(-c2ccc(Cl)cc2Cl)n1-c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL963902";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139276";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL361119";"";"None";"465.77";"1";"7.83";"3b";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1OCc1ccccc1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL827164";"Inhibitory concentration tested against human Cannabinoid receptor 2 (hCB2)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";""
"CHEMBL4283589";"";"None";"500.66";"2";"6.57";"22";"C=C1C[C@H]2c3c(cc(CCCCC)cc3OS(=O)(=O)c3ccc(C)cc3)OC(C)(C)[C@@H]2CC1OO";"IC50";"'='";"2060.0";"nM";"5.69";"";"";"UO_0000065";"11.36";"0.22";"-0.88";"6.93";"0";"CHEMBL4253358";"Displacement of [3H]CP-55,940 from recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 90 mins by topcount method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL497925";"";"None";"501.85";"2";"6.64";"31";"CCc1c(C2=NC3(CCCCC3)C(=O)N2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"496.7";"nM";"6.30";"";"";"UO_0000065";"12.56";"0.26";"-0.34";"10.63";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL464085";"";"None";"628.78";"2";"9.34";"9ae";"CCc1c(-c2nnc(C3(c4ccc(Cl)cc4)CCC3)o2)nc(-c2ccc(Cl)cc2Cl)n1-c1ccc(Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL963902";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139276";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL4451981";"";"None";"365.52";"0";"4.93";"21";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c2cccnc21";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL1449870";"";"None";"391.48";"0";"2.92";"SID99303178";"N=c1c(C(=O)NC2CCCC2)cc2c(=O)n3ccccc3nc2n1C1CCCC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1703772";"";"None";"389.46";"0";"3.40";"SID99303154";"O=C(N1CCC(n2nc(-c3ccccc3)oc2=O)CC1)C1(c2ccccc2)CC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3353439";"";"None";"472.36";"0";"4.65";"17";"CC1CCC(NC(=O)c2cc3cc(Br)cnc3n(Cc3ccc(F)cc3)c2=O)CC1";"IC50";"'='";"0.72";"nM";"9.14";"";"";"UO_0000065";"19.36";"0.42";"4.49";"14.29";"0";"CHEMBL3383059";"Displacement of [3H]CP-55,940 from human recombinant CB2R expressed in HEK-293 cells after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352718";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307715";""
"CHEMBL3669060";"";"None";"460.89";"0";"3.94";"BDBM176608";"CCOC(=O)COc1cc(-c2nc(NCCc3ccc(F)cc3)nc(OC)n2)ccc1Cl";"IC50";"'='";"10.0";"nM";"8.00";"";"322578";"UO_0000065";"17.36";"0.34";"4.06";"8.38";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3965133";"";"None";"489.52";"0";"3.08";"BDBM242448";"COc1cc(Nc2ccc(S(=O)(=O)NCCN3CCOCC3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"3704.0";"nM";"5.43";"";"422794";"UO_0000065";"11.10";"0.22";"2.35";"6.09";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4534867";"";"None";"369.44";"0";"4.39";"25";"CC(C)c1ccc(C(=O)C2CCN(C(=O)c3ccc(F)c(O)c3)CC2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4424605";"Displacement of [3H]CP55,940 to human CB2 receptor expressed in cell membranes after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422672";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4575018";"";"None";"383.46";"0";"4.61";"24";"CCCCc1ccc(C(=O)C2CCN(C(=O)c3cc(O)ccc3F)CC2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4424605";"Displacement of [3H]CP55,940 to human CB2 receptor expressed in cell membranes after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422672";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL178372";"";"None";"438.48";"0";"3.76";"9b";"CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4c(c3)OCO4)c(=O)[nH]c12";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL3353439";"";"None";"472.36";"0";"4.65";"17";"CC1CCC(NC(=O)c2cc3cc(Br)cnc3n(Cc3ccc(F)cc3)c2=O)CC1";"IC50";"'='";"31.6";"nM";"7.50";"";"";"UO_0000065";"15.88";"0.34";"2.85";"11.72";"0";"CHEMBL3383061";"Antagonist activity at human recombinant CB2R expressed in U2OS cells assessed as inhibition of WIN-55212-induced beta-arrestin-GFP binding to receptor preincubated for 15 mins by fluorescent microscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352718";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307757";""
"CHEMBL3669056";"";"None";"464.90";"0";"4.68";"BDBM176604";"COc1nc(NCCc2ccc(OC(F)F)cc2)nc(-c2ccc(Cl)c(C(C)(C)O)c2)n1";"IC50";"'='";"1.2";"nM";"8.92";"";"322561";"UO_0000065";"19.19";"0.38";"4.24";"9.98";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669078";"";"None";"381.39";"0";"3.96";"BDBM176629";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3ccc(F)cc3[nH]2)n1";"IC50";"'='";"48.0";"nM";"7.32";"";"322536";"UO_0000065";"19.19";"0.36";"3.36";"9.67";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669079";"";"None";"377.42";"0";"4.13";"BDBM176630";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3cc(C)ccc3[nH]2)n1";"IC50";"'='";"24.0";"nM";"7.62";"";"322537";"UO_0000065";"20.19";"0.37";"3.49";"10.06";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2163927";"";"None";"406.53";"0";"4.29";"(S)-51";"CC(C)[C@H]1COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163928";"";"None";"420.55";"0";"4.68";"(R)-58";"CC(C)C[C@@H]1COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL1928586";"SERINOLAMIDE A";"None";"383.62";"1";"5.49";"3";"CCCCCCCCCCCCC/C=C/CCC(=O)N(C)[C@H](CO)COC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1932156";"Displacement of [3H]CP55940 from human recombinant CB2 receptor expressed in HEK293 cells after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1926606";"1";"Scientific Literature";"J Nat Prod";"2011";"CHEMBL3307715";""
"CHEMBL1082305";"6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)";"None";"461.78";"1";"6.51";"14b, Enantiomer 2";"CC1(C)CC(C(N)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"2480.0";"nM";"5.61";"";"";"UO_0000065";"12.14";"0.26";"-0.90";"8.60";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1765154";"";"None";"369.89";"0";"4.63";"Table 1, R2C2, 2";"O=C(c1ccc(Cl)cc1)N1CC[C@](O)(c2ccccc2)[C@H]2CCCC[C@@H]21";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765281";"";"None";"404.43";"0";"4.39";"4-10";"O=C(c1ccc(C(F)(F)F)nc1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765256";"";"None";"403.44";"0";"5.00";"2-8";"O=C(c1ccccc1)N1CC[C@](O)(c2cccc(C(F)(F)F)c2)[C@H]2CCCC[C@@H]21";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL411110";"";"None";"335.41";"0";"2.79";"11";"O=C(NN1CCCCC1)c1cc(-n2cccc2)n(-c2ccccc2)n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL261612";"";"None";"349.44";"0";"3.10";"12";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccccc2)c1-n1cccc1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3669076";"";"None";"442.29";"0";"4.58";"BDBM176626";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3cc(Br)ccc3[nH]2)n1";"IC50";"'='";"17.0";"nM";"7.77";"";"322532";"UO_0000065";"17.57";"0.38";"3.19";"10.26";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL466685";"";"None";"492.45";"1";"6.37";"36";"CC(C)(C)c1nc(N2CCNCC2)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2n1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"11.67";"0.23";"-0.63";"10.65";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL410243";"";"None";"415.43";"0";"4.06";"6i";"CCOCCn1/c(=N/C(=O)c2cccc(C(F)(F)F)c2F)cc(C(C)(C)C)n1C";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"20.30";"0.40";"4.37";"17.38";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL272754";"";"None";"393.45";"0";"4.60";"6d";"Cc1c(C(=O)/N=c2\cc(C(C)(C)C)n(C)n2CC2CC2)cccc1C(F)(F)F";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"20.23";"0.39";"3.36";"20.26";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL255347";"";"None";"366.38";"0";"4.68";"3";"Cc1c(C(C)C)o/c(=N\C(=O)c2cccc(C(F)(F)F)c2)n1CC1CC1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"20.80";"0.40";"2.94";"16.04";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL256696";"";"None";"383.44";"0";"4.41";"2";"CC(C)(C)c1nn(CC2CC2)/c(=N/C(=O)c2cccc(C(F)(F)F)c2)s1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"17.01";"0.34";"2.11";"13.81";"0";"CHEMBL920995";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3308072";""
"CHEMBL3669104";"";"None";"394.41";"0";"4.10";"BDBM176655";"COc1ccc2oc(-c3nc(NCCc4ccc(F)cc4)nc(OC)n3)cc2c1";"IC50";"'='";"12.0";"nM";"7.92";"";"322563";"UO_0000065";"20.08";"0.37";"3.82";"9.62";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669052";"";"None";"354.39";"0";"3.35";"BDBM176600";"COc1cccc(-c2nc(NCCc3ccc(F)cc3)nc(OC)n2)c1";"IC50";"'='";"29.0";"nM";"7.54";"";"322516";"UO_0000065";"21.27";"0.40";"4.19";"10.90";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1765155";"";"None";"386.50";"0";"4.53";"Table 1, R3C2, 2";"O=C(c1ccc2ccccc2n1)N1CC[C@](O)(c2ccccc2)[C@H]2CCCC[C@@H]21";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL3669091";"";"None";"375.41";"0";"3.89";"BDBM176642";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cccc3ncccc23)n1";"IC50";"'='";"47.0";"nM";"7.33";"";"322549";"UO_0000065";"19.52";"0.36";"3.44";"10.06";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669092";"";"None";"375.41";"0";"3.89";"BDBM176643";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc3ncccc3c2)n1";"IC50";"'='";"32.0";"nM";"7.50";"";"322550";"UO_0000065";"19.96";"0.37";"3.60";"10.29";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669087";"";"None";"364.38";"0";"4.09";"BDBM176638";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3ccccc3o2)n1";"IC50";"'='";"5.0";"nM";"8.30";"";"322545";"UO_0000065";"22.78";"0.42";"4.21";"11.36";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669089";"";"None";"375.41";"0";"3.89";"BDBM176640";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cnc3ccccc3c2)n1";"IC50";"'='";"34.0";"nM";"7.47";"";"322547";"UO_0000065";"19.89";"0.36";"3.58";"10.26";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669058";"";"None";"412.47";"0";"3.58";"BDBM176606";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(OC)c(C(C)(C)O)c2)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"322573";"UO_0000065";"21.82";"0.41";"5.42";"10.07";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4563408";"";"None";"625.47";"2";"6.58";"38";"O=C(Nc1ccc(OC(F)F)nc1)NC1CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4365010";"Displacement of [3H]WIN55212-2 from recombinant human CB2 receptor after 120 mins by scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364254";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3669066";"";"None";"370.45";"0";"4.06";"BDBM176614";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(SC)cc2)n1";"IC50";"'='";"14.0";"nM";"7.85";"";"322520";"UO_0000065";"21.20";"0.41";"3.79";"13.11";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4577767";"";"None";"386.86";"1";"5.50";"27";"COC(=O)c1cccc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)s2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL4788749";"";"None";"365.42";"0";"3.52";"40";"CCCCCn1nc(C(=O)NC(C)(C)CO)cc1-c1ccc(F)cc1F";"IC50";"'='";"87.1";"nM";"7.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4775757";"Antagonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 assessed as inhibition of CP55940-induced calcium mobilization pre-incubated for 15 mins before CP55940 addition";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765487";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr"
"CHEMBL4796229";"";"None";"388.35";"0";"3.63";"42";"CCCCCn1nc(C(=O)NC(C)(C)CO)c(Br)c1C(C)(C)C";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4775757";"Antagonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 assessed as inhibition of CP55940-induced calcium mobilization pre-incubated for 15 mins before CP55940 addition";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765487";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr"
"CHEMBL2163932";"";"None";"335.36";"0";"2.99";"39";"CCC1COc2cccc3c(=O)c(C(=O)Nc4ccncc4)cn1c23";"IC50";"'='";"683.0";"nM";"6.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2019083";"";"None";"402.54";"0";"3.82";"7";"CCCCn1c2c(cc(C(=O)NC3(C(=O)O)CCCCC3)c1=O)CCCCCC2";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2020077";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release after 45 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2016545";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL1760935";"";"None";"406.48";"0";"2.85";"14a";"O=C(NCC1(CO)CCCC1)c1nc(CN2CCC(F)(F)CC2)n2ccccc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL520416";"";"None";"407.95";"1";"5.30";"3a";"Cc1c(C(=O)NN2CCCCC2)cc(-c2ccccc2)n1Cc1ccc(Cl)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL981472";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143356";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"1, SR-141716,rimonabant";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1760.0";"nM";"5.75";"";"";"UO_0000065";"12.41";"0.26";"-0.19";"11.47";"1";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL3696852";"";"None";"345.49";"0";"2.93";"BDBM163071";"CN(C)CCn1ncc2c(=O)n(C3CC(C)(C)CC(C)(C)C3)ncc21";"IC50";"'='";"105.0";"nM";"6.98";"";"306211";"UO_0000065";"20.20";"0.38";"4.05";"12.47";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3596746";"";"None";"297.40";"0";"4.06";"12a";"O=C(CCCCCOc1ccc2ccccc2c1)NC1CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL521216";"";"None";"473.79";"1";"7.49";"21";"C=Cc1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1050.0";"nM";"5.98";"";"";"UO_0000065";"12.62";"0.26";"-1.51";"10.54";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL3669097";"";"None";"375.41";"0";"3.89";"BDBM176648";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cncc3ccccc23)n1";"IC50";"'='";"21.0";"nM";"7.68";"";"322555";"UO_0000065";"20.45";"0.37";"3.79";"10.54";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL271611";"";"None";"480.83";"1";"5.68";"43";"Cc1c(C(=O)NN2CCCCC2)nn(-c2c(Cl)cc(Cl)cc2Cl)c1-n1c(C)ccc1C";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"11.02";"0.23";"-0.38";"9.62";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL487381";"";"None";"625.24";"2";"6.89";"43c";"FC(F)(F)C1(c2nnc(-c3nn(-c4ccc(Cl)cc4Cl)c(-c4ccc(Br)cc4)c3Cn3cncn3)o2)CC1";"IC50";"'='";"948.0";"nM";"6.02";"";"";"UO_0000065";"9.63";"0.22";"-0.87";"6.89";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL1765278";"";"None";"375.47";"0";"3.86";"page no 2364, R1C1, Enantiomer 3a";"O=C(c1cccc2[nH]ncc12)N1CCC(O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL3350363";"";"None";"465.58";"0";"3.52";"18e";"C[S@+]([O-])Cc1ccc(C(=O)Nc2cccnc2C(=O)NCC2CCOCC2)c2ccccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL4536045";"";"None";"369.44";"0";"4.39";"23";"CC(C)c1ccc(C(=O)C2CCN(C(=O)c3cc(O)ccc3F)CC2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4424605";"Displacement of [3H]CP55,940 to human CB2 receptor expressed in cell membranes after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422672";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3658400";"";"None";"489.58";"0";"3.51";"6g";"O=C(c1ccc2c(ccn2-c2ccc(F)cc2)c1)N1CC(N2CCN(C(=O)c3nccs3)CC2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624589";"Binding affinity to CB2 receptor (unknown origin)";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622904";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";""
"CHEMBL4094388";"";"None";"419.50";"0";"4.41";"15";"C[C@H]1CC[C@@H](NC(=O)c2cc(-c3ccccc3)nn(Cc3ccc(F)cc3)c2=O)CC1";"IC50";"'='";"35.2";"nM";"7.45";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3998735";"Inverse agonist activity at human CB2 receptor expressed in HEK293 EBNA cell membranes after 30 mins by [35S]-GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997787";"1";"Scientific Literature";"Eur J Med Chem";"2017";"CHEMBL3307715";""
"CHEMBL3596750";"";"None";"343.42";"0";"3.46";"13b";"CCOC(=O)CNC(=O)CCCCCOc1cccc2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL3596749";"";"None";"297.40";"0";"4.06";"12b";"O=C(CCCCCOc1cccc2ccccc12)NC1CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL3596755";"";"None";"337.51";"0";"4.04";"17b";"CCS(=O)(=O)NCCCCCSc1ccc2ccccc2c1";"IC50";"'='";"5020.0";"nM";"5.30";"";"";"UO_0000065";"15.70";"0.33";"1.26";"11.48";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL1760940";"";"None";"452.44";"0";"3.63";"22a";"O=C(NC(c1ccncc1)c1ccc(F)cc1)c1nc(N2CCC(F)(F)C2)c2cnccn12";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL3669084";"";"None";"363.40";"0";"3.82";"BDBM176635";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cccc3[nH]ccc23)n1";"IC50";"'='";"27.0";"nM";"7.57";"";"322542";"UO_0000065";"20.83";"0.38";"3.75";"10.00";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3099056";"";"None";"416.88";"0";"4.22";"BDBM176622";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(Cl)c(C(C)(C)O)c2)n1";"IC50";"'='";"0.4";"nM";"9.40";"";"322528";"UO_0000065";"22.54";"0.44";"5.18";"11.72";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900276";"";"None";"449.88";"0";"4.20";"BDBM242474";"O=S(=O)(NCC1CCOCC1)c1ccc(Nc2cccnc2Cl)cc1C(F)(F)F";"IC50";"'='";"2819.0";"nM";"5.55";"";"422826";"UO_0000065";"12.34";"0.26";"1.35";"6.91";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL500689";"";"None";"475.81";"1";"6.06";"18";"CCc1c(C2=NC(=O)C(C)(C)N2C)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"2736.6";"nM";"5.56";"";"";"UO_0000065";"11.69";"0.25";"-0.50";"11.02";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL480540";"";"None";"540.67";"2";"7.20";"9j";"O=C(Cn1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2Cl)n1)NCc1ccccc1Cl";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"Rimonabant";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1760.0";"nM";"5.75";"";"";"UO_0000065";"12.41";"0.26";"-0.19";"11.47";"1";"CHEMBL1038202";"Displacement of [3H]WIN-552122 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156125";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL231245";"";"None";"416.95";"1";"5.68";"36";"C[C@H](NC(=O)CCc1ccccc1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1368.0";"nM";"5.86";"";"";"UO_0000065";"14.06";"0.27";"0.18";"11.09";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL371252";"";"None";"558.85";"2";"6.50";"24";"COCCn1c(=O)c(C(C)=O)c(NC(C)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc21";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"10.28";"0.21";"-0.76";"6.36";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL1707797";"";"None";"440.97";"0";"3.55";"SID87544617";"O=C(Nc1cc(S(=O)(=O)N2CCOCC2)ccc1Cl)c1cc2c(s1)CCCC2";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL497879";"";"None";"495.33";"1";"6.17";"22";"Cc1c(C2=NC(=O)C(C)(C)N2C)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C(F)(F)F)cc1";"IC50";"'='";"3968.0";"nM";"5.40";"";"";"UO_0000065";"10.90";"0.22";"-0.77";"10.70";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL219188";"";"None";"456.41";"1";"6.68";"10d";"CC(NC(=O)C(C)(C)Oc1ccc(Cl)cc1)C(Cc1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"610.0";"nM";"6.21";"";"";"UO_0000065";"13.62";"0.27";"-0.47";"16.21";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL1484306";"";"None";"396.52";"0";"3.68";"SID87225742";"Cc1nc(N2CCN(C(=O)c3ccco3)CC2)c2c3c(sc2n1)CC(C)CC3";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1724622";"";"None";"442.59";"0";"2.50";"SID87544624";"CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(C(=O)N2CCN(c3ccccc3)CC2)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1386881";"";"None";"379.48";"1";"5.15";"SID87225769";"COc1ccc(CNCCC(c2ccc(F)cc2)c2ccc(OC)cc2)cc1";"IC50";"'='";"24200.0";"nM";"4.62";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1697974";"";"None";"464.61";"0";"3.69";"SID87544638";"COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1cc2c(s1)CCCCCC2";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1416366";"";"None";"491.64";"0";"4.84";"SID87225723";"C=CCN(CC=C)S(=O)(=O)c1ccc(NC(=S)NC(=O)c2ccc(-c3ccccc3)cc2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3590648";"";"None";"408.46";"1";"5.23";"63";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(C(F)(F)F)ccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL512436";"";"None";"454.92";"1";"5.12";"23";"CC(C)(C)c1nc2nc(-c3ccccc3Cl)c(-c3ccc(C#N)cc3)cc2c2n[nH]c(=O)n12";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"10.43";"0.20";"-0.38";"4.76";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1575373";"";"None";"492.04";"1";"5.04";"SID87225768";"Cc1cc(OCC(=O)Nc2ccc(S(=O)(=O)NC3=NCCCCC3)cc2)c(C(C)C)cc1Cl";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1367646";"";"None";"470.55";"0";"2.77";"SID87544647";"COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(-n2nc(C)cc2C)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1549881";"";"None";"296.33";"0";"3.90";"SID87225756";"Cc1n[nH]c(-c2ccc(O)c(C)c2O)c1Oc1ccccc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1464477";"";"None";"379.26";"0";"4.86";"SID87225777";"Cc1ccc(-n2cc3c(-c4cccc(Br)c4)nnc(C)c3n2)cc1";"IC50";"'='";"23800.0";"nM";"4.62";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1709590";"";"None";"475.64";"0";"3.50";"SID87544640";"O=C(Nc1cc(S(=O)(=O)N2CCOCC2)ccc1N1CCCC1)c1cc2c(s1)CCCC2";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1494709";"";"None";"436.56";"0";"2.91";"SID87225730";"COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1cc2c(s1)CCCC2";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL203560";"";"None";"440.50";"0";"3.90";"9j";"CCCCCOc1c(OC)ccc2cc(C(=O)NCCc3ccc(O)c(O)c3)c(O)nc12";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL204387";"";"None";"424.50";"0";"4.20";"9h";"CCCCCOc1c(OC)ccc2cc(C(=O)NCCc3ccc(O)cc3)c(O)nc12";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL373626";"";"None";"490.95";"1";"6.44";"44";"C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"13.96";"0.28";"0.41";"13.38";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL2163936";"";"None";"368.48";"0";"4.19";"43";"CCCC1COc2cccc3c(=O)c(C(=O)NC4CCCCCC4)cn1c23";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL4174271";"";"None";"357.85";"0";"3.39";"48";"CCN1CCN(c2nc(C)nc3oc(-c4ccccc4Cl)nc23)CC1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4147299";"Neutral antagonist activity at human CB2 assessed as inhibition of WIN552122-induced suppression of cAMP formation preincubated for 15 mins followed by forskolin addition for 30 mins measured after 1 hr by HTRF assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145495";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL3669075";"";"None";"368.42";"0";"2.80";"BDBM176625";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(N(C)C)nc2)n1";"IC50";"'='";"35.0";"nM";"7.46";"";"322531";"UO_0000065";"20.24";"0.38";"4.66";"9.80";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1089352";"";"None";"439.34";"1";"7.28";"6h";"CC(C)(C)C(=O)c1oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c1N";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"13.02";"0.26";"-1.56";"8.28";"0";"CHEMBL1115256";"Inhibition of human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL520078";"";"None";"590.50";"1";"3.70";"59";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3noc(=O)[nH]3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL521382";"";"None";"527.84";"2";"7.09";"32b";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2Cn2cccn2)o1";"IC50";"'='";"979.0";"nM";"6.01";"";"";"UO_0000065";"11.38";"0.23";"-1.08";"8.06";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL1718537";"";"None";"398.58";"0";"4.11";"SID99303126";"Cc1nc(N2CCN(C(=O)C3CCCCC3)CC2)c2c3c(sc2n1)CCCC3";"IC50";"'>'";"16800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL476254";"";"None";"559.33";"1";"4.56";"34";"O=C(Cc1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(Br)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL482308";"";"None";"489.77";"1";"6.03";"13f";"O=C(Cn1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)n1)NCc1ccccc1F";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL462052";"";"None";"529.54";"2";"7.41";"22";"CCC/C=C/c1ccc(-c2c(C)c(C(=O)NN3CC4CCCC4C3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"5412.8";"nM";"5.27";"";"";"UO_0000065";"9.95";"0.21";"-2.14";"10.50";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL460131";"";"None";"527.52";"2";"6.74";"13";"CCCC#Cc1ccc(-c2c(C)c(C(=O)NN3CC4CCCC4C3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"785.1";"nM";"6.11";"";"";"UO_0000065";"11.57";"0.24";"-0.63";"12.17";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL2163580";"";"None";"392.50";"0";"4.04";"(S)-36";"CC[C@H]1COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"413.0";"nM";"6.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL482221";"";"None";"459.03";"1";"6.72";"3c";"Cc1c(C(=O)NC2C3CC4CC(C3)CC2C4)cc(-c2ccccc2)n1Cc1ccc(Cl)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"17.34";"0.33";"1.24";"23.39";"0";"CHEMBL981472";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143356";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL3696850";"";"None";"387.53";"0";"2.70";"BDBM163069";"CC1(C)CC(n2ncc3c(cnn3CCN3CCOCC3)c2=O)CC(C)(C)C1";"IC50";"'='";"8.5";"nM";"8.07";"";"306209";"UO_0000065";"20.83";"0.39";"5.37";"12.38";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL485753";"";"None";"479.77";"1";"7.32";"13";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2CF)o1";"IC50";"'='";"1120.0";"nM";"5.95";"";"";"UO_0000065";"12.40";"0.26";"-1.37";"10.49";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL509751";"";"None";"647.36";"2";"7.69";"43e";"Cc1ccc(C2(c3nnc(-c4nn(-c5ccc(Cl)cc5Cl)c(-c5ccc(Br)cc5)c4Cn4cncn4)o3)CC2)cc1";"IC50";"'='";"579.0";"nM";"6.24";"";"";"UO_0000065";"9.64";"0.21";"-1.45";"7.13";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"Rimonabant";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1760.0";"nM";"5.75";"";"";"UO_0000065";"12.41";"0.26";"-0.19";"11.47";"1";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL487384";"";"None";"633.34";"2";"7.38";"43d";"Clc1ccc(-n2nc(-c3nnc(C4(c5ccccc5)CC4)o3)c(Cn3cncn3)c2-c2ccc(Br)cc2)c(Cl)c1";"IC50";"'='";"242.0";"nM";"6.62";"";"";"UO_0000065";"10.45";"0.23";"-0.76";"7.57";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL487170";"";"None";"519.82";"2";"6.91";"9";"CC(=O)OCc1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"11.32";"0.24";"-1.02";"7.09";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL493068";"";"None";"530.53";"2";"5.70";"46";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CCNC(C)C)s1";"IC50";"'='";"7179.1";"nM";"5.14";"";"";"UO_0000065";"9.70";"0.20";"-0.56";"8.27";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL522824";"";"None";"563.55";"2";"7.33";"42";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CCCc2ccccc2)s1";"IC50";"'='";"1749.8";"nM";"5.76";"";"";"UO_0000065";"10.22";"0.21";"-1.57";"11.48";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL385033";"";"None";"456.41";"1";"6.68";"35a";"C[C@H](NC(=O)C(C)(C)Oc1cccc(Cl)c1)[C@@H](Cc1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"14.73";"0.30";"0.04";"17.54";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"SR-141716";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"13.41";"0.28";"0.28";"12.40";"1";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL3613097";"";"None";"475.08";"1";"7.42";"6";"Cc1ccc(Cn2cc(C(=O)N[C@@H]3C(C)(C)C4CC[C@@]3(C)C4)cc2-c2ccc(Cl)c(C)c2)cc1";"IC50";"'='";"171.4";"nM";"6.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3615750";"Antagonist/inverse agonist activity at human CB2 receptor transfected in Chem4 cell membranes after 30 mins by [35S]-GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Chem4";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611977";"1";"Scientific Literature";"Eur J Med Chem";"2015";"None";""
"CHEMBL466110";"";"None";"492.37";"1";"6.75";"10";"CC(C)c1nc(OCc2ncon2)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2n1";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"10.56";"0.21";"-1.55";"5.99";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL459305";"";"None";"513.49";"2";"6.35";"26";"CCC#Cc1ccc(-c2c(C)c(C(=O)NN3CC4CCCC4C3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"921.0";"nM";"6.04";"";"";"UO_0000065";"11.75";"0.24";"-0.31";"12.03";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL461427";"";"None";"501.48";"2";"6.50";"27";"CCC#Cc1ccc(-c2c(C)c(C(=O)NN3CCCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"1057.8";"nM";"5.98";"";"";"UO_0000065";"11.92";"0.25";"-0.52";"11.91";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3410721";"";"None";"359.42";"0";"3.65";"42";"CCCOc1c(OC)ccc2cc(C(=O)NC3CCCCC3)c(=O)oc12";"IC50";"'='";"807.0";"nM";"6.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3410725";"";"None";"333.38";"0";"3.12";"46";"CCCCOc1c(OC)ccc2cc(C(=O)NC(C)C)c(=O)oc12";"IC50";"'='";"162.0";"nM";"6.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL265787";"";"None";"497.77";"1";"6.06";"33";"CC(=O)Nc1c(C#N)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"12.34";"0.25";"0.08";"7.00";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL202202";"";"None";"471.77";"1";"6.74";"19";"CC(=O)c1c(C)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"12.41";"0.26";"-0.89";"11.27";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL202201";"";"None";"530.80";"2";"5.36";"28";"CC(=O)c1c(NC(=O)CO)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"10.26";"0.21";"0.08";"5.37";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL1701630";"";"None";"464.61";"0";"3.54";"SID87544641";"CCC1CCc2sc(C(=O)Nc3cc(S(=O)(=O)N4CCOCC4)ccc3OC)cc2C1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1702427";"";"None";"505.58";"1";"4.78";"SID87544680";"COc1ccc(-c2csc(NC(=O)CSc3nnc4c(C)cc5cc6c(cc5n34)OCO6)n2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1446359";"";"None";"449.52";"0";"2.28";"SID87225739";"C/C(C=NNC(=O)c1nnn(-c2nonc2N)c1CN1CCC(C)CC1)=C/c1ccccc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1369676";"";"None";"451.54";"0";"2.67";"SID87225736";"CCCN(CCC)Cc1c(C(=O)NN=C/C(C)=C\c2ccccc2)nnn1-c1nonc1N";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL229820";"";"None";"435.65";"1";"5.90";"29";"CCCCCCc1ccc(OCCCCCCCCCCCC(=O)NCCO)cc1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL906562";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143734";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"CHEMBL3307715";""
"CHEMBL2163944";"";"None";"406.53";"0";"4.29";"51";"CC(C)C1COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"12.4";"nM";"7.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163941";"";"None";"352.43";"0";"3.41";"48";"O=C(NC1CCCCC1)c1cn2c3c(cccc3c1=O)OCC2C1CC1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL512410";"";"None";"381.27";"1";"5.56";"27";"Cc1nc(N)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2n1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"15.63";"0.31";"0.40";"9.21";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL511774";"";"None";"465.43";"1";"7.78";"39";"CC(C)Nc1nc(C(C)(C)C)nc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL411112";"";"None";"436.30";"0";"4.77";"14";"N#Cc1c(C(=O)NCc2ccc(Cl)c(Cl)c2)nn(-c2ccccc2)c1-n1cccc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"12.15";"0.24";"0.53";"7.01";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL2316407";"";"None";"416.53";"0";"4.08";"9b";"CN(C)Cc1ccc(C(=O)Nc2cccnc2C(=O)NCC2CCC2)c2ccccc12";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"16.14";"0.30";"2.64";"9.04";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL2316404";"";"None";"390.44";"0";"3.42";"8n";"COc1ccc(NC(=O)c2ccnc3ccccc23)c(C(=O)NCC2CCC2)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.93";"0.33";"3.58";"7.51";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL1082305";"6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)";"None";"461.78";"1";"6.51";"14b, Enantiomer 2";"CC1(C)CC(C(N)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL4086649";"";"None";"466.03";"1";"5.69";"17";"Cc1ccc(-c2cc(C(=O)NC34CC5CC(CC(C5)C3)C4)c(=O)n(C3CCCC3)n2)cc1Cl";"IC50";"'='";"295.5";"nM";"6.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3998735";"Inverse agonist activity at human CB2 receptor expressed in HEK293 EBNA cell membranes after 30 mins by [35S]-GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997787";"1";"Scientific Literature";"Eur J Med Chem";"2017";"CHEMBL3307715";""
"CHEMBL2316383";"";"None";"465.58";"0";"3.52";"18c";"C[S+]([O-])Cc1ccc(C(=O)Nc2cccnc2C(=O)NCC2CCOCC2)c2ccccc12";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"12.03";"0.23";"2.08";"5.42";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL2316405";"";"None";"433.46";"0";"3.34";"8o";"O=C(NCC1CCOCC1)c1ncccc1NC(=O)c1ccc(C(=O)O)c2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL3696828";"";"None";"263.73";"0";"2.71";"BDBM163046";"CCCNc1cnn(-c2ccccc2)c(=O)c1Cl";"IC50";"'>'";"10000.0";"nM";"";"";"306185";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL517388";"";"None";"400.91";"1";"5.98";"8b, URB-447";"Cc1c(C(=O)c2ccccc2)c(N)c(-c2ccccc2)n1Cc1ccc(Cl)cc1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"18.43";"0.35";"1.41";"15.38";"0";"CHEMBL981472";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143356";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL523875";"";"None";"386.50";"0";"2.37";"16";"CN(C(=O)n1c(=O)n(CCN2CCOCC2)c2ccccc21)C1CCCCC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL995594";"Displacement of [3H]CP-55940 from human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150312";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL3956145";"";"None";"376.44";"0";"4.14";"BDBM242509";"O=S(=O)(NCC1CC1)c1ccc(NC2CCCCC2)cc1C(F)(F)F";"IC50";"'='";"135.0";"nM";"6.87";"";"422869";"UO_0000065";"18.25";"0.38";"2.73";"11.80";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3669062";"";"None";"446.91";"0";"4.39";"BDBM176610";"COc1nc(NCCc2ccc(OCF)cc2)nc(-c2ccc(Cl)c(C(C)(C)O)c2)n1";"IC50";"'='";"3.9";"nM";"8.41";"";"322584";"UO_0000065";"18.82";"0.37";"4.02";"9.41";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669070";"";"None";"382.40";"0";"3.13";"BDBM176618";"COC(=O)c1cccc(-c2nc(NCCc3ccc(F)cc3)nc(OC)n2)c1";"IC50";"'='";"38.0";"nM";"7.42";"";"322524";"UO_0000065";"19.40";"0.36";"4.29";"8.61";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3775328";"";"None";"421.55";"0";"4.20";"20";"CCCCCn1cc(C(=O)NC2CCCCCC2)c(=O)n2nc(-c3ccccc3)nc12";"IC50";"'='";"142.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL467921";"";"None";"455.91";"0";"4.52";"48";"CC(C)(C)c1nc2nc(-c3ccccc3Cl)c(-c3cnccc3C#N)cc2c2n[nH]c(=O)n12";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"10.41";"0.20";"0.22";"4.21";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL262865";"";"None";"354.49";"0";"3.84";"CAS No.A-796260";"CC1(C)C(C(=O)c2cn(CCN3CCOCC3)c3ccccc23)C1(C)C";"IC50";"'='";"0.77";"nM";"9.11";"";"";"UO_0000065";"25.71";"0.48";"5.27";"26.44";"0";"CHEMBL1022320";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139386";"1";"Scientific Literature";"J Med Chem";"2009";"None";""
"CHEMBL2316396";"";"None";"389.46";"0";"3.64";"8f";"O=C(NCC1CCOCC1)c1ncccc1NC(=O)c1cccc2ccccc12";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"16.91";"0.31";"2.95";"8.20";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL1731489";"";"None";"527.52";"1";"3.03";"SID87544644";"O=C(Nc1cc(S(=O)(=O)N2CCOCC2)ccc1OCC(F)(F)F)c1ccc(N2CCCC2=O)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3774794";"";"None";"502.66";"1";"4.42";"39";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)n2nc(N(C)Cc3ccccc3)nc12";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL466223";"";"None";"398.51";"0";"2.04";"A1";"CC1CCC(NC(=O)c2cc3cccnc3n(CCN3CCOCC3)c2=O)CC1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"16.76";"0.31";"4.64";"8.73";"0";"CHEMBL3383059";"Displacement of [3H]CP-55,940 from human recombinant CB2R expressed in HEK-293 cells after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352718";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307715";""
"CHEMBL463847";"";"None";"504.90";"2";"6.24";"29b";"O=C(NC1CCCCCC1)N1CCN(C(c2ccc(Br)cc2)c2ccccc2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL602102";"";"None";"596.32";"2";"6.49";"52b";"Cc1cc(Br)ccc1CNC(=O)c1nn(-c2ccccc2Cl)c(-c2ccc(Cl)cc2)c1Cn1cncn1";"IC50";"'='";"3510.0";"nM";"5.46";"";"";"UO_0000065";"9.15";"0.20";"-1.04";"7.03";"0";"CHEMBL1074128";"Displacement of [3H]WIN-55212-2 from human recombinant CB2 receptor expressed in CHO-K1 cell membrane";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159084";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL244607";"";"None";"402.49";"1";"6.85";"15";"O=C(c1cccc2ccccc12)c1ccc(OCCc2ccccc2)c2ccccc12";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"14.16";"0.25";"-1.15";"21.67";"0";"CHEMBL895094";"Displacement of [3H]CP-55940 human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148711";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3307512";""
"CHEMBL231642";"";"None";"388.90";"1";"5.36";"32";"C[C@H](NC(=O)c1ccccc1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1907.0";"nM";"5.72";"";"";"UO_0000065";"14.71";"0.28";"0.36";"10.81";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL2316403";"";"None";"360.42";"0";"3.41";"8m";"O=C(NCC1CCC1)c1ncccc1NC(=O)c1ccnc2ccccc12";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"19.66";"0.36";"3.68";"8.44";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL1481494";"";"None";"528.59";"2";"5.57";"SID99303186";"COc1ccc(-c2cc(C(=O)Nc3ccc(S(=O)(=O)Nc4onc(C)c4C)cc3)c3ccccc3n2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL188";"WIN-552122";"None";"426.52";"0";"4.60";"2, WIN 55,212-2";"Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"19.85";"0.36";"3.87";"19.38";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL519731";"";"None";"554.87";"2";"7.82";"27b";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2COc2ccccn2)o1";"IC50";"'='";"2040.0";"nM";"5.69";"";"";"UO_0000065";"10.26";"0.21";"-2.13";"7.22";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL262865";"";"None";"354.49";"0";"3.84";"A-796260";"CC1(C)C(C(=O)c2cn(CCN3CCOCC3)c3ccccc23)C1(C)C";"IC50";"'='";"0.77";"nM";"9.11";"";"";"UO_0000065";"25.71";"0.48";"5.27";"26.44";"1";"CHEMBL921013";"Binding affinity to CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143973";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";""
"CHEMBL2163571";"";"None";"461.61";"0";"4.64";"56";"CCC1COc2c(N3CCCC3)ccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL1714418";"";"None";"406.53";"0";"2.90";"SID87544762";"O=C(Nc1cccc(S(=O)(=O)N2CCOCC2)c1)c1cc2c(s1)CCCC2";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1719997";"";"None";"399.50";"0";"3.70";"SID87544699";"COc1ccc2c(c1)cc(C)c1nnc(SCC(=O)Nc3nc(C)cs3)n12";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4586819";"";"None";"407.94";"1";"5.20";"6";"CCCCCCCN1C(=O)C2C3c4ccccc4C(Cl)(c4ccccc43)C2C1=O";"IC50";"'='";"9880.0";"nM";"5.00";"";"";"UO_0000065";"12.27";"0.24";"-0.19";"13.39";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL1736309";"";"None";"381.41";"0";"3.05";"SID99303150";"O=C(Cc1ccc(F)cc1)N1CCC(n2nc(-c3ccccc3)oc2=O)CC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL2163574";"";"None";"326.40";"0";"3.02";"(S)-31";"C[C@H]1COc2cccc3c(=O)c(C(=O)NC4CCCCC4)cn1c23";"IC50";"'='";"724.0";"nM";"6.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL4541878";"";"None";"403.52";"0";"4.31";"12";"CCCCCCCOCC12c3ccccc3C(c3ccccc31)C1C(=O)NC(=O)C12";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"14.98";"0.28";"1.74";"10.91";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL1727119";"";"None";"443.57";"0";"2.29";"SID87544627";"Cc1cccc(N2CCN(C(=O)c3cccc(S(=O)(=O)N4CCOCC4)c3)CC2)c1C";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4457335";"";"None";"373.50";"0";"4.85";"3";"CCCCCCCN1C(=O)C2C3c4ccccc4C(c4ccccc43)C2C1=O";"IC50";"'='";"7940.0";"nM";"5.10";"";"";"UO_0000065";"13.66";"0.25";"0.25";"13.64";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL1397703";"";"None";"429.50";"0";"2.09";"SID87544619";"O=C(Nc1cccc(S(=O)(=O)N2CCOCC2)c1)c1ccc(N2CCCC2=O)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1718432";"";"None";"479.56";"1";"5.19";"SID85285580";"COc1ccc2cc(C)c3nnc(SCC(=O)Nc4nc(-c5ccc(F)cc5)cs4)n3c2c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3975461";"";"None";"334.36";"0";"2.97";"BDBM242513";"O=S(=O)(NCC1CC1)c1ccc(NC2CC2)cc1C(F)(F)F";"IC50";"'='";"151400.0";"nM";"";"Outside typical range";"422873";"UO_0000065";"";"";"";"";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3922691";"";"None";"376.48";"0";"3.44";"BDBM242481";"COc1ccc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C)c2)c(OC)c1";"IC50";"'='";"1029.0";"nM";"5.99";"";"422835";"UO_0000065";"15.90";"0.31";"2.55";"7.81";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL519252";"";"None";"572.53";"1";"4.75";"57";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3cn[nH]c3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL1084558";"";"None";"456.39";"1";"6.95";"5j";"O=C1CC2(CCSCC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"11.17";"0.23";"-1.85";"13.01";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1086492";"";"None";"453.37";"1";"6.15";"5l";"CN1CCC2(CC1)CC(=O)c1cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc1O2";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1084820";"(2S)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)";"None";"511.45";"2";"6.75";"12f, Enantiomer 2";"C[C@H](O)C(=O)NC1CC2(CCCCC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"9.78";"0.20";"-1.75";"7.00";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1083619";"(2R)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)";"None";"511.45";"2";"6.75";"12h, Enantiomer 2";"C[C@@H](O)C(=O)NC1CC2(CCCCC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"10.69";"0.21";"-1.28";"7.65";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1083014";"N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX)";"None";"491.80";"1";"6.09";"13d, Enantiomer 2";"CC1(C)CC(NC(=O)CO)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"6610.0";"nM";"5.18";"";"";"UO_0000065";"10.53";"0.22";"-0.91";"7.25";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1082321";"6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(1-HYDROXY-2-METHYLPROPAN-2-YL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)";"None";"533.88";"2";"6.91";"14d, Enantiomer 2";"CC(C)(CO)NC(=O)C1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"7450.0";"nM";"5.13";"";"";"UO_0000065";"9.60";"0.20";"-1.78";"7.18";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL1084556";"";"None";"424.33";"1";"7.00";"5h";"O=C1CC2(CCCC2)Oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"13.02";"0.26";"-1.48";"14.09";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL220360";"TARANABANT";"3.0";"515.96";"2";"6.31";"3, MK-0364";"C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1170.0";"nM";"5.93";"";"";"UO_0000065";"11.50";"0.23";"-0.38";"7.91";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL1459029";"";"None";"475.60";"1";"5.08";"SID87225725";"COc1ccc2c(c1)cc(C)c1nnc(SCC(=O)N(C)c3nc(-c4ccccc4)cs3)n12";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1389833";"";"None";"281.36";"0";"4.17";"SID87225735";"CC(C)=CC(=O)Nc1ccc(OCc2ccccc2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1699880";"";"None";"445.57";"1";"5.35";"SID87544630";"Cc1ccc(-c2csc(NC(=O)CSc3nnc4cc(C)c5ccccc5n34)n2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1730617";"";"None";"424.54";"0";"2.90";"SID87544646";"CCc1cc(C(=O)Nc2cc(S(=O)(=O)N3CCOCC3)ccc2OC)sc1C";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3774919";"";"None";"473.62";"0";"4.76";"28";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)n2nc(-c3ccc(C)cc3)nc12";"IC50";"'='";"12.6";"nM";"7.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL3774406";"";"None";"397.52";"0";"3.09";"18";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)n2nc(C)nc12";"IC50";"'='";"865.0";"nM";"6.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL2316262";"";"None";"459.59";"0";"4.45";"10";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)n2nc(-c3ccccc3)nc12";"IC50";"'='";"8.6";"nM";"8.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL487162";"";"None";"548.86";"2";"7.26";"22";"COC(=O)NC(C)c1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL3774483";"";"None";"449.56";"0";"4.04";"29";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)n2nc(-c3ccco3)nc12";"IC50";"'='";"124.0";"nM";"6.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL3975387";"";"None";"366.41";"0";"2.84";"BDBM242515";"COCCCNc1ccc(S(=O)(=O)NCC2CC2)c(C(F)(F)F)c1";"IC50";"'='";"1599.0";"nM";"5.80";"";"422875";"UO_0000065";"15.82";"0.33";"2.96";"8.60";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4167940";"";"None";"356.42";"0";"4.99";"8a";"O=C(c1cccc2ccccc12)c1ccc(OCCCO)c2ccccc12";"IC50";"'='";"14670.0";"nM";"4.83";"";"";"UO_0000065";"13.56";"0.24";"-0.16";"10.39";"0";"CHEMBL4157966";"Displacement of [3H]CP55940 from membrane bound human CB2 receptor after 1 hr by beta scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152361";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3981700";"";"None";"498.35";"0";"4.37";"BDBM242429";"O=S(=O)(NCCN1CCOCC1)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"1837.0";"nM";"5.74";"";"422763";"UO_0000065";"11.51";"0.25";"1.37";"8.12";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1385076";"";"None";"470.64";"0";"3.12";"SID87225729";"Cc1cccc(N2CCN(C(=O)c3cc(S(=O)(=O)N(C)C)ccc3N3CCCC3)CC2)c1C";"IC50";"'='";"15100.0";"nM";"4.82";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3341893";"";"None";"427.34";"1";"6.30";"42";"O=C(Nc1cc(Cl)cc(Cl)c1)Nc1cccc(-c2cccc(N3CCCC3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3366075";"Antagonist activity at human CB2 receptor stably expressed in CHO-RD-HGA16 cells assessed as inhibition of CP55,940-induced calcium mobilization after 15 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351332";"1";"Scientific Literature";"J Med Chem";"2014";"None";""
"CHEMBL2316400";"";"None";"391.43";"0";"2.43";"8j";"O=C(NCC1CCOCC1)c1ncccc1NC(=O)c1cccc2nccnc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL270345";"";"None";"387.39";"0";"2.23";"35";"Cc1c(C(=O)NN2CCOCC2)nn(-c2ccc(F)cc2F)c1-n1cccc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL410913";"";"None";"461.30";"1";"5.49";"36";"Cc1c(C(=O)NCc2ccc(Cl)c(Cl)c2)nn(-c2ccc(F)cc2F)c1-n1cccc1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"13.66";"0.28";"0.81";"12.15";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3669068";"";"None";"368.37";"0";"3.07";"BDBM176616";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc3c(c2)OCO3)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"322522";"UO_0000065";"21.84";"0.41";"4.98";"10.26";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL220360";"TARANABANT";"3.0";"515.96";"2";"6.31";"2, MK-0634";"C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"285.0";"nM";"6.54";"";"";"UO_0000065";"12.69";"0.25";"0.24";"8.73";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL272035";"";"None";"494.21";"1";"6.52";"29";"Cc1c(C(=O)NCc2ccc(Cl)c(Cl)c2)nn(-c2ccc(Cl)c(Cl)c2)c1-n1cccc1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"13.60";"0.30";"0.20";"12.96";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL2023576";"";"None";"450.58";"0";"4.97";"14";"O=C(O)Cc1cccc(NC(=O)c2cc3c(n(CC4CCCCC4)c2=O)CCCCCC3)c1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL2316395";"";"None";"387.48";"0";"4.80";"8e";"O=C(NCC1CCCCC1)c1cccnc1NC(=O)c1cccc2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL3696820";"";"None";"250.34";"0";"2.73";"BDBM163038";"CC1(C)CC(n2ncc(O)cc2=O)CC(C)(C)C1";"IC50";"'='";"1819.0";"nM";"5.74";"";"306177";"UO_0000065";"22.93";"0.44";"3.01";"10.41";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3986276";"";"None";"388.42";"0";"3.35";"BDBM242490";"CCn1nccc1Nc1ccc(S(=O)(=O)NCC2CC2)c(C(F)(F)F)c1";"IC50";"'='";"2747.0";"nM";"5.56";"";"422844";"UO_0000065";"14.32";"0.29";"2.21";"7.32";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL371214";"";"None";"312.50";"1";"6.38";"JWH133";"CCCC(C)(C)c1ccc2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"20.03";"0.37";"-0.12";"67.82";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL2316401";"";"None";"360.42";"0";"3.41";"8k";"O=C(NCC1CCC1)c1ncccc1NC(=O)c1cccc2cnccc12";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"20.59";"0.38";"4.01";"8.84";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL487091";"";"None";"573.52";"1";"3.94";"52";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-n3nccn3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL3898362";"";"None";"370.40";"0";"4.14";"BDBM242434";"O=S(=O)(NCC1CC1)c1ccc(Nc2ccccc2)cc1C(F)(F)F";"IC50";"'='";"198.0";"nM";"6.70";"";"422772";"UO_0000065";"18.10";"0.37";"2.56";"11.52";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1223258";"";"None";"604.95";"2";"7.74";"17r";"Clc1ccc(-c2c(Cn3cncn3)c(-c3nnc(C4(c5ccc(Cl)cc5)CC4)s3)nn2-c2ccccc2Cl)cc1";"IC50";"'='";"265.0";"nM";"6.58";"";"";"UO_0000065";"10.87";"0.22";"-1.16";"8.85";"0";"CHEMBL1227204";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221281";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL2163578";"";"None";"354.45";"0";"3.80";"(S)-35";"CC[C@H]1COc2cccc3c(=O)c(C(=O)NC4CCCCCC4)cn1c23";"IC50";"'='";"682.0";"nM";"6.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163573";"";"None";"326.40";"0";"3.02";"(R)-31";"C[C@@H]1COc2cccc3c(=O)c(C(=O)NC4CCCCC4)cn1c23";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163945";"";"None";"392.50";"0";"3.83";"52";"CC1(C)COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"242.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163943";"";"None";"404.51";"0";"4.04";"50";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cn2c3c(cccc3c1=O)OCC2C1CC1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163939";"";"None";"368.48";"0";"4.11";"46";"CCCC1COc2ccc(C)c3c(=O)c(C(=O)NC4CCCCC4)cn1c23";"IC50";"'='";"122.0";"nM";"6.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL529214";"";"None";"605.58";"1";"4.38";"63";"O=C1CSC(c2cc(C(F)(F)F)cc(S(=O)(=O)N3CCN(C(=O)[C@@H]4C[C@H]4c4ccc(C(F)(F)F)cc4)CC3)c2)=N1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL487294";"";"None";"573.52";"1";"3.94";"53";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-n3cncn3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL2387185";"";"None";"394.56";"0";"4.97";"22e";"CCCCn1c2c(cc(C(=O)NC(C)(C)c3ccccc3)c1=O)CCCCCC2";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2389080";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385064";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL2163964";"";"None";"354.45";"0";"3.80";"35";"CCC1COc2cccc3c(=O)c(C(=O)NC4CCCCCC4)cn1c23";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163933";"";"None";"341.39";"0";"3.05";"40";"CCC1COc2cccc3c(=O)c(C(=O)Nc4nccs4)cn1c23";"IC50";"'='";"1127.0";"nM";"5.95";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL374291";"";"None";"490.86";"1";"7.34";"1";"CC(NC(=O)C(C)(C)Oc1ccc(Cl)cc1)C(Cc1ccc(Cl)cc1)c1ccc(Cl)cc1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"12.14";"0.25";"-1.38";"15.55";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL3410714";"";"None";"408.29";"0";"4.41";"34";"CCCOc1cc(Br)cc2cc(C(=O)NC3CCCCC3)c(=O)oc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3410724";"";"None";"345.40";"0";"3.12";"45";"CCCCOc1c(OC)ccc2cc(C(=O)NCC3CC3)c(=O)oc12";"IC50";"'='";"1177.0";"nM";"5.93";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL230294";"";"None";"402.93";"1";"5.29";"35";"C[C@H](NC(=O)Cc1ccccc1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL4527708";"";"None";"509.44";"2";"6.01";"5; V3a";"CC[C@]12CCCN(C(=O)c3cccc(Br)c3)CCc3c(n(c4ccccc34)C(=O)C1)[C@@H]2OC";"IC50";"'='";"25700.0";"nM";"4.59";"";"";"UO_0000065";"9.01";"0.19";"-1.42";"8.91";"0";"CHEMBL4344226";"Antagonist activity at human Gi/o-coupled CNR2 expressed in CHOK1 cells assessed as inhibition in CP55940-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CP55940 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342456";"1";"Scientific Literature";"J Med Chem";"2020";"None";""
"CHEMBL244403";"";"None";"368.48";"1";"6.79";"CB-13, SAB378, CRA13; 4";"CCCCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"14.32";"0.26";"-1.51";"20.06";"0";"CHEMBL4157966";"Displacement of [3H]CP55940 from membrane bound human CB2 receptor after 1 hr by beta scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152361";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4161845";"";"None";"370.45";"1";"5.38";"8b";"O=C(c1cccc2ccccc12)c1ccc(OCCCCO)c2ccccc12";"IC50";"'='";"5050.0";"nM";"5.30";"";"";"UO_0000065";"14.30";"0.26";"-0.08";"11.38";"0";"CHEMBL4157966";"Displacement of [3H]CP55940 from membrane bound human CB2 receptor after 1 hr by beta scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152361";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL1288693";"";"None";"254.28";"0";"3.29";"III";"O=C(O)CCC(=O)/C=C/c1ccc2ccccc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1288149";"";"None";"293.37";"0";"3.48";"XIII";"O=C(/C=C/c1ccc2ccccc2c1)CCC(=O)NC1CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL486756";"";"None";"475.81";"1";"7.41";"4ha";"CCc1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"2330.0";"nM";"5.63";"";"";"UO_0000065";"11.84";"0.25";"-1.78";"9.93";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL1084848";"";"None";"426.34";"1";"7.25";"5c";"CCC1(CC)CC(=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2O1";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"12.61";"0.25";"-1.87";"13.72";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL2019082";"";"None";"456.63";"0";"4.85";"6";"O=C(N[C@H](C(=O)O)C1CCCCC1)c1cc2c(n(CC3CCCCC3)c1=O)CCCCCC2";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL387027";"";"None";"457.40";"1";"6.08";"43";"C[C@H](NC(=O)C(C)(C)Oc1ccc(Cl)cn1)[C@@H](Cc1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.30";"0.31";"0.92";"13.67";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL4587421";"";"None";"491.59";"1";"6.85";"2";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(OCCN(C)Cc3ccccc3)cc2)cc1";"IC50";"'='";"2630.0";"nM";"5.58";"";"";"UO_0000065";"11.35";"0.21";"-1.27";"10.75";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4527727";"";"None";"505.61";"2";"7.24";"3";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(OCCCN(C)Cc3ccccc3)cc2)cc1";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"12.57";"0.23";"-0.88";"12.25";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL460796";"";"None";"564.84";"1";"4.45";"(-)-12c";"N/C(=N\S(=O)(=O)c1ccc(I)cc1)N1C[C@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'>'";"33000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL966990";"Binding affinity to human CB2 receptor by [35S]GTPgammaS binding assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140076";"1";"Scientific Literature";"J Med Chem";"2008";"None";""
"CHEMBL500437";"";"None";"520.26";"2";"6.17";"20";"CCc1c(C2=NC(=O)C(C)(C)N2C)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1";"IC50";"'='";"768.4";"nM";"6.11";"";"";"UO_0000065";"11.75";"0.27";"-0.06";"12.11";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL3120210";"";"None";"426.90";"0";"4.25";"5m";"COc1ccc(-c2nn(C(=O)NC3CCCCC3)c(=O)n2-c2ccc(Cl)cc2)cc1";"IC50";"'='";"6080.0";"nM";"5.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL3120204";"";"None";"434.88";"0";"4.75";"5g";"COc1ccc(-c2nn(C(=O)Nc3ccc(Cl)cc3)c(=O)n2-c2ccc(C)cc2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL526089";"";"None";"457.36";"1";"5.16";"21";"COc1ccc(-c2c(C)c(C3=NC(=O)C(C)(C)N3C)nn2-c2ccc(Cl)cc2Cl)cc1";"IC50";"'='";"1058.5";"nM";"5.97";"";"";"UO_0000065";"13.06";"0.26";"0.82";"10.01";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL1730076";"";"None";"350.81";"0";"4.45";"SID99303164";"COc1ccc(-c2nnc(C)c3nn(-c4ccc(Cl)cc4)cc23)cc1";"IC50";"'='";"13200.0";"nM";"4.88";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL2153763";"";"None";"568.10";"1";"4.00";"35";"COc1cccc(S(=O)(=O)/N=C(\N[C@H](C(N)=O)C(C)C)N2CC(c3ccccc3)C(c3ccc(Cl)cc3)=N2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL1702412";"";"None";"407.54";"0";"3.48";"SID99303136";"Cc1nc(N2CCN(C(=O)c3ccncc3)CC2)c2c3c(sc2n1)CC(C)CC3";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1336209";"";"None";"465.60";"1";"5.25";"SID99303146";"CCN(CC)S(=O)(=O)c1ccc(NC(=O)c2cc(-c3cccs3)nc3ccccc23)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1706882";"";"None";"474.63";"0";"4.28";"SID99303134";"Cc1nc(N2CCN(C(=O)c3ccc4c(c3)nc(C)n4C)CC2)c2c3c(sc2n1)CC(C)CC3";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1729109";"";"None";"300.37";"0";"4.10";"SID99303163";"Cc1ccc(-c2nnc(C)c3nn(-c4ccccc4)cc23)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL567461";"";"None";"447.97";"0";"4.72";"3g";"C[C@H](NC(=O)C(C)(C)Nc1ccncn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"14020.0";"nM";"4.85";"";"";"UO_0000065";"10.83";"0.21";"0.13";"5.35";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1836121";"";"None";"432.52";"0";"3.80";"48d";"CCOC(=O)/C(=C/c1cn(CCN2CCOCC2)c2ccccc12)C(=O)c1ccccc1";"IC50";"'='";"6220.0";"nM";"5.21";"";"";"UO_0000065";"12.04";"0.22";"1.41";"8.57";"0";"CHEMBL1837632";"Displacement of [3H]-WIN 55,212-2 from human CB2 receptor expressed in human HEK293 cells after 90 mins by radioligand assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833961";"1";"Scientific Literature";"Eur J Med Chem";"2011";"CHEMBL3307715";""
"CHEMBL520543";"";"None";"604.49";"1";"4.96";"(+/-)-50";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(C(O)C(F)(F)F)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL3696825";"";"None";"263.38";"0";"3.06";"BDBM163043";"CNc1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1";"IC50";"'='";"2089.0";"nM";"5.68";"";"306182";"UO_0000065";"21.57";"0.41";"2.62";"12.11";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL494299";"";"None";"516.54";"2";"8.07";"32";"CCCCC#Cc1ccc(-c2c(C)c(C(=O)NCCCCCC)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"260.6";"nM";"6.58";"";"";"UO_0000065";"12.75";"0.26";"-1.49";"14.03";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL3590295";"";"None";"400.52";"0";"4.23";"69";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(OC)cc(OC)c21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL2153758";"";"None";"574.49";"1";"3.37";"29";"NC(=O)[C@@H](O)CCN/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL158784";"RAC-IBIPINABANT";"None";"487.41";"0";"4.76";"SLV-319";"CN/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL2163959";"";"None";"454.57";"0";"4.99";"30";"Cc1cc2c3c(c1)c(=O)c(C(=O)NC14CC5CC(CC(C5)C1)C4)cn3C(c1ccccc1)CO2";"IC50";"'='";"472.0";"nM";"6.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2153663";"";"None";"544.46";"1";"4.01";"17";"NC(=O)CCN/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL3696835";"";"None";"362.86";"0";"2.25";"BDBM163054";"Cc1cc(C)cc(-n2ncc(NCCN3CCOCC3)c(Cl)c2=O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"306194";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2316392";"";"None";"388.47";"0";"4.19";"8b";"O=C(NCC1CCCCC1)c1nccnc1NC(=O)c1cccc2ccccc12";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"15.07";"0.28";"1.66";"6.97";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL522904";"";"None";"475.81";"1";"6.06";"33";"CCc1c(C2=NC(C)(C)C(=O)N2C)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"4326.9";"nM";"5.36";"";"";"UO_0000065";"11.27";"0.24";"-0.70";"10.62";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL232730";"";"None";"352.59";"1";"5.52";"13";"CSC(=S)N1CC(C)(C)CS/C1=N\c1ccccc1C(C)C";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL888167";"Agonist activity at human CB2 in CHO cells assessed as inhibition of cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140004";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL3895908";"";"None";"385.41";"0";"3.40";"BDBM242516";"O=S(=O)(NCC1CC1)c1ccc(NCc2ccccn2)cc1C(F)(F)F";"IC50";"'='";"1373.0";"nM";"5.86";"";"422876";"UO_0000065";"15.21";"0.31";"2.46";"8.25";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL513121";"";"None";"438.36";"1";"6.97";"40";"COc1nc(C(C)(C)C)nc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"8400.0";"nM";"5.08";"";"";"UO_0000065";"11.58";"0.23";"-1.89";"10.60";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL3669072";"";"None";"443.50";"0";"2.78";"BDBM176620";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cccc(S(=O)(=O)NC3CC3)c2)n1";"IC50";"'='";"2.7";"nM";"8.57";"";"322526";"UO_0000065";"19.32";"0.38";"5.79";"8.08";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3775265";"";"None";"468.60";"0";"2.62";"35";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)n2nc(N3CCOCC3)nc12";"IC50";"'='";"162.0";"nM";"6.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL3086846";"";"None";"289.42";"0";"3.45";"4";"C/C=C/C=C/C=C\CC/C=C/C=C/C(=O)NCC(C)(C)O";"IC50";"'='";"197.0";"nM";"6.71";"";"";"UO_0000065";"23.17";"0.44";"3.26";"13.59";"0";"CHEMBL3089351";"Displacement of [3H]-CP55940 from human CB2 receptor expressed in CHO cells preincubated for 1 hr followed by radioligand addition measured after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3085628";"1";"Scientific Literature";"J Nat Prod";"2013";"CHEMBL3308072";""
"CHEMBL371214";"";"None";"312.50";"1";"6.38";"JWH133";"CCCC(C)(C)c1ccc2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21";"IC50";"'='";"81.8";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4426148";"Agonist activity at human CB2 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP accumulation after 60 mins by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425113";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL2010907";"";"None";"402.56";"0";"4.12";"4k";"CCCNC(=O)c1c(NC(=O)C23CC4CC(CC(C4)C2)C3)sc2c1CCOC2";"IC50";"'='";"11.22";"nM";"7.95";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2013482";"Agonist activity at human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP production after 20 mins by ELISA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307715";""
"CHEMBL2010900";"";"None";"422.50";"0";"3.68";"4d";"O=C(c1c(NC(=O)C23CC4CC(CC2C4)C3)sc2c1CCOC2)N1CC(F)(F)C1";"IC50";"'='";"0.1995";"nM";"9.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2013482";"Agonist activity at human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP production after 20 mins by ELISA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307715";""
"CHEMBL2010898";"";"None";"388.53";"0";"3.73";"4b";"CCCNC(=O)c1c(NC(=O)C23CC4CC(CC2C4)C3)sc2c1CCOC2";"IC50";"'='";"1.95";"nM";"8.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2013482";"Agonist activity at human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP production after 20 mins by ELISA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307715";""
"CHEMBL2010902";"";"None";"386.56";"0";"4.53";"4f";"CCCNC(=O)c1c(NC(=O)C23CC4CC(CC2C4)C3)sc2c1CCCC2";"IC50";"'='";"83.18";"nM";"7.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2013478";"Agonist activity at human recombinant CB2 receptor expressed in HEK293 cells co-expressing chimeric Gaq/o protein by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307715";""
"CHEMBL519214";"";"None";"491.81";"1";"6.99";"12b";"COCc1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"375.0";"nM";"6.43";"";"";"UO_0000065";"13.07";"0.27";"-0.56";"9.74";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL2010904";"";"None";"401.58";"0";"3.64";"4h";"CCCNC(=O)c1c(NC(=O)C23CC4CC(CC2C4)C3)sc2c1CCN(C)C2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2013478";"Agonist activity at human recombinant CB2 receptor expressed in HEK293 cells co-expressing chimeric Gaq/o protein by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307715";""
"CHEMBL2163965";"";"None";"374.44";"0";"3.66";"19";"O=C(NC1CCCC1)c1cn2c3c(cccc3c1=O)OCC2c1ccccc1";"IC50";"'='";"472.0";"nM";"6.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL425163";"";"None";"561.84";"2";"8.37";"16c";"CCCNC(=O)c1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1OCc1ccc(F)c(F)c1";"IC50";"'='";"815.0";"nM";"6.09";"";"";"UO_0000065";"10.84";"0.22";"-2.28";"11.89";"0";"CHEMBL827164";"Inhibitory concentration tested against human Cannabinoid receptor 2 (hCB2)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";""
"CHEMBL1814463";"";"None";"392.50";"0";"4.04";"36";"CCC1COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL3353439";"";"None";"472.36";"0";"4.65";"17";"CC1CCC(NC(=O)c2cc3cc(Br)cnc3n(Cc3ccc(F)cc3)c2=O)CC1";"IC50";"";"";"";"";"";"ND(Insoluble)";"";"";"";"";"";"0";"CHEMBL3383064";"Antagonist activity at human recombinant CB2R expressed in WIN-55212-stimulated U2OS cells assessed as increase in forskolin-mediated cAMP level after 30 mins by time-resolved fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352718";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307757";""
"CHEMBL1411573";"";"None";"395.26";"0";"4.56";"SID99303161";"COc1ccc(-n2cc3c(-c4cccc(Br)c4)nnc(C)c3n2)cc1";"IC50";"'='";"5400.0";"nM";"5.27";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1710129";"";"None";"358.51";"0";"3.18";"SID99303189";"Cc1nc(N2CCN(C(=O)C(C)C)CC2)c2c3c(sc2n1)CCCC3";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3639679";"";"None";"473.53";"0";"2.27";"BDBM176664";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(CO)c(S(=O)(=O)NC3CC3)c2)n1";"IC50";"'='";"25.0";"nM";"7.60";"";"322574";"UO_0000065";"16.05";"0.31";"5.33";"6.02";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1715275";"";"None";"406.56";"0";"4.09";"SID99303129";"Cc1nc(N2CCN(C(=O)c3ccccc3)CC2)c2c3c(sc2n1)CC(C)CC3";"IC50";"'>'";"9180.0";"nM";"";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1725686";"";"None";"436.58";"0";"3.91";"SID99303128";"Cc1cccc(OCC(=O)N2CCN(c3nc(C)nc4sc5c(c34)CCCC5)CC2)c1";"IC50";"'>'";"11000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3964264";"";"None";"432.51";"0";"4.01";"BDBM242465";"O=S(=O)(NCC1CCOCC1)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"53.11";"nM";"7.28";"";"422817";"UO_0000065";"16.82";"0.34";"3.26";"10.79";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3900989";"";"None";"405.83";"0";"4.19";"BDBM242492";"O=S(=O)(NCC1CC1)c1ccc(Nc2cccnc2Cl)cc1C(F)(F)F";"IC50";"'='";"95.6";"nM";"7.02";"";"422846";"UO_0000065";"17.30";"0.37";"2.83";"9.87";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3669112";"";"None";"410.49";"0";"4.35";"BDBM176663";"CCC(O)(CC)c1cccc(-c2nc(NCCc3ccc(F)cc3)nc(OC)n2)c1";"IC50";"'='";"21.0";"nM";"7.68";"";"322572";"UO_0000065";"18.70";"0.35";"3.33";"9.58";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2163948";"";"None";"422.53";"0";"4.05";"55";"CCC1COc2c(OC)ccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2153771";"";"None";"643.60";"1";"4.15";"43";"CC(C)[C@H](N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(=O)N[C@@H](C)C(N)=O";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL4474515";"";"None";"397.71";"1";"7.02";"25";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2cc(Cl)cc(Cl)c2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL2163949";"";"None";"388.47";"0";"4.05";"20";"O=C(NC1CCCCC1)c1cn2c3c(cccc3c1=O)OCC2c1ccccc1";"IC50";"'='";"15.2";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL3669064";"";"None";"384.41";"0";"3.36";"BDBM176612";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(OC)c(OC)c2)n1";"IC50";"'='";"11.0";"nM";"7.96";"";"322518";"UO_0000065";"20.70";"0.39";"4.60";"10.15";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669067";"";"None";"410.45";"0";"3.45";"BDBM176615";"COC(=O)CCc1cccc(-c2nc(NCCc3ccc(F)cc3)nc(OC)n2)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"322521";"UO_0000065";"19.30";"0.36";"4.47";"9.19";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669054";"";"None";"397.84";"0";"4.48";"BDBM176602";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3c(Cl)cccc3[nH]2)n1";"IC50";"'='";"7.0";"nM";"8.15";"";"322533";"UO_0000065";"20.50";"0.40";"3.67";"10.77";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669055";"";"None";"381.39";"0";"3.96";"BDBM176603";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3cc(F)ccc3[nH]2)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"322535";"UO_0000065";"20.77";"0.39";"3.96";"10.46";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914033";"";"None";"441.30";"1";"5.83";"BDBM242436";"CCCCNS(=O)(=O)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"290.0";"nM";"6.54";"";"422775";"UO_0000065";"14.81";"0.33";"0.71";"11.23";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1223330";"";"None";"654.44";"2";"7.46";"17v";"FC(F)(F)c1ccccc1-n1nc(-c2nnc(C3(C(F)(F)F)CCC3)s2)c(Cn2cncn2)c1-c1ccc(Br)cc1";"IC50";"'='";"27.6";"nM";"7.56";"";"";"UO_0000065";"11.55";"0.25";"0.10";"10.17";"0";"CHEMBL1227204";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221281";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL4539701";"";"None";"533.67";"2";"8.02";"5";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(OCCCCCN(C)Cc3ccccc3)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL1223260";"";"None";"606.86";"2";"6.71";"17t";"FC(F)(F)C1(c2nnc(-c3nn(-c4ccccc4Cl)c(-c4ccc(Br)cc4)c3Cn3cncn3)s2)CC1";"IC50";"'='";"124.0";"nM";"6.91";"";"";"UO_0000065";"11.38";"0.25";"0.20";"9.29";"0";"CHEMBL1227204";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221281";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL2153764";"";"None";"587.49";"1";"2.73";"36";"NC(=O)CNC(=O)CN/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL3891046";"";"None";"428.61";"1";"6.86";"BDBM235938";"CCCCCCC(C)(C)c1cc(OC)c(C2=C[C@@H]3CC[C@@]2(C(=O)O)C3(C)C)c(OC)c1";"IC50";"'='";"330.0";"nM";"6.48";"";"411176";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3669117";"";"None";"509.99";"1";"3.31";"BDBM176669";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(Cl)c(OCCCNS(C)(=O)=O)c2)n1";"IC50";"'='";"18.0";"nM";"7.75";"";"322581";"UO_0000065";"15.19";"0.31";"4.43";"6.72";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2153762";"";"None";"526.02";"1";"3.06";"34";"C[C@H](N/C(=N\S(=O)(=O)c1ccc(O)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL2163957";"";"None";"454.57";"0";"4.99";"28";"Cc1ccc(C2COc3cccc4c(=O)c(C(=O)NC56CC7CC(CC(C7)C5)C6)cn2c34)cc1";"IC50";"'='";"2215.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163954";"";"None";"454.57";"1";"5.07";"25";"CC1Oc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn(c23)C1c1ccccc1";"IC50";"'='";"1684.0";"nM";"5.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163947";"";"None";"428.48";"0";"4.32";"54";"CCC1COc2c(F)c(F)cc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"145.0";"nM";"6.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2023581";"";"None";"457.60";"0";"4.42";"19";"O=C(O)Cc1csc(NC(=O)c2cc3c(n(CC4CCCCC4)c2=O)CCCCCC3)n1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL3590647";"";"None";"419.36";"0";"4.97";"62";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(Br)ccc21";"IC50";"'='";"1680.0";"nM";"5.78";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL1452827";"";"None";"453.59";"0";"4.17";"SID87225733";"CC(C)NS(=O)(=O)c1ccc(NC(=S)NC(=O)c2ccc(-c3ccccc3)cc2)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3942034";"";"None";"446.45";"0";"4.03";"BDBM242437";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)c(OC(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"72.0";"nM";"7.14";"";"422777";"UO_0000065";"16.00";"0.33";"3.11";"8.32";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3951944";"";"None";"502.60";"2";"5.05";"BDBM242501";"CC(C)(C)OC(=O)CN(CC1CC1)S(=O)(=O)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"7663.0";"nM";"5.12";"";"422856";"UO_0000065";"10.18";"0.21";"0.07";"6.76";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3956119";"";"None";"446.45";"0";"3.49";"BDBM242447";"COc1cc(Nc2ccc(S(=O)(=O)N3CCOCC3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"923.0";"nM";"6.04";"";"422793";"UO_0000065";"13.52";"0.27";"2.54";"7.83";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1288180";"";"None";"311.38";"0";"2.70";"XVI";"C[C@H](CO)NC(=O)CCC(=O)/C=C/c1ccc2ccccc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1288239";"";"None";"325.41";"0";"2.74";"XXIII";"O=C(CCC(=O)NCCO)CCc1ccc(-c2ccccc2)cc1";"IC50";"'='";"8850.0";"nM";"5.05";"";"";"UO_0000065";"15.53";"0.29";"2.31";"7.61";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL1928587";"";"None";"394.60";"1";"7.03";"4";"C=C(CCCCCCCCCCCCC)CCCC(=O)O/C=C\COC(C)=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1932156";"Displacement of [3H]CP55940 from human recombinant CB2 receptor expressed in HEK293 cells after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1926606";"1";"Scientific Literature";"J Nat Prod";"2011";"CHEMBL3307715";""
"CHEMBL3956145";"";"None";"376.44";"0";"4.14";"BDBM242509";"O=S(=O)(NCC1CC1)c1ccc(NC2CCCCC2)cc1C(F)(F)F";"IC50";"'='";"143.0";"nM";"6.84";"";"422868";"UO_0000065";"18.18";"0.37";"2.70";"11.76";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"1, SR-141716A";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1631.1";"nM";"5.79";"";"";"UO_0000065";"12.48";"0.26";"-0.15";"11.54";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL3957211";"";"None";"390.47";"0";"4.38";"BDBM242507";"CC1CCC(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)CC1";"IC50";"'='";"358.0";"nM";"6.45";"";"422866";"UO_0000065";"16.51";"0.34";"2.07";"11.08";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3669081";"";"None";"393.42";"0";"3.83";"BDBM176632";"COc1ccc2[nH]c(-c3nc(NCCc4ccc(F)cc4)nc(OC)n3)cc2c1";"IC50";"'='";"21.0";"nM";"7.68";"";"322539";"UO_0000065";"19.52";"0.36";"3.85";"9.04";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL409150";"";"None";"489.35";"1";"6.10";"39";"Cc1c(C(=O)NCc2ccc(Cl)c(Cl)c2)nn(-c2ccc(F)cc2F)c1-n1c(C)ccc1C";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"10.83";"0.22";"-0.80";"10.22";"0";"CHEMBL933207";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142276";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL398713";"";"None";"426.50";"1";"5.33";"4-27";"COc1ccc(C(F)(F)F)cc1C(=O)/N=c1\sc(C(C)(C)C)c(C)n1CC1CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"20.92";"0.42";"3.59";"20.47";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL248386";"";"None";"410.51";"1";"5.63";"4-26";"Cc1ccc(C(F)(F)F)cc1C(=O)/N=c1\sc(C(C)(C)C)c(C)n1CC1CC1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"21.14";"0.42";"3.05";"25.26";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL247817";"";"None";"362.93";"0";"4.96";"4-3";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2cccc(Cl)c2)n1CC1CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"21.21";"0.44";"2.74";"22.41";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL2071061";"";"None";"341.84";"0";"3.94";"11";"CCc1c(C(=O)NCCc2ccc(N)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL2071063";"";"None";"369.90";"0";"4.42";"13";"CCc1c(C(=O)NCCc2ccc(N(C)C)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL3934176";"";"None";"386.53";"1";"5.43";"BDBM235947";"CCCCCc1cc(OC)c(C2=C[C@H]3CC[C@]2(C(=O)OC)C3(C)C)c(OC)c1";"IC50";"'='";"313.0";"nM";"6.50";"";"411182";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL1534425";"";"None";"486.58";"1";"5.41";"SID99303168";"O=C(Nc1ccc(S(=O)(=O)Nc2nccs2)cc1)c1cc(-c2ccccc2)nc2ccccc12";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL490027";"";"None";"564.55";"1";"4.59";"48";"CC(C)(O)c1cc(C(F)(F)F)cc(S(=O)(=O)N2CCN(C(=O)[C@@H]3C[C@H]3c3ccc(C(F)(F)F)cc3)CC2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL3696829";"";"None";"269.78";"0";"3.22";"BDBM163047";"CCCNc1cnn(C2CCCCC2)c(=O)c1Cl";"IC50";"'='";"10000.0";"nM";"5.00";"";"306186";"UO_0000065";"18.53";"0.38";"1.78";"10.66";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL487585";"";"None";"528.83";"2";"6.49";"32e";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2Cn2ccnn2)o1";"IC50";"'='";"1120.0";"nM";"5.95";"";"";"UO_0000065";"11.25";"0.23";"-0.54";"6.80";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL3639956";"";"None";"441.41";"0";"3.53";"BDBM163051";"CC1(C)CC(n2ncc(NCCN3CCOCC3)c(Br)c2=O)CC(C)(C)C1";"IC50";"'='";"22.4";"nM";"7.65";"";"306191";"UO_0000065";"17.33";"0.39";"4.12";"12.88";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2010902";"";"None";"386.56";"0";"4.53";"4f";"CCCNC(=O)c1c(NC(=O)C23CC4CC(CC2C4)C3)sc2c1CCCC2";"IC50";"'='";"9.772";"nM";"8.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2013482";"Agonist activity at human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP production after 20 mins by ELISA";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307715";""
"CHEMBL4450625";"";"None";"371.89";"1";"5.78";"33";"CN(C)c1cccc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)s2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL2010900";"";"None";"422.50";"0";"3.68";"4d";"O=C(c1c(NC(=O)C23CC4CC(CC2C4)C3)sc2c1CCOC2)N1CC(F)(F)C1";"IC50";"'='";"5.623";"nM";"8.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2013478";"Agonist activity at human recombinant CB2 receptor expressed in HEK293 cells co-expressing chimeric Gaq/o protein by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307715";""
"CHEMBL4163588";"";"None";"343.82";"0";"3.00";"47";"Cc1nc(N2CCN(C)CC2)c2nc(-c3ccccc3Cl)oc2n1";"IC50";"'='";"930.0";"nM";"6.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4147300";"Neutral antagonist activity at human CB2 assessed as restoration of forskolin-induced cAMP formation preincubated for 15 mins followed by forskolin addition for 30 mins measured after 1 hr by HTRF assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145495";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL1288120";"";"None";"297.35";"0";"2.31";"XI";"O=C(/C=C/c1ccc2ccccc2c1)CCC(=O)NCCO";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"20.18";"0.37";"3.69";"9.04";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL489425";"";"None";"472.45";"0";"4.14";"1";"O=C(C1CCCCC1)N1CCN(S(=O)(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL3613101";"";"None";"475.08";"1";"7.28";"10";"Cc1ccc(Cn2cc(C(=O)NC[C@@H]3CCC4C[C@@H]3C4(C)C)cc2-c2ccc(Cl)c(C)c2)cc1";"IC50";"'='";"1816.0";"nM";"5.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3615750";"Antagonist/inverse agonist activity at human CB2 receptor transfected in Chem4 cell membranes after 30 mins by [35S]-GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Chem4";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611977";"1";"Scientific Literature";"Eur J Med Chem";"2015";"None";""
"CHEMBL1717402";"";"None";"337.38";"0";"1.60";"SID99303137";"CNC(=O)c1cc2c(=O)n3ccccc3nc2n(C2CCCC2)c1=N";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1765267";"";"None";"350.46";"0";"3.68";"4-4";"Cc1cccc(C(=O)N2CC[C@@](O)(c3ccccc3)[C@@H]3CCCC[C@@H]32)n1";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL4105512";"";"None";"324.77";"0";"4.44";"21";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cncnc2)c1";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL1416169";"";"None";"487.57";"0";"4.81";"SID99303190";"O=C(Nc1ccc(S(=O)(=O)Nc2nccs2)cc1)c1cc(-c2ccncc2)nc2ccccc12";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1506227";"";"None";"275.74";"0";"3.10";"22";"O=C(NCCc1ccncc1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL2387183";"";"None";"358.53";"0";"4.37";"22c";"CCCCn1c2c(cc(C(=O)NC3CCCCC3)c1=O)CCCCCC2";"IC50";"'<'";"0.2";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2389080";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385064";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL555610";"";"None";"430.92";"1";"5.98";"4-24";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2cc(C(F)(F)F)ccc2Cl)n1CC1CC1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"20.14";"0.42";"2.70";"25.26";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL392836";"";"None";"417.72";"1";"7.03";"4a";"CC(C)Oc1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2)cc1C#N";"IC50";"'='";"860.0";"nM";"6.07";"";"";"UO_0000065";"14.52";"0.31";"-0.96";"13.21";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL244403";"";"None";"368.48";"1";"6.79";"13";"CCCCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"19.02";"0.34";"0.22";"26.65";"0";"CHEMBL895094";"Displacement of [3H]CP-55940 human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148711";"1";"Scientific Literature";"J Med Chem";"2007";"CHEMBL3307512";""
"CHEMBL1722279";"";"None";"475.56";"0";"4.77";"SID87544679";"Cc1cc2cc3c(cc2n2c(SCC(=O)Nc4nc(-c5ccccc5)cs4)nnc12)OCO3";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL5090102";"";"None";"467.57";"1";"6.69";"7-cis";"Cc1c(C(=O)Nc2cccc(/N=N\c3ccccc3)c2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL1095990";"";"None";"475.80";"1";"7.11";"13";"CC(=O)N[C@@H]1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"12.44";"0.26";"-1.19";"11.56";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL248109";"";"None";"442.78";"1";"7.24";"5b";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1N1CCCCC1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"12.19";"0.25";"-1.84";"13.52";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL246932";"";"None";"485.80";"1";"8.54";"3j";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Sc1ccc(F)cc1";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"10.88";"0.23";"-3.26";"14.41";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL392626";"";"None";"520.63";"2";"9.35";"3h";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1Oc1cc(Cl)cc(Cl)c1";"IC50";"'='";"5600.0";"nM";"5.25";"";"";"UO_0000065";"10.09";"0.22";"-4.10";"11.44";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL3959113";"";"None";"475.32";"1";"6.23";"BDBM242486";"O=S(=O)(NCc1ccccc1)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"6000.0";"nM";"5.22";"";"422840";"UO_0000065";"10.99";"0.24";"-1.01";"8.97";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3931637";"";"None";"483.30";"0";"4.74";"BDBM242487";"COC(=O)C1(NS(=O)(=O)c2ccc(Nc3ccc(Cl)cc3Cl)cc2C(F)(F)F)CC1";"IC50";"'='";"6404.0";"nM";"5.19";"";"422841";"UO_0000065";"10.75";"0.24";"0.45";"6.15";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL2316406";"";"None";"403.48";"0";"4.16";"9a";"COCc1ccc(C(=O)Nc2cccnc2C(=O)NCC2CCC2)c2ccccc12";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"19.14";"0.35";"3.56";"9.61";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL2316376";"";"None";"498.59";"0";"4.45";"13a";"COc1ccc(NC(=O)c2ccc(Cn3ccnn3)c3ccccc23)c(C(=O)NCC2CCCCC2)n1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"13.96";"0.26";"2.51";"6.27";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL1223329";"";"None";"620.89";"2";"7.10";"17u";"FC(F)(F)C1(c2nnc(-c3nn(-c4ccccc4Cl)c(-c4ccc(Br)cc4)c3Cn3cncn3)s2)CCC1";"IC50";"'='";"73.6";"nM";"7.13";"";"";"UO_0000065";"11.49";"0.26";"0.03";"9.60";"0";"CHEMBL1227204";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221281";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL4858380";"";"None";"280.78";"0";"3.77";"23";"O=C(NCCc1cccs1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL1900669";"";"None";"296.80";"0";"1.71";"24";"CN1CCN(CCNC(=O)Nc2ccc(Cl)cc2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL4865266";"";"None";"275.74";"0";"3.10";"27";"O=C(NCCc1cccnc1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL4538576";"";"None";"408.55";"0";"3.07";"23";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cn(CCN2CCOCC2)c2ccncc12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL3964915";"";"None";"388.46";"0";"3.99";"BDBM242480";"O=S(=O)(NCC1CC1)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"20.0";"nM";"7.70";"";"422833";"UO_0000065";"19.82";"0.40";"3.71";"13.23";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3986903";"";"None";"453.44";"0";"3.36";"BDBM242489";"CN1C(=O)c2ccc(Nc3ccc(S(=O)(=O)NCC4CC4)c(C(F)(F)F)c3)cc2C1=O";"IC50";"'='";"2414.0";"nM";"5.62";"";"422843";"UO_0000065";"12.39";"0.25";"2.26";"5.88";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1095554";"";"None";"577.90";"2";"8.28";"12m";"CC1(C)C[C@@H](NC(=O)c2ccc3[nH]ncc3c2)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"9.64";"0.20";"-2.71";"6.97";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL1095151";"";"None";"555.89";"2";"7.75";"12j";"Cc1n[nH]c(C)c1C(=O)N[C@@H]1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"10.14";"0.21";"-2.11";"7.06";"0";"CHEMBL1105737";"Displacement of [3H]CP-55940 from human recombinant cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157794";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";""
"CHEMBL4473103";"";"None";"469.49";"1";"7.23";"11";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(NCc3cc(F)cc(F)c3)cc2)cc1";"IC50";"'='";"1150.0";"nM";"5.94";"";"";"UO_0000065";"12.65";"0.23";"-1.29";"11.54";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4543379";"";"None";"559.61";"2";"8.82";"9";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(N(Cc3ccc(F)cc3)Cc3ccc(F)cc3)cc2)cc1";"IC50";"'='";"1650.0";"nM";"5.78";"";"";"UO_0000065";"10.33";"0.19";"-3.04";"13.55";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4528445";"";"None";"328.82";"1";"5.71";"12";"O=C(Nc1ccc(Cl)cc1)Nc1cc(-c2ccccc2)cs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL2316380";"";"None";"441.50";"0";"3.05";"13e";"O=C(NCC1CCC1)c1nccnc1NC(=O)c1ccc(Cn2ccnn2)c2ccccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL2316387";"";"None";"440.51";"0";"3.66";"9f";"O=C(NCC1CCC1)c1ncccc1NC(=O)c1ccc(Cn2ccnn2)c2ccccc12";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"16.32";"0.30";"3.53";"7.06";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL466470";"";"None";"424.33";"1";"6.67";"30";"CC(C)(C)c1nc(O)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2n1";"IC50";"'='";"8600.0";"nM";"5.07";"";"";"UO_0000065";"11.94";"0.24";"-1.60";"8.60";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL466084";"";"None";"508.45";"2";"6.97";"14b";"CCN(CC)C(=O)c1nc(NC(C)C)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2n1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"9.68";"0.19";"-2.05";"6.93";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL513648";"";"None";"479.46";"1";"8.17";"38";"CC(C)(C)Nc1nc(C(C)(C)C)nc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL466111";"";"None";"492.37";"1";"5.99";"11";"CC(C)c1nc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c(=O)n1Cc1ncon1";"IC50";"'='";"9800.0";"nM";"5.01";"";"";"UO_0000065";"10.17";"0.20";"-0.98";"5.78";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL4783221";"";"None";"321.34";"0";"2.59";"35";"CCCCCn1nc(C(=O)NC(C)(C)CO)cc1C(F)(F)F";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4775757";"Antagonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 assessed as inhibition of CP55940-induced calcium mobilization pre-incubated for 15 mins before CP55940 addition";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765487";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr"
"CHEMBL3927601";"";"None";"400.42";"0";"4.15";"BDBM242433";"COc1ccc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)cc1";"IC50";"'='";"179.0";"nM";"6.75";"";"422771";"UO_0000065";"16.85";"0.34";"2.60";"10.01";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL466883";"";"None";"457.79";"1";"7.20";"32";"CC(C)(C)c1nc(N)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n1";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"11.54";"0.24";"-1.92";"8.17";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL2153672";"";"None";"586.54";"2";"5.03";"24";"CC(C)(C)[C@H](N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL3949388";"";"None";"414.63";"1";"6.76";"BDBM235934";"CCCCCCC(C)(C)c1cc(OC)c(C2=C[C@@H]3CC[C@@]2(CO)C3(C)C)c(OC)c1";"IC50";"'='";"425.0";"nM";"6.37";"";"411172";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3922512";"";"None";"334.42";"0";"4.78";"9g";"COc1ccc(C(=O)n2c(C3CCCCC3)nc3ccccc32)cc1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"16.60";"0.30";"0.77";"12.59";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL4086756";"";"None";"391.69";"1";"6.96";"32";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccc(Cl)c(Cl)c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3961507";"";"None";"432.37";"0";"4.80";"BDBM242461";"O=S(=O)(NCc1ccco1)c1ccc(Nc2ccc(F)cc2F)cc1C(F)(F)F";"IC50";"'='";"1176.0";"nM";"5.93";"";"422811";"UO_0000065";"13.71";"0.28";"1.13";"8.31";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3963183";"";"None";"338.38";"0";"3.40";"BDBM242463";"O=S(=O)(NCC1CC1)c1ccc(Nc2ccc(F)cc2F)cc1";"IC50";"'='";"1900.0";"nM";"5.72";"";"422812";"UO_0000065";"16.91";"0.34";"2.32";"9.83";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1713770";"";"None";"330.39";"0";"4.11";"SID99303167";"COc1ccc(-c2nnc(C)c3nn(-c4ccc(C)cc4)cc23)cc1";"IC50";"'>'";"15600.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1765253";"";"None";"369.89";"0";"4.63";"2-5";"O=C(c1ccccc1)N1CC[C@](O)(c2cccc(Cl)c2)[C@H]2CCCC[C@@H]21";"IC50";"'='";"493.0";"nM";"6.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765161";"";"None";"386.50";"0";"4.53";"Table 1, R3C2, 3";"O=C(c1ccc2ccccc2n1)N1CC[C@](O)(c2ccccc2)[C@H]2CCCC[C@H]21";"IC50";"'='";"0.82";"nM";"9.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL4291156";"";"None";"465.55";"0";"4.94";"20";"COc1ccc(C(=O)c2cn(CC3CCOCC3)c3c(OCCCCC(=O)O)cccc23)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4255276";"Inverse agonist activity at N-terminal HA-tagged human CB2 receptor expressed in HEK293 cells transfected with YFP-Epac-RLuc assessed as increase in forskolin-stimulated cAMP level by BRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251662";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL1765261";"";"None";"374.48";"0";"4.46";"3-4";"O=C(c1ccc2[nH]ccc2c1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL188";"WIN-552122";"None";"426.52";"0";"4.60";"2, WIN-55212-2";"Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"20.09";"0.37";"3.97";"19.61";"0";"CHEMBL4344063";"Displacement of [3H]WIN 55212-2 from human CB2 receptor incubated for 120 mins by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342449";"1";"Scientific Literature";"J Nat Prod";"2020";"None";""
"CHEMBL3935866";"";"None";"296.39";"0";"4.70";"17k";"CCc1sc2ccccc2c1C(=O)c1ccc(OC)cc1";"IC50";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"17.48";"0.34";"0.48";"19.70";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL1569796";"";"None";"281.79";"0";"2.95";"30";"O=C(NCCN1CCCCC1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL3920211";"";"None";"404.50";"0";"4.92";"BDBM242523";"CC(C)(NS(=O)(=O)c1ccc(NC2CCCCC2)cc1C(F)(F)F)C1CC1";"IC50";"'='";"95.0";"nM";"7.02";"";"422883";"UO_0000065";"17.36";"0.36";"2.10";"12.07";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3914550";"";"None";"326.40";"1";"5.15";"8j";"O=C(c1cccc2ccccc12)n1c(C2CCC2)nc2ccccc21";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"16.11";"0.29";"0.11";"15.07";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL2387182";"";"None";"318.46";"0";"3.45";"22b";"CCCCn1c2c(cc(C(=O)NC(C)C)c1=O)CCCCCC2";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2389080";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385064";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL2387077";"";"None";"340.42";"0";"2.65";"18d";"CCCCn1c2c(cc(C(=O)NCc3ccccc3)c1=O)COCC2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2389080";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385064";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"CHEMBL3308072";""
"CHEMBL3916164";"";"None";"288.37";"1";"5.29";"20";"O=C(c1cc2ccccc2s1)c1cccc2ccccc12";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"18.68";"0.35";"0.10";"31.56";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL226591";"";"None";"489.59";"1";"5.30";"16";"Cc1ccc(OC(C)(C)C(=O)N[C@@H](C)[C@@H](Cc2ccc(OCCF)cc2)c2cccc(C#N)c2)nc1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL889637";"Agonist activity at human CB2R";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146232";"1";"Scientific Literature";"J Med Chem";"2007";"None";""
"CHEMBL111";"RIMONABANT";"4.0";"463.80";"1";"5.94";"Rimonabant; SR141716A";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1760.0";"nM";"5.75";"";"";"UO_0000065";"12.41";"0.26";"-0.19";"11.47";"1";"CHEMBL950211";"Displacement of [3H]WIN-55212-2 from human cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143900";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";""
"CHEMBL4286213";"";"None";"360.49";"0";"4.61";"29";"CCCCCc1cc(O)c2c(c1)OC(C)(C)C1=C2C(O)C(C)(OC)CC1";"IC50";"'='";"599.0";"nM";"6.22";"";"";"UO_0000065";"17.26";"0.33";"1.61";"10.56";"0";"CHEMBL4253358";"Displacement of [3H]CP-55,940 from recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 90 mins by topcount method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL3775199";"";"None";"421.55";"0";"4.12";"26";"CCCCCn1cc(C(=O)NC2CCCCC2)c(=O)n2nc(-c3ccc(C)cc3)nc12";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL401132";"";"None";"430.92";"1";"5.98";"4-22";"Cc1c(C(C)(C)C)s/c(=N\C(=O)c2cccc(C(F)(F)F)c2Cl)n1CC1CC1";"IC50";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"21.78";"0.46";"3.41";"27.32";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL4581327";"";"None";"329.81";"1";"5.11";"35";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2ccncc2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL4554290";"";"None";"406.92";"1";"5.12";"28";"CS(=O)(=O)c1cccc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)s2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL466681";"";"None";"423.35";"1";"6.55";"31";"CC(C)(C)c1nc(N)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2n1";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"12.54";"0.25";"-1.24";"8.21";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL501851";"";"None";"667.78";"2";"8.03";"43f";"Clc1ccc(C2(c3nnc(-c4nn(-c5ccc(Cl)cc5Cl)c(-c5ccc(Br)cc5)c4Cn4cncn4)o3)CC2)cc1";"IC50";"'='";"1050.0";"nM";"5.98";"";"";"UO_0000065";"8.95";"0.20";"-2.05";"6.84";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL505814";"";"None";"623.33";"2";"7.92";"42f";"Clc1ccc(-c2c(Cn3cncn3)c(-c3nnc(C4(c5ccc(Cl)cc5)CC4)o3)nn2-c2ccc(Cl)cc2Cl)cc1";"IC50";"'='";"1480.0";"nM";"5.83";"";"";"UO_0000065";"9.35";"0.19";"-2.09";"6.67";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL1222969";"";"None";"610.88";"2";"7.64";"17c";"FC(F)(F)C1(c2nnc(-c3nn(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)c3Cn3cncn3)s2)CCC1";"IC50";"'='";"505.0";"nM";"6.30";"";"";"UO_0000065";"10.31";"0.22";"-1.34";"8.47";"0";"CHEMBL1227204";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO-K1 cells after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221281";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307512";""
"CHEMBL4472298";"";"None";"365.52";"0";"4.93";"36";"CCCCCn1c(C(=O)NC23CC4CC(CC(C4)C2)C3)cc2cnccc21";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL4089126";"";"None";"323.78";"1";"5.05";"18";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccccn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL2019090";"S-777469";"2.0";"414.48";"0";"3.42";"15, S-777469";"CCc1c(C)cc(C(=O)NC2(C(=O)O)CCCCC2)c(=O)n1Cc1ccc(F)cc1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2020077";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release after 45 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2016545";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL4441955";"";"None";"365.52";"0";"4.93";"37";"CCCCCn1c(C(=O)NC23CC4CC(CC(C4)C2)C3)cc2cccnc21";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL4528735";"";"None";"381.52";"0";"3.90";"43";"O=C(NC12CC3CC(CC(C3)C1)C2)c1nc2ccccc2n1CCCCCO";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL4065139";"";"None";"378.90";"1";"6.95";"36";"CC(C)(C)c1ccc(-c2cccc(NC(=O)Nc3ccc(Cl)cc3)c2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL389252";"";"None";"513.72";"2";"7.17";"27";"CCCCCCc1ccc(OCCCCCCCCCCC(=O)NCCc2ccc(O)c(O)c2)cc1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL906562";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143734";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"CHEMBL3307715";""
"CHEMBL3410719";"";"None";"380.24";"0";"3.63";"39";"CCCCOc1cc(Br)cc2cc(C(=O)NC3CC3)c(=O)oc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL247997";"";"None";"358.51";"0";"4.32";"4-7";"COc1cccc(C(=O)/N=c2\sc(C(C)(C)C)c(C)n2CC2CC2)c1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"21.25";"0.42";"3.30";"17.48";"0";"CHEMBL925386";"Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140512";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL4757403";"";"None";"453.51";"1";"5.56";"22a";"O=C(c1ccc(Sc2ccccc2)cc1)C1CCN(C(=O)c2cc(O)c(F)cc2F)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4733366";"Displacement of [3H]CP55940 from human CB2 receptor incubated for 90 mins by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732057";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.5 hr"
"CHEMBL229816";"";"None";"513.72";"2";"7.44";"28";"CCCCCCc1ccc(OCCCCCCCCCCC(=O)NCc2ccc(OC)c(O)c2)cc1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL906562";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143734";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"CHEMBL3307715";""
"CHEMBL4438782";"";"None";"408.55";"0";"3.07";"24";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cn(CCN2CCOCC2)c2ncccc12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL2338173";"";"None";"408.55";"0";"3.07";"12";"O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(CCN2CCOCC2)c2ccccc12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL4073727";"";"None";"398.89";"1";"7.32";"38";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cccc(-c3ccccc3)c2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3774717";"";"None";"489.62";"0";"4.46";"25";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)n2nc(-c3ccc(OC)cc3)nc12";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL4067924";"";"None";"323.78";"1";"5.05";"19";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cccnc2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4097779";"";"None";"352.82";"1";"5.66";"23";"COc1cccc(-c2cccc(NC(=O)Nc3ccc(Cl)cc3)c2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4081586";"";"None";"410.90";"1";"7.22";"45";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2ccc3c(c2)Cc2ccccc2-3)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL474601";"";"None";"498.24";"1";"6.67";"9d";"O=C(Cn1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2Cl)n1)NC1CCCCC1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL480541";"";"None";"540.67";"2";"7.20";"9k";"O=C(Cn1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2Cl)n1)NCc1ccc(Cl)cc1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL201388";"";"None";"556.88";"2";"7.51";"22";"CC(=O)Nc1c(C(C)=O)c(=O)n(CC(C)C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"9.35";"0.19";"-2.30";"6.42";"0";"CHEMBL854080";"Binding affinity at the CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149424";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4557358";"";"None";"386.54";"1";"5.32";"34";"CCCCCCC(C)(C)c1cc(OCCO)c2c(c1)OC(C)(C)c1cn[nH]c1-2";"IC50";"'='";"21.6";"nM";"7.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4426148";"Agonist activity at human CB2 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP accumulation after 60 mins by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425113";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL4783715";"";"None";"323.48";"0";"3.16";"37";"CCCCCn1nc(C(=O)NC(C)(C)CO)cc1CC(C)(C)C";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4775757";"Antagonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 assessed as inhibition of CP55940-induced calcium mobilization pre-incubated for 15 mins before CP55940 addition";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765487";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr"
"CHEMBL4783200";"";"None";"343.90";"0";"3.52";"41";"CCCCCn1nc(C(=O)NC(C)(C)CO)c(Cl)c1C(C)(C)C";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4775757";"Antagonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 assessed as inhibition of CP55940-induced calcium mobilization pre-incubated for 15 mins before CP55940 addition";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765487";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr"
"CHEMBL4791274";"";"None";"324.47";"0";"2.45";"44";"CCCCCn1nc(C(=O)NC(C)(C)CO)c(N)c1C(C)(C)C";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4775757";"Antagonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 assessed as inhibition of CP55940-induced calcium mobilization pre-incubated for 15 mins before CP55940 addition";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765487";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr"
"CHEMBL4562832";"";"None";"410.60";"1";"6.77";"41";"CCCCCCC(C)(C)c1cc2c(c3c1CCCO3)-c1nn(CC)cc1C(C)(C)O2";"IC50";"'='";"25.5";"nM";"7.59";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4426148";"Agonist activity at human CB2 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP accumulation after 60 mins by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425113";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL2163960";"";"None";"326.40";"0";"3.02";"31";"CC1COc2cccc3c(=O)c(C(=O)NC4CCCCC4)cn1c23";"IC50";"'='";"245.0";"nM";"6.61";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL5089064";"";"None";"481.60";"1";"6.37";"11-trans";"Cc1c(C(=O)NCc2ccc(/N=N/c3ccccc3)cc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL4079520";"";"None";"422.57";"1";"5.71";"B";"CCOc1ccc(Nc2nc3cc(C(=O)N(CC)CC)ccc3n2CCC(C)C)cc1";"IC50";"'='";"1995.26";"nM";"5.70";"";"";"UO_0000065";"13.49";"0.25";"-0.01";"9.60";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL5092678";"";"None";"467.57";"1";"6.69";"8-cis";"Cc1c(C(=O)Nc2ccc(/N=N\c3ccccc3)cc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL487171";"";"None";"535.88";"2";"7.63";"25";"CC(=O)SCc1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1480.0";"nM";"5.83";"";"";"UO_0000065";"10.88";"0.23";"-1.80";"7.90";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL486562";"";"None";"493.80";"1";"7.88";"19";"CC(F)c1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"924.0";"nM";"6.03";"";"";"UO_0000065";"12.22";"0.26";"-1.85";"10.64";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL486154";"";"None";"487.82";"1";"7.88";"24";"C=C(C)c1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1730.0";"nM";"5.76";"";"";"UO_0000065";"11.81";"0.25";"-2.12";"10.16";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL520542";"";"None";"489.83";"1";"7.80";"4hb";"CCCc1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL487380";"";"None";"571.27";"2";"6.35";"43b";"CC1(c2nnc(-c3nn(-c4ccc(Cl)cc4Cl)c(-c4ccc(Br)cc4)c3Cn3cncn3)o2)CC1";"IC50";"'='";"407.0";"nM";"6.39";"";"";"UO_0000065";"11.19";"0.25";"0.04";"7.31";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL487178";"";"None";"573.28";"2";"6.60";"43a";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Br)cc3)c2Cn2cncn2)o1";"IC50";"'='";"513.0";"nM";"6.29";"";"";"UO_0000065";"10.97";"0.25";"-0.31";"7.19";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL519875";"";"None";"505.83";"2";"7.07";"23";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C(C)(C)O)o1";"IC50";"'='";"1670.0";"nM";"5.78";"";"";"UO_0000065";"11.42";"0.24";"-1.29";"7.51";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL2163572";"";"None";"527.11";"0";"3.80";"57";"CCC1COc2c(N3CCN(C)CC3)ccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23.Cl";"IC50";"'='";"196.0";"nM";"6.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163934";"";"None";"342.44";"0";"3.60";"41";"CCC1COc2cccc3c(=O)c(C(=O)N(C(C)C)C(C)C)cn1c23";"IC50";"'='";"423.0";"nM";"6.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL5081238";"";"None";"509.65";"2";"6.80";"16-trans";"Cc1c(C(=O)NCCCc2cccc(/N=N/c3ccccc3)c2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL466884";"";"None";"477.78";"1";"7.57";"34";"Nc1nc(-c2ccc(Cl)cc2)nc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL3909664";"";"None";"457.52";"0";"4.22";"BDBM242477";"CN(C)c1ccc(Nc2ccc(S(=O)(=O)NCC3CCOCC3)c(C(F)(F)F)c2)cc1";"IC50";"'='";"1520.0";"nM";"5.82";"";"422829";"UO_0000065";"12.72";"0.26";"1.60";"8.23";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3906510";"";"None";"434.52";"0";"4.04";"BDBM242475";"CCCN(CC1CC1)c1ccc(S(=O)(=O)NCC2CCOCC2)c(C(F)(F)F)c1";"IC50";"'='";"743.0";"nM";"6.13";"";"422827";"UO_0000065";"14.11";"0.29";"2.09";"10.45";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4584483";"";"None";"358.85";"1";"5.72";"31";"COc1ccc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)s2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL3696838";"";"None";"470.80";"0";"3.67";"BDBM163057";"O=c1c(Cl)c(NCCN2CCOCC2)cnn1-c1cc(C(F)(F)F)cc(C(F)(F)F)c1";"IC50";"'>'";"10000.0";"nM";"";"";"306197";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL487158";"";"None";"461.78";"1";"7.16";"4h";"Cc1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"1410.0";"nM";"5.85";"";"";"UO_0000065";"12.67";"0.27";"-1.31";"10.31";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL4760215";"";"None";"302.41";"0";"3.93";"2";"CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1C[C@H](O)C(C)=C[C@@H]21";"IC50";"'='";"807.7";"nM";"6.09";"";"";"UO_0000065";"20.15";"0.38";"2.16";"12.26";"0";"CHEMBL4668801";"Displacement of [3H]-CP-55,940 from recombinant human CB2R expressed in HEK293 cell membranes after 90 mins";"B";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"Kidney";"HEK293";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665697";"1";"Scientific Literature";"J Nat Prod";"2020";"None";"TIME = 1.5 hr"
"CHEMBL4860953";"";"None";"260.72";"0";"3.66";"13";"O=C(NCc1ccccc1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL487500";"";"None";"574.50";"1";"4.41";"55";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3ncon3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL487499";"";"None";"573.52";"1";"3.94";"54";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-n3ccnn3)cc(C(F)(F)F)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL486548";"";"None";"477.78";"1";"6.34";"10";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2CO)o1";"IC50";"'='";"1810.0";"nM";"5.74";"";"";"UO_0000065";"12.02";"0.25";"-0.60";"7.46";"0";"CHEMBL940411";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152292";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL2316408";"";"None";"438.53";"0";"4.87";"9c";"O=C(NCC1CCC1)c1ncccc1NC(=O)c1ccc(Cn2cccc2)c2ccccc12";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"14.75";"0.27";"1.60";"8.51";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL4085745";"";"None";"338.79";"1";"5.36";"24";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cccc(O)c2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4102237";"";"None";"336.82";"1";"5.96";"28";"Cc1ccccc1-c1cccc(NC(=O)Nc2ccc(Cl)cc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4586739";"";"None";"402.54";"0";"3.88";"11";"CCCCCCCNCC12c3ccccc3C(c3ccccc31)C1C(=O)NC(=O)C12";"IC50";"'='";"3930.0";"nM";"5.41";"";"";"UO_0000065";"13.43";"0.25";"1.53";"9.29";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL1466203";"";"None";"326.30";"0";"2.63";"SID87225773";"COC(=O)C1=C(N)c2c(F)cccc2C1(C#N)c1ccc(F)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4532823";"";"None";"295.39";"0";"3.26";"33";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cc2cnccc2[nH]1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL1460039";"";"None";"350.30";"0";"4.18";"SID87225771";"COc1ccc(-c2c(C(F)(F)F)n[nH]c2-c2ccc(O)cc2O)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4755606";"";"None";"435.47";"0";"5.00";"22b";"O=C(c1ccc(Cc2ccccc2)cc1)C1CCN(C(=O)c2cc(O)c(F)cc2F)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4733366";"Displacement of [3H]CP55940 from human CB2 receptor incubated for 90 mins by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732057";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.5 hr"
"CHEMBL2019080";"";"None";"428.57";"0";"4.21";"4";"O=C(NC1(C(=O)O)CCCC1)c1cc2c(n(CC3CCCCC3)c1=O)CCCCCC2";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2020077";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release after 45 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2016545";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL459309";"";"None";"514.28";"2";"6.11";"6";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)s1";"IC50";"'='";"894.6";"nM";"6.05";"";"";"UO_0000065";"11.76";"0.28";"-0.06";"12.06";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL494300";"";"None";"514.52";"2";"7.82";"33";"CCCCC#Cc1ccc(-c2c(C)c(C(=O)NC3CCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"278.3";"nM";"6.55";"";"";"UO_0000065";"12.74";"0.26";"-1.26";"13.97";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL219480";"";"None";"457.95";"1";"6.31";"35e";"C[C@H](NC(=O)C(C)(C)Oc1cc(F)cc(F)c1)[C@@H](Cc1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"14.63";"0.29";"0.39";"17.48";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL4095946";"";"None";"463.63";"1";"5.15";"31";"CCOc1ccc(Nc2nc3cc(C(=O)N(CC)CC)ccc3n2CCN2CCCCC2)cc1";"IC50";"'='";"12589.25";"nM";"4.90";"";"";"UO_0000065";"10.57";"0.20";"-0.25";"7.82";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL230822";"";"None";"459.40";"1";"5.56";"11";"C[C@H](NS(=O)(=O)c1cccc(Cl)c1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"807.7";"nM";"6.09";"";"";"UO_0000065";"13.26";"0.28";"0.53";"8.71";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL230713";"";"None";"459.40";"1";"5.56";"10";"C[C@H](NS(=O)(=O)c1ccccc1Cl)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"668.2";"nM";"6.17";"";"";"UO_0000065";"13.44";"0.28";"0.62";"8.83";"0";"CHEMBL887422";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";""
"CHEMBL1813666";"AUROGLAUCIN";"None";"298.38";"0";"4.56";"6";"C/C=C/C=C/C=C/c1c(O)cc(CC=C(C)C)c(O)c1C=O";"IC50";"'='";"19900.0";"nM";"4.70";"";"";"UO_0000065";"15.76";"0.29";"0.14";"8.17";"0";"CHEMBL1814857";"Displacement of [3H]CP-55,940 from human CB2 receptor expressed in CHO-K1 cells after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1811804";"1";"Scientific Literature";"J Nat Prod";"2011";"CHEMBL3307512";""
"CHEMBL572097";"";"None";"497.04";"1";"6.48";"3p";"C[C@H](NC(=O)C(C)(C)Nc1cc2ccccc2cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"117.0";"nM";"6.93";"";"";"UO_0000065";"13.95";"0.26";"0.45";"8.91";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL5075936";"";"None";"509.65";"2";"6.80";"16-cis";"Cc1c(C(=O)NCCCc2cccc(/N=N\c3ccccc3)c2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL4291438";"";"None";"500.66";"2";"6.57";"21";"CCCCCc1cc2c(c(OS(=O)(=O)c3ccc(C)cc3)c1)[C@@H]1CC(C)(OO)C=C[C@H]1C(C)(C)O2";"IC50";"'='";"421.0";"nM";"6.38";"";"";"UO_0000065";"12.73";"0.25";"-0.19";"7.77";"0";"CHEMBL4253358";"Displacement of [3H]CP-55,940 from recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 90 mins by topcount method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL4532907";"";"None";"523.63";"2";"8.55";"7";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(N(Cc3ccccc3)Cc3ccccc3)cc2)cc1";"IC50";"'='";"3640.0";"nM";"5.44";"";"";"UO_0000065";"10.39";"0.19";"-3.11";"12.74";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL469771";"";"None";"611.33";"2";"8.21";"12q";"CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Br)cc3)c2C(=O)Nc2ccccc2)o1";"IC50";"'='";"386.0";"nM";"6.41";"";"";"UO_0000065";"10.49";"0.23";"-1.80";"7.47";"0";"CHEMBL957520";"Displacement of [3H]WIN-55212-2 from human recombinant cannabinoid CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153946";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL1765158";"";"None";"342.48";"0";"2.62";"Table 1, R6C2, 2";"CN1CCC(C(=O)N2CC[C@](O)(c3ccccc3)[C@H]3CCCC[C@@H]32)C1";"IC50";"'>'";"17000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765252";"";"None";"369.89";"0";"4.63";"2-4";"O=C(c1ccccc1)N1CC[C@](O)(c2ccc(Cl)cc2)[C@H]2CCCC[C@@H]21";"IC50";"'='";"155.0";"nM";"6.81";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1542448";"";"None";"365.23";"0";"4.55";"SID99303160";"Cc1nnc(-c2cccc(Br)c2)c2cn(-c3ccccc3)nc12";"IC50";"'='";"10400.0";"nM";"4.98";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1760939";"";"None";"358.44";"0";"1.45";"17b";"O=C(NCC1(CO)CCCC1)c1nc(N2CCOCC2)n2ccccc12";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1763799";"Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP level";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759910";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL3341880";"";"None";"383.46";"0";"4.86";"29";"N#Cc1ccc(NC(=O)Nc2cccc(-c3cccc(N4CCCC4)n3)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3366075";"Antagonist activity at human CB2 receptor stably expressed in CHO-RD-HGA16 cells assessed as inhibition of CP55,940-induced calcium mobilization after 15 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351332";"1";"Scientific Literature";"J Med Chem";"2014";"None";""
"CHEMBL4093478";"";"None";"353.81";"1";"5.05";"15";"COc1cccc(-c2cccc(NC(=O)Nc3ccc(Cl)cc3)c2)n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL2414027";"";"None";"408.54";"1";"5.61";"271; ALIAE247";"CCCCCOc1ccc(-c2cc(C(=O)NC34CC5CC(CC(C5)C3)C4)no2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4683847";"Displacement of [3H]-CP55940 from recombinant human CB2 receptor expressed in CHO cells incubated for 90 mins by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680160";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.5 hr"
"CHEMBL3696837";"";"None";"385.69";"0";"3.99";"BDBM163056";"CN(C)c1cnn(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c(=O)c1Cl";"IC50";"'>'";"10000.0";"nM";"";"";"306196";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3915237";"";"None";"404.45";"0";"3.93";"BDBM242502";"O=S(=O)(NOCC1CC1)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"1579.0";"nM";"5.80";"";"422857";"UO_0000065";"14.34";"0.29";"1.87";"8.60";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL2335715";"";"None";"263.38";"0";"2.90";"3";"C/C=C/C=C/C=C/CC/C=C/C(=O)NCC(C)(C)O";"IC50";"'='";"131.0";"nM";"6.88";"";"";"UO_0000065";"26.13";"0.49";"3.98";"13.95";"0";"CHEMBL3089351";"Displacement of [3H]-CP55940 from human CB2 receptor expressed in CHO cells preincubated for 1 hr followed by radioligand addition measured after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3085628";"1";"Scientific Literature";"J Nat Prod";"2013";"CHEMBL3308072";""
"CHEMBL3696844";"";"None";"362.86";"0";"2.25";"BDBM163063";"Cc1ccc(C)c(-n2ncc(NCCN3CCOCC3)c(Cl)c2=O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"306203";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2023577";"";"None";"450.58";"0";"4.97";"15";"O=C(O)Cc1ccc(NC(=O)c2cc3c(n(CC4CCCCC4)c2=O)CCCCCC3)cc1";"IC50";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL3596754";"";"None";"272.35";"0";"3.06";"19c";"NC(=O)NCCCCCOc1cccc2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL3353451";"";"None";"504.63";"1";"3.71";"23";"COc1ccc(-c2cnc3c(c2)cc(C(=O)NC2CCC(C)CC2)c(=O)n3CCN2CCOCC2)cc1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"14.40";"0.27";"3.56";"8.48";"0";"CHEMBL3383061";"Antagonist activity at human recombinant CB2R expressed in U2OS cells assessed as inhibition of WIN-55212-induced beta-arrestin-GFP binding to receptor preincubated for 15 mins by fluorescent microscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352718";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307757";""
"CHEMBL1711005";"";"None";"498.69";"0";"3.92";"SID87544629";"CCN(CC)S(=O)(=O)c1ccc(N2CCC(C)CC2)c(C(=O)N2CCN(c3ccccc3)CC2)c1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL2153770";"";"None";"625.15";"1";"3.11";"42";"COc1ccc(S(=O)(=O)/N=C(\N[C@H](C(=O)NCC(N)=O)C(C)C)N2CC(c3ccccc3)C(c3ccc(Cl)cc3)=N2)cc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL3917967";"";"None";"316.43";"1";"5.85";"16k";"CCc1sc2ccccc2c1C(=O)c1cccc2ccccc12";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"17.50";"0.33";"-0.31";"32.44";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL2153662";"";"None";"530.44";"1";"3.62";"16, JD-5006";"NC(=O)CN/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL2153769";"";"None";"629.57";"1";"3.76";"41";"CC(C)[C@H](N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(=O)NCC(N)=O";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL1431310";"";"None";"484.96";"0";"4.11";"SID87225764";"COc1ccc(S(=O)(=O)Nc2ccc(F)cc2)cc1N(C)S(=O)(=O)c1ccc(Cl)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1705015";"";"None";"460.58";"0";"3.96";"SID87544635";"CC(C)Oc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1cc2ccccc2s1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1613157";"";"None";"375.47";"0";"4.74";"SID87225741";"COc1ccc(CNCCC(c2ccccc2)c2ccc3c(c2)OCO3)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL5082618";"";"None";"495.63";"1";"6.41";"14-cis";"Cc1c(C(=O)NCCc2ccc(/N=N\c3ccccc3)cc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL5085907";"";"None";"481.60";"1";"6.37";"9-trans";"Cc1c(C(=O)NCc2ccccc2/N=N/c2ccccc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL2163926";"";"None";"406.53";"0";"4.29";"(R)-51";"CC(C)[C@@H]1COc2cccc3c(=O)c(C(=O)NC45CC6CC(CC(C6)C4)C5)cn1c23";"IC50";"'='";"9.84";"nM";"8.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL1354041";"";"None";"501.97";"1";"4.46";"SID87225749";"COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1765274";"";"None";"356.51";"0";"3.01";"5-4";"CN1CCC(C(=O)N2CC[C@@](O)(c3ccccc3)[C@@H]3CCCC[C@@H]32)CC1";"IC50";"'='";"395.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765092";"";"None";"419.55";"0";"4.50";"page no 2364, R2C1, Enantiomer 3b";"O=C(c1csc(-c2ccncc2)n1)N1CCC(O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"5221.0";"nM";"5.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765285";"";"None";"370.49";"0";"2.53";"5-6";"CN1CC(C(=O)N2CC[C@@](O)(c3ccccc3)[C@@H]3CCCC[C@@H]32)CCC1=O";"IC50";"'='";"135.0";"nM";"6.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765282";"";"None";"337.42";"0";"2.77";"4-11";"O=C(c1ccncn1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765278";"";"None";"375.47";"0";"3.86";"page no 2364, R2C1, Enantiomer 3a";"O=C(c1cccc2[nH]ncc12)N1CCC(O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL3410722";"";"None";"373.45";"0";"4.04";"43";"CCCCOc1c(OC)ccc2cc(C(=O)NC3CCCCC3)c(=O)oc12";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3410723";"";"None";"387.48";"0";"4.43";"44";"CCCCCOc1c(OC)ccc2cc(C(=O)NC3CCCCC3)c(=O)oc12";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL4845929";"";"None";"300.79";"0";"4.19";"18";"O=C(NCC1(c2ccccc2)CC1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL1705027";"";"None";"424.54";"0";"2.90";"SID87544623";"CCc1sc(C(=O)Nc2cc(S(=O)(=O)N3CCOCC3)ccc2OC)cc1C";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4747880";"";"None";"316.40";"0";"4.02";"5";"CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C(=O)O)=C[C@@H]21";"IC50";"'='";"3715.0";"nM";"5.43";"";"";"UO_0000065";"17.16";"0.32";"1.41";"8.13";"0";"CHEMBL4668801";"Displacement of [3H]-CP-55,940 from recombinant human CB2R expressed in HEK293 cell membranes after 90 mins";"B";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"Kidney";"HEK293";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665697";"1";"Scientific Literature";"J Nat Prod";"2020";"None";"TIME = 1.5 hr"
"CHEMBL1360165";"";"None";"274.75";"0";"3.70";"8; RSCB: 6KQI";"O=C(NCCc1ccccc1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL1765246";"";"None";"374.48";"0";"4.46";"Table 1, R4C2, 3";"O=C(c1cccc2[nH]ccc12)N1CC[C@](O)(c2ccccc2)[C@H]2CCCC[C@H]21";"IC50";"'='";"0.62";"nM";"9.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1421591";"";"None";"443.50";"1";"5.31";"SID17412501";"CCCCC1(Cc2cccc([N+](=O)[O-])c2)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1445966";"";"None";"345.40";"0";"3.72";"SID87225755";"Cc1ccc2c(c1)C(c1ccc(O)cc1)(c1ccc(O)cc1)C(=O)N2C";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL2023045";"";"None";"450.58";"0";"4.64";"7";"O=C(N[C@H](C(=O)O)c1ccccc1)c1cc2c(n(CC3CCCCC3)c1=O)CCCCCC2";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL2153768";"";"None";"627.12";"1";"1.84";"40";"COc1ccc(S(=O)(=O)/N=C(\N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)N2CC(c3ccccc3)C(c3ccc(Cl)cc3)=N2)cc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL3590296";"";"None";"422.57";"0";"4.86";"70";"CCCCCN1C(=O)/C(=C/NC23CC4CC(CC(C4)C2)C3)C(=O)c2cc(OC)ccc21";"IC50";"'='";"81.7";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL2153664";"";"None";"558.49";"1";"4.25";"18";"CC(CN/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL2153772";"";"None";"661.57";"1";"1.84";"44";"C[C@@H](O)[C@H](N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(=O)N[C@@H](CO)C(N)=O";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2156597";"Displacement of 3[H]ligand from recombinant human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL4790905";"";"None";"295.43";"0";"2.70";"36";"CCCCCn1nc(C(=O)NC(C)(C)CO)cc1C(C)C";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4775757";"Antagonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 assessed as inhibition of CP55940-induced calcium mobilization pre-incubated for 15 mins before CP55940 addition";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765487";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr"
"CHEMBL3341861";"";"None";"392.89";"1";"5.65";"2; PSNCBAM-1";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cccc(N3CCCC3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4877430";"";"None";"345.87";"0";"4.55";"11";"CCN(CC)c1ccc(CCNC(=O)Nc2ccc(Cl)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL4294653";"";"None";"506.64";"2";"5.38";"25";"COc1ccc(C(=O)c2cn(CC3CCOCC3)c3c(OCCCCCCNC(C)=O)cccc23)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4255276";"Inverse agonist activity at N-terminal HA-tagged human CB2 receptor expressed in HEK293 cells transfected with YFP-Epac-RLuc assessed as increase in forskolin-stimulated cAMP level by BRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251662";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL4458260";"";"None";"500.73";"2";"6.56";"9";"CCCCCCCNCC12c3ccccc3C(c3ccccc31)C1C(=O)N(CCCCCCC)C(=O)C12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL3944807";"";"None";"358.51";"1";"7.02";"16m";"CCCCCc1sc2ccccc2c1C(=O)c1cccc2ccccc12";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"16.42";"0.31";"-1.13";"34.48";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3950235";"";"None";"320.39";"0";"4.39";"9h";"COc1ccc(C(=O)n2c(C3CCCC3)nc3ccccc32)cc1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"17.66";"0.32";"1.27";"12.82";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL4580323";"";"None";"329.81";"1";"5.11";"34";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2cccnc2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL559612";"CP-55940";"None";"376.58";"1";"5.66";"CP55940";"CCCCCCC(C)(C)c1ccc([C@@H]2C[C@H](O)CC[C@H]2CCCO)c(O)c1";"IC50";"'='";"8.3";"nM";"8.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4426148";"Agonist activity at human CB2 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP accumulation after 60 mins by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425113";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL4585657";"";"None";"343.47";"1";"5.92";"42";"CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)c1cnoc1-2";"IC50";"'='";"134.0";"nM";"6.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4426148";"Agonist activity at human CB2 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP accumulation after 60 mins by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425113";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL4444725";"";"None";"357.49";"1";"6.23";"43";"CCCCCCC(C)(C)c1cc(OC)c2c(c1)OC(C)(C)c1cnoc1-2";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4426148";"Agonist activity at human CB2 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP accumulation after 60 mins by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425113";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3775267";"";"None";"494.04";"1";"5.10";"23";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c(=O)n2nc(-c3ccc(Cl)cc3)nc12";"IC50";"'='";"24.6";"nM";"7.61";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778968";"Antagonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of WIN 55,212-2 mediated suppression of forksolin induced cAMP production by scintillation counting analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774386";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308072";""
"CHEMBL3907434";"";"None";"394.50";"1";"6.96";"24";"COc1ccc(-c2sc3ccccc3c2C(=O)c2cccc3ccccc23)cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"14.84";"0.28";"-1.11";"22.26";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3341861";"";"None";"392.89";"1";"5.65";"2; PSNCBAM-1";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cccc(N3CCCC3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL4542455";"";"None";"422.92";"1";"5.65";"6";"COc1ccc(-c2cccc(N3CCCC3)n2)cc1NC(=O)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL4527602";"";"None";"328.82";"1";"5.71";"11";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2ccccc2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL247706";"";"None";"458.78";"1";"7.23";"5e";"CC(C)(C)C(=O)Nc1nc(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2)cc1C#N";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"12.58";"0.26";"-1.46";"8.77";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL394736";"";"None";"476.75";"1";"6.98";"5d";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1-n1nnc2ccccc21";"IC50";"'='";"465.0";"nM";"6.33";"";"";"UO_0000065";"13.28";"0.27";"-0.65";"9.40";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL246931";"";"None";"453.28";"1";"7.66";"3i";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccccc2Cl)nc1Oc1ccc(F)c(F)c1";"IC50";"'='";"5700.0";"nM";"5.24";"";"";"UO_0000065";"11.57";"0.23";"-2.42";"11.42";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL247105";"";"None";"405.29";"1";"5.99";"7c";"Cn1cc(-c2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2C#N)cn1";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"13.52";"0.27";"-0.51";"10.06";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL204232";"NAPHTHYRIDINONE";"None";"514.80";"2";"6.39";"EUB0000296";"CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"IC50";"";"4627.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL4882621";"Radioligand Binding Assay (CNR2)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Additional information: Measurement of the reduction in binding of [3H]CP-55940 (a hCB1r agonist) to recombinant human CB1r expressed in CHO cell membranes in the presence of the test compound | Assay publication: PMID: 16263284";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507287";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";""
"CHEMBL3895577";"";"None";"294.35";"0";"3.86";"9e";"COc1ccc(C(=O)n2c(C(C)C)nc3ccccc32)cc1";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"18.67";"0.34";"1.63";"12.45";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL2387541";"TETRAHYDROCANNABIVARIN";"2.0";"286.42";"0";"4.96";"1; Delta9-THCV";"CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21";"IC50";"'='";"17.6";"nM";"7.75";"";"";"UO_0000065";"27.07";"0.50";"2.79";"26.32";"0";"CHEMBL4668801";"Displacement of [3H]-CP-55,940 from recombinant human CB2R expressed in HEK293 cell membranes after 90 mins";"B";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"Kidney";"HEK293";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665697";"1";"Scientific Literature";"J Nat Prod";"2020";"None";"TIME = 1.5 hr"
"CHEMBL515118";"";"None";"471.78";"1";"5.89";"13c";"O=C(Cn1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)n1)NCc1ccccc1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1034819";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141022";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";""
"CHEMBL202852";"";"None";"394.47";"0";"4.45";"9c";"CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccccc3)c(O)nc12";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL204760";"";"None";"426.47";"0";"3.86";"9k";"CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc(O)c(O)c3)c(O)nc12";"IC50";"'='";"3981.07";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL467329";"";"None";"489.37";"1";"5.78";"24";"CC(C)(C)c1nc2nc(-c3ccc(C#N)cc3Cl)c(-c3ccc(Cl)cc3)cc2c2n[nH]c(=O)n12";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"9.65";"0.19";"-1.06";"4.73";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL467328";"";"None";"464.36";"1";"5.90";"43";"CC(C)(C)c1nc2nc(-c3ccccc3Cl)c(-c3cccc(Cl)c3)cc2c2n[nH]c(=O)n12";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"11.99";"0.24";"-0.33";"7.33";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL4099590";"";"None";"373.84";"1";"6.20";"44";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cnc3ccccc3c2)c1";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4041236";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4038344";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3120208";"";"None";"418.88";"1";"5.05";"5k";"Cc1ccc(NC(=O)n2nc(-c3ccc(C)cc3)n(-c3ccc(Cl)cc3)c2=O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3124135";"Antagonist activity at CB2 receptor (unknown origin) stably expressed in CHO cells co-expressing co-expressing Ga15/16 assessed as calcium current after 45 mins by fluo-4 AM assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3120110";"1";"Scientific Literature";"Eur J Med Chem";"2014";"CHEMBL3308072";""
"CHEMBL464872";"";"None";"490.87";"1";"5.85";"29a";"O=C(NC1CCCCC1)N1CCN(C(c2ccc(Br)cc2)c2ccccc2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL247910";"";"None";"500.81";"2";"6.54";"4d";"N#Cc1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1OCCNC(=O)C1CCC1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"12.67";"0.26";"-0.19";"8.46";"0";"CHEMBL903521";"Binding affinity at CB2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139131";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";""
"CHEMBL511727";"";"None";"410.30";"1";"6.49";"28";"CC(C)c1nc(O)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2n1";"IC50";"'='";"7300.0";"nM";"5.14";"";"";"UO_0000065";"12.52";"0.25";"-1.35";"8.72";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL512957";"";"None";"458.78";"1";"6.91";"5";"CC(C)(C)c1nc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc2c(=O)[nH]1";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"11.46";"0.24";"-1.65";"8.97";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL4290707";"";"None";"370.49";"1";"5.22";"27";"CCCCCc1cc(OC(C)=O)c2c(c1)OC(C)(C)C1=C2C2OC2(C)CC1";"IC50";"'='";"927.0";"nM";"6.03";"";"";"UO_0000065";"16.28";"0.31";"0.81";"12.55";"0";"CHEMBL4253358";"Displacement of [3H]CP-55,940 from recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 90 mins by topcount method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL4591294";"";"None";"329.81";"1";"5.11";"14";"O=C(Nc1ccc(Cl)cc1)Nc1ncc(-c2ccccc2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL4790896";"";"None";"354.45";"0";"2.78";"43";"CCCCCn1nc(C(=O)NC(C)(C)CO)c([N+](=O)[O-])c1C(C)(C)C";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4775757";"Antagonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 assessed as inhibition of CP55940-induced calcium mobilization pre-incubated for 15 mins before CP55940 addition";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765487";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr"
"CHEMBL487853";"";"None";"480.87";"1";"6.40";"15a";"O=C(NC1CCCCC1)N1CCN(C(c2ccc(Cl)cc2)c2cccc(Cl)c2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL4291438";"";"None";"500.66";"2";"6.57";"21";"CCCCCc1cc2c(c(OS(=O)(=O)c3ccc(C)cc3)c1)[C@@H]1CC(C)(OO)C=C[C@H]1C(C)(C)O2";"IC50";"'='";"1750.0";"nM";"5.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4253360";"Agonist activity at recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 2 hrs by [35S]GTP-gammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL3353442";"";"None";"477.40";"0";"2.80";"18";"CC1CCC(NC(=O)c2cc3cc(Br)cnc3n(CCN3CCOCC3)c2=O)CC1";"IC50";"'='";"32.1";"nM";"7.49";"";"";"UO_0000065";"15.70";"0.34";"4.69";"9.80";"0";"CHEMBL3383061";"Antagonist activity at human recombinant CB2R expressed in U2OS cells assessed as inhibition of WIN-55212-induced beta-arrestin-GFP binding to receptor preincubated for 15 mins by fluorescent microscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352718";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307757";""
"CHEMBL2316388";"";"None";"420.47";"0";"2.78";"10a";"O=C(NCC1CCC1)c1nc(OCCO)ccc1NC(=O)c1ccnc2ccccc12";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"13.32";"0.25";"2.82";"4.94";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL2316410";"";"None";"439.52";"0";"4.26";"9e";"O=C(NCC1CCC1)c1ncccc1NC(=O)c1ccc(Cn2cccn2)c2ccccc12";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"16.29";"0.30";"2.90";"8.05";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL1288148";"";"None";"345.40";"0";"4.55";"XII";"O=C(/C=C/c1ccc2ccccc2c1)CCC(=O)Nc1ccc(O)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292717";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287804";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3307715";""
"CHEMBL460343";"";"None";"515.51";"2";"6.74";"15";"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C#CCC(C)C)s1";"IC50";"'='";"385.9";"nM";"6.41";"";"";"UO_0000065";"12.44";"0.26";"-0.33";"12.79";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL460132";"";"None";"515.51";"2";"6.89";"14";"CCCC#Cc1ccc(-c2c(C)c(C(=O)NN3CCCCCC3)nn2-c2ccc(Cl)cc2Cl)s1";"IC50";"'='";"1499.2";"nM";"5.82";"";"";"UO_0000065";"11.30";"0.23";"-1.07";"11.61";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL4790368";"";"None";"335.49";"0";"3.62";"39";"CCCCCn1nc(C(=O)NC(C)(C)CO)cc1C1CCCCC1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4775757";"Antagonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 assessed as inhibition of CP55940-induced calcium mobilization pre-incubated for 15 mins before CP55940 addition";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765487";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr"
"CHEMBL4282604";"";"None";"365.43";"0";"4.01";"9f";"COc1ccc(C(=O)c2cn(CC3CCOCC3)c3c(O)cccc23)cc1";"IC50";"'='";"271.7";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4255276";"Inverse agonist activity at N-terminal HA-tagged human CB2 receptor expressed in HEK293 cells transfected with YFP-Epac-RLuc assessed as increase in forskolin-stimulated cAMP level by BRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251662";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL4575047";"";"None";"365.52";"0";"4.93";"6; APINACA, AKB-48";"CCCCCn1nc(C(=O)NC23CC4CC(CC(C4)C2)C3)c2ccccc21";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL4587190";"";"None";"365.52";"0";"4.93";"20";"CCCCCn1cc(C(=O)NC23CC4CC(CC(C4)C2)C3)c2cnccc21";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL4448334";"";"None";"387.52";"1";"5.02";"7";"CCCCCCCN1C(=O)C2C3c4ccccc4C(C)(c4ccccc43)C2C1=O";"IC50";"'='";"3860.0";"nM";"5.41";"";"";"UO_0000065";"13.97";"0.25";"0.39";"14.48";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL467529";"";"None";"454.92";"1";"5.12";"25";"CC(C)(C)c1nc2nc(-c3ccccc3C#N)c(-c3ccc(Cl)cc3)cc2c2n[nH]c(=O)n12";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"12.35";"0.23";"0.50";"5.64";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL1765280";"";"None";"337.42";"0";"2.77";"4-9";"O=C(c1ncccn1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL472300";"";"None";"494.89";"1";"6.79";"15b";"O=C(NC1CCCCCC1)N1CCN(C(c2ccc(Cl)cc2)c2cccc(Cl)c2Cl)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988124";"Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157137";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307512";""
"CHEMBL4545503";"";"None";"408.55";"0";"3.07";"39";"O=C(NC12CC3CC(CC(C3)C1)C2)c1cc2cnccc2n1CCN1CCOCC1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL527081";"";"None";"537.88";"2";"7.38";"16";"Cc1c(C2=NC(=O)C(C)(C)N2Cc2ccccc2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"5126.9";"nM";"5.29";"";"";"UO_0000065";"9.84";"0.20";"-2.09";"10.48";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL4074747";"";"None";"511.67";"2";"6.54";"32";"CCN(CC)C(=O)c1ccc2c(c1)nc(Nc1ccc(Oc3ccccc3)cc1)n2CCN1CCCCC1";"IC50";"'='";"7943.28";"nM";"5.10";"";"";"UO_0000065";"9.97";"0.18";"-1.44";"8.14";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4281658";"";"None";"356.51";"1";"5.96";"7";"CCCCCc1cc(OC(C)=O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21";"IC50";"'='";"518.0";"nM";"6.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4253360";"Agonist activity at recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 2 hrs by [35S]GTP-gammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL567876";"";"None";"461.01";"1";"5.64";"3e";"Cc1ccnc(NC(C)(C)C(=O)N[C@@H](C)[C@@H](Cc2ccc(Cl)cc2)c2cccc(C#N)c2)c1";"IC50";"'='";"547.0";"nM";"6.26";"";"";"UO_0000065";"13.58";"0.26";"0.62";"8.05";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL2010905";"";"None";"364.51";"0";"3.58";"4i";"CCCNC(=O)c1c(NC(=O)C2C(C)(C)C2(C)C)sc2c1CCOC2";"IC50";"'='";"52.48";"nM";"7.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2013478";"Agonist activity at human recombinant CB2 receptor expressed in HEK293 cells co-expressing chimeric Gaq/o protein by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307715";""
"CHEMBL2316385";"";"None";"436.54";"0";"3.29";"18g, enantiomer of 18f";"C[S+]([O-])Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC2CCC2)c2ccccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL3696842";"";"None";"314.82";"0";"1.40";"BDBM163061";"CC(C)(C)n1ncc(NCCN2CCOCC2)c(Cl)c1=O";"IC50";"'>'";"10000.0";"nM";"";"";"306201";"UO_0000065";"";"";"";"";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2316397";"";"None";"359.43";"0";"4.02";"8g";"O=C(NCC1CCC1)c1ncccc1NC(=O)c1cccc2ccccc12";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"21.10";"0.38";"3.57";"10.67";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL2316398";"";"None";"397.43";"0";"2.26";"8h";"O=C(Nc1cccnc1C(=O)NCC1CCOCC1)c1cccc2c1OCCO2";"IC50";"'='";"5700.0";"nM";"5.24";"";"";"UO_0000065";"13.20";"0.25";"2.98";"5.31";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL1553629";"";"None";"409.96";"1";"5.35";"1; Org27569";"CCc1c(C(=O)NCCc2ccc(N3CCCCC3)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL3912660";"";"None";"461.37";"0";"4.21";"BDBM242452";"COc1cc(Nc2cc(Cl)c(S(=O)(=O)NCC3CCCO3)c(Cl)c2)cc(OC)c1";"IC50";"'='";"221.0";"nM";"6.66";"";"422798";"UO_0000065";"14.43";"0.31";"2.45";"7.75";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3669069";"";"None";"382.40";"0";"3.11";"BDBM176617";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc3c(c2)OCCO3)n1";"IC50";"'='";"14.0";"nM";"7.85";"";"322523";"UO_0000065";"20.54";"0.38";"4.74";"10.02";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2071062";"";"None";"355.87";"0";"4.40";"12";"CCc1c(C(=O)NCCc2ccc(NC)cc2)[nH]c2ccc(Cl)cc12";"IC50";"'='";"9130.0";"nM";"5.04";"";"";"UO_0000065";"14.16";"0.28";"0.64";"8.85";"0";"CHEMBL2073236";"Allosteric modulation of human recombinant CB2 receptor expressed in HEK293 cells assessed as inhibition of [3H]CP55940 binding";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069250";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307715";""
"CHEMBL2163931";"";"None";"356.47";"0";"3.90";"38";"CCC1COc2cccc3c(=O)c(C(=O)NC(C)CCC(C)C)cn1c23";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL2163952";"";"None";"468.60";"1";"5.46";"23";"CC12CC3CC(C)(C1)CC(NC(=O)c1cn4c5c(cccc5c1=O)OCC4c1ccccc1)(C3)C2";"IC50";"'='";"18.3";"nM";"7.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169617";"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163236";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";""
"CHEMBL203924";"";"None";"442.94";"0";"4.73";"9g";"CCCCCOc1c(OC)ccc2cc(C(=O)NCCc3ccc(Cl)cc3)c(=O)[nH]c12";"IC50";"'='";"5.012";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL1684950";"SUVECALTAMIDE";"2.0";"380.41";"0";"4.57";"CX-8998";"CC(C)c1ccc(CC(=O)N[C@H](C)c2ccc(OCC(F)(F)F)cn2)cc1";"IC50";"'='";"5340.0";"nM";"5.27";"";"";"UO_0000065";"13.86";"0.27";"0.70";"10.29";"0";"CHEMBL5051299";"Inhibition of CB2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5050846";"38";"Patent Bioactivity Data";"";"";"None";""
"CHEMBL499075";"";"None";"489.83";"1";"6.59";"12";"CCCN1C(c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C)=NC(=O)C1(C)C";"IC50";"'='";"5510.1";"nM";"5.26";"";"";"UO_0000065";"10.74";"0.22";"-1.33";"10.42";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL3897023";"";"None";"406.38";"0";"4.42";"BDBM242460";"O=S(=O)(NCC1CC1)c1ccc(Nc2ccc(F)cc2F)cc1C(F)(F)F";"IC50";"'='";"132.0";"nM";"6.88";"";"422808";"UO_0000065";"16.93";"0.35";"2.46";"11.82";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL519389";"";"None";"586.50";"1";"4.44";"49";"O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(C(F)(F)F)cc(C(F)(F)CO)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL5080263";"";"None";"495.63";"1";"6.41";"13-trans";"Cc1c(C(=O)NCCc2cccc(/N=N/c3ccccc3)c2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL5087154";"";"None";"509.65";"2";"6.80";"17-trans";"Cc1c(C(=O)NCCCc2ccc(/N=N/c3ccccc3)cc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL360104";"";"None";"547.82";"2";"7.98";"16b";"CCNC(=O)c1cc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)nc1OCc1ccc(F)c(F)c1";"IC50";"'='";"820.0";"nM";"6.09";"";"";"UO_0000065";"11.11";"0.23";"-1.89";"11.88";"0";"CHEMBL827164";"Inhibitory concentration tested against human Cannabinoid receptor 2 (hCB2)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";""
"CHEMBL4471684";"";"None";"441.57";"1";"7.72";"18";"CCCCCCCNc1ccc(C(=O)c2c(-c3ccc(OC)cc3)oc3ccccc23)cc1";"IC50";"'='";"1540.0";"nM";"5.81";"";"";"UO_0000065";"13.16";"0.24";"-1.91";"11.29";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL3669103";"";"None";"380.45";"0";"4.56";"BDBM176654";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cc3ccccc3s2)n1";"IC50";"'='";"4.0";"nM";"8.40";"";"322562";"UO_0000065";"22.07";"0.42";"3.84";"14.01";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669110";"";"None";"478.47";"0";"4.34";"BDBM176661";"COc1nc(NCCc2ccc(OC(F)(F)F)cc2)nc(-c2ccc(OC)c(C(C)(C)O)c2)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"322569";"UO_0000065";"16.82";"0.32";"3.71";"8.16";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3891231";"";"None";"430.45";"0";"4.15";"BDBM242431";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"58.1";"nM";"7.24";"";"422769";"UO_0000065";"16.81";"0.34";"3.09";"9.44";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3912856";"";"None";"362.45";"0";"3.14";"BDBM242438";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CC3)cc2)cc(OC)c1";"IC50";"'='";"6000.0";"nM";"5.22";"";"422781";"UO_0000065";"14.41";"0.29";"2.08";"6.81";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3944295";"";"None";"436.40";"0";"4.18";"BDBM242439";"O=S(=O)(NCC1CCCO1)c1ccc(Nc2ccc(F)cc2F)cc1C(F)(F)F";"IC50";"'='";"1638.0";"nM";"5.79";"";"422784";"UO_0000065";"13.26";"0.27";"1.61";"8.58";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3919567";"";"None";"430.49";"0";"4.25";"BDBM242503";"CC(=O)N(CC1CC1)S(=O)(=O)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"467.0";"nM";"6.33";"";"422860";"UO_0000065";"14.71";"0.30";"2.08";"9.52";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4294558";"";"None";"407.51";"1";"5.10";"16b";"CCCOc1cccc2c(C(=O)c3ccc(OC)cc3)cn(CC3CCOCC3)c12";"IC50";"'='";"30.6";"nM";"7.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4255276";"Inverse agonist activity at N-terminal HA-tagged human CB2 receptor expressed in HEK293 cells transfected with YFP-Epac-RLuc assessed as increase in forskolin-stimulated cAMP level by BRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251662";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL3945989";"";"None";"406.47";"0";"3.91";"BDBM242449";"O=S(=O)(NCC1CCCO1)c1ccc(NC2CCCCC2)cc1C(F)(F)F";"IC50";"'='";"428.0";"nM";"6.37";"";"422795";"UO_0000065";"15.67";"0.32";"2.46";"9.44";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3944086";"";"None";"410.47";"0";"3.04";"BDBM242442";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CCCO3)cc2F)cc(OC)c1";"IC50";"'='";"706.0";"nM";"6.15";"";"422787";"UO_0000065";"14.99";"0.30";"3.11";"7.16";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL583240";"";"None";"574.27";"2";"7.31";"16g";"Cc1nnc(-c2c(-c3nnc(C(C)(C)C)o3)nn(-c3ccc(Cl)cc3Cl)c2-c2ccc(Br)cc2)o1";"IC50";"'='";"414.0";"nM";"6.38";"";"";"UO_0000065";"11.11";"0.25";"-0.93";"6.67";"0";"CHEMBL1038202";"Displacement of [3H]WIN-552122 from human CB2 receptor expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156125";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307512";""
"CHEMBL3906874";"";"None";"350.41";"0";"3.61";"BDBM242517";"CCCCNc1ccc(S(=O)(=O)NCC2CC2)c(C(F)(F)F)c1";"IC50";"'='";"2253.0";"nM";"5.65";"";"422877";"UO_0000065";"16.12";"0.34";"2.04";"9.70";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL5092058";"";"None";"380.79";"0";"3.11";"None";"Cc1cn([C@H](C)CC#N)c(=O)c2cc(Cn3nc(C(F)F)cc3Cl)nn12";"IC50";"'>'";"10.0";"µM";"";"Non standard unit for type";"";"";"";"";"";"";"0";"CHEMBL5058709";"CNR2 Eurofins SafetyScan (Receptor)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Measured component: cAMP | Reference compound: SR 144528 | Reference compound IC50 = 26.0 nM";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5058641";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2022";"None";"Compound concentration = 10.0 µM"
"CHEMBL444302";"";"None";"437.50";"0";"0.79";"27";"NC(=O)[C@H](Cc1ccccc1)NC(=O)n1c(=O)n(CCN2CCOCC2)c2ccccc21";"IC50";"'>'";"2500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL995594";"Displacement of [3H]CP-55940 from human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150312";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL1709480";"";"None";"407.43";"0";"2.64";"SID99303151";"O=C(Cc1ccc2c(c1)OCO2)N1CCC(n2nc(-c3ccccc3)oc2=O)CC1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL489429";"";"None";"405.35";"0";"3.41";"3";"O=C(C1CCCCC1)N1CCN(S(=O)(=O)c2cc(Cl)cc(Cl)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1011884";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153427";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";""
"CHEMBL1082330";"6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(HYDROXYMETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)";"None";"504.85";"2";"6.14";"17a, Enantiomer 1";"CN1c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc2C(C(=O)NCO)CC1(C)C";"IC50";"'='";"801.0";"nM";"6.10";"";"";"UO_0000065";"12.08";"0.25";"-0.04";"9.31";"0";"CHEMBL1120213";"Binding affinity to human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158602";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL3971088";"";"None";"476.90";"1";"5.27";"BDBM242500";"CC(C)(NS(=O)(=O)c1ccc(Nc2ccc(C(=O)O)cc2Cl)cc1C(F)(F)F)C1CC1";"IC50";"'='";"1253.0";"nM";"5.90";"";"422855";"UO_0000065";"12.38";"0.26";"0.63";"6.18";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4443830";"";"None";"387.52";"1";"5.24";"4";"CCCCCCCCN1C(=O)C2C3c4ccccc4C(c4ccccc43)C2C1=O";"IC50";"'='";"8740.0";"nM";"5.06";"";"";"UO_0000065";"13.05";"0.24";"-0.18";"13.53";"0";"CHEMBL4340151";"Displacement of [3H]-CP55940 from human recombinant cannabinoid CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339223";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307715";""
"CHEMBL3353436";"";"None";"359.45";"0";"3.45";"14";"CC1CCC(NC(=O)c2cc3cccnc3n(CCCCF)c2=O)CC1";"IC50";"'='";"5.35";"nM";"8.27";"";"";"UO_0000065";"23.01";"0.43";"4.82";"12.93";"0";"CHEMBL3383059";"Displacement of [3H]CP-55,940 from human recombinant CB2R expressed in HEK-293 cells after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352718";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307715";""
"CHEMBL4281658";"";"None";"356.51";"1";"5.96";"7";"CCCCCc1cc(OC(C)=O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21";"IC50";"'='";"316.0";"nM";"6.50";"";"";"UO_0000065";"18.23";"0.34";"0.54";"18.30";"0";"CHEMBL4253358";"Displacement of [3H]CP-55,940 from recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 90 mins by topcount method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL2316390";"";"None";"420.94";"1";"6.06";"4";"O=C(NCC1CCCCC1)c1cc(Cl)ccc1NC(=O)c1cccc2ccccc12";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"13.65";"0.26";"-0.32";"9.87";"0";"CHEMBL2317163";"Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311293";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";""
"CHEMBL3590646";"";"None";"374.91";"0";"4.87";"61";"CCCCCN1C(=O)/C(=C/NC2CCCCC2)C(=O)c2cc(Cl)ccc21";"IC50";"'='";"1510.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3940055";"";"None";"492.52";"0";"3.75";"BDBM242458";"COCCN(CCOC)S(=O)(=O)c1ccc(Nc2cc(OC)cc(OC)c2)cc1C(F)(F)F";"IC50";"'='";"4000.0";"nM";"5.40";"";"422804";"UO_0000065";"10.96";"0.22";"1.65";"6.25";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL1542604";"";"None";"314.77";"0";"4.42";"SID99303170";"COc1ccc(-c2[nH]nc(C)c2-c2ccc(Cl)cc2)c(O)c1";"IC50";"'='";"5220.0";"nM";"5.28";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL5078575";"";"None";"467.57";"1";"6.69";"6-cis";"Cc1c(C(=O)Nc2ccccc2/N=N\c2ccccc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL3596738";"";"None";"263.34";"0";"3.69";"6a";"O=C(/C=C/C=C/c1ccc2ccccc2c1)NC1CC1";"IC50";"'='";"3020.0";"nM";"5.52";"";"";"UO_0000065";"20.96";"0.38";"1.83";"18.97";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL1765159";"";"None";"335.45";"0";"3.98";"Table 1, R1C2, 3";"O=C(c1ccccc1)N1CC[C@](O)(c2ccccc2)[C@H]2CCCC[C@H]21";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765269";"";"None";"326.40";"0";"2.10";"4-6";"O=C(c1nnc[nH]1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"282.0";"nM";"6.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL1765271";"";"None";"356.51";"0";"3.15";"5-1";"CN1CCCCC1C(=O)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL263915";"";"None";"501.85";"2";"7.36";"6u";"Cc1c(-c2nnnn2C2CCCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1";"IC50";"'='";"818.0";"nM";"6.09";"";"";"UO_0000065";"12.13";"0.25";"-1.27";"9.91";"0";"CHEMBL950211";"Displacement of [3H]WIN-55212-2 from human cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143900";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";""
"CHEMBL3669096";"";"None";"419.46";"0";"4.21";"BDBM176647";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(OC)c3nc(C)ccc23)n1";"IC50";"'='";"38.0";"nM";"7.42";"";"322554";"UO_0000065";"17.69";"0.33";"3.21";"9.04";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3926974";"";"None";"498.40";"1";"5.62";"BDBM242473";"CN(C)CC(C)(C)CNS(=O)(=O)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F";"IC50";"'='";"6000.0";"nM";"5.22";"";"422825";"UO_0000065";"10.48";"0.23";"-0.40";"8.50";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL2023046";"";"None";"450.58";"0";"4.64";"8";"O=C(N[C@@H](C(=O)O)c1ccccc1)c1cc2c(n(CC3CCCCC3)c1=O)CCCCCC2";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL3669065";"";"None";"369.36";"0";"3.25";"BDBM176613";"COc1nc(NCCc2ccc(F)cc2)nc(-c2cccc([N+](=O)[O-])c2)n1";"IC50";"'='";"29.0";"nM";"7.54";"";"322519";"UO_0000065";"20.41";"0.38";"4.29";"7.31";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3234707";"";"None";"399.38";"0";"3.76";"BDBM50005908";"CN(C)CCNc1cnn(C2CC(C)(C)CC(C)(C)C2)c(=O)c1Br";"IC50";"'='";"42.0";"nM";"7.38";"";"306190";"UO_0000065";"18.47";"0.42";"3.62";"14.71";"0";"CHEMBL3707717";"Radioligand Binding Assay: Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor concentration; PerkinElmer) were used for the radioligand binding studies. The composition of incubation buffer for CB1 assay was 50 mM Tris base, 2.5 mM EDTA, 5 mM MgCl.sub.2 and 0.5 mg/ml fatty acid free BSA and for CB2 assay was 50 mM Tris base, 2.5 mM EGTA, 5 mM MgCl.sub.2 and 1 mg/ml fatty acid free BSA; pH was adjusted to 7.4 by adding 1N HCl. Plasma membranes were diluted with incubation buffer to provide a final protein concentration of 2.4 .mu.g (CB1) or 8 .mu.g (CB2) per well in non-binding surface polystyrene 96-well assay plates (Corning). Compound solutions were prepared in silanized glass tubes and dispensed using pipette tips with SUPERSLIK.TM. surface. Competition studies were performed using a final concentration of 0.72 nM [.sup.3H]-CP 55,940 (100-180 Ci/mmol, specific activity; PerkinElmer) against test compounds.";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"EBNA";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638668";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1386647";"";"None";"398.56";"0";"3.90";"SID49727351";"Cc1nc(N2CCN(C(=O)c3cccs3)CC2)c2c3c(sc2n1)CCCC3";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738548";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL385767";"";"None";"439.96";"1";"6.17";"35d";"C[C@H](NC(=O)C(C)(C)Oc1cccc(F)c1)[C@@H](Cc1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"14.86";"0.29";"0.37";"17.06";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL412262";"IBIPINABANT";"2.0";"487.41";"0";"4.76";"SLV-319";"CN/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1C[C@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"12.23";"0.25";"1.20";"8.04";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL2019086";"";"None";"454.54";"0";"4.21";"11";"O=C(NC1(C(=O)O)CCCCC1)c1cc2c(n(Cc3ccc(F)cc3)c1=O)CCCCCC2";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2020077";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release after 45 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2016545";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL381313";"";"None";"438.48";"0";"4.43";"9a";"CCCCCOc1c(OC)ccc2cc(NC(=O)Cc3ccc4c(c3)OCO4)c(O)nc12";"IC50";"'='";"19.95";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL3590298";"";"None";"436.60";"1";"5.17";"72";"CCCCCN1C(=O)/C(=C/NC23CC4CC(CC(C4)C2)C3)C(=O)c2cc(OC)cc(C)c21";"IC50";"'='";"45.3";"nM";"7.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3591170";"Antagonist activity against CB2R (unknown origin) CHO cells stably expressing Galpha16 assessed as inhibition of CP55940-induced increase in intracellular calcium level pre-treated 10 mins before CP55940 stimulation by microplate reader based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588836";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL3964264";"";"None";"432.51";"0";"4.01";"BDBM242465";"O=S(=O)(NCC1CCOCC1)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"48.8";"nM";"7.31";"";"422816";"UO_0000065";"16.90";"0.34";"3.30";"10.84";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3913773";"";"None";"455.50";"0";"3.97";"BDBM242470";"O=S(=O)(NCC1CC1)c1ccc(Nc2ccc(N3CCOCC3)cc2)cc1C(F)(F)F";"IC50";"'='";"2150.0";"nM";"5.67";"";"422822";"UO_0000065";"12.44";"0.25";"1.70";"8.02";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3979104";"";"None";"448.85";"0";"4.49";"BDBM242498";"O=C(O)c1ccc(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)c(Cl)c1";"IC50";"'='";"997.0";"nM";"6.00";"";"422853";"UO_0000065";"13.37";"0.28";"1.51";"6.28";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL567513";"";"None";"500.05";"2";"5.82";"3o";"C[C@H](NC(=O)C(C)(C)Nc1nc2ccccc2n1C)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"1414.0";"nM";"5.85";"";"";"UO_0000065";"11.70";"0.22";"0.03";"7.07";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL466063";"";"None";"382.25";"1";"5.68";"26";"Cc1nc(O)c2cc(-c3ccc(Cl)cc3)c(-c3ccccc3Cl)nc2n1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL980656";"Binding affinity to human cannabinoid CB2R expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138592";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL382676";"";"None";"423.51";"0";"4.07";"9i";"CCCCCOc1c(OC)ccc2cc(C(=O)NCCc3ccc(N)cc3)c(O)nc12";"IC50";"'='";"3.162";"nM";"8.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL861409";"Inhibition of [35S]GTP-gamma-S binding to human CB2 receptor expressed in CHO cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139010";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL3780852";"";"None";"426.53";"0";"4.74";"7c";"CCCCCn1c(=O)c(C(=O)NC23CC4CC(CC(C4)C2)C3)c(O)c2ccc(F)cc21";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"19.82";"0.37";"3.72";"11.85";"0";"CHEMBL3782259";"Displacement of [3H]-CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells after 90 mins by Competition binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779817";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3410729";"";"None";"439.46";"0";"4.03";"JTE-907";"CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4c(c3)OCO4)c(=O)oc12";"IC50";"'='";"644.0";"nM";"6.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3411784";"Antagonist activity at CB2 receptor (unknown origin) expressed in CHO cells up to 10 uM incubated for 10 mins prior to CP55940 addition by calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407392";"1";"Scientific Literature";"Eur J Med Chem";"2015";"CHEMBL3308072";""
"CHEMBL1765266";"";"None";"339.44";"0";"2.71";"4-3";"Cn1ccnc1C(=O)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"124.0";"nM";"6.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL460797";"";"None";"564.84";"1";"4.45";"(+)-12c";"N/C(=N\S(=O)(=O)c1ccc(I)cc1)N1C[C@@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1";"IC50";"'>'";"33000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL966990";"Binding affinity to human CB2 receptor by [35S]GTPgammaS binding assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140076";"1";"Scientific Literature";"J Med Chem";"2008";"None";""
"CHEMBL2019078";"";"None";"470.65";"1";"5.39";"1";"O=C(NC1(C(=O)O)CCCCCCC1)c1cc2c(n(CC3CCCCC3)c1=O)CCCCCC2";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2020077";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release after 45 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2016545";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL1765268";"";"None";"434.46";"0";"4.32";"4-5";"O=C(c1ccc(OCC(F)(F)F)nc1)N1CC[C@@](O)(c2ccccc2)[C@@H]2CCCC[C@@H]21";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767776";"Agonist activity at human CB2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-induced cAMP production treated 15 mins before forskolin challenge measured after 1 hr by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1765069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307512";""
"CHEMBL427236";"";"None";"490.86";"1";"7.34";"(S,S)-2";"C[C@H](NC(=O)C(C)(C)Oc1ccc(Cl)cc1)[C@@H](Cc1ccc(Cl)cc1)c1ccc(Cl)cc1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL3099054";"";"None";"434.87";"0";"4.52";"3";"CC(C)(O)c1cc(-c2nc(NCCc3ccc(F)cc3)nc(OCF)n2)ccc1Cl";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"20.36";"0.40";"4.33";"11.05";"0";"CHEMBL3101345";"Binding affinity to human CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3098084";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";""
"CHEMBL2299366";"";"None";"275.74";"0";"3.10";"21";"O=C(NCCc1ccccn1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL4099175";"";"None";"441.58";"1";"6.32";"39";"CCOc1ccc(Cc2nc3cc(NC(=O)c4ccccc4)ccc3n2CCC(C)C)cc1";"IC50";"'='";"3981.07";"nM";"5.40";"";"";"UO_0000065";"12.23";"0.22";"-0.92";"9.62";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4856192";"";"None";"359.51";"1";"6.19";"GBD-003; 4";"CCCCCn1cc(C(=O)c2ccc3c(c2)CC(C)(C)C3)c2ccccc21";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4826249";"Antagonist activity at human CB2 receptor expressed in CHO cell membrane assessed as reduction in CP55940-induced [35S]GTPgammaS binding by liquid scintillation spectrophotometry";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825669";"1";"Scientific Literature";"J Med Chem";"2021";"None";""
"CHEMBL523394";"";"None";"423.47";"0";"0.92";"26";"NC(=O)[C@@H](NC(=O)n1c(=O)n(CCN2CCOCC2)c2ccccc21)c1ccccc1";"IC50";"'>'";"2500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL995594";"Displacement of [3H]CP-55940 from human CB2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150312";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL461862";"";"None";"483.85";"1";"6.39";"9";"Cc1c(C(=O)NN2CCCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)s1";"IC50";"'='";"2156.1";"nM";"5.67";"";"";"UO_0000065";"11.71";"0.26";"-0.72";"11.30";"0";"CHEMBL1003145";"Displacement of [3H]CP-55940 from human CB2 receptor expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140049";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307715";""
"CHEMBL220360";"TARANABANT";"3.0";"515.96";"2";"6.31";"48, MK-0364";"C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"12.67";"0.25";"0.23";"8.72";"1";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL3897023";"";"None";"406.38";"0";"4.42";"BDBM242460";"O=S(=O)(NCC1CC1)c1ccc(Nc2ccc(F)cc2F)cc1C(F)(F)F";"IC50";"'='";"132.0";"nM";"6.88";"";"422809";"UO_0000065";"16.93";"0.35";"2.46";"11.82";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3916878";"";"None";"460.47";"0";"3.92";"BDBM242445";"COc1cc(Nc2ccc(S(=O)(=O)NCC3CCCO3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"180.0";"nM";"6.75";"";"422791";"UO_0000065";"14.65";"0.30";"2.82";"7.85";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL525551";"";"None";"475.81";"1";"6.20";"11";"CCN1C(c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C)=NC(=O)C1(C)C";"IC50";"'='";"1173.7";"nM";"5.93";"";"";"UO_0000065";"12.46";"0.26";"-0.27";"11.75";"0";"CHEMBL1020742";"Displacement of [3H]CP-55940 from human recombinant CB2R expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137779";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3307715";""
"CHEMBL3946454";"";"None";"426.46";"0";"3.86";"BDBM242455";"O=S(=O)(NCC1CCCO1)c1ccc(N2CCc3ccccc32)cc1C(F)(F)F";"IC50";"'='";"2778.0";"nM";"5.56";"";"422801";"UO_0000065";"13.03";"0.26";"1.70";"9.48";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4075256";"";"None";"436.60";"1";"5.58";"30";"CCOc1ccc(CNc2nc3cc(C(=O)N(CC)CC)ccc3n2CCC(C)C)cc1";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"14.66";"0.27";"0.82";"10.78";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4572697";"";"None";"346.81";"1";"5.85";"19";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2cccc(F)c2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL1393182";"";"None";"283.76";"0";"1.79";"25";"O=C(NCCN1CCOCC1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL3916891";"";"None";"344.48";"1";"6.48";"16n";"CC(C)Cc1sc2ccccc2c1C(=O)c1cccc2ccccc12";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"16.54";"0.31";"-0.78";"33.39";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL1733898";"";"None";"450.58";"0";"3.30";"SID87544636";"COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1cc2c(s1)CCCCC2";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4443032";"";"None";"323.78";"1";"5.05";"7";"O=C(Nc1ccc(Cl)cc1)Nc1cc(-c2ccccc2)ccn1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL4542852";"";"None";"328.82";"1";"5.71";"13";"O=C(Nc1ccc(Cl)cc1)Nc1csc(-c2ccccc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL3781781";"";"None";"467.40";"1";"5.76";"6";"O=C(NN1CCCCC1)c1nn(-c2ccc(Cl)cc2Cl)c2c1Cc1cc(C3CC3)ccc1-2";"IC50";"'='";"294.2";"nM";"6.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3782508";"Antagonist/inverse agonist activity at human CB2 receptors expressed in human Chem4 cell membrane incubated for 30 mins by [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Chem4";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779789";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";""
"CHEMBL3781178";"";"None";"518.49";"2";"7.33";"15";"O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(-c2ccc(Cl)cc2Cl)c2c1Cc1cc(C3CC3)ccc1-2";"IC50";"'='";"50.7";"nM";"7.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3782508";"Antagonist/inverse agonist activity at human CB2 receptors expressed in human Chem4 cell membrane incubated for 30 mins by [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Chem4";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779789";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";""
"CHEMBL4859201";"";"None";"278.74";"0";"3.61";"29";"Cc1ccc(CCNC(=O)Nc2ccc(Cl)cc2)o1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL4473425";"";"None";"458.52";"1";"6.82";"14";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(NCc3ccc(C#N)cc3)cc2)cc1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"15.37";"0.27";"0.23";"9.36";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL3907018";"";"None";"478.49";"1";"5.22";"BDBM242457";"COc1cc(Nc2ccc(S(=O)(=O)N3CCc4ccccc43)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"2080.0";"nM";"5.68";"";"422803";"UO_0000065";"11.87";"0.24";"0.46";"8.37";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4466342";"";"None";"383.46";"0";"4.61";"26";"CCCCc1ccc(C(=O)C2CCN(C(=O)c3ccc(F)c(O)c3)CC2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4424605";"Displacement of [3H]CP55,940 to human CB2 receptor expressed in cell membranes after 90 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422672";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4472252";"";"None";"370.86";"1";"5.92";"26";"CC(=O)c1cccc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)s2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL3960083";"";"None";"324.45";"1";"5.34";"17n";"COc1ccc(C(=O)c2c(CC(C)C)sc3ccccc23)cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"18.97";"0.37";"0.81";"23.40";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL4464917";"";"None";"363.27";"1";"6.37";"21";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2ccccc2Cl)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL3897023";"";"None";"406.38";"0";"4.42";"BDBM242460";"O=S(=O)(NCC1CC1)c1ccc(Nc2ccc(F)cc2F)cc1C(F)(F)F";"IC50";"'='";"106.0";"nM";"6.97";"";"422806";"UO_0000065";"17.16";"0.35";"2.55";"11.98";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4520615";"";"None";"397.47";"1";"6.16";"16";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(NCC3CC3)cc2)cc1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"16.07";"0.29";"0.23";"12.41";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL5090191";"";"None";"495.63";"1";"6.41";"12-cis";"Cc1c(C(=O)NCCc2ccccc2/N=N\c2ccccc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL4565207";"";"None";"295.39";"0";"3.26";"17";"O=C(NC12CC3CC(CC(C3)C1)C2)c1c[nH]c2ccncc12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL3341861";"";"None";"392.89";"1";"5.65";"2; PSNCBAM-1";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cccc(N3CCCC3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL4855779";"";"None";"302.81";"0";"4.48";"16";"CC(C)(Cc1ccccc1)NC(=O)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL4860635";"";"None";"310.73";"0";"4.25";"17";"O=C(NCC(F)(F)c1ccccc1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL3669086";"";"None";"363.40";"0";"3.82";"BDBM176637";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc3cc[nH]c3c2)n1";"IC50";"'='";"14.0";"nM";"7.85";"";"322544";"UO_0000065";"21.61";"0.40";"4.03";"10.37";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3669085";"";"None";"363.40";"0";"3.82";"BDBM176636";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc3[nH]ccc3c2)n1";"IC50";"'='";"34.0";"nM";"7.47";"";"322543";"UO_0000065";"20.55";"0.38";"3.65";"9.86";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2023048";"";"None";"436.55";"1";"5.04";"10";"O=C(O)c1ccccc1NC(=O)c1cc2c(n(CC3CCCCC3)c1=O)CCCCCC2";"IC50";"'='";"167.0";"nM";"6.78";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL2023579";"";"None";"443.57";"0";"4.49";"17";"O=C(O)c1csc(NC(=O)c2cc3c(n(CC4CCCCC4)c2=O)CCCCCC3)n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2025419";"Agonist activity at human CB2 receptor expressed in CHO cells assessed as increase in forskolin-induced cAMP levels after 20 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";""
"CHEMBL4450873";"";"None";"397.71";"1";"7.02";"24";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2ccc(Cl)c(Cl)c2)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL4076334";"";"None";"441.58";"1";"6.32";"20b";"CCOc1ccc(Cc2nc3cc(C(=O)Nc4ccccc4)ccc3n2CCC(C)C)cc1";"IC50";"'='";"15848.93";"nM";"4.80";"";"";"UO_0000065";"10.87";"0.20";"-1.52";"8.55";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL4061358";"";"None";"435.61";"1";"5.85";"20a";"CCOc1ccc(Cc2nc3cc(C(=O)NCCC(C)C)ccc3n2CCC(C)C)cc1";"IC50";"'='";"794.33";"nM";"6.10";"";"";"UO_0000065";"14.00";"0.26";"0.25";"10.86";"0";"CHEMBL4023567";"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 3 hrs by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020829";"1";"Scientific Literature";"J Med Chem";"2018";"None";""
"CHEMBL1836189";"";"None";"421.52";"0";"3.31";"48c";"N#C/C(=C\c1cn(CCN2CCOCC2)c2ccccc12)S(=O)(=O)c1ccccc1";"IC50";"'='";"40.1";"nM";"7.40";"";"";"UO_0000065";"17.55";"0.34";"4.09";"9.82";"0";"CHEMBL1837632";"Displacement of [3H]-WIN 55,212-2 from human CB2 receptor expressed in human HEK293 cells after 90 mins by radioligand assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833961";"1";"Scientific Literature";"Eur J Med Chem";"2011";"CHEMBL3307715";""
"CHEMBL559612";"CP-55940";"None";"376.58";"1";"5.66";"11; CP55940";"CCCCCCC(C)(C)c1ccc([C@@H]2C[C@H](O)CC[C@H]2CCCO)c(O)c1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4775757";"Antagonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 assessed as inhibition of CP55940-induced calcium mobilization pre-incubated for 15 mins before CP55940 addition";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765487";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr"
"CHEMBL4590582";"";"None";"364.80";"1";"5.99";"20";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2ccc(F)cc2F)s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4416369";"Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by calcium-5 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414612";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308072";""
"CHEMBL404282";"";"None";"532.27";"2";"6.94";"9d";"CCc1c(-c2nnnn2C2CCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1";"IC50";"'='";"1930.0";"nM";"5.71";"";"";"UO_0000065";"10.74";"0.24";"-1.23";"9.30";"0";"CHEMBL950211";"Displacement of [3H]WIN-55212-2 from human cannabinoid CB2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143900";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";""
"CHEMBL3968910";"";"None";"503.50";"2";"5.82";"BDBM242454";"COc1cc(Nc2ccc(S(=O)(=O)Nc3cccc4cnccc34)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"6000.0";"nM";"5.22";"";"422800";"UO_0000065";"10.37";"0.20";"-0.60";"5.83";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL2113250";"";"None";"474.40";"1";"6.82";"10b";"C[C@H](NC(=O)C(C)(C)Oc1ccc(Cl)cc1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(F)c1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"13.23";"0.27";"-0.54";"16.37";"0";"CHEMBL911627";"Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138208";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3308072";""
"CHEMBL4791212";"";"None";"293.41";"0";"2.45";"38";"CCCCCn1nc(C(=O)NC(C)(C)CO)cc1C1CC1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4775757";"Antagonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 assessed as inhibition of CP55940-induced calcium mobilization pre-incubated for 15 mins before CP55940 addition";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765487";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr"
"CHEMBL5092588";"";"None";"495.63";"1";"6.41";"13-cis";"Cc1c(C(=O)NCCc2cccc(/N=N\c3ccccc3)c2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL3669074";"";"None";"412.47";"0";"3.58";"BDBM176624";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(C(C)(C)O)c(OC)c2)n1";"IC50";"'='";"17.0";"nM";"7.77";"";"322530";"UO_0000065";"18.84";"0.35";"4.19";"8.69";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1546161";"";"None";"300.75";"0";"4.12";"SID861762";"Cc1n[nH]c(-c2ccc(O)cc2O)c1-c1ccc(Cl)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738041";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL4856560";"";"None";"302.80";"0";"4.44";"15";"CC(C)(CNC(=O)Nc1ccc(Cl)cc1)c1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL3911005";"";"None";"414.63";"1";"7.06";"BDBM235940";"CCCCCCC(C)(C)c1cc(OC)c(C2C(=O)[C@]3(C)CC[C@H]2C3(C)C)c(OC)c1";"IC50";"'='";"321.0";"nM";"6.49";"";"411178";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4440448";"";"None";"295.39";"0";"3.26";"18";"O=C(NC12CC3CC(CC(C3)C1)C2)c1c[nH]c2ncccc12";"IC50";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4374872";"Antagonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 pre-incubated for 10 mins and later treated with 100 nM CB-receptor agonist, CP55940 by Fluo-4-AM dye based calcium mobilization assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373687";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3307512";""
"CHEMBL3669119";"";"None";"442.49";"0";"3.74";"BDBM176671";"COc1nc(NCCc2ccc(OCF)cc2)nc(-c2ccc(OC)c(C(C)(C)O)c2)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"322585";"UO_0000065";"18.18";"0.34";"4.31";"8.16";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3596748";"";"None";"301.39";"0";"2.89";"10b";"O=C(CCCCCOc1cccc2ccccc12)NCCO";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL3669109";"";"None";"507.98";"1";"3.02";"BDBM176660";"COc1nc(NCCc2ccc(F)cc2)nc(-c2ccc(Cl)c(S(=O)(=O)N3CCOCC3)c2)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"322568";"UO_0000065";"16.78";"0.34";"5.50";"8.00";"0";"CHEMBL3706285";"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638626";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3960324";"";"None";"458.50";"0";"4.93";"BDBM242494";"COc1cc(Nc2ccc(S(=O)(=O)NC(C)(C)C3CC3)c(C(F)(F)F)c2)cc(OC)c1";"IC50";"'='";"430.0";"nM";"6.37";"";"422848";"UO_0000065";"13.89";"0.28";"1.44";"8.30";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL5091980";"";"None";"481.60";"1";"6.37";"11-cis";"Cc1c(C(=O)NCc2ccc(/N=N\c3ccccc3)cc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL5093760";"";"None";"509.65";"2";"6.80";"15-cis";"Cc1c(C(=O)NCCCc2ccccc2/N=N\c2ccccc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL5082613";"";"None";"509.65";"2";"6.80";"15-trans";"Cc1c(C(=O)NCCCc2ccccc2/N=N/c2ccccc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL5092088";"";"None";"467.57";"1";"6.69";"8-trans";"Cc1c(C(=O)Nc2ccc(/N=N/c3ccccc3)cc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL3963126";"";"None";"416.65";"1";"6.85";"BDBM235941";"CCCCCCC(C)(C)c1cc(OC)c(C2C(O)[C@]3(C)CC[C@H]2C3(C)C)c(OC)c1";"IC50";"'='";"925.0";"nM";"6.03";"";"411179";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4856374";"";"None";"267.76";"0";"2.56";"26";"O=C(NCCN1CCCC1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL4552932";"";"None";"519.64";"2";"7.63";"4";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(OCCCCN(C)Cc3ccccc3)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4442990";"";"None";"451.50";"1";"7.09";"8";"COc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(NCc3ccc(F)cc3)cc2)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"15.85";"0.29";"0.06";"13.90";"0";"CHEMBL4365104";"Displacement of 3[H]-CP55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes measured after 90 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364258";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4869544";"";"None";"288.78";"0";"4.09";"14";"O=C(NCCCc1ccccc1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL4747585";"";"None";"435.52";"1";"5.42";"21a";"O=C(c1ccc(Sc2ccccc2)cc1)C1CCN(C(=O)c2cc(O)ccc2F)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4733366";"Displacement of [3H]CP55940 from human CB2 receptor incubated for 90 mins by radioligand binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732057";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.5 hr"
"CHEMBL3973699";"";"None";"467.34";"1";"6.22";"BDBM242485";"CC(C)(NS(=O)(=O)c1ccc(Nc2ccc(Cl)cc2Cl)cc1C(F)(F)F)C1CC1";"IC50";"'='";"440.0";"nM";"6.36";"";"422839";"UO_0000065";"13.60";"0.30";"0.14";"10.92";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL568849";"";"None";"450.97";"1";"5.23";"3h";"Cc1cc(NC(C)(C)C(=O)N[C@@H](C)[C@@H](Cc2ccc(Cl)cc2)c2cccc(C#N)c2)on1";"IC50";"'='";"3863.0";"nM";"5.41";"";"";"UO_0000065";"12.00";"0.23";"0.18";"5.95";"0";"CHEMBL1044349";"Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155311";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";""
"CHEMBL3920181";"";"None";"328.42";"1";"5.22";"8c";"CCCCc1nc2ccccc2n1C(=O)c1cccc2ccccc12";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"17.57";"0.32";"0.55";"16.54";"0";"CHEMBL3873274";"Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 1.5 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872225";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3307715";""
"CHEMBL3596747";"";"None";"343.42";"0";"3.46";"13a";"CCOC(=O)CNC(=O)CCCCCOc1ccc2ccccc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598594";"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596121";"1";"Scientific Literature";"Medchemcomm";"2014";"CHEMBL3307715";""
"CHEMBL3897023";"";"None";"406.38";"0";"4.42";"BDBM242460";"O=S(=O)(NCC1CC1)c1ccc(Nc2ccc(F)cc2F)cc1C(F)(F)F";"IC50";"'='";"215.0";"nM";"6.67";"";"422810";"UO_0000065";"16.41";"0.34";"2.25";"11.46";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL5091640";"";"None";"481.60";"1";"6.37";"9-cis";"Cc1c(C(=O)NCc2ccccc2/N=N\c2ccccc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL5082876";"";"None";"467.57";"1";"6.69";"6-trans";"Cc1c(C(=O)Nc2ccccc2/N=N/c2ccccc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL5094165";"";"None";"467.57";"1";"6.69";"7-trans";"Cc1c(C(=O)Nc2cccc(/N=N/c3ccccc3)c2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL1701470";"";"None";"487.58";"0";"2.87";"SID87225731";"CC(C)Oc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(N2CCCC2=O)cc1";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL1453321";"";"None";"363.44";"1";"5.33";"SID87225734";"COc1cc2c(cc1NC(=O)CSc1ccccc1)oc1ccccc12";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3957211";"";"None";"390.47";"0";"4.38";"BDBM242507";"CC1CCC(Nc2ccc(S(=O)(=O)NCC3CC3)c(C(F)(F)F)c2)CC1";"IC50";"'='";"471.0";"nM";"6.33";"";"422865";"UO_0000065";"16.20";"0.33";"1.95";"10.87";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL2010898";"";"None";"388.53";"0";"3.73";"4b";"CCCNC(=O)c1c(NC(=O)C23CC4CC(CC2C4)C3)sc2c1CCOC2";"IC50";"'='";"70.79";"nM";"7.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2013478";"Agonist activity at human recombinant CB2 receptor expressed in HEK293 cells co-expressing chimeric Gaq/o protein by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307715";""
"CHEMBL1545328";"";"None";"441.00";"1";"6.87";"SID87225732";"O=C(CSc1nc2ccccc2s1)N1c2ccccc2Sc2ccc(Cl)cc21";"IC50";"'>'";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737948";"PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";""
"CHEMBL3938540";"";"None";"404.50";"0";"4.92";"BDBM242505";"O=S(=O)(NCC1CC1)c1ccc(NC2CCCCCCC2)cc1C(F)(F)F";"IC50";"'='";"91.0";"nM";"7.04";"";"422863";"UO_0000065";"17.41";"0.36";"2.12";"12.10";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL3964524";"";"None";"418.48";"0";"3.76";"BDBM242450";"O=S(=O)(NCC1CCCO1)c1ccc(NC2CC3CCC2C3)cc1C(F)(F)F";"IC50";"'='";"75.0";"nM";"7.12";"";"422796";"UO_0000065";"17.03";"0.35";"3.36";"10.57";"0";"CHEMBL3888919";"Binding Assay: The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonist [3H]CP55940 (168 Ci/mmol; PerkinElmer) from the human CB1 (hCB1) or human CB2 (hCB2) receptors on membranes derived from stably transfected HEK-293 cells (PerkinElmer). Membranes were diluted in assay buffer (50 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, 1 mg/ml BSA, pH=7.4). The amount of membrane was determined for each batch of membranes according to protein binding assay. The minimum amount of membrane that gave 50% specific binding was used for the binding assay. In most assays, binding was tested using 8 μg and 4 μg protein of hCB1 and hCB2 membranes, respectively. The tested compounds were dissolved in DMSO and diluted in assay buffer to a final concentration of 0.1% solvent. Total binding of [3H]CP55940 was evaluated with 1.5 nM to hCB1 and with 0.5 nM to hCB2, according to Kd affinity of [3H]CP55940 for the respective membranes. The ability of the tested compounds to displace [3H]CP55940 was evaluated first at a single concentration point of 100 nM for binding toward hCB2 or hCB1. In certain cases, the displacement was tested at compound concentrations ranging from 0.03 nM to 10 μM. Non-specific binding was measured by the addition of 1 μM of unlabelled CP55940 to the tubes. Binding assays were performed in triplicate in a total volume of 500 μl for 60 minutes at 30° C., in a shaking bath. Free and bound radioligands were separated by rapid filtration through GF/C filter plates (PerkinElmer) that had been presoaked with 0.1% Polyethylenimine (Sigma). Filters were shaken for 1 hour in 7 ml scintillation fluid (PerkinElmer) and radioactivity was determined by liquid scintillation counter (Wallac; PerkinElmer).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886886";"37";"BindingDB Database";"";"2016";"CHEMBL3307715";""
"CHEMBL4294111";"";"None";"402.53";"1";"5.18";"30";"CCCCCc1cc(O)c2c(c1)OC(C)(C)C1=C2C(OC(C)=O)C(C)(OC)CC1";"IC50";"'='";"1980.0";"nM";"5.70";"";"";"UO_0000065";"14.17";"0.27";"0.52";"8.78";"0";"CHEMBL4253358";"Displacement of [3H]CP-55,940 from recombinant human full length CB2 receptor expressed in HEK293 cell membranes after 90 mins by topcount method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";""
"CHEMBL3921607";"";"None";"414.63";"1";"6.76";"BDBM235935";"CCCCCCC(C)(C)c1cc(OC)c(C2=C[C@H]3CC[C@]2(CO)C3(C)C)c(OC)c1";"IC50";"'='";"162.0";"nM";"6.79";"";"411173";"UO_0000065";"";"";"";"";"0";"CHEMBL3888624";"cAMP Assay: Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells were incubated with 40 μl DMEM/F12 containing 0.5% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich) for 30 minutes prior to 15 min stimulation with 50 μM forskolin (Tocris Cookson) and varying concentrations of indicated compounds at 37° C., 5% CO2. Assays were stopped by removal of media and addition of 100% ice cold ethanol. Plates were then frozen for a minimum of two hours before complete evaporation of ethanol. The well contents were then reconstituted in 50 μl cAMP assay buffer (20 mM HEPES pH 7.5 and 5 mM EDTA). Half of the reconstituted sample was transferred to round bottom 96-well plates (Greiner Bio-One GmbH) with 50 μl 0.01% w/v PKA (cAMP dependent protein kinase (Sigma-Aldrich) in 1 mM Na citrate pH 6.5 with 2 mM dithiothreitol) and 25 μl [3H]-cAMP (at 22 nM in cAMP assay buffer) (GE Healthcare, Life Sciences). This was allowed to equilibrate for 3-18 hours. Following this a charcoal slurry (5% (w/v) activated charcoal and 0.2% (w/v) BSA in cAMP assay buffer) was added to the samples and the plates centrifuged at 3000×g, 4° C. for 5 min.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886783";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL5094751";"";"None";"481.60";"1";"6.37";"10-trans";"Cc1c(C(=O)NCc2cccc(/N=N/c3ccccc3)c2)nn(CCCCCO)c1-c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL5083983";"";"None";"495.63";"1";"6.41";"12-trans";"Cc1c(C(=O)NCCc2ccccc2/N=N/c2ccccc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
"CHEMBL4854166";"";"None";"300.79";"0";"4.24";"19";"O=C(Nc1ccc(Cl)cc1)NC1(Cc2ccccc2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL4871432";"";"None";"280.78";"0";"3.77";"28";"O=C(NCCc1ccsc1)Nc1ccc(Cl)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836432";"Antagonist activity at human CB2 receptor expressed in CHO-RD-HGA16 cells overexpressing Galpha16 assessed as inhibition of CP55940-stimulated calcium mobilization preincubated for 15 mins followed by agonist addition and measured every 1 sec for 90 secs by Calcium-3 dye based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-RD-HGA16";"None";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834454";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"Time = 180.0 sec"
"CHEMBL5070839";"";"None";"509.65";"2";"6.80";"17-cis";"Cc1c(C(=O)NCCCc2ccc(/N=N\c3ccccc3)cc2)nn(CCCCCO)c1-c1ccccc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054059";"Antagonist activity at human CB2 Receptor expressed in CHO cell membranes measured after 24 hrs by HTRF assay";"F";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"CHO";"Cell membrane";"";"";"";"CHEMBL253";"Cannabinoid CB2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053505";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr"
